"companyid","keydevid","transcriptid","headline","mostimportantdateutc","keydeveventtypename","companyname","speakertypename","componenttextpreview","word_count","componenttext"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Operator","Good day, ladies and gentlemen and welcome to the Q4 2009 Tenet Healthcare Earnings Conference Call. My name is Kiana, and I will be your operator for today. [Operator Instructions] I would now like to turn the conference over to your host for today, Mr.",53,"Good day, ladies and gentlemen and welcome to the Q4 2009 Tenet Healthcare Earnings Conference Call. My name is Kiana, and I will be your operator for today. [Operator Instructions] I would now like to turn the conference over to your host for today, Mr. Thomas Rice, Senior Vice President. You may proceed."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, operator, and good morning, everyone. First, the management will be making forward-looking statements on this call. These statements are based on management's current expectations, and are subject to risks and uncertainties that may cause those",98,"Thank you, operator, and good morning, everyone. First, the management will be making forward-looking statements on this call. These statements are based on management's current expectations, and are subject to risks and uncertainties that may cause those forward-looking statements to be materially incorrect. Management cautions you not to rely on and makes no promises to update any of the forward-looking statements. During the Q&A portion of the call, callers are requested to limit themselves to one question and one follow-up question. At this time, I will turn the call over to Trevor Fetter, Tenet's President and CEO. Trevor?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, Tom, and good morning, everyone. I'm very pleased with our results for 2009. The recession made it a difficult year to navigate, but we focused on the basics and delivered very solid progress. Adjusted EBITDA was $982 million, a 33% increase ov",1125,"Thank you, Tom, and good morning, everyone. I'm very pleased with our results for 2009. The recession made it a difficult year to navigate, but we focused on the basics and delivered very solid progress. Adjusted EBITDA was $982 million, a 33% increase over 2008. We extended for a fifth year, Tenet's strong record of growth in EBITDA and EBITDA margin. Our EBITDA in 2009 was more than twice what Tenet generated in 2004 when we had 40% more hospitals than we have today. Our adjusted free cash flow improved by almost $400 million to positive $165 million. While adjusted free cash flow excludes our payments to the Department of Justice, worth noting that we will make the last of these payments in August. It brings us on track to begin generating positive absolute free cash flow and marking another important milestone for the company.I'd like to begin by giving you a summary of how we generated these results. One of the most important objectives was to control costs, and we did that very well. We made serious cost cuts in virtually all areas of our business. This showed up in our results every quarter. We had dramatic reductions in employee turnover and the use of contract labor. For several years, we've been working hard to reduce turnover. Having achieved solid gains in 2009, we took actions to maintain them. In Q4, we decided to make a $16 million discretionary contribution to the 401(k) accounts of our employees who are not eligible to participate in our incentive compensation plan. We also provided non-executive employees with merit increases above the rate of inflation. I mentioned these actions in order to point out that we've made investments in keeping our employee retention and satisfaction high.We also met our objectives with regard to pricing. The mix shift that occurred in 2009  made these pricing increases less obvious, but they are very real. Health insurers recognize the value in retaining access to the quality of care that Tenet hospitals are able to provide their members, and we've been able to negotiate appropriate pricing increases. So with cost and pricing being two parameters, more or less under our direct control, we met and significantly exceeded all our performance objectives in these areas.Turning to measures for which we have less direct control. We had a much better year with regard to bad-debt expense than anyone might have projected last January. The volume picture however, was mixed. We were very pleased with the 3.4% year-over-year growth in the same-hospital outpatient [indiscernible]. Because margins are generally higher on the outpatient side, this growth helped us expand overall margins.Same-hospital admissions were down 0.6% year-over-year, while total admissions were are up by 0.2%, basically flat. One area of disappointment in 2009 was Commercial admission, which declined for the year by 4.7%. We had anecdotal evidence that these declines are consistent with the commercial volume declines our affiliated physicians are experiencing. We hear from our health plan customers that they saw declines at similar rates. Continued weakness in the economy appears to be the main driver of this segment of the business. We have a broad group of initiatives to gain market share, but the environment for commercial admission is very tough. Unfortunately, the trend has not improved so far this year, with the year-over-year comparisons somewhat weaker than what we saw in Q4. It's pretty clear that we're off to a slow start for the year as far as volumes are concerned. Our outlook assumes overall volumes to be flat and commercial volumes down 3%.  The silver lining to the soft commercial volume story was we achieved very strong earnings improvement in 2009 in spite of it. The changes we made to our cost structure has enhanced the potential profitability and operating leverage of the company. For example, if we can generate even modest volume increases going forward, we believe we are well positioned to achieve significant growth in earnings and cash flow.Let me now turn to some high-level comments on our outlook for 2010. As you read in this morning's press release, we are projecting growth in adjusted EBITDA some place between flat and up 7%. I'd like to highlight a few of the assumptions driving these numbers.  First, in order to optimize the financial impact of the Health Information Technology provision in last year's stimulus bill, we expect to incur incremental clinical information technology expenses of about $40 million in 2010. As we've said in the past, we had already planned to make the investments but now to qualify in the government incentive payment, we will accelerate their implementation. The adverse impact of these expenditures on 2010 EBITDA is largely a timing issue. This is because there's an 18-month mismatch between the early expenses of the program and the revenue recognition that begins no later than early 2012.  P&L impact of this initiative is truly significant when we consider that it reduces our expected EBITDA growth rate by four percentage points. These expenses will improve an important part of our business and are designed to meaningfully enhance patient care and long-term profitability. People have more to say about this program and how it advances our Medicare Performance Initiative. All things considered, we see 2010 as a transition year. It will be a year of significant technology investment, potential risks from increasing bad debt, state Medicaid cuts and hopefully the tail end of the recession due to weakness in commercial volumes. Even after taking all the upside and downside risks into account, we expect to see profitability growth of up to 7% and expect to generate more than $100 million in adjusted free cash flow. In other words, our outlook for the free cash flow could well be positive in 2010, even including the burden of the cash outflow for our final DOJ payments.To summarize, I feel very good about the progress we made in 2009. We are heading into 2010 strongly positioned to deal with the challenges confronting the industry. Before I turn things over to Steve, let me tell you about some changes to our Investor Relations program this year. Instead of holding our annual investor Day in Dallas, we've decided to be more visible and accessible on the road. We intend to visit various cities in order to meet with more of you in person, and we plan to participate in a few more conferences than in prior years.  We've also decided to shorten our quarterly pre-announcement quiet [ph] period in order to accommodate more of your requests for meetings. I'll be anxious to get your feedback throughout the year as to whether this is a better approach. In the meantime, let me now turn things over to Steve Newman. Steve?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, Trevor, and good morning, everyone. I'd like to touch on four topics important to both short and long-term success: Our Medical Staff Development activities, our Health Information Technology initiatives, the status of our Medicare performance",1061,"Thank you, Trevor, and good morning, everyone. I'd like to touch on four topics important to both short and long-term success: Our Medical Staff Development activities, our Health Information Technology initiatives, the status of our Medicare performance initiative and an update on our volume-building activities through innovations and marketing. We believe that the vast majority of new physicians joining our medical staffs are doing so as a result of our value proposition of having high-quality, efficiently operated inpatient and outpatient services. This value proposition is supplemented through the activities of our Med3000 Practice Resources joint venture, which I'll talk more about later. As I mentioned in our previous call, we have focused more effort on attracting high-quality, hard-working productive physicians, and assimilating them more effectively into our medical staffs and hospitals. As a result, we're seeing tangible benefits from our more focused efforts. Let's turn to review of the recent progress we've made in medical staff development. In 2009, we attracted 855 active staff physicians, net of attrition. 249 of these physicians, net of attrition, joined us in the fourth quarter. We accomplished this through a variety of means although the overwhelming focus was on the redirection of existing physicians. If necessary to meet demonstrated community need, we relocate certain physicians in a particular specialty, but relocations generally represent less than 10% of our growth in medical staff. Physician employment represents an even smaller share of our growth because we are utilizing this tactic very selectively.Due to our improved assimilation process and because of improvement of the facilities and services we provide to physicians, the class of 2009 is among the most productive classes we've ever assembled. While the class of '08 has been extremely productive, the class of '09 is already outperforming them on several measures, while maintaining a commitment to our quality standards. Compared to the class of '08, these new '09 physicians are averaging 46% more total admissions, 27% more commercial admissions and 32% more commercial outpatient visits.  This productivity data is based upon Q4 performance only and therefore, we expect even greater productivity gains from the class of '09 as their relatively young relationships mature over the next 12 months. We believe our improvements in quality efficiency service and other initiatives will strengthen our relationship with these and future physicians.Let's turn to a brief discussion on Health Information Technology or HIT. HIT is the glue that joins the existing strategies we've shared with you over the last three years. By the end of 2010, 19 of our hospitals will have begun installing advanced clinical systems. These activities will result in each hospital having a Computerized Physician Order Entry System, CPOE,  and an electronic health record at the completion of deployment. The implementation at each hospital is expected to take 16 to 21 months, depending upon its existing systems. It's the 16-to-21-month implementation period, which is the determinant of Trevor's earlier statement that we expect to earn the first of the incentive payments by early 2012. While this hospital-based program is proceeding, we will simultaneously deploy our physician office HIT  plan. This plan utilizes the resources of our joint venture, Med3000 Practice Resources. We will deploy a suite of products that includes an office-based electronic health record, a patient health record, E-prescribing technology and electronic data interchange capabilities for claim submissions. These new initiatives have been designed to dovetail smoothly with our existing systems. First, the Computerized Physician Order Entry System  will contain over 600 standardized order sets. A number of these sets were developed to execute our Medicare Performance Initiative. This CPOE will allow us to accelerate the standardization of care in our hospitals, both improving clinical outcomes and driving down variable cost at the bedside. Second, the broad implementation of HIT will eliminate redundancy and increase the efficiency of care. This brings with it staffing efficiencies and will accelerate our efforts to optimize labor and supply costs. These clinical systems also will provide us with improved patient safety and clinical outcomes, further advancing our long-standing commitment to quality. Finally, the HIT offering for physician practices will more tightly align our affiliated physicians with our hospitals. It's an effective sales tool for our physician relationship program representatives since our hospitals will be able to provide advanced IT systems to help physicians improve their practice efficiencies and obtain office-based financial incentives under the ARRA high-tech funding program.Next, I want to offer a couple of comments on Phase I of our Medicare Performance Initiative rollout. Our MPI teams are currently deployed in 16 hospitals. We expect to have completed Phase I of MPI at 42 hospitals by the end of December 2010 with all hospitals being completed by the end of Q1 2011. As you know, Phase I focuses on the development of a customized list, a five DRGs at each hospital, where we identify the largest opportunity to decrease variable cost, while improving clinical outcomes. It is important to remember that simultaneously, we have ongoing resource utilization initiatives such as medication use management and standardization programs in cardiac rhythm management devices and orthopedic and spinal implants.  We expect these combined programs to yield $28 million to $32 million of cost savings in 2010. Additionally, all of the savings from the progress made through these initiatives this year will not be fully visible until 2011, due to the timing of the rollout and the phase in adoption of the clinical delivery system changes. I continue to be excited about the prospects for MPI, and our early results strengthen my confidence.Finally, turning to volume growth, we remain excited about our many initiatives designed to capture incremental market share. I'm particularly enthusiastic about our business-to-business initiative in Texas and Florida, which take advantage of the employer channel to capture patients covered by commercial insurance. We also are enjoying increasing success in our direct-mail marketing initiatives, as we expand our use of variable dynamic printing to customize our mail drops. These programs are data intensive, and include active and precise monitoring of the reactions of patients we know are covered by commercial insurance. We are using more Internet marketing, and are employing search engine optimization strategies to target select and receptive populations focused on both wellness and specific disease management. These initiatives are all designed to gain market share. With that, let me now turn [Audio Gap]Chief Financial Officer, Biggs Porter. Biggs?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, Steve, and good morning, everyone. As both Steve and Trevor discussed, despite the dramatic decline in discretionary consumer spending experienced in most sectors of the economy, Tenet's admission exhibited only modest decline, while outpatient",2048,"Thank you, Steve, and good morning, everyone. As both Steve and Trevor discussed, despite the dramatic decline in discretionary consumer spending experienced in most sectors of the economy, Tenet's admission exhibited only modest decline, while outpatient extended it's [indiscernible] vigorous growth, with an increase of 3.5% in the fourth quarter. Flu provided us with a modest boost to our volume statistics, but because of its low-margin value, contributed little incremental to the bottom line. Commercial volumes are weaker than expected in the fourth quarter with declines of 5.3% in commercial admissions and 3.9% in commercial outpatient visits. As our pricing remains strong, even these softer volumes resulted in solid same-hospital revenue growth of 3.5%. This pricing growth included a 2.8% increase in patient revenue from commercial managed care, demonstrating continued pricing growth given the context of declining commercial volumes.As most of you know, we do not disclose specific number for our commercial pricing increase, but I will note that our pricing increase in the fourth quarter was our strongest quarter in 2009. After making some minor tweaks to normalize our revenue reflecting prior-year cost of work [ph] adjustments and a favorable one-time item in 2008, revenue growth was an even stronger 3.7%. Cost control continues to contribute to wider margins. With controllable operating expense growing by just 2.7% and an even more restraining 2.5% on a per-adjusted-patient-day basis. Even these modest increases would've been still better and we not elected to make a discretionary increase in our 401(k) match to employees who are not eligible for incentive compensation. That added $16 million to SWB. Without this discretionary expense items, the increase in controllable cost for APD would have been 1.6%.  We will only make discretionary contributions such as this in the future if we have substantial increases in year-over-year profitability or if necessary to meet competitive pressures. Supply and expense increased by 1.9% for APD,  a larger increase than we've seen recently. This was driven by increased usage of high cost pharmaceuticals and Biologics, as well continued growth in the use of implantable devices. As growth in the usage of implantable devices is highly correlated with growth in higher-margin procedures, this growth of supply cost is not entirely unwelcome. Other operating expense increased by $11 million or 2.2% per APD. This increase was in part, due to lower cost allocations for information systems and business office cost of discontinued operations, which require the absorption of some of those cost by continuing operations. Malpractice expense declined by $4 million, continuing a favorable trend we've seen throughout 2009. We will continue to drive on this but for actual [ph] reason we don't forecast net reductions year-over-year in 2010, although, at a rising risk-free interest rate environment, it is possible.Bad debt expense rose by $12 million as the bad debt ratio increased by 30 basis points to 7.9%. This is another area where despite continuing employment weakness in many of our markets, we outperformed the earlier expectations. This increase was impacted by higher pricing, as well as a 240 basis point decline in our self-pay collection rate area during the course of the year. But was helped by decline in uninsured volumes. Sequentially however, our collection rate was substantially unchanged for the third quarter.Turning to cash and cash flow, we ended the year with $690 million in cash, a decline of $41 million from September 30, but somewhat higher than the $525 million to $660 million we had projected in our 2009 outlook. Among other items, our cash position was impacted by, higher-than-anticipated capital expenditures, which came in at $192 million, including an acceleration of HIT CapEx of $18 million and $58 million in an early tax payment otherwise scheduled for 2010, which will save us interest cost between now or what was otherwise a June projected payment date. We also saw a benefit of $25 million with another improvement in our accounts receivable. Day sales outstanding declined to 46 days  at year end, down from 47 days at September 30. Since we started the year at 50 days, this was a significant improvement during the course of the year.Let me now turn to our outlook for 2010. We've provided a fair amount of detail on our 2010 outlook in both our press release and slides we posted to the Tenet website this morning. The headline is we expect adjusted EBITDA to be in the range of $985 million to $1,050,000,000. This range includes at both ends, incremental HIT expense in 2010 of  approximately $40 million as I will discuss more in a moment.  Without that spending, our range for 2010  for adjusted EBITDA would have been $1,025,000,000 to $1,090,000,000. We have considered numerous variables, representing both risks and opportunities in setting the range of adjusted EBITDA. These include variables related to state funding and the continued unknowns related to the economy. In absolute terms, these variables create a potentially broader set of outcomes than what is expressed in our outlook range. We presume that neither anything bad nor anything good happens in setting the adjusted EBITDA range, but we have considered continued adverse mix shift away from commercial and higher bad debt expense in even the upper end of the range.  At the middle of the range, we would expect commercial inpatient volumes to be in the range of a negative 3% year-over-year in 2010, but still represents a recovery from the declines we've recently experiences. At the lower end of the range, all other things equal, could accommodate bigger commercial volume declines, increases in the uninsured, lower state funding and/or additional declines in the collectability of self-pay and balance after accounts. Our outlook assumes total admissions will be approximately flat to growth of plus or minus 50 basis points. We continue to remain cautious on the outlook for commercial volume growth and our outlook assumes it will be premature to expect the eventual recovery in commercial admissions to occur in 2010.Our assumptions are considerably more robust on the outpatient side, where we are assuming growth of 3% to 4% and significantly greater stability in terms of payer mix.We assume pricing increases of 2% to 3% in, in-patient revenue per admission and somewhat stronger 3% to 4% increase in outpatient revenue per visit, with the greater visibility of pricing growth on the outpatient side being helped by our assumption of stable payer mix on outpatient. These assumptions would afford us 2010 revenue growth of 4% to 6%, in line to modestly stronger than the same-hospital net revenue growth of 4.3% we recorded in 2009. As we disclosed on our third quarter 10-Q, we have a potential to receive as much as $60 million in annual revenues attributable to 2010 for the California provider fee legislation. This is one of the many variables we considered to setting our range. In fact, it could be a greater amount if retroactive treatment is being appropriated [ph] by CMS. Controllable operating expenses are assumed to grow by 4% to 6%. This growth was significantly impacted by $40 million in incremental expense for clinical information technology spending. This HIT spending is tied to our plans to comply with the American Recovery and Reinvestment Act or ARRA and we expect this investment to qualify us for significant incentive payments, starting in either late 2011 or early 2012. As we said last fall, this spending is consistent with our existing plans to invest in HIT, but in order to qualify for as much as a thorough [ph] incentive payments by achieving meaningful use of milestones as we can achieve, we elected to accelerate that spending. We believe this increased spending on HIT should be considered as [indiscernible] non-recurring in its EBITDA effects in 2010 and 2011, as beginning in 2012 and in future years, we anticipate there will be incentive revenue and operational other benefits which will offset this incremental expense. Although we are very far along in our scheduling of the work, we will continue to work the schedule against the requirements as they evolve, so it is possible we will see further change, including in the timing of this expense. Without that $40 million in incremental accelerated HIT expense, the assumed 2010 outlook growth in controllable operating expenses will decline by a little over 50 basis points to 3.5% to 5.5%. Although we will continuously work on cost improvement and expect to yield on these efforts in 2010, including in our supplies and Medicare Performance Initiatives, the incremental savings from these in 2010 will be more modest than the approximately $188 million we achieved on our various initiatives in 2009. We assume bad debt expense to be in the range of 7.8% to 8.8% of net operating revenues. This would be a modest increase at the lower end of the range to a significant increase at the higher end, relative to the 7.7% recorded in 2009. But also note that this range encompasses the 8% total company bad debt ratio with which the ended the year. In terms of dollars, this would be an increase of roughly $30 million to $140 million relative to the $697 million of bad debt expense recorded in 2009.Turning to the outlook for cash. We provided the details on Slide 25 on the web. A few comments on the major items. We are looking for capital expenditures in the range of $475 million to $525 million, or $20 million to $70 million increase over the $455 million in CapEx in continuing operation in 2009. Included in this outlook is approximately $7 million in HIT CapEx, a $20 million increase over the aggregate $50 million HIT capital expenditures remaining in 2009. This HIT requirement is a principal reason for raising our CapEx outlook for 2010.Based on our above assumptions, we expect adjusted free cash flow from continuing operations in the range of $105 million to $125 million. I'll remind you that free cash flow in 2010 will include the final $17 million we will pay as a part of our government settlement. Retirement and obligation this year, clears the runway for increasing positive free cash flow in the future. These assumptions would result to the cash position at December 31, 2010 in the range of $630 million to $700 million. Question frequently arises as to what we believe we can achieve in EBITDA margin over time. In the near term, the effect of the economy on state funding, commercial volumes and account collectability continues to create an uncertain environment, making it difficult to create a timetable and slope for improvement. Over the intermediate to longer term, federal funding is also certain to contain pressures which you must offset through other efforts. The highest target we put out for ourselves when we first gave intermediate-term guidance a few years ago was 13%, but we also said that, that does not necessarily represent a ceiling. Irrespective of geographic and business mix considerations relative to our peers, we have excess capacity and a high fixed-cost base. Stabilizing commercial volumes as the economy improves, and achieving aggregate growth therefore, are one key to our continued margin improvements as we go forward. We also expect our MPI and other cost-control initiatives and increasing emphasis on higher-margin Outpatient business, organically or through continuous selective acquisitions to contribute measurably to EBITDA margin over the next two to three years. How fast these efforts fall to the bottom line will depend significantly on the externalities, I've already described.In summary, in 2009, we were able to accomplish the following key elements of performance. We constrained growth in bad debt expense, a strong outpatient volume growth which mitigated the revenue impact of softer commercial admissions, had solid revenue growth, excellent cost control and strong cash flow. We remain confident that our initiatives to drive revenue growth, reduce cost and drive increasingly positive bottom-line free cash flow will be successful. The ranges we've assumed in 2010 for pricing revenues and adjusted EBITDA allow for factors [ph] that are partially or totally out of our control, related to recession.  But having said that, the value of our initiatives were clearly demonstrated in 2009, creating a step function increase in our profitability and cash flow and providing strong foundation for future growth.With that, I'll ask the operator to open the floor for questions. Operator?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Operator","[Operator Instructions] Our first question is going to come from the line of Shelley Gnall of Goldman Sachs.",18,"[Operator Instructions] Our first question is going to come from the line of Shelley Gnall of Goldman Sachs."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","The unemployment rate in you key markets actually look like it improved in December. So I'm just wondering what are your thoughts reflected in guidance for sort of macro trends in your markets? And is the high end of guidance reflecting some sort of impro",51,"The unemployment rate in you key markets actually look like it improved in December. So I'm just wondering what are your thoughts reflected in guidance for sort of macro trends in your markets? And is the high end of guidance reflecting some sort of improvement in overall sort of unemployment rate?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","I think that the unemployment rates, as we've seen, don't have a big effect on our uninsured volumes. We do think that it's contributing to the overall softness in commercial volumes and as you said, commercial enrollments have declined over the last year",173,"I think that the unemployment rates, as we've seen, don't have a big effect on our uninsured volumes. We do think that it's contributing to the overall softness in commercial volumes and as you said, commercial enrollments have declined over the last year or so. So there is a correlation there. But I think, that broadly speaking, we will see our markets mainly [ph] largely as the national markets are with stabilizing unemployment levels. Outside of the effects on volumes, there is also a positive effect on that potentially with respect to our collections or bad debt expense experience because what we've seen is historically, although there's not a great correlation between unemployment and uninsured volumes, there is a correlation between unemployment and our collection rates. So as unemployment has stabilized, we will expect our collection rates to stabilize. It remains a risk, and we'll have to see how truly that plays out in 2010, but some potential first move, further up in out outlook range if in fact collection rates are stable."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","If your unemployment situation in your market actually improve, would that be upside to your guidance range?",17,"If your unemployment situation in your market actually improve, would that be upside to your guidance range?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","It would move us up in the range. Keeping in line at the middle of the range, we assume that there were commercial volume losses year-over-year of a negative 3%. And so any improvement off of that as a result of greater unemployment would move us up in th",50,"It would move us up in the range. Keeping in line at the middle of the range, we assume that there were commercial volume losses year-over-year of a negative 3%. And so any improvement off of that as a result of greater unemployment would move us up in the range."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","On then on the other operating expenses, and you back out the healthcare technology operating costs, it looks like you're guiding to sort of, I think, you said 3.5% to 5.5% for controllable operating expense growth in 2010. That's certainly more cost infl",72,"On then on the other operating expenses, and you back out the healthcare technology operating costs, it looks like you're guiding to sort of, I think, you said 3.5% to 5.5% for controllable operating expense growth in 2010. That's certainly more cost inflation than you would expect to see in a deflationary environment. So why have we moved meaningfully away from the sort of deflationary environment that benefited operating costs in 2009?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, 2009 benefited significantly from the $188 million of cost reductions we put in place effectively at the beginning of the year, which every quarter positively affected what otherwise would be seen as another wave of inflation. We are still targeting",96,"Well, 2009 benefited significantly from the $188 million of cost reductions we put in place effectively at the beginning of the year, which every quarter positively affected what otherwise would be seen as another wave of inflation. We are still targeting cost reductions in 2010. Steve mentioned approximately $30 million from MPI and other supply-related initiatives, which we expect to contribute to beating what otherwise would be an inflationary cost pressure, but it's just starting on the same magnitude as what we were able to accomplish in 2009 in more of a step-function type of basis."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So your operating costs are now seeing inflation back to the historical 3% to 5% range, is that fair to say?",21,"So your operating costs are now seeing inflation back to the historical 3% to 5% range, is that fair to say?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","That's what we're starting out with respect to this outlook, yes.",12,"That's what we're starting out with respect to this outlook, yes."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Darren Lehrich of Deutsche Bank.",13,"Our next question comes from the line of Darren Lehrich of Deutsche Bank."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I guess, I just wanted to start out with the $40 million of expenditure related to your Healthcare IT initiatives and just the philosophy around expensing that versus capitalizing that. We're seeing definitely some divergence within the peer group about h",81,"I guess, I just wanted to start out with the $40 million of expenditure related to your Healthcare IT initiatives and just the philosophy around expensing that versus capitalizing that. We're seeing definitely some divergence within the peer group about how to treat those types of expenses and we'd love to get your thoughts on how you are thinking about it? It would appear that you're expensing virtually all of the implementation cost. But can you just walk us through that?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, we're not expensing all of the implementation cost, they're just [indiscernible] amount of capital being spent next year, $70 million as we indicated in the release and in my comments. I can't speak to everybody else's accounting policies. I can alw",158,"Well, we're not expensing all of the implementation cost, they're just [indiscernible] amount of capital being spent next year, $70 million as we indicated in the release and in my comments. I can't speak to everybody else's accounting policies. I can always speak to our own. We interpret the accounting standards on this as certainly as we think is appropriate. But incremental cost that we are taking to the bottom line or projecting to get to the bottom line are largely training costs, planning, data conversion costs. And then to the extent we bring up our production environment prior to being fully utilized, that also falls to the bottom line as an unabsorbed cost. So those are the three elements of cost hitting expense next year, which as I said, is a two-year phenomenon 2012. By the time we got out to 2010, that incremental expense should be offset by incentive dollars and beyond that by operational benefits."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Is there any additional risks element that you're embedding into guidance as it relates to potential implementation problems that you may have any or anything like that, and any thoughts there?",32,"Is there any additional risks element that you're embedding into guidance as it relates to potential implementation problems that you may have any or anything like that, and any thoughts there?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, I mean, the $40 million represents a best estimate, we would hope at the end of the day, that ends up being conservative. But I'm not going to promise that.",31,"Well, I mean, the $40 million represents a best estimate, we would hope at the end of the day, that ends up being conservative. But I'm not going to promise that."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Let me just ask a question related to volume growth and the medical staff growth has been very good. Dr. Newman's been talking about some of those trends and we've obviously seen very good outpatient growth. I'm just wondering if TRP is going to change at",104,"Let me just ask a question related to volume growth and the medical staff growth has been very good. Dr. Newman's been talking about some of those trends and we've obviously seen very good outpatient growth. I'm just wondering if TRP is going to change at all with regard to how the focus is, my sense is at least that you've been focusing a great deal of attention on improving the outpatient access points for your referring physicians and is there a chance that you may have missed some inpatient opportunity as that process rolled out? Can you just give us some comments  there."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","We'll, Darren, I think you're right. I think, that we continue to learn how to improve the efficacy of our physician relationship program. There are a couple of things we're doing to upscale that function and make it more effective in terms of capturing o",275,"We'll, Darren, I think you're right. I think, that we continue to learn how to improve the efficacy of our physician relationship program. There are a couple of things we're doing to upscale that function and make it more effective in terms of capturing our target, which is more commercial managed care inpatient volume. Number one, we're arming those PRP reps with items that we say are in their goodie bag, which is the tools and techniques to help the physicians practice more efficiently and effectively. We mentioned earlier, the deployment of our office base HIT suite. That will once again attract, not only physicians affiliated with our hospitals today but those are not affiliated that have a high book of commercial managed care business today. I think the second thing we've learned is how to improve our targeting. It's fascinating that a significant amount of the value league is occurring in physicians that are not our most frequent admitters. Overtime, our referring physicians, especially our primary care physicians, don't come to the hospital as frequently as they used to. So in addition to deploying hospital list that are full-time within the facility to take those referrals, we have to strengthen our outreach to those doctors who we don't see walking around the hospitals very frequently. Additionally, we're improving the assimilation of those new to staff by introducing them to their referral sources. So I do believe that we have an opportunity to improve the output and efficacy of our physician relationship program, and we'll go after those value leagues that today are causing us to not have increase in commercial managed care admissions."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Adam Feinstein of Barclays Capital.",13,"Our next question comes from the line of Adam Feinstein of Barclays Capital."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","This is actually Brendan Strong dialing in on Adam's behalf today. First, I just had a couple of questions here on guidance. And really the first one is, as you think about 2009, you guys did a really, really good job managing your costs. And then it look",119,"This is actually Brendan Strong dialing in on Adam's behalf today. First, I just had a couple of questions here on guidance. And really the first one is, as you think about 2009, you guys did a really, really good job managing your costs. And then it looks like EBITDA for the year ended coming in a lot better than what you had initially expected and even what you had expected as recently as the third quarter call. And so you ended up paying out this extra 401(k) match. Is there any way to think about that as really like a one-time item this quarter unless EBITDA for 2010 ends up being much higher than you're currently expecting?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","I had a little trouble hearing you Adam, but if you're asking on the 401(k) match, was it a one-time item? Yes. I said in my comments, it should be considered a one-time item. Well, I'll repeat that if we have some substantial increases in future earnings",72,"I had a little trouble hearing you Adam, but if you're asking on the 401(k) match, was it a one-time item? Yes. I said in my comments, it should be considered a one-time item. Well, I'll repeat that if we have some substantial increases in future earnings or if competitive pressures should cause us to increase or make a further discretionary 401(k) match in the future. It's not in the 2010 outlook."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","Brendan, just one clarification. So we're making that announcement today, and we're setting the expectation for employees of what Biggs just said, that this is not something that is a permanent match but it's a match that would -- it's an additional contr",118,"Brendan, just one clarification. So we're making that announcement today, and we're setting the expectation for employees of what Biggs just said, that this is not something that is a permanent match but it's a match that would -- it's an additional contribution that would be made again only if our performance in 2010 were substantially greater than in 2009. So we've left ourselves that flexibility and we called it out, so that you could make your own judgment as to whether to treat that as a one-time item or not. And just one other last point of clarification, that contribution was made only to the accounts of employees who are not part of the incentive compensation plans."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Biggs, just one other question. On the tax rate, you guys are assuming a 40% tax rate for 2010 but you've got the significant NOL there. I'm just trying to understand that a little bit better. Ultimately, do you think your taxes ended up coming in a lot l",63,"Biggs, just one other question. On the tax rate, you guys are assuming a 40% tax rate for 2010 but you've got the significant NOL there. I'm just trying to understand that a little bit better. Ultimately, do you think your taxes ended up coming in a lot lower than what you're including in guidance? Just any color would be helpful around that."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","The 40% represents, on a normalized basis, what we think we would have as an effective tax rate, Federal and State combined. As it is, the only thing that we are effectively paying at this point in time on a current income is state taxes, which have been",150,"The 40% represents, on a normalized basis, what we think we would have as an effective tax rate, Federal and State combined. As it is, the only thing that we are effectively paying at this point in time on a current income is state taxes, which have been running more in the $15 million to $20 million kind of level on an annual basis. So that's, if you will, the state effects. And then the federal effects, at this point of course, have been offset by the NOL. We would expect that NOL is going to start to demonstrate its value as we go into the future and produce taxable income. And we're happy to be -- on the one hand, you don't want to be a taxpayer. We'll be happy to be in a position where we're generating taxable income and start to utilize the value of that NOL."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Just to clarify there though. Let's say for example, when you end up reporting first quarter results. What type of a -- do you think you will be reporting like a 40% tax rate on the income statement or do you think it would end up being lower than that?",50,"Just to clarify there though. Let's say for example, when you end up reporting first quarter results. What type of a -- do you think you will be reporting like a 40% tax rate on the income statement or do you think it would end up being lower than that?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","No. In terms of reported basis, in the first quarter, we would anticipate still just having state taxes effectively flowing through to the bottom line.",25,"No. In terms of reported basis, in the first quarter, we would anticipate still just having state taxes effectively flowing through to the bottom line."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Sheryl Skolnick of CRT Capital Group.",14,"Our next question comes from the line of Sheryl Skolnick of CRT Capital Group."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","First of all, I don't understand why you're giving -- to follow up on that one, I don't understand, with the NOL, why you bother to confuse us with the 40% tax rate when the NOL is roughly $2.5 billion in which shelves are a considerable amount of income",306,"First of all, I don't understand why you're giving -- to follow up on that one, I don't understand, with the NOL, why you bother to confuse us with the 40% tax rate when the NOL is roughly $2.5 billion in which shelves are a considerable amount of income for the next several years, positively impacting your cash flow. I think it just confuses the issue and makes for estimates versus guidance comparisons to be negative, which I don't think you need. The second thing is, I guess where I'm coming out on this quarter was, that the right read is I think you'll confirm, given the $16 million of discretionary payments that were certainly not expected in my model, that the earnings power of the company in the fourth quarter from an EBITDA perspective was much stronger than anticipated. And I guess we're all sitting here, with the stock down 9%, a little bit disappointed that the 2010 commentary sounds so funereal. Now let's all recognize -- recognizing that it's your job to be prudent and it's your job to be conservative, it's a little troubling to have the answer to the question, why are you assuming your cost going up 3% to 5%, or are you assuming a return to inflationary trends be positive when the articulation of where those pressures are hasn't been precise. So I would ask for better articulation of that. And then the second issue around that is, if you're rolling out Medicare performance initiative this year and you're not rolled out to all the hospitals, and your supply initiatives are only partially rolled out, the ones that go hand in glove with that. Aren't there additional cost in your numbers that would show up in the other operating expense related to the Medicare performance initiative that you haven't enumerated?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","I think that, to tell you the last piece first, the Medicare forms, does it really affect the number of items of performance, wherever costs is incurred it's a potential we're able to drive it down by reducing variability, length of stay, improving staffi",231,"I think that, to tell you the last piece first, the Medicare forms, does it really affect the number of items of performance, wherever costs is incurred it's a potential we're able to drive it down by reducing variability, length of stay, improving staffing as a result of that, and our supplies and everything else. So there are certainly going to be effects more broadly than just looking at supplies, which is something as typically been focused on when we talk about the MPI effort. Back to the broader question on inflationary pressures, we did give a relatively normal looking merit increase in the fourth quarter. We talked about that when we issued our third quarter outlook. So there's built in inflationary pressure on SWB from that action. And as Trevor mentioned, it was above what the rate of inflation has been. Union contracts also provide for some set increases which are not tied to inflationary measures. And so the SWB line is not going to move literally with inflation or the absence of it for 2010. On the supply side, certainly, we expect to be able to continue to drive down costs using MPI and our other initiatives. But when you look at it across the entirety of our costs, that $30 million that Steve mentioned that get somewhat muted by the numerator and denominator effect, besides the number [ph]."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I guess where I'm going with this is, some of this is that you just did such a good job in 2010 that it's hard to repeat the performance, but you have other initiatives that you're spending money on in 2009 and 2010 that will begin to show results in 2010",272,"I guess where I'm going with this is, some of this is that you just did such a good job in 2010 that it's hard to repeat the performance, but you have other initiatives that you're spending money on in 2009 and 2010 that will begin to show results in 2010. And I guess, I'm a little bit concerned because I would think that the employment situation hasn't gotten that much better that your retention rates should still be strong and improving the programs you have on labor retention, and around reducing turnover, should be strong and improving. Your contract labor costs control should be strong and improving. Your other operating expenses I think have been historically low. Obviously, there are some twisting around of that because of a new IT initiative and some cost associated with that, which you've articulated in detail. But I can't help feeling, and I'd be okay with this, I mean it's your job to be conservative, but I can't help feeling that there's still a lot going on that would suggest separate and apart from labor where yes, calling that out is important. The other costs probably -- the pressure probably shouldn't be above an inflationary environment where we're not really in an inflation -- above an inflation rate where we're not really in an inflationary environment. So I'm a little -- I think I know the answer, which is that, this is your first look at 2010 guidance, and someone at some place told you to set it conservatively. I think that was right, but I kind of like an answer to that question."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","One area where we are possibly being served, I mentioned in my comments, is malpractice expense. We drove, systematically, malpractice expense down during 2009, repeatedly making actuarial adjustments for favorable experience. At this point in time, we're",229,"One area where we are possibly being served, I mentioned in my comments, is malpractice expense. We drove, systematically, malpractice expense down during 2009, repeatedly making actuarial adjustments for favorable experience. At this point in time, we're not forecasting similar reductions to occur in 2010, so our guidance does not embed a continued reduction in malpractice. Having said that, we certainly have all of our efforts aimed in that direction, and that is one of the things that would influence the other cost category. And it's one area where we may prove to be conservative. Secondly, as I said, in an environment of rising risk-free, and in this case, discount rates, there also is a favorable impact on malpractice expense. It doesn't affect the cash piece of it, but it would affect the expense piece of it. We haven't presumed that into our forecast as well. But as we know, based upon -- in fact since the [ph] last week, that is very feasible to happen on the course of this year. And if that does, then that will provide lift as well. So there are areas of conservatism, but I'm not going to go as far as to lay it out and say, yes, this is a conservative number. And it's not a reasonable estimate on our part as obligation to go ahead and give a reasonable estimate."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then also, keep in mind that if we add back the $40 million, it's still substantially higher than it used to be, so maybe I should stop complaining, the EBITDA I mean. And then the other thing that I'm a little bit -- I have to go back to, on the phys",160,"And then also, keep in mind that if we add back the $40 million, it's still substantially higher than it used to be, so maybe I should stop complaining, the EBITDA I mean. And then the other thing that I'm a little bit -- I have to go back to, on the physician recruitment in relationship. There was some mention of the third quarter call, Steve, that you stepped back and you took a look at the physicians recruited in the program through third quarter and felt that you needed to make some adjustments in terms of the appropriateness of those recruits and their commitment to generate volume. Now you're telling us in the fourth quarter that the volumes in the class of 2009 are comparing favorably to 2008. Should we not be concerned about that? Have you addressed those issues? Do you have the right roadmap going forward? And what would be your outlook for physician recruitment for 2010."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, Sheryl, I think you're exactly right. I think that the statistics I gave about the productivity of the class of '09 compared to the class of '08 was only for the date range of Q4, which means we have been able to make a mid course correction in how",295,"Well, Sheryl, I think you're exactly right. I think that the statistics I gave about the productivity of the class of '09 compared to the class of '08 was only for the date range of Q4, which means we have been able to make a mid course correction in how we focus those PRP reps. I think one of the issues that we identified and we alluded to in the Q3 call was, we may not have worked on the on-boarding and the assimilation process of doctors that join the staff as well as we could have. I think by focusing the PRP reps on those new recruits, as well as those that have not yet joined the staff, and then subdividing the ones that have joined by the ones that put a minority of their work at the hospital, will increase our yield in terms of total referred inpatient and outpatient volume, as well as commercial managed care. So we are learning. We have changed things as a result of the observations we shared with you in Q3 conference call, and I think we're making progress. Over time, I think the goal will be to actually add fewer physicians who each contribute more in terms of meaningful inpatient and outpatient volumes that meet our community need and prevent patients from having to out-migrate from our service area, so that for 2010, we'll probably target 800 to 900 active staff physicians net of attrition. So I think you're right. I think we have made changes. We continue to improve that targeting. We improved our business intelligence at the hospital level so that those PRP reps know which physicians to call on, and they have work plans that are defined for them a week in advance."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I guess in summary, if I can, am I supposed to take away from this that you're doing your job in giving guidance at the beginning of a very uncertain environment, of your very uncertain environment, by not overreaching by trying to make it, I'll say, and",100,"I guess in summary, if I can, am I supposed to take away from this that you're doing your job in giving guidance at the beginning of a very uncertain environment, of your very uncertain environment, by not overreaching by trying to make it, I'll say, and maybe not your words, as conservative as it's reasonable to make it? But that the actual earnings power of the company could be as much as going up by $100 million in EBITDA? And that there is significant progress having been made despite the reduction in commercial managed care trends? Is that fair?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","That's the part where we can't -- as I said earlier, we're not going to say that our range is not reasonable that yes, there is...",27,"That's the part where we can't -- as I said earlier, we're not going to say that our range is not reasonable that yes, there is..."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","No, I said reasonable...",4,"No, I said reasonable..."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","There is potentially greater earnings power than what's reflected as looking at the range by virtue of the non-recurring hit from HIT. And the fact that it is an uncertain environment, that's going to hold us back for a limited period of time here. But we",63,"There is potentially greater earnings power than what's reflected as looking at the range by virtue of the non-recurring hit from HIT. And the fact that it is an uncertain environment, that's going to hold us back for a limited period of time here. But we expect that as the economy recovers, that our results return to a more steep upward trajectory."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Jason Gurda of Leerink Swann.",13,"Our next question comes from the line of Jason Gurda of Leerink Swann."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Wanted to ask about your accounts receivable. Looks like DSOs have been coming down every quarter this year. What's been driving that? Is there a point where you expect that to level off? How does that tie in also with your current bad debt expensing poli",46,"Wanted to ask about your accounts receivable. Looks like DSOs have been coming down every quarter this year. What's been driving that? Is there a point where you expect that to level off? How does that tie in also with your current bad debt expensing policy?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, we haven't changed our bad debt expensing policy. We continue to reserve at the point of discharge for whatever our historic collection experience has been. So there's no reflection of a change in policy in the days and receivable. The collection ra",375,"Well, we haven't changed our bad debt expensing policy. We continue to reserve at the point of discharge for whatever our historic collection experience has been. So there's no reflection of a change in policy in the days and receivable. The collection rate, overall, has diminished on the 18 months look back basis over the course of the last couple of years, declining down to the third quarter at roughly 30%, then it stayed relatively flat in the fourth quarter, which is a positive sign. But what has improved over time was our upfront collection. So collecting more at point of service has been one of the contributors to our accounts receivable improvements, as well as the fact that we continuously improve our processes for integrating with the payers. We have much more electronic exchange of information. Quicker adjudication of bills, et cetera, with our managed care payers, which enables us to collect more timely. We've also been driving down the discharge, but not sent to payer time cycles. So we get bills out in the door faster. We get paid faster. That's been a systematic approach over the last year. We have routine so-called, cash is king calls, with all of our hospitals where we go over those kinds of metrics, talk about cycle times on the receivable side, also look at inventories, which isn't a part of your question, to measure there we're driving down those as well. So it's a very concerted effort between what happens within Conifer, what happens within our hospitals on everything associated with cycle time process, upfront collections, which have been driving down the receivables balances. And we obviously have been very successful. And one of the thing we're worried about, in 2009 in a recessionary environment, was that the fact that we'll go the other way, that we would have people paying us more slowly. And to the extent that has happened, it's been offset, as if by the increasing point of service collections. If you look to 2010, we're not projecting in our guidance that we continue to decline days and receivables, but there is certainly something that we're going to go try to accomplish as we continue to refine the process and reduce cycle times."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then as your upfront collections continue to improve, is that putting downward pressure on the bad debt expense each quarter?",21,"And then as your upfront collections continue to improve, is that putting downward pressure on the bad debt expense each quarter?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","It does have a favorable impact, how much is hard to say. Because the question is, are you collecting from the same people faster or are you collecting from people otherwise wouldn't have paid? And it's going to be sum of both, but it's very difficult to",52,"It does have a favorable impact, how much is hard to say. Because the question is, are you collecting from the same people faster or are you collecting from people otherwise wouldn't have paid? And it's going to be sum of both, but it's very difficult to measure one versus the other."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","On the California issue that you're -- or at least California's waiting to hear back from CMS. Do you have an expected timeframe on that?",26,"On the California issue that you're -- or at least California's waiting to hear back from CMS. Do you have an expected timeframe on that?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","It's the middle of the year. And since you bring that up. I'm not reading your early notes this morning and some others if there's some questions or interpretational issues as to what we've actually reflected in outlook for that. So if you will, I'll take",349,"It's the middle of the year. And since you bring that up. I'm not reading your early notes this morning and some others if there's some questions or interpretational issues as to what we've actually reflected in outlook for that. So if you will, I'll take this as an opportunity to clarify. The release said that we had $35 million of state cuts outside of California, which are partially offset by the receipt of up to $60 million of the California provider fee. The California provider fee is one of many risks and opportunities included to say in the range. So we look at every risk, every opportunity. We look at the probability of its occurrence as a basis for determining what kind of a range of outcomes we should expect for the year. So in this case, effectively what's included in the range for the California provider fee or for other things beginning with [ph] risks and opportunities are factored numbers. So if I was doing a walk forward to the middle of our range, I would use $30 million as the amount to include for the California provider fee. So not the full amount but a factored amount. And you get there by your saying it was approved prospectively or it's a probabilistic outcome along with the others considered in setting the range. So if not, I think appropriate people can conclude that we've put $60 million into all levels of the range for the California provider fee, and that our outlook is conditional upon $60 million. The bottom line of all that is that, when and if the provider fee is approved, which I said, might not be towards -- or the middle of the year, we would not want analysts to immediately add the gross value of that fee to our outlook range. We'll need to reassess the range against all our areas of performance, all the risks and opportunities, cost, revenue, volume or otherwise, in assessing how that  provider fee would affect the range, if we'd move it up or down or what."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So just to clarify what you said, the midpoint of the guidance, assuming nothing else changed. Let's just assume all the other states come in fine. The midpoint of the guidance range was how much from the California provider program? $30 million?",42,"So just to clarify what you said, the midpoint of the guidance, assuming nothing else changed. Let's just assume all the other states come in fine. The midpoint of the guidance range was how much from the California provider program? $30 million?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","30.",1,"30."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Ralph Giacobbe of Credit Suisse.",13,"Our next question comes from the line of Ralph Giacobbe of Credit Suisse."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","In the press release, you talked about certain regions showing better volume trends. What about within commercial bucket? Are you seeing any better, maybe even potentially positive trends in any region or is it managed care pressure basically similar acro",40,"In the press release, you talked about certain regions showing better volume trends. What about within commercial bucket? Are you seeing any better, maybe even potentially positive trends in any region or is it managed care pressure basically similar across-the-board?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","Ralph, I think we've seen some variability in commercial managed care. I think that there is some correlation with unemployment but it's not an extremely strong correlation with unemployment. Within certain micro-markets, we see strength. For example, a s",74,"Ralph, I think we've seen some variability in commercial managed care. I think that there is some correlation with unemployment but it's not an extremely strong correlation with unemployment. Within certain micro-markets, we see strength. For example, a strong place might be Atlanta. A strong place may be Palm Beach County relative to other facilities. But in general, the decline is fairly broad-based with occasional points of rightness within the group of 49 hospitals."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Anymore detail, I think you mentioned a certain initiative to gain share in Texas and Florida specifically, around commercial? Anymore color on that?",23,"Anymore detail, I think you mentioned a certain initiative to gain share in Texas and Florida specifically, around commercial? Anymore color on that?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","Yes. Specifically, a great example of our business-to-business initiative in Florida is the relationship with BankAtlantic, whereby we provide on-site screenings for their employees' education programs, flu shots, things of that nature on site. We're doin",160,"Yes. Specifically, a great example of our business-to-business initiative in Florida is the relationship with BankAtlantic, whereby we provide on-site screenings for their employees' education programs, flu shots, things of that nature on site. We're doing that with a number of other large regional employers in many of our markets. We've had a similar issue and initiative in several of our Texas markets, which are proving to be very effective in opening that channel to accessing commercial managed care patients at the business level rather than simply focusing on physician referrals for commercial managed care. Our commercial payers are actually helping us with this, encouraging us to do this. Because in our meetings with them, they tell us that we are a high-quality provider from the assessments they give. We are in their centers of excellence designation program. And to the extent they are not able to do hard steerage [ph], they certainly help us in those connections with businesses."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Operator","Next question comes from the line of Gary Lieberman of Wells Fargo.",12,"Next question comes from the line of Gary Lieberman of Wells Fargo."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I guess I just needed to follow up on the last question regarding the commercial visions. You talked about this in the past. But is your sense that, that you're losing share or is that your sense of the markets that you're in is sort of everybody's seeing",65,"I guess I just needed to follow up on the last question regarding the commercial visions. You talked about this in the past. But is your sense that, that you're losing share or is that your sense of the markets that you're in is sort of everybody's seeing it across the board decrease. What sort of the dynamic do you think is going on there?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","From our discussion, Gary, with a number of the large national payer leadership teams as well as large regional teams, we don't think we're losing share. That may be true in a couple of isolated incidents, but our volumes in commercial managed care are pr",131,"From our discussion, Gary, with a number of the large national payer leadership teams as well as large regional teams, we don't think we're losing share. That may be true in a couple of isolated incidents, but our volumes in commercial managed care are pretty consistent with their losses in the markets in which we operate across the country. That said, we're not satisfied with shrinking commercial volumes, even if the universe of addressable or contestable patients is shrinking and that's why I mentioned our upscaled efforts to take market share and commercial managed care to access the other channels by which we can get those patients other than simply referrals from physicians. So we are focused on taking market share and growing commercial managed care even in a shrinking environment."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then just one housekeeping item. I'm not sure if you gave it. But do you have the compact discounts in the quarter?",23,"And then just one housekeeping item. I'm not sure if you gave it. But do you have the compact discounts in the quarter?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","We don't track those effectively anymore. It's all just embedded into our routine.",14,"We don't track those effectively anymore. It's all just embedded into our routine."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Kemp Dolliver of Avondale Partners.",13,"Our next question comes from the line of Kemp Dolliver of Avondale Partners."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Question relates to the stimulus bill spending on HCIT. You're going to spend about $110 million this year between capital and operating expenses. So as you look down the road to 2012 and beyond, what is your thinking with regard to how much of that you w",49,"Question relates to the stimulus bill spending on HCIT. You're going to spend about $110 million this year between capital and operating expenses. So as you look down the road to 2012 and beyond, what is your thinking with regard to how much of that you will ultimately recoup?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","I would refer you to the 10-K. We break out what the total project is expected to be over its life and what the incentive dollars are expected to be. And then above and beyond that, we expect to have operational benefits, which we haven't quantified. So i",116,"I would refer you to the 10-K. We break out what the total project is expected to be over its life and what the incentive dollars are expected to be. And then above and beyond that, we expect to have operational benefits, which we haven't quantified. So it leaves you short of being able to totally answer your question as to what the economic effects are. But I'll go back and say this was something we were going to do anyway. So we felt like it had value anyway. We're just accelerating. So since we felt like it added anyway, we felt like the economics were there for executing this program just on different timetable."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And my other question relates to expenses. You've mentioned, with regard to the uptick in expense growth in 2010 versus 2009. The absence of a large cost reduction program and probably a little bit more generous wage increases. But it strikes me while I d",110,"And my other question relates to expenses. You've mentioned, with regard to the uptick in expense growth in 2010 versus 2009. The absence of a large cost reduction program and probably a little bit more generous wage increases. But it strikes me while I do the math, that the overall cost or approach to cost discipline is still probably where it was a year ago? Is that fair? Or the mindset that profitability of the business environment's a little bit better than what you thought a year ago? So at the margin, there are some things you're willing to do that you might not have done this time last year?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","I would say we're not relaxing on anything. Our discipline in terms of cost management is now very ingrained. And we are seeing continued success in terms of how the hospitals are managing staffing and flexing appropriately and avoiding contract labor and",156,"I would say we're not relaxing on anything. Our discipline in terms of cost management is now very ingrained. And we are seeing continued success in terms of how the hospitals are managing staffing and flexing appropriately and avoiding contract labor and overtime. And just being on a day-to-day basis, much more effective than we were a few years ago as a result of all the processes we've installed. So nothing has changed along those regards. We always, even last year, we had to make decisions about, is there something that we should be investing in for the future. And so it's not to say that there is zero dollars being invested for the future discretionarily even in 2009. There were some but it's going to stay something that we're going to be conservative with respect to -- and just day to day, it's a matter of being absolutely diligent with respect to cost control."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Justin Lake of UBS.",12,"Our next question comes from the line of Justin Lake of UBS."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","You made some comments around the fourth quarter being particularly strong on the commercial pricing side. Can you give us a little more color there around what was particularly strong there? And maybe just talk the differences between pricing and mix?",41,"You made some comments around the fourth quarter being particularly strong on the commercial pricing side. Can you give us a little more color there around what was particularly strong there? And maybe just talk the differences between pricing and mix?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, we don't give out literally what our price increases are because it ends up being used against us negatively in our negotiations because everybody wants to be at the average. So we stopped giving that information a few years ago. There was some lift",103,"Well, we don't give out literally what our price increases are because it ends up being used against us negatively in our negotiations because everybody wants to be at the average. So we stopped giving that information a few years ago. There was some lift in commercial managed care, case management index, some lift in acuity. We've talked about that over the last several months, that even though volumes were down, there was a positive shift in terms of patient mix. It's not triply quantified, but that has been a positive, that's been a trend over the last, almost nine months I think."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Sure. So you're not saying basically that your contracting has gone significantly better in the last quarter or two?",19,"Sure. So you're not saying basically that your contracting has gone significantly better in the last quarter or two?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","No. The contracting has stayed on the path we've talked about previously. Our rate of increases, nothing changed significantly in the fourth quarter. And as we said before, the pure rate increases for 2010, we expect it to be in line with what we experien",49,"No. The contracting has stayed on the path we've talked about previously. Our rate of increases, nothing changed significantly in the fourth quarter. And as we said before, the pure rate increases for 2010, we expect it to be in line with what we experienced in 2009 as well."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Typically, you'll give us a little bit of visibility into what you've seen the first month of the quarter. Is there anything you could tell us about January, particularly on the commercial volume side?",34,"Typically, you'll give us a little bit of visibility into what you've seen the first month of the quarter. Is there anything you could tell us about January, particularly on the commercial volume side?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","As Trevor mentioned earlier, and as I've said in the past, we want to try to work our way away from giving that information, because as often as not, it ends up being different from what the full quarter view is. So we have decided at this point in time n",85,"As Trevor mentioned earlier, and as I've said in the past, we want to try to work our way away from giving that information, because as often as not, it ends up being different from what the full quarter view is. So we have decided at this point in time not to give specific stats. But Trevor did mention that the first quarter was starting out somewhat softer than what we ended the fourth quarter with, and that would be with respect to commercial volumes."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our final question will come from the line of Whit Mayo of Robert Baird.",14,"Our final question will come from the line of Whit Mayo of Robert Baird."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Just wanted to follow-up on that last question, Biggs. Just any issues to think about with weather in the first quarter and just any perspective around that?",28,"Just wanted to follow-up on that last question, Biggs. Just any issues to think about with weather in the first quarter and just any perspective around that?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'm sorry, issues?",4,"I'm sorry, issues?"
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","I don't think that we have any particular insights about the first quarter whether it was weather-driven. I've heard that with respect to retailers, but I wouldn't want to speculate. All we want to say was that the trends are a little bit, in my opening c",114,"I don't think that we have any particular insights about the first quarter whether it was weather-driven. I've heard that with respect to retailers, but I wouldn't want to speculate. All we want to say was that the trends are a little bit, in my opening comments at least, that the trends year-to-date are a little bit weaker than the fourth quarter, and we're off to a slow start in terms of volumes for the year. But then to remind you that our guidance for 2010 assumed flat volumes and down 3% on commercial. So did you have a follow-up question? Because we want to give everyone a break before the HMA call."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Yes, No. And just wanted to clarify the comments that you made about self-pay collection rates. Just wasn't sure if you said that it was down sequentially or flat sequentially.",30,"Yes, No. And just wanted to clarify the comments that you made about self-pay collection rates. Just wasn't sure if you said that it was down sequentially or flat sequentially."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","It's essentially flat sequentially, third quarter to fourth quarter.",10,"It's essentially flat sequentially, third quarter to fourth quarter."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'm sorry we weren't able to take all the question but we are mindful of the fact that the HMA earnings call begins in about 10 minutes. I just want to make a couple of closing comments before we concluded the call. 2009 was clearly a very important year",247,"I'm sorry we weren't able to take all the question but we are mindful of the fact that the HMA earnings call begins in about 10 minutes. I just want to make a couple of closing comments before we concluded the call. 2009 was clearly a very important year for us. It was a watershed in many respects. We showed very strong improvement in EBITDA and continuing a trend that has gone on for a number of years. We made major changes to the cost structure, which we are not letting up on. We did very well on pricing. We continue to have visibility into pricing along into the future. And we made major progress in strengthening our medical staff. We think those improvements are sustainable and represent a foundation for the future. But sitting here early in 2010, it's a very challenging year for which to forecast. I think many of your questions and comments have pointed that out. I would just say, we faced over the past several years much larger challenges and we have been able to overcome them, and we have confidence as we enter 2010 and look forward to spending more time in person with you. And as I mentioned, having a high degree of visibility out there than we have had in prior years. So thanks everybody for participating. Take a little bit of a break before your next call. And operator, this concludes the call for us. Thank you."
107911,85037470,51207,"Tenet Healthcare Corp., Q4 2009 Earnings Call, Feb 23, 2010",2010-02-23,"Earnings Calls","Tenet Healthcare Corporation","Operator","Thank you for your participation in today's conference. This concludes the presentation. You may now disconnect and have a great day.",22,"Thank you for your participation in today's conference. This concludes the presentation. You may now disconnect and have a great day."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Operator","Good day, ladies and gentlemen, and welcome to the Q1 2010 Tenet Healthcare Earnings Conference Call. My name is Caitlin, and I will be your operator for today. [Operator Instructions] I would now like to turn the conference over to your host for today's",56,"Good day, ladies and gentlemen, and welcome to the Q1 2010 Tenet Healthcare Earnings Conference Call. My name is Caitlin, and I will be your operator for today. [Operator Instructions] I would now like to turn the conference over to your host for today's call, Mr. Thomas Rice, Senior Vice President of Investor Relations. Please proceed."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, operator, and good morning, everyone. Tenet's management will be making forward-looking statements on this morning's call. These statements are based on management's current expectation and are subject to risks and uncertainties that may cause",97,"Thank you, operator, and good morning, everyone. Tenet's management will be making forward-looking statements on this morning's call. These statements are based on management's current expectation and are subject to risks and uncertainties that may cause those forward-looking statements to be materially incorrect. Management cautions you not to rely on and makes no promises to update any of the forward-looking statements. During the Q&A portion of the call, callers are requested to limit themselves to one question and one follow-up question. 
At this time, I will turn the call over to Trevor Fetter, Tenet's President and CEO."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thanks, Tom, and good morning, everyone. I said on our February conference call that we're making changes to our Investor Relations program for 2010. As you've already noticed, we shorted our earnings release significantly. Our intention is to narrow the",895,"Thanks, Tom, and good morning, everyone. I said on our February conference call that we're making changes to our Investor Relations program for 2010. As you've already noticed, we shorted our earnings release significantly. Our intention is to narrow the focus to the key items driving our performance in the quarter. Let me assure all of you, we value the extent of our disclosures, that we're still completely committed to transparency. All of the information you're used to seeing in our earnings release is still in our 10-Q. 
We're also going to streamline this call. Biggs and I will be the only speakers making prepared remarks, but Steve Newman and others are here to answer questions. We've cut the length of our remarks to 10 minutes, so that we'll have plenty of time for Q&A and can still finish the call within one hour. So in the spirit of being concise, let me jump right into a discussion of our results. 
I'm very pleased with our adjusted EBITDA for the first quarter, which grew more than 7% over last year's first quarter and reached a margin of 12.7%, our highest quarterly margin in seven years. Our adjusted EBITDA in the first quarter was greater than in any first quarters in 2003, and we achieved it with half the number of hospitals we had then. On the basis of the strong start to the year, we are confirming our existing full year outlook for adjusted EBITDA in a range of $985 million to $1,050,000,000. 
While we achieved our earnings objective for the quarter, volumes were soft, but our performance was excellent in the other key economic drivers of acuity, pricing and cost control. Our proven ability to control cost has significant positive implications for our longer-term operating leverage. Once we achieve a meaningful and sustained recovery in volumes, we now had to turn the resulting revenue growth into attractive growth on the bottom line.  This quarter, for example, we took a decline of 2% in admissions, turned it into 3.4% growth in revenues and into more than double that rate of growth in EBITDA. We should be able to do better than that with some volume growth. 
While volumes for the first quarter were disappointing, the month-by-month trajectory of volumes was encouraging. To be specific, January and February were weak but the trend was better in March. On the outpatient side, the year-over-year growth rates in March were more than 500 basis points stronger than February, indicating one of the strongest snap backs we've ever seen. 
The trend in admissions through the first 28 days in April was similar to March, although commercial is trending a bit stronger and outpatient visits are trending a bit weaker. This shows the kind of short-term volatility in patient volumes that we've talked about on prior calls.
Other companies have mentioned that bad weather, lack of flu, declining birthrates and bad economic conditions depressed volumes. And although we agree that they had an effect, it's difficult to quantify precisely. 
Our admissions through the emergency department continue to achieve positive year-over-year growth in the quarter. This indicates that our soft volumes are primarily limited to our Elective business. This should not surprising as elective procedures are most directly impacted by a slow economy.
Strong growth in revenues per unit continues to make a significant contribution to our earnings momentum. In patient revenue per admission ran 160 basis points stronger than the midpoint of our outlook assumption, and the favorable variance was more than 400 basis points on the outpatient side. Our pricing was enhanced by higher acuity, particularly in our commercial business. And given that 80% of our contract volume is negotiated for 2010 and more than 60% for 2011, we are confident this strength will continue to help drive our earnings growth.
As I mentioned earlier, cost control was once against stellar in the quarter. Total controllable costs increased by only 1.3%. Now practice expense continue to decline, and we even picked up $2 million in savings in the quarter from reduced rent at our new corporate headquarters. 
Bad debt expense increased in the quarter, but the fully allocated cost of providing uncompensated care, that is care to both uninsured and charity patients, increased by only $6 million from last year's first quarter. This is far smaller than the $33 million increase in bad debt expense year-over-year. The tangible EBITDA impact, of course, is strictly limited to the cost of care as opposed to the largely offsetting movements in revenue and bad debt line items.
These numerous factors all helped us improve adjusted free cash flow in the quarter by $33 million compared to last year's first quarter. The first quarter is always the lowest in terms of adjusted free cash flow due to the timing of certain annual cash payments but clearly, it is trending in the right direction. 
To summarize, I'm pleased with our response to the continued weak economy and soft-volume environment in the quarter. When confronted by this extraordinary challenges, our hospital management teams responded quickly and effectively to maintain our positive earnings trajectory. Now with the resumption of volume growth, I'm confident we can generate some truly outstanding bottom line performance. 
Let me turn things over to Biggs who will share some commentary on our outlook. And then, open up the call to Q&A. Biggs?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, Trevor, and good morning, everyone. I will limit my introductory comments this morning to the refinements we are making to our outlook for 2010. Our most important comment is that we are confirming the outlook range for adjusted EBITDA for 2010",905,"Thank you, Trevor, and good morning, everyone. I will limit my introductory comments this morning to the refinements we are making to our outlook for 2010. Our most important comment is that we are confirming the outlook range for adjusted EBITDA for 2010. Earlier in the year, we set our outlook range of $985 million to $1,050,000,000. That range continues to appear very realistic to us. 
The summary of our refinements to our outlook assumptions is provided on Slide 6 on the web. On that slide, you'll see that softer volumes in our first quarter have caused us to re-evaluate our volume outlook for the year. Our outlook for admissions growth has been reduced by 100 basis points. We're now assuming admissions will decline 50 to 150 basis points in 2010 as contrasted with our initial assumption of approximately flat admissions for the year. 
Because our initial assumption for 2010 growth in outpatient visits was significantly stronger, we reduced the outlook on the outpatient side by a more significant 200 basis points. Having said that, much of the volume declines in the first quarter relative to last year and correspondingly the variance in our expectation for the year is in lower acuity conditions. So the revenue and EBITDA effects are not as significant. 
Accordingly, pricing on a per patient basis is favorably impacted by this patient mix shift to higher acuity. We're now significantly more positive on the growth we assume can be achieved in unit revenues. Our assumption for growth in inpatient revenue per admission is now more bullish 300 to 400 basis points, representing an enhancement to our initial growth assumption of 100 basis points. We are making similar 100 basis point refinement to our assumed growth in outpatient revenue per visit to a new range of 400 to 500 basis points.
These enhanced assumptions for pricing significantly mitigate the adverse impact on assumed 2010 revenues. We believe only a $50 million decrease and assume 2010 revenues would be necessary to reflect lower volume projection. We believe this modest reduction in our revenue outlook can be offset by an equal, if not greater reduction in our outlook for 2010 controllable costs.
About half of these savings are directly linked to the revised volume projection, and the remaining related to enhanced assumptions regarding incremental cost efficiencies. These efficiencies include the improvements in productivity, malpractice and other controllable expenses we benefited from in the quarter. 
Before leaving our cost assumptions, let me remind you, again, that we've included a $40 million in assumed incremental cost in our 2010 outlook to cover the impact of our accelerated HIT program. As we proceed with the implementation, we continue to look for opportunities to reduce the 2010 expense. But at this time, we're going to remain conservative with respect to this $40 million estimate. This program continues to be implemented on schedule, and we expect to begin generating some offsetting revenues as early as late next year and to be completely offsetting in this incremental expense by revenues and operating benefits beginning in 2012.  The increase in bad debt expense we experienced in the first quarter is fully consistent with our prior outlook, which therefore remains unchanged. 
We had no cause, at this point, to change any of the other assumptions embedded in our outlook. In particular, there is nothing incremental to report on the California provider fee, although investors should be aware that this is only $30 million in the middle of our range, and there is considerable upside to that number.
As these assumptions for softer volumes offset by higher acuity, per unit revenue and cost reductions are worked through our models. The result is confirmation of our pre-existing 2010 range for adjusted EBITDA. With no change to our EBITDA outlook, there is no change to our GAAP earnings, although we've made certain adjustments to our share count, in part reflecting changes in our share price.
We've also added an outlook line item for EPS reflecting tax expense without any pro forma normalization for changes in our NOL valuation allowance. Book tax expense could, in fact, become significantly favorable this year should we qualify for the recognition in the tax provision of some or all of the $1 billion benefit of our NOL carry forward and other deferred tax benefits prior to year-end 2010. Under Generally Accepted Accounting Principles, this recognition occurs when the company has demonstrated that there is a reasonable expectation of future taxable income sufficient to realize the benefit of the NOL. Due to our demonstrated improved performance, we are approaching that point in time and will continue to assess this quarterly.
In summary, we remain confident that our initiatives to drive revenue growth, control costs and drive increasingly positive bottom line profitability and free cash flow will be successful. The ranges we have assumed in 2010 for pricing, revenues and adjusted EBITDA allow for effects, either partially or totally out of our control, related to the recession. We believe the recent pattern of volume declines will improve and on an intraperiod basis, these trends are improving. 
Looking past 2010, I will also reiterate that as the economy improve, we believe we will see improvement in commercial volumes and bad debt expense and believe we will also benefit from our initiatives to grow outpatient volumes organically and through selective acquisitions. 
With that, I'll ask the operator to open the floor for questions. Operator?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Operator","[Operator Instructions] Your first question comes from the line of Tom Gallucci of Lazard Capital Markets.",16,"[Operator Instructions] Your first question comes from the line of Tom Gallucci of Lazard Capital Markets."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Obviously, you've done a strong job on the cost control side. Just looking at the volumes a little bit more closely, how do you sort of view your market share, I guess. Do you think that the pressures that you're seeing out there are equal or perhaps, you",62,"Obviously, you've done a strong job on the cost control side. Just looking at the volumes a little bit more closely, how do you sort of view your market share, I guess. Do you think that the pressures that you're seeing out there are equal or perhaps, your losing any market share, I guess both overall and then particularly, within the managed-care?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","We share your concerns regarding market share. And during Q1, we did a very deep dive into our market share across the country. And our results really were quite encouraging. For example, if you'd look at our hospitals in the following states, you get the",95,"We share your concerns regarding market share. And during Q1, we did a very deep dive into our market share across the country. And our results really were quite encouraging. For example, if you'd look at our hospitals in the following states, you get the following results. California was up 0.1%,  Florida was up 0.3%, Texas was up 1.2%, Missouri was up 0.3%, Georgia was flat, and our only state that was down was North Carolina, where we lost market share of 1.1%. This covered the change in market share between 2008 and through 12/31/09."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Okay. So that was your estimated change in market share for your facilities in those markets?",16,"Okay. So that was your estimated change in market share for your facilities in those markets?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","That's right, Tom.",4,"That's right, Tom."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then just maybe can you give us a little bit more detail, we've seen a lot of headlines over the last couple of years about managed-care relationships and, in certain cases, expanding those. But can you talk about maybe a little bit an update on what",80,"And then just maybe can you give us a little bit more detail, we've seen a lot of headlines over the last couple of years about managed-care relationships and, in certain cases, expanding those. But can you talk about maybe a little bit an update on what you're doing in terms of either positioning, creating or working on splitter-type docs to really get the leverage out of the contracts that you're signing and get the volumes through the door ultimately?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","I think those are both important aspects that we're working on, Tom. We have a big push to make sure all of our active medical staff are participating in the networks of the managed-care companies that we've contracted with. We see variability across the",140,"I think those are both important aspects that we're working on, Tom. We have a big push to make sure all of our active medical staff are participating in the networks of the managed-care companies that we've contracted with. We see variability across the country by pair in terms of that. They range from 70% to 90%. We're trying to push all of them to the 90% level. That gives our doctors the opportunity to take care of those patients that are inpatient and outpatient facilities. We're also organizing our physicians in selected markets around the country to contract with managed-care payers on a single signature. Done that in a couple of areas, we continue to do that. We believe that's a proactive strategy, getting us ready for the post-health reform era with bundling and creating accountable care organizations."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Operator","Your next question comes from the line of Adam Feinstein of Barclays Capital.",13,"Your next question comes from the line of Adam Feinstein of Barclays Capital."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Maybe just a couple of questions on the cost management, obviously, very strong trends there. So just maybe a few things I want to go into. I guess last quarter, you called out some items that were somewhat one-time in nature, in terms of labor costs, in",103,"Maybe just a couple of questions on the cost management, obviously, very strong trends there. So just maybe a few things I want to go into. I guess last quarter, you called out some items that were somewhat one-time in nature, in terms of labor costs, in terms of merit increases and 401(k) matching, but I would expect there was probably some fall through. So I guess last quarter you caught about like $25 million of incremental cost. I was just wondering if any of those costs were still -- any incremental cost there in the first quarter that we should think about?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","No, there weren't any unusual one-time type of expenses or step-ups over the prior year to note in the first quarter. The HIT expenses, which we of course said we expected for the full year, were very evident in the first quarter. That will ramp up more l",51,"No, there weren't any unusual one-time type of expenses or step-ups over the prior year to note in the first quarter. The HIT expenses, which we of course said we expected for the full year, were very evident in the first quarter. That will ramp up more later in the year."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then as we look at the cost, once again, great cost management, controllable operating cost of 1.3%. And now the quarter, on a per adjusted patient day basis of 3.5%, which is still a lower than normalized number. But just curious as you guys think ab",110,"And then as we look at the cost, once again, great cost management, controllable operating cost of 1.3%. And now the quarter, on a per adjusted patient day basis of 3.5%, which is still a lower than normalized number. But just curious as you guys think about it, do you look at more at the total number? Or do you look at it more on an adjusted patient day? So just as you guys think about that, and I know what was going on with patient days, but I guess just trying to think about in terms of managing the business, in terms of how you guys analyze those metrics?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, we look at it both ways. Certainly, the benefit of looking it on a patient-day basis is it normalize it for volumes swings. So that is an important metric. It is not a perfect metric because, as we know, shifts between inpatient and outpatient and o",93,"Well, we look at it both ways. Certainly, the benefit of looking it on a patient-day basis is it normalize it for volumes swings. So that is an important metric. It is not a perfect metric because, as we know, shifts between inpatient and outpatient and other mixed shifts can create some distortion in the stat. So it's not a perfect stat. And you have to always be aware of that, but it is best one available and it is one we used on a regular basis to look at our cost performance."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So you guys are think that, that 3.5% is a better way to think about cost relative to the 1.3%?",20,"So you guys are think that, that 3.5% is a better way to think about cost relative to the 1.3%?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, at the end of the day, obviously driving down total costs relative while you're trying to drive up revenue is the key. And so total cost performance is important. If we're looking at productivity, yes, we try to get down to a patient-day basis, but",66,"Well, at the end of the day, obviously driving down total costs relative while you're trying to drive up revenue is the key. And so total cost performance is important. If we're looking at productivity, yes, we try to get down to a patient-day basis, but obviously the bottom line is the most important thing. And so at a macro level, we have to manage to."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I guess on the 10-Q, you mentioned -- you were talking about some of the regional variability here and the talked about three out of four regions suddenly decline in volumes. And then on the outpatient side, just mentioned that the central region did well",85,"I guess on the 10-Q, you mentioned -- you were talking about some of the regional variability here and the talked about three out of four regions suddenly decline in volumes. And then on the outpatient side, just mentioned that the central region did well. So I was just curious if you could just talk a little bit more on the regions, and I guess what was it about the central region which led to better volume growth than some of the other regions?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Adam, that's correct. We did say that in the Q. I want to give you some additional color about outpatient visits and variation by region. Certainly, our outpatient declines across the company were largely related to imaging declines. About 70% of the tota",197,"Adam, that's correct. We did say that in the Q. I want to give you some additional color about outpatient visits and variation by region. Certainly, our outpatient declines across the company were largely related to imaging declines. About 70% of the total was hospital-based imaging being declined for the quarter, also with outpatient laboratory testing contributed to that. It's only isolated to two sites in California. And to some extent, also compromised in Texas with respect to outpatient. That may sound odd since Texas is part of the central region. But in those two sites in California, physician IPA-owned facilities opened, which took imaging and laboratory testing out of the hospitals. And we have a unique situation in Texas where freestanding emergency rooms were approved by legislature. That then pulled some visits out of our hospitals, especially in Houston and Dallas. So central was stronger in aggregate, but those two issues really aggregated to keep our outpatient visits negative. And when you consider the lack of flu-types syndromes that we saw last year in our ERs, which we didn't see this year, I think our aggregate performance down 0.6% and emergency visits really was quite minimal."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Operator","Your next question comes from the line of Ralph Giacobbe of Crdit Suisse.",13,"Your next question comes from the line of Ralph Giacobbe of Crdit Suisse."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I know you guys don't give quarterly guidance, but is it fair to look at the progression of EBITDA we saw last year as sort of a way to think about this year? Or should we be thinking about that differently?",42,"I know you guys don't give quarterly guidance, but is it fair to look at the progression of EBITDA we saw last year as sort of a way to think about this year? Or should we be thinking about that differently?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","You're right, we don't give quarterly guidance. And actually at this point, I'd have to go back to look at the progression last year. I think that last year was flatter than what we've experienced from a seasonal fluctuations standpoint in the past. While",156,"You're right, we don't give quarterly guidance. And actually at this point, I'd have to go back to look at the progression last year. I think that last year was flatter than what we've experienced from a seasonal fluctuations standpoint in the past. While we're in a recession, I think it's a little harder to say that normal seasonal patterns work. We certainly are expecting that as the economy stabilizes and improves that we will see some positive trends as we proceed through the year. And in particular, the fact that we were off to a slow start on volumes, we expect to see that turned and for those trends to improve through the remainder of the year. So it makes it I think a little bit harder to say it's going to look like the past. I'm sorry that doesn't answer -- it give you two clear view but that's all I can give."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I mean, last year, I think it was something like 27% or 28% EBITDA came in the first quarter. Now, obviously, this first quarter is a little bit weaker as it relates to the volumes side of things. So I was just wondering if that wasn't the right way to th",63,"I mean, last year, I think it was something like 27% or 28% EBITDA came in the first quarter. Now, obviously, this first quarter is a little bit weaker as it relates to the volumes side of things. So I was just wondering if that wasn't the right way to think about things because last year, obviously, disproportionate came in the first quarter?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, I think if you -- certainly, if you look at our outlook for the year of $985 million to $1.050 billion that suggest that there's some variation in the first quarter and remainder of the year. That's about as far as I'd come to giving you quarter-by-",49,"Well, I think if you -- certainly, if you look at our outlook for the year of $985 million to $1.050 billion that suggest that there's some variation in the first quarter and remainder of the year. That's about as far as I'd come to giving you quarter-by-quarter look."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then just want to go back to your comments on the managed care side, I think you said 80% of the book was done for 2010, 60%, 2011. Can you give us just the average rates between those years?",40,"And then just want to go back to your comments on the managed care side, I think you said 80% of the book was done for 2010, 60%, 2011. Can you give us just the average rates between those years?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'm sorry, what do you mean the...",8,"I'm sorry, what do you mean the..."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Or range? Just your pricing point increases.",7,"Or range? Just your pricing point increases."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","In terms of pricing, I think the ballot say this year should be the same as last year. And then we were not quite at the point of projecting the 2011 numbers yet, even though our 60% in, we have pretty good visibility, which is at the point of 2011 guidan",51,"In terms of pricing, I think the ballot say this year should be the same as last year. And then we were not quite at the point of projecting the 2011 numbers yet, even though our 60% in, we have pretty good visibility, which is at the point of 2011 guidance."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Operator","Your next question comes from the line of Shelly Gnall of Goldman Sachs.",13,"Your next question comes from the line of Shelly Gnall of Goldman Sachs."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","A question on the supply cost. So at first, it just looks like there's some improvement here. As a percent of revenue, you've got the supply cost down to 17% now. That's down 30 basis points year-over-year. But if we look at the supply cost per adjusted a",129,"A question on the supply cost. So at first, it just looks like there's some improvement here. As a percent of revenue, you've got the supply cost down to 17% now. That's down 30 basis points year-over-year. But if we look at the supply cost per adjusted admission, I guess we're seeing -- is that first, is how you look at it? And would you agree that we're seeing 3% inflation on the supply cost so far this year? So if that's the right way to look at it, can you tell us if we're seeing any of the benefits from your MPI initiative at this point in the results? Especially, are we seeing any of the $30 million supply cost savings that were guided in the last call?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Biggs, why don't you address the outlook related part of the question. We'll have Steve say a little bit about MPI and some of the accomplishments there in the supply chain.",31,"Biggs, why don't you address the outlook related part of the question. We'll have Steve say a little bit about MPI and some of the accomplishments there in the supply chain."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, I think we were pleased with our supply cost performance in the quarter. I think you had a question as to we ever look at it on a patient day basis. I think that there are problems with looking at supplies like -- and I'm going to go back to earlier",182,"Well, I think we were pleased with our supply cost performance in the quarter. I think you had a question as to we ever look at it on a patient day basis. I think that there are problems with looking at supplies like -- and I'm going to go back to earlier question, in this case, you can have a mix affecting the areas in which supply expenses are incurred that don't show up in the adjusted patient day denominator. So by example, if you have more surgeries, it does proportionally change your patient days but it may change your supply more significantly. So you really have to dig in and understand on a specific basis what's happening in the business, now that supplies are performing against that. So admittedly, it's hards for you all to do it, totally from the outside looking in. So for the year, we certainly still believe we're going to get yield from all of our supplies initiatives, including MPI, nothing has changed there. I'll let Steve talk to what we've been able to do so far."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Shelley, just for example, in the first quarter, our spinal surgeries were up significantly year-over-year. Those are very high-cost implants, yet each of those still just contributes the same as any other surgical procedure in terms of adjusted admission",131,"Shelley, just for example, in the first quarter, our spinal surgeries were up significantly year-over-year. Those are very high-cost implants, yet each of those still just contributes the same as any other surgical procedure in terms of adjusted admissions. We're doing a number of things in MPI to continue to drive our supply cost down. The impact from MPI is both short-term and long-term. We're able to certainly continue our efforts to drive down individual unit pricing. In terms of implants, we just had a concession on our cardiacs stent implants with another 10% drop. That, combined with more appropriate utilization, is going to continue to drive down our supply cost in cardiac interventions. So I think those are two examples of how we're continuing to drive our supply cost down."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","To Steve, to follow-up with what we've seen so far, I guess. If you are able to consolidate vendors, for example, in the spinal side or on the cardiac side, for the hospitals where you're doing MPI on a targeted DRGs right now, is it too soon to see the s",109,"To Steve, to follow-up with what we've seen so far, I guess. If you are able to consolidate vendors, for example, in the spinal side or on the cardiac side, for the hospitals where you're doing MPI on a targeted DRGs right now, is it too soon to see the supply cost savings in the results that came out today? So if you do consolidate vendors or limit your product selection, does that contracting take time to flow through, so we wouldn't see it until next quarter, six months from now? I mean, does it get push out like that? Or will we see some cost savings in realtime?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","I think to answer your question directly, Shelley, some of the savings you would've seen in the quarter in cardiac, especially those where we touched those first-wave hospitals and some of the cardiac DRGs in 2009, they would in fact show up in this quart",94,"I think to answer your question directly, Shelley, some of the savings you would've seen in the quarter in cardiac, especially those where we touched those first-wave hospitals and some of the cardiac DRGs in 2009, they would in fact show up in this quarter. Others, as we flow-through, take more time to develop. So it's both short- and longer-term cost savings in the supply area. Also, I should mention that we're working continuously on length of stay and driving down other variable costs, other than the supply cost, through the Medicare performance initiative."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","On the charity care, you're seeing less charity care in the quarter. Can you talk a little bit about what's driving that? Is that the Right Care Right Place initiative?",30,"On the charity care, you're seeing less charity care in the quarter. Can you talk a little bit about what's driving that? Is that the Right Care Right Place initiative?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, I think that it will be a combination of things. It would be the right care, right place initiative. Also our eligibility program where we have reps in all the hospitals working to get people qualify for Medicaid. So we're pretty confident that over",105,"Well, I think that it will be a combination of things. It would be the right care, right place initiative. Also our eligibility program where we have reps in all the hospitals working to get people qualify for Medicaid. So we're pretty confident that over the last couple of years, we've gotten more people qualify for Medicaid than we had previously. So those are the two primary drivers. There's also some evidence, anecdotal, that some undocumented immigrants are returning to their home economies due to job loss, that's, once again, harder to quantify our track. But all those things are having an effect, we believe."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Operator","Your next question comes from the line of Sheryl Skolnick of CRT Capital Group.",14,"Your next question comes from the line of Sheryl Skolnick of CRT Capital Group."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","The first thing is, I'm going to go back to MPI and I think that there was some interesting disclosures in the Q with respect to the supply cost, et cetera. But what I'm more interested in is, we saw, despite a significant increase in acuity that drove re",110,"The first thing is, I'm going to go back to MPI and I think that there was some interesting disclosures in the Q with respect to the supply cost, et cetera. But what I'm more interested in is, we saw, despite a significant increase in acuity that drove really, I think, perhaps even record rates of growth on outpatient revenue per visit, as well as strong growth on net revenue per adjusted admission. Despite that higher acuity, we saw a reduction in the average length of stay. Now that to me is fascinating. Is this proof of Medicare performance initiative beginning to take root? That's part one of the question."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","I think the short answer to your question is yes. And it is particularly noteworthy that the length of stay was down in the quarter, because our OB deliveries were down 4% or over 730 deliveries. Those, as you know, have a length of stay of between one an",126,"I think the short answer to your question is yes. And it is particularly noteworthy that the length of stay was down in the quarter, because our OB deliveries were down 4% or over 730 deliveries. Those, as you know, have a length of stay of between one and two days and tend to pull down the overall length of stay. So with the absence of those, you would have expected our length of stay to creep up. So I do think the effort that we're putting into the Medicare performance initiative and the rollout of our case management program aggressively to each hospital has made a difference in the length of stay, which then will affect our variable costs and our profitability for inpatient stay."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","The second question is, as we look at the Medicare performance initiative across the board, you addressed the issue of it being both a short-term and a long-term performance. But as you look at your pace at which you're rolling out, the degree to which ph",109,"The second question is, as we look at the Medicare performance initiative across the board, you addressed the issue of it being both a short-term and a long-term performance. But as you look at your pace at which you're rolling out, the degree to which physicians are accepting this, recognizing the changing -- you're not changing employee-physician behavior and as much as you're changing community-based physician behavior, which is the harder thing to do. What has been your experience in your track record to date? How many hospitals have it? How may hospitals are scheduled to get it? And I'll then stop there and let you answer that question."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","With respect to how many have completed Phase I of MPI, they're 20. We expect remaining hospitals to be completed with Phase I rollout by the end of the first quarter of '11. We've also begun Phase II at some of our early hospitals that would be the secon",186,"With respect to how many have completed Phase I of MPI, they're 20. We expect remaining hospitals to be completed with Phase I rollout by the end of the first quarter of '11. We've also begun Phase II at some of our early hospitals that would be the second five MS-DRGs with respect to loss related to excessive variable cost. Back to the issue of physicians, we continue to find physicians interested in learning more about the Medicare performance initiative. We kicked off MPI at one of our Houston hospitals yesterday. We had 30 physicians in attendance. Our Corporate Chief Medical Officer was there as well as our Regional Chief Medical Officer. And I think as the environment changes, as healthcare reform moves forward, as physicians understand their performance, both in their office as well as in-hospitals and outpatient facilities, is being measured by both commercial and governmental payers, with the potential for their pro fees to be affected, they are coming on board with the idea they should participate us. So I do believe that the embracing of MPI by physicians is increasing with time."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And pro fees are professional fees in the aspect of...",11,"And pro fees are professional fees in the aspect of..."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Sorry for the acronym.",4,"Sorry for the acronym."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Yes, and all of that makes a very good sense. I don't know of any doctor wants to stand up in front of it at court and say, ""I take pride and I'm providing lousy care at a high price."" And then if I can move on to another question, which is, given where t",193,"Yes, and all of that makes a very good sense. I don't know of any doctor wants to stand up in front of it at court and say, ""I take pride and I'm providing lousy care at a high price."" And then if I can move on to another question, which is, given where the performance is today -- I'm going to step back from the detail this quarter, given where the performance is today, would you describe the company as having moved out of the initial phases of the turnaround and into the middle innings, number one. Number two, if so, what is more crucial to do right now? And include in this, please, an update on your physician recruiting. Is it to recruit the right physicians in the right markets? Is it to -- as well as the Medicare performance initiative? Is it the control of costs? Is it expansion through acquisitions? Can you give us an idea of your strategic thought process about where the business is today and where it needs to go, say, in the next three years or pick a time frame, but where you are today?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Sheryl, this is Trevor. You know that sports analogies are not my forte, so the...",15,"Sheryl, this is Trevor. You know that sports analogies are not my forte, so the..."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Yes, well the only other thing was to second trimester pregnancy and I don't think people would appreciate either.",19,"Yes, well the only other thing was to second trimester pregnancy and I don't think people would appreciate either."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","No, that wouldn't be any better. So I'll defer on the innings question. I think we clearly put all of the clean up and all of the legacy issues behind us. And so we're just really operating the company in a way where we're focused on the basics of buildin",272,"No, that wouldn't be any better. So I'll defer on the innings question. I think we clearly put all of the clean up and all of the legacy issues behind us. And so we're just really operating the company in a way where we're focused on the basics of building volume, making sure that the pricing increases we are able to get are fair and appropriate and controlling cost. And driving cash through a variety of initiatives, we don't necessarily talk about it on this call, but we've done very well in bringing working capital out of the business. And even seemingly little things, I threw out that little factoid about the savings in rent on our headquarters move. But basically, every decision we make is made with the cost imperative in mind. So I would say that for some time, we've been operating in more of a stable environment. Clearly, volume remains our number one challenge. A few weeks ago, we had our 350 top hospitals and corporate managers here in Dallas for a conference, that was basically the entire topic. So the initiatives we have on volume, the initiatives we have around recruiting physicians, the MPI initiative, which is very directly focused on cost and quality and improving that, those are the engines that we are counting on to continue to drive improvements in the economics. And I think we're approaching a level where although our margins are still low relative to the industry peers, they're not orders of magnitude low like they were and we are within reach continuing to improve the levels that we can be proud of."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","As we look at your guidance for this year, and I think this is a question earlier for Biggs, you did nearly $300 million in EBITDA this quarter. It appears to be as clean an EBITDA number as we've generally seen, so accepting that. And as you've noted, vo",208,"As we look at your guidance for this year, and I think this is a question earlier for Biggs, you did nearly $300 million in EBITDA this quarter. It appears to be as clean an EBITDA number as we've generally seen, so accepting that. And as you've noted, volumes were especially weak, perhaps, affected by weather and lack of flu, the volume comps just simply get a little bit easier, given that weather may straighten itself out, the economy may improve, it just seems to me that if you've done better in the first quarter relative to the midpoint of your guidance, why would you then therefore be -- unless you thought you were going to do this all, why would you therefore be sort of apart from just generally being conservative, doesn't sort of stand to reason that the implied numbers from consensus don't give you enough credit for getting traction on all of the positive things you've identified, but do give you credit for not getting traction on the commercial managed care. Is it simply that given where you are today, it's just more appropriate to be conservative? Because when I look at your numbers and the way they work, I have trouble keeping them down."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, I think that there's a couple of points of conservatism or couple of points where mathematically, there's some cost increase remainder of the year, such as in healthcare IT where we haven't spent much in the first quarter and that's going to go up i",337,"Well, I think that there's a couple of points of conservatism or couple of points where mathematically, there's some cost increase remainder of the year, such as in healthcare IT where we haven't spent much in the first quarter and that's going to go up in the remainder of the year, so that sort of clearly identifiable as a variance in future quarters relative to this one. But having said that, your question is still a good one. I do think we're conservative with respect to cost performance otherwise. Malpractice expense, very low in the first quarter. We find that very challenging to forecast and won't give line item guidance. But in a nutshell, we presume the remainder of the year that it goes back up from this first quarter level to stay conservative along that point, and it's quite possible that we will be better than that. As I mentioned before just besides our efforts to control malpractice expense, the fact that there will be likely increasing discount rates into the future will cost that expense to be lower. But at this point in time, that's a difficult thing to forecast just like the economy, so we have left it at a conservative point. Same with our overall cost performance, I think, that we had a very good first quarter. Everything worked well even in a period where we had declining volumes. I think that we haven't fully extended that level of performance out for the remainder of the year to stay conservative as we watch the economy, but once again, we will see how that unfolds. In balance, as I said, we think that our outlook, we're very comfortable with it. I think that we're conservative on the cost, as I said. On the volume side, we still have some improvement to accomplish, so we've decided to leave it alone in the aggregate as far as the overall EBITDA outlook looks. But you're right to look at the cost and say, ""Gee, it appears conservative."""
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Operator","Your next question comes from the line of John Rex of JPMorgan.",12,"Your next question comes from the line of John Rex of JPMorgan."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Just picking up and continuing on kind of the cost commentary you just gave there. So I just want to focus particular on the op expense line. And we think about some of the elements you said that maybe that were running at lower levels than you expect for",100,"Just picking up and continuing on kind of the cost commentary you just gave there. So I just want to focus particular on the op expense line. And we think about some of the elements you said that maybe that were running at lower levels than you expect for the full year. Can you help us size -- if we're jumping off from the absolute dollar level that you reported in the 1Q, what do you think should be kind of more normalized quarterly run rate for that category when you think about some of the elements you just described?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","To be clear, there's nothing in the quarter which isn't repeatable. So I've mentioned malpractice expense and the fact that it could go up, we're very conservative with respect to that point. However it is possible that it will stay at a very low level th",101,"To be clear, there's nothing in the quarter which isn't repeatable. So I've mentioned malpractice expense and the fact that it could go up, we're very conservative with respect to that point. However it is possible that it will stay at a very low level throughout the year. Just difficult to forecast. So I want to resist the temptation, try to create some new run rate and suggest that empirically there's a number in there. It was just what you should multiply times four to get to a full year estimate, because I think that it doesn't quite work that cleanly."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So you wouldn't spike out anything all that unusual -- I mean, so let's take malpractice and set that kind of difficult forecast. Is there any other item you want to spike out and say kind of unusually low in the Q? Or x malpractice, is this a decent run",63,"So you wouldn't spike out anything all that unusual -- I mean, so let's take malpractice and set that kind of difficult forecast. Is there any other item you want to spike out and say kind of unusually low in the Q? Or x malpractice, is this a decent run rate to be thinking about for the stepping off here in 1Q?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","I think, as I said, everything is repeatable. There is good cost performance across the board. If you look at everything from utility, to contract labor, expenses, everything was running well. We managed very effectively all of our efforts over the last c",135,"I think, as I said, everything is repeatable. There is good cost performance across the board. If you look at everything from utility, to contract labor, expenses, everything was running well. We managed very effectively all of our efforts over the last couple of years to fine tune. Our cost management practices were evident. So I don't think there's anything else that I would pick at and say, ""Gee, there is a single event which would unwind or some trend that would unwind."" Malpractice, this is a single largest one in which it's relatively low in the quarter. It could stay low. But for the sake of the forecast, we haven't predicted that. And then HIT expense, we said, will go up over the remainder of the year as that's to more back-end loaded effort."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I appreciate the share data you gave. Just want to be clear on that, was that all in share, or was that managed care volume only?",26,"I appreciate the share data you gave. Just want to be clear on that, was that all in share, or was that managed care volume only?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","That's all payors. It's not possible for us to really get to universe, specifically, of the commercial managed care covered lives and utilization, so we used all payor data.",30,"That's all payors. It's not possible for us to really get to universe, specifically, of the commercial managed care covered lives and utilization, so we used all payor data."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","It would seem like just given where the volumes are running that there has been a share loss on the commercial side, and I know this is going to be way more of an art than a science, but if you think about kind of disaggregating kind of the economic impac",75,"It would seem like just given where the volumes are running that there has been a share loss on the commercial side, and I know this is going to be way more of an art than a science, but if you think about kind of disaggregating kind of the economic impact in your market from what you think the share loss impact might be, when we see kind of the commercial volumes where they're trending?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","So this is highly speculative. But if we look at corporate lives from Q1 '09 through the end of Q1 '10, there's about a 2.8% decrease in commercial managed care covered lives. In couple with that not only the decrease in covered lives but the utilization",98,"So this is highly speculative. But if we look at corporate lives from Q1 '09 through the end of Q1 '10, there's about a 2.8% decrease in commercial managed care covered lives. In couple with that not only the decrease in covered lives but the utilization rates of those covered lives that's still have commercial managed care coverage, then you'll have to say that our losses are pretty much about what the shrinkage in the coverage and utilization is and therefore, I would come to the conclusion, we're not losing commercial market share in most of our markets."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So your expectation right now would be a stabilizing economy would at least kind of bring you back to kind of more flattish performance on the commercial side? Is that all that would take to get there, I guess, to stabilize in those numbers? Or is that mo",61,"So your expectation right now would be a stabilizing economy would at least kind of bring you back to kind of more flattish performance on the commercial side? Is that all that would take to get there, I guess, to stabilize in those numbers? Or is that more so you have to achieve some progress on the physician recruiting targets also?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","We got to do both. First of all, you have to have job creation, get the enrollment numbers up. Presumably, there's some pent-up demand when people become re-employed and re-insured again and then of course, the physician. All of the efforts Steve talked a",52,"We got to do both. First of all, you have to have job creation, get the enrollment numbers up. Presumably, there's some pent-up demand when people become re-employed and re-insured again and then of course, the physician. All of the efforts Steve talked about earlier on the physician side are incredibly important."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'd give you one leading indicator to look at. And while our outpatient surgeries in aggregate across the company were down in three of the four regions, those outpatient surgeries were up for the quarter and outpatient surgeries are frequently more elect",63,"I'd give you one leading indicator to look at. And while our outpatient surgeries in aggregate across the company were down in three of the four regions, those outpatient surgeries were up for the quarter and outpatient surgeries are frequently more elective surgery, and that might be an early indication of the consumer deciding to move forward and have those procedures done."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","If I was taking the commentary you gave on your March and your April results, assuming that continues and a lot can happen, but would your expectation be the 2Q should show your meaningfully better commercial volume results?",38,"If I was taking the commentary you gave on your March and your April results, assuming that continues and a lot can happen, but would your expectation be the 2Q should show your meaningfully better commercial volume results?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","It's too early to make a prediction like that.",10,"It's too early to make a prediction like that."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Operator","Your next question comes from the line of Doug Simpson of Morgan Stanley.",13,"Your next question comes from the line of Doug Simpson of Morgan Stanley."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","If we try to strip out the cyclical factors and we just think about continued benefit buy downs and the pricing activity you've seen, how would you sort of set up a three-year trend line for commercial volumes if you could isolate some of the shorter-term",48,"If we try to strip out the cyclical factors and we just think about continued benefit buy downs and the pricing activity you've seen, how would you sort of set up a three-year trend line for commercial volumes if you could isolate some of the shorter-term dynamics?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'd say it's impossible to answer that question. It's probably a question more appropriate for somebody following managed care, one of the managed-care companies. But really hard for us to have visibility into that.",35,"I'd say it's impossible to answer that question. It's probably a question more appropriate for somebody following managed care, one of the managed-care companies. But really hard for us to have visibility into that."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then just to follow on the comments on the commercial volumes, are you thinking about potential -- looking into the second half of this year, as people start to hit the 18-month limit around the July, August time frame for the COBRA benefit, is that s",79,"And then just to follow on the comments on the commercial volumes, are you thinking about potential -- looking into the second half of this year, as people start to hit the 18-month limit around the July, August time frame for the COBRA benefit, is that something we should be thinking about in the second half of the year for any impact on volumes? Is that something that would show up, or does it not really move the needle?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","We've been asked so many times about COBRA. And as you realize, when patients come into our hospitals, they either have insurance or they don't. We don't know if they've obtained that insurance under COBRA. I suppose that expression of opinion seems to me",61,"We've been asked so many times about COBRA. And as you realize, when patients come into our hospitals, they either have insurance or they don't. We don't know if they've obtained that insurance under COBRA. I suppose that expression of opinion seems to me like COBRA benefit has become pretty popular. It is on the verge of becoming an entitlement."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","And we also tried to estimate the effects. And although we don't have empirical data based upon statistics provided by managed-care payors and others, we don't believe it has significant impact on us. That could be wrong. We don't believe so.",41,"And we also tried to estimate the effects. And although we don't have empirical data based upon statistics provided by managed-care payors and others, we don't believe it has significant impact on us. That could be wrong. We don't believe so."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Is there any directional commentary just in the second half cash flow seasonality just as we're thinking through the models?",21,"Is there any directional commentary just in the second half cash flow seasonality just as we're thinking through the models?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well the most significant element of cash flow seasonality is in the first quarter, we have a big usage in working capital related to the payment of 401(k), our incentive compensation plans and the normal pay down of payables that occurs after having a bu",89,"Well the most significant element of cash flow seasonality is in the first quarter, we have a big usage in working capital related to the payment of 401(k), our incentive compensation plans and the normal pay down of payables that occurs after having a build up at the end of the year. That effectively reverses itself over the remainder of the year. So if you look at our cash walk-forward, you'd see that working capital for the next three quarters is expected to be a significant source of cash."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","In each of the three quarters?",6,"In each of the three quarters?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Yes. Particularly, it builds up I think in the fourth quarter. Some of the things like incentive comp, 401(k) build more or less over the course of the year, but we talk about payables growth, that's more of a fourth quarter activity.",42,"Yes. Particularly, it builds up I think in the fourth quarter. Some of the things like incentive comp, 401(k) build more or less over the course of the year, but we talk about payables growth, that's more of a fourth quarter activity."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Operator","Your next question comes from the line of Whit Mayo of Robert Baird.",13,"Your next question comes from the line of Whit Mayo of Robert Baird."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","You've alluded recently to me what seems to be a more aggressive posture with regards to outpatient investments and service line development. Maybe, Trevor, can you talk a little bit about how you're thinking about in-market acquisitions now and how impor",50,"You've alluded recently to me what seems to be a more aggressive posture with regards to outpatient investments and service line development. Maybe, Trevor, can you talk a little bit about how you're thinking about in-market acquisitions now and how important that is to your overall strategy going forward?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","That's a very timely question because actually, last Friday, we closed on an outpatient acquisition, outpatient center acquisition in Nacogdoches, Texas. So acquiring outpatient centers is a key part of our outpatient development strategy. We are taking a",137,"That's a very timely question because actually, last Friday, we closed on an outpatient acquisition, outpatient center acquisition in Nacogdoches, Texas. So acquiring outpatient centers is a key part of our outpatient development strategy. We are taking a more aggressive position at least in terms of activity in looking at inpatient acquisitions. We're little reluctant to get involved in this acquisition. I might characterize that as turnaround where you've got a system in distress that's leading, and a lot of capital in some time is required to turn it around. But we've at least made it clear to brokers who are involved in the traffic of these types of transactions that people that they should talk to about it. We find the outpatient segment a more fertile opportunity but obviously small dollars and a smaller impact."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And maybe any way to maybe sort of size up expectations of maybe what we can expect to see over the course of the next 12 months or so?",29,"And maybe any way to maybe sort of size up expectations of maybe what we can expect to see over the course of the next 12 months or so?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","I don't think so. At this point, I've always been reluctant to give expectations around acquisition pipelines, because it can put undue pressure on the people inside the company try and make acquisitions work that otherwise we shouldn't make. But I think",56,"I don't think so. At this point, I've always been reluctant to give expectations around acquisition pipelines, because it can put undue pressure on the people inside the company try and make acquisitions work that otherwise we shouldn't make. But I think you can expect us to announce and disclose them as we do them."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Operator","Your next question comes from the line of John Ransom of Raymond James.",13,"Your next question comes from the line of John Ransom of Raymond James."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Just trying to get a little more behind the strong pricing, is that truly all pricing or was there some acuity in there as well?",25,"Just trying to get a little more behind the strong pricing, is that truly all pricing or was there some acuity in there as well?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","It's clearly both. We do have strong pricing increases, result of all the negotiation that have taken place over the last couple of years. But in addition, it is a fair amount of acuity in the quarter too, so that's one thing that you look through the rem",86,"It's clearly both. We do have strong pricing increases, result of all the negotiation that have taken place over the last couple of years. But in addition, it is a fair amount of acuity in the quarter too, so that's one thing that you look through the remainder of the year. We would expect the same year-over-year increase in per-unit revenue that we had in the first quarter on commercial. But it's still expected to be favorable and aligned with last year from negotiation standpoint."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","For example, what was your Medicare exchange quarter-over-quarter?",8,"For example, what was your Medicare exchange quarter-over-quarter?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","It went up a few percent.",6,"It went up a few percent."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So if you had a guess, is that 60/40 price acuity, 70/30, 80/20, 50/50. I mean, just some ballpark number?",20,"So if you had a guess, is that 60/40 price acuity, 70/30, 80/20, 50/50. I mean, just some ballpark number?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","I don't have the exact stats here and I don't want to guess.",14,"I don't have the exact stats here and I don't want to guess."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","The second question, just kind of going back, I'm always interested in when companies talk about things for a while and they try things to see how they work out. I know you had this big program under an old regime to have engage these footer positions and",98,"The second question, just kind of going back, I'm always interested in when companies talk about things for a while and they try things to see how they work out. I know you had this big program under an old regime to have engage these footer positions and you also had a big -- you were earlier than most in terms of focusing on quality. So now that we're kind of three to five years beyond that, can you look back on that and say what worked and what didn't worked and how we should think about it?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Short answer, John, would be we're very happy we focused on quality. We continue to drive on quality. We're trying to improve patient safety. We've been continuously disappointed that we haven't been rewarded with both hard steerage and enough premium eve",117,"Short answer, John, would be we're very happy we focused on quality. We continue to drive on quality. We're trying to improve patient safety. We've been continuously disappointed that we haven't been rewarded with both hard steerage and enough premium even though we're getting incentive payments from commercial payers today for the effort that we put in, but we continue to believe long term, it's the right strategy. With respect to our Physician Relationship Program, we're continually refining that. We've recently changed the incentive comp of the PRP representatives, the organization of that comp. We're improving their targeting on a monthly basis and we continue to believe that we'll pay dividends and we're confident in those strategies."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Operator","And your last question comes from the line of Justin Lake of UBS.",13,"And your last question comes from the line of Justin Lake of UBS."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Just a quick follow-up on some of the commercial questions. I was wondering if you could -- you talk about the disparity between price there, obviously mix is improving. Can you talk about the differential between elective admissions or schedule admission",58,"Just a quick follow-up on some of the commercial questions. I was wondering if you could -- you talk about the disparity between price there, obviously mix is improving. Can you talk about the differential between elective admissions or schedule admissions versus admissions coming from the ER on the commercial side and how that might have changed?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","I think, the short answer would be, Justin, that we've seen weakness in our elective admissions and it seems to permeate preferentially the commercial line. As you might expect with their deductibles and co-pays and people not wanting to miss work, their",84,"I think, the short answer would be, Justin, that we've seen weakness in our elective admissions and it seems to permeate preferentially the commercial line. As you might expect with their deductibles and co-pays and people not wanting to miss work, their elective surgeries on the inpatient basis would be down. On the other hand, Medicare elective admissions are not down significantly and those people have annual co-pays deductibles that don't change dramatically year-for-year. And if they're on fixed incomes, neither do their incomes."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And does the average acuity of an elective admission, I would assume, is probably lower than something coming through the emergency room? Would that be driving some of the mix shift?",31,"And does the average acuity of an elective admission, I would assume, is probably lower than something coming through the emergency room? Would that be driving some of the mix shift?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","That's generally correct.",4,"That's generally correct."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Is there a way to, I mean, think about that from a market share standpoint? I would assume that the market share of emerging admissions is less tied to things like physician recruitment, and your capital spending, things like that, what others are doing i",83,"Is there a way to, I mean, think about that from a market share standpoint? I would assume that the market share of emerging admissions is less tied to things like physician recruitment, and your capital spending, things like that, what others are doing in the market, the ambulance is going to come to the closest hospital rather than an elective procedure? Is there a way to think about that from a market share perspective and kind of relate it versus the economy?"
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'm not sure you could really interrelate those variables and draw our market share conclusion from that, Justin.",19,"I'm not sure you could really interrelate those variables and draw our market share conclusion from that, Justin."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'm sorry we're not able to take everyone's question, but we were determined to leave this call at a one-hour time length. If you have further questions, feel free to call us. Also, I'd like to remind everyone that we will be in New York next week present",69,"I'm sorry we're not able to take everyone's question, but we were determined to leave this call at a one-hour time length. If you have further questions, feel free to call us. Also, I'd like to remind everyone that we will be in New York next week presenting at the BofA Conference and we look forward to seeing many of you there. So operator, this concludes the call."
107911,100324930,59497,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Operator","Ladies and gentlemen, thank you for your participation in today's conference. This concludes the presentation. You may now disconnect. Have a great day.",23,"Ladies and gentlemen, thank you for your participation in today's conference. This concludes the presentation. You may now disconnect. Have a great day."
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Operator","Good day, ladies and gentlemen, and welcome to the Q1 2010 Tenet Healthcare Earnings Conference Call. My name is Caitlin, and I will be your operator for today. [Operator Instructions] I would now like to turn the conference over to your host for today's",56,"Good day, ladies and gentlemen, and welcome to the Q1 2010 Tenet Healthcare Earnings Conference Call. My name is Caitlin, and I will be your operator for today. [Operator Instructions] I would now like to turn the conference over to your host for today's call, Mr. Thomas Rice, Senior Vice President of Investor Relations. Please proceed.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, operator, and good morning, everyone. Tenet's management will be making forward-looking statements on this morning's call. These statements are based on management's current expectation and are subject to risks and uncertainties that may cause",97,"Thank you, operator, and good morning, everyone. Tenet's management will be making forward-looking statements on this morning's call. These statements are based on management's current expectation and are subject to risks and uncertainties that may cause those forward-looking statements to be materially incorrect. Management cautions you not to rely on and makes no promises to update any of the forward-looking statements. During the Q&A portion of the call, callers are requested to limit themselves to one question and one follow-up question. 
At this time, I will turn the call over to Trevor Fetter, Tenet's President and CEO.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thanks, Tom, and good morning, everyone. I said on our February conference call that we're making changes to our Investor Relations program for 2010. As you've already noticed, we shorted our earnings release significantly. Our intention is to narrow the",895,"Thanks, Tom, and good morning, everyone. I said on our February conference call that we're making changes to our Investor Relations program for 2010. As you've already noticed, we shorted our earnings release significantly. Our intention is to narrow the focus to the key items driving our performance in the quarter. Let me assure all of you, we value the extent of our disclosures, that we're still completely committed to transparency. All of the information you're used to seeing in our earnings release is still in our 10-Q. 
We're also going to streamline this call. Biggs and I will be the only speakers making prepared remarks, but Steve Newman and others are here to answer questions. We've cut the length of our remarks to 10 minutes, so that we'll have plenty of time for Q&A and can still finish the call within one hour. So in the spirit of being concise, let me jump right into a discussion of our results. 
I'm very pleased with our adjusted EBITDA for the first quarter, which grew more than 7% over last year's first quarter and reached a margin of 12.7%, our highest quarterly margin in seven years. Our adjusted EBITDA in the first quarter was greater than in any first quarters in 2003, and we achieved it with half the number of hospitals we had then. On the basis of the strong start to the year, we are confirming our existing full year outlook for adjusted EBITDA in a range of $985 million to $1,050,000,000. 
While we achieved our earnings objective for the quarter, volumes were soft, but our performance was excellent in the other key economic drivers of acuity, pricing and cost control. Our proven ability to control cost has significant positive implications for our longer-term operating leverage. Once we achieve a meaningful and sustained recovery in volumes, we now had to turn the resulting revenue growth into attractive growth on the bottom line.  This quarter, for example, we took a decline of 2% in admissions, turned it into 3.4% growth in revenues and into more than double that rate of growth in EBITDA. We should be able to do better than that with some volume growth. 
While volumes for the first quarter were disappointing, the month-by-month trajectory of volumes was encouraging. To be specific, January and February were weak but the trend was better in March. On the outpatient side, the year-over-year growth rates in March were more than 500 basis points stronger than February, indicating one of the strongest snap backs we've ever seen. 
The trend in admissions through the first 28 days in April was similar to March, although commercial is trending a bit stronger and outpatient visits are trending a bit weaker. This shows the kind of short-term volatility in patient volumes that we've talked about on prior calls.
Other companies have mentioned that bad weather, lack of flu, declining birthrates and bad economic conditions depressed volumes. And although we agree that they had an effect, it's difficult to quantify precisely. 
Our admissions through the emergency department continue to achieve positive year-over-year growth in the quarter. This indicates that our soft volumes are primarily limited to our Elective business. This should not surprising as elective procedures are most directly impacted by a slow economy.
Strong growth in revenues per unit continues to make a significant contribution to our earnings momentum. In patient revenue per admission ran 160 basis points stronger than the midpoint of our outlook assumption, and the favorable variance was more than 400 basis points on the outpatient side. Our pricing was enhanced by higher acuity, particularly in our commercial business. And given that 80% of our contract volume is negotiated for 2010 and more than 60% for 2011, we are confident this strength will continue to help drive our earnings growth.
As I mentioned earlier, cost control was once against stellar in the quarter. Total controllable costs increased by only 1.3%. Now practice expense continue to decline, and we even picked up $2 million in savings in the quarter from reduced rent at our new corporate headquarters. 
Bad debt expense increased in the quarter, but the fully allocated cost of providing uncompensated care, that is care to both uninsured and charity patients, increased by only $6 million from last year's first quarter. This is far smaller than the $33 million increase in bad debt expense year-over-year. The tangible EBITDA impact, of course, is strictly limited to the cost of care as opposed to the largely offsetting movements in revenue and bad debt line items.
These numerous factors all helped us improve adjusted free cash flow in the quarter by $33 million compared to last year's first quarter. The first quarter is always the lowest in terms of adjusted free cash flow due to the timing of certain annual cash payments but clearly, it is trending in the right direction. 
To summarize, I'm pleased with our response to the continued weak economy and soft-volume environment in the quarter. When confronted by this extraordinary challenges, our hospital management teams responded quickly and effectively to maintain our positive earnings trajectory. Now with the resumption of volume growth, I'm confident we can generate some truly outstanding bottom line performance. 
Let me turn things over to Biggs who will share some commentary on our outlook. And then, open up the call to Q&A. Biggs?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, Trevor, and good morning, everyone. I will limit my introductory comments this morning to the refinements we are making to our outlook for 2010. Our most important comment is that we are confirming the outlook range for adjusted EBITDA for 2010",905,"Thank you, Trevor, and good morning, everyone. I will limit my introductory comments this morning to the refinements we are making to our outlook for 2010. Our most important comment is that we are confirming the outlook range for adjusted EBITDA for 2010. Earlier in the year, we set our outlook range of $985 million to $1,050,000,000. That range continues to appear very realistic to us. 
The summary of our refinements to our outlook assumptions is provided on Slide 6 on the web. On that slide, you'll see that softer volumes in our first quarter have caused us to re-evaluate our volume outlook for the year. Our outlook for admissions growth has been reduced by 100 basis points. We're now assuming admissions will decline 50 to 150 basis points in 2010 as contrasted with our initial assumption of approximately flat admissions for the year. 
Because our initial assumption for 2010 growth in outpatient visits was significantly stronger, we reduced the outlook on the outpatient side by a more significant 200 basis points. Having said that, much of the volume declines in the first quarter relative to last year and correspondingly the variance in our expectation for the year is in lower acuity conditions. So the revenue and EBITDA effects are not as significant. 
Accordingly, pricing on a per patient basis is favorably impacted by this patient mix shift to higher acuity. We're now significantly more positive on the growth we assume can be achieved in unit revenues. Our assumption for growth in inpatient revenue per admission is now more bullish 300 to 400 basis points, representing an enhancement to our initial growth assumption of 100 basis points. We are making similar 100 basis point refinement to our assumed growth in outpatient revenue per visit to a new range of 400 to 500 basis points.
These enhanced assumptions for pricing significantly mitigate the adverse impact on assumed 2010 revenues. We believe only a $50 million decrease and assume 2010 revenues would be necessary to reflect lower volume projection. We believe this modest reduction in our revenue outlook can be offset by an equal, if not greater reduction in our outlook for 2010 controllable costs.
About half of these savings are directly linked to the revised volume projection, and the remaining related to enhanced assumptions regarding incremental cost efficiencies. These efficiencies include the improvements in productivity, malpractice and other controllable expenses we benefited from in the quarter. 
Before leaving our cost assumptions, let me remind you, again, that we've included a $40 million in assumed incremental cost in our 2010 outlook to cover the impact of our accelerated HIT program. As we proceed with the implementation, we continue to look for opportunities to reduce the 2010 expense. But at this time, we're going to remain conservative with respect to this $40 million estimate. This program continues to be implemented on schedule, and we expect to begin generating some offsetting revenues as early as late next year and to be completely offsetting in this incremental expense by revenues and operating benefits beginning in 2012.  The increase in bad debt expense we experienced in the first quarter is fully consistent with our prior outlook, which therefore remains unchanged. 
We had no cause, at this point, to change any of the other assumptions embedded in our outlook. In particular, there is nothing incremental to report on the California provider fee, although investors should be aware that this is only $30 million in the middle of our range, and there is considerable upside to that number.
As these assumptions for softer volumes offset by higher acuity, per unit revenue and cost reductions are worked through our models. The result is confirmation of our pre-existing 2010 range for adjusted EBITDA. With no change to our EBITDA outlook, there is no change to our GAAP earnings, although we've made certain adjustments to our share count, in part reflecting changes in our share price.
We've also added an outlook line item for EPS reflecting tax expense without any pro forma normalization for changes in our NOL valuation allowance. Book tax expense could, in fact, become significantly favorable this year should we qualify for the recognition in the tax provision of some or all of the $1 billion benefit of our NOL carry forward and other deferred tax benefits prior to year-end 2010. Under Generally Accepted Accounting Principles, this recognition occurs when the company has demonstrated that there is a reasonable expectation of future taxable income sufficient to realize the benefit of the NOL. Due to our demonstrated improved performance, we are approaching that point in time and will continue to assess this quarterly.
In summary, we remain confident that our initiatives to drive revenue growth, control costs and drive increasingly positive bottom line profitability and free cash flow will be successful. The ranges we have assumed in 2010 for pricing, revenues and adjusted EBITDA allow for effects, either partially or totally out of our control, related to the recession. We believe the recent pattern of volume declines will improve and on an intraperiod basis, these trends are improving. 
Looking past 2010, I will also reiterate that as the economy improve, we believe we will see improvement in commercial volumes and bad debt expense and believe we will also benefit from our initiatives to grow outpatient volumes organically and through selective acquisitions. 
With that, I'll ask the operator to open the floor for questions. Operator?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Operator","[Operator Instructions] Your first question comes from the line of Tom Gallucci of Lazard Capital Markets.",16,"[Operator Instructions] Your first question comes from the line of Tom Gallucci of Lazard Capital Markets.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Obviously, you've done a strong job on the cost control side. Just looking at the volumes a little bit more closely, how do you sort of view your market share, I guess. Do you think that the pressures that you're seeing out there are equal or perhaps, you",62,"Obviously, you've done a strong job on the cost control side. Just looking at the volumes a little bit more closely, how do you sort of view your market share, I guess. Do you think that the pressures that you're seeing out there are equal or perhaps, your losing any market share, I guess both overall and then particularly, within the managed-care?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","We share your concerns regarding market share. And during Q1, we did a very deep dive into our market share across the country. And our results really were quite encouraging. For example, if you'd look at our hospitals in the following states, you get the",95,"We share your concerns regarding market share. And during Q1, we did a very deep dive into our market share across the country. And our results really were quite encouraging. For example, if you'd look at our hospitals in the following states, you get the following results. California was up 0.1%,  Florida was up 0.3%, Texas was up 1.2%, Missouri was up 0.3%, Georgia was flat, and our only state that was down was North Carolina, where we lost market share of 1.1%. This covered the change in market share between 2008 and through 12/31/09.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Okay. So that was your estimated change in market share for your facilities in those markets?",16,"Okay. So that was your estimated change in market share for your facilities in those markets?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","That's right, Tom.",4,"That's right, Tom.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then just maybe can you give us a little bit more detail, we've seen a lot of headlines over the last couple of years about managed-care relationships and, in certain cases, expanding those. But can you talk about maybe a little bit an update on what",80,"And then just maybe can you give us a little bit more detail, we've seen a lot of headlines over the last couple of years about managed-care relationships and, in certain cases, expanding those. But can you talk about maybe a little bit an update on what you're doing in terms of either positioning, creating or working on splitter-type docs to really get the leverage out of the contracts that you're signing and get the volumes through the door ultimately?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","I think those are both important aspects that we're working on, Tom. We have a big push to make sure all of our active medical staff are participating in the networks of the managed-care companies that we've contracted with. We see variability across the",140,"I think those are both important aspects that we're working on, Tom. We have a big push to make sure all of our active medical staff are participating in the networks of the managed-care companies that we've contracted with. We see variability across the country by pair in terms of that. They range from 70% to 90%. We're trying to push all of them to the 90% level. That gives our doctors the opportunity to take care of those patients that are inpatient and outpatient facilities. We're also organizing our physicians in selected markets around the country to contract with managed-care payers on a single signature. Done that in a couple of areas, we continue to do that. We believe that's a proactive strategy, getting us ready for the post-health reform era with bundling and creating accountable care organizations.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Operator","Your next question comes from the line of Adam Feinstein of Barclays Capital.",13,"Your next question comes from the line of Adam Feinstein of Barclays Capital.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Maybe just a couple of questions on the cost management, obviously, very strong trends there. So just maybe a few things I want to go into. I guess last quarter, you called out some items that were somewhat one-time in nature, in terms of labor costs, in",103,"Maybe just a couple of questions on the cost management, obviously, very strong trends there. So just maybe a few things I want to go into. I guess last quarter, you called out some items that were somewhat one-time in nature, in terms of labor costs, in terms of merit increases and 401(k) matching, but I would expect there was probably some fall through. So I guess last quarter you caught about like $25 million of incremental cost. I was just wondering if any of those costs were still -- any incremental cost there in the first quarter that we should think about?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","No, there weren't any unusual one-time type of expenses or step-ups over the prior year to note in the first quarter. The HIT expenses, which we of course said we expected for the full year, were very evident in the first quarter. That will ramp up more l",51,"No, there weren't any unusual one-time type of expenses or step-ups over the prior year to note in the first quarter. The HIT expenses, which we of course said we expected for the full year, were very evident in the first quarter. That will ramp up more later in the year.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then as we look at the cost, once again, great cost management, controllable operating cost of 1.3%. And now the quarter, on a per adjusted patient day basis of 3.5%, which is still a lower than normalized number. But just curious as you guys think ab",110,"And then as we look at the cost, once again, great cost management, controllable operating cost of 1.3%. And now the quarter, on a per adjusted patient day basis of 3.5%, which is still a lower than normalized number. But just curious as you guys think about it, do you look at more at the total number? Or do you look at it more on an adjusted patient day? So just as you guys think about that, and I know what was going on with patient days, but I guess just trying to think about in terms of managing the business, in terms of how you guys analyze those metrics?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, we look at it both ways. Certainly, the benefit of looking it on a patient-day basis is it normalize it for volumes swings. So that is an important metric. It is not a perfect metric because, as we know, shifts between inpatient and outpatient and o",93,"Well, we look at it both ways. Certainly, the benefit of looking it on a patient-day basis is it normalize it for volumes swings. So that is an important metric. It is not a perfect metric because, as we know, shifts between inpatient and outpatient and other mixed shifts can create some distortion in the stat. So it's not a perfect stat. And you have to always be aware of that, but it is best one available and it is one we used on a regular basis to look at our cost performance.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So you guys are think that, that 3.5% is a better way to think about cost relative to the 1.3%?",20,"So you guys are think that, that 3.5% is a better way to think about cost relative to the 1.3%?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, at the end of the day, obviously driving down total costs relative while you're trying to drive up revenue is the key. And so total cost performance is important. If we're looking at productivity, yes, we try to get down to a patient-day basis, but",66,"Well, at the end of the day, obviously driving down total costs relative while you're trying to drive up revenue is the key. And so total cost performance is important. If we're looking at productivity, yes, we try to get down to a patient-day basis, but obviously the bottom line is the most important thing. And so at a macro level, we have to manage to.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I guess on the 10-Q, you mentioned -- you were talking about some of the regional variability here and the talked about three out of four regions suddenly decline in volumes. And then on the outpatient side, just mentioned that the central region did well",85,"I guess on the 10-Q, you mentioned -- you were talking about some of the regional variability here and the talked about three out of four regions suddenly decline in volumes. And then on the outpatient side, just mentioned that the central region did well. So I was just curious if you could just talk a little bit more on the regions, and I guess what was it about the central region which led to better volume growth than some of the other regions?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Adam, that's correct. We did say that in the Q. I want to give you some additional color about outpatient visits and variation by region. Certainly, our outpatient declines across the company were largely related to imaging declines. About 70% of the tota",197,"Adam, that's correct. We did say that in the Q. I want to give you some additional color about outpatient visits and variation by region. Certainly, our outpatient declines across the company were largely related to imaging declines. About 70% of the total was hospital-based imaging being declined for the quarter, also with outpatient laboratory testing contributed to that. It's only isolated to two sites in California. And to some extent, also compromised in Texas with respect to outpatient. That may sound odd since Texas is part of the central region. But in those two sites in California, physician IPA-owned facilities opened, which took imaging and laboratory testing out of the hospitals. And we have a unique situation in Texas where freestanding emergency rooms were approved by legislature. That then pulled some visits out of our hospitals, especially in Houston and Dallas. So central was stronger in aggregate, but those two issues really aggregated to keep our outpatient visits negative. And when you consider the lack of flu-types syndromes that we saw last year in our ERs, which we didn't see this year, I think our aggregate performance down 0.6% and emergency visits really was quite minimal.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Operator","Your next question comes from the line of Ralph Giacobbe of Crdit Suisse.",13,"Your next question comes from the line of Ralph Giacobbe of Crdit Suisse.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I know you guys don't give quarterly guidance, but is it fair to look at the progression of EBITDA we saw last year as sort of a way to think about this year? Or should we be thinking about that differently?",42,"I know you guys don't give quarterly guidance, but is it fair to look at the progression of EBITDA we saw last year as sort of a way to think about this year? Or should we be thinking about that differently?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","You're right, we don't give quarterly guidance. And actually at this point, I'd have to go back to look at the progression last year. I think that last year was flatter than what we've experienced from a seasonal fluctuations standpoint in the past. While",156,"You're right, we don't give quarterly guidance. And actually at this point, I'd have to go back to look at the progression last year. I think that last year was flatter than what we've experienced from a seasonal fluctuations standpoint in the past. While we're in a recession, I think it's a little harder to say that normal seasonal patterns work. We certainly are expecting that as the economy stabilizes and improves that we will see some positive trends as we proceed through the year. And in particular, the fact that we were off to a slow start on volumes, we expect to see that turned and for those trends to improve through the remainder of the year. So it makes it I think a little bit harder to say it's going to look like the past. I'm sorry that doesn't answer -- it give you two clear view but that's all I can give.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I mean, last year, I think it was something like 27% or 28% EBITDA came in the first quarter. Now, obviously, this first quarter is a little bit weaker as it relates to the volumes side of things. So I was just wondering if that wasn't the right way to th",63,"I mean, last year, I think it was something like 27% or 28% EBITDA came in the first quarter. Now, obviously, this first quarter is a little bit weaker as it relates to the volumes side of things. So I was just wondering if that wasn't the right way to think about things because last year, obviously, disproportionate came in the first quarter?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, I think if you -- certainly, if you look at our outlook for the year of $985 million to $1.050 billion that suggest that there's some variation in the first quarter and remainder of the year. That's about as far as I'd come to giving you quarter-by-",49,"Well, I think if you -- certainly, if you look at our outlook for the year of $985 million to $1.050 billion that suggest that there's some variation in the first quarter and remainder of the year. That's about as far as I'd come to giving you quarter-by-quarter look.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then just want to go back to your comments on the managed care side, I think you said 80% of the book was done for 2010, 60%, 2011. Can you give us just the average rates between those years?",40,"And then just want to go back to your comments on the managed care side, I think you said 80% of the book was done for 2010, 60%, 2011. Can you give us just the average rates between those years?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'm sorry, what do you mean the...",8,"I'm sorry, what do you mean the...
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Or range? Just your pricing point increases.",7,"Or range? Just your pricing point increases.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","In terms of pricing, I think the ballot say this year should be the same as last year. And then we were not quite at the point of projecting the 2011 numbers yet, even though our 60% in, we have pretty good visibility, which is at the point of 2011 guidan",51,"In terms of pricing, I think the ballot say this year should be the same as last year. And then we were not quite at the point of projecting the 2011 numbers yet, even though our 60% in, we have pretty good visibility, which is at the point of 2011 guidance.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Operator","Your next question comes from the line of Shelly Gnall of Goldman Sachs.",13,"Your next question comes from the line of Shelly Gnall of Goldman Sachs.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","A question on the supply cost. So at first, it just looks like there's some improvement here. As a percent of revenue, you've got the supply cost down to 17% now. That's down 30 basis points year-over-year. But if we look at the supply cost per adjusted a",129,"A question on the supply cost. So at first, it just looks like there's some improvement here. As a percent of revenue, you've got the supply cost down to 17% now. That's down 30 basis points year-over-year. But if we look at the supply cost per adjusted admission, I guess we're seeing -- is that first, is how you look at it? And would you agree that we're seeing 3% inflation on the supply cost so far this year? So if that's the right way to look at it, can you tell us if we're seeing any of the benefits from your MPI initiative at this point in the results? Especially, are we seeing any of the $30 million supply cost savings that were guided in the last call?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Biggs, why don't you address the outlook related part of the question. We'll have Steve say a little bit about MPI and some of the accomplishments there in the supply chain.",31,"Biggs, why don't you address the outlook related part of the question. We'll have Steve say a little bit about MPI and some of the accomplishments there in the supply chain.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, I think we were pleased with our supply cost performance in the quarter. I think you had a question as to we ever look at it on a patient day basis. I think that there are problems with looking at supplies like -- and I'm going to go back to earlier",182,"Well, I think we were pleased with our supply cost performance in the quarter. I think you had a question as to we ever look at it on a patient day basis. I think that there are problems with looking at supplies like -- and I'm going to go back to earlier question, in this case, you can have a mix affecting the areas in which supply expenses are incurred that don't show up in the adjusted patient day denominator. So by example, if you have more surgeries, it does proportionally change your patient days but it may change your supply more significantly. So you really have to dig in and understand on a specific basis what's happening in the business, now that supplies are performing against that. So admittedly, it's hards for you all to do it, totally from the outside looking in. So for the year, we certainly still believe we're going to get yield from all of our supplies initiatives, including MPI, nothing has changed there. I'll let Steve talk to what we've been able to do so far.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Shelley, just for example, in the first quarter, our spinal surgeries were up significantly year-over-year. Those are very high-cost implants, yet each of those still just contributes the same as any other surgical procedure in terms of adjusted admission",131,"Shelley, just for example, in the first quarter, our spinal surgeries were up significantly year-over-year. Those are very high-cost implants, yet each of those still just contributes the same as any other surgical procedure in terms of adjusted admissions. We're doing a number of things in MPI to continue to drive our supply cost down. The impact from MPI is both short-term and long-term. We're able to certainly continue our efforts to drive down individual unit pricing. In terms of implants, we just had a concession on our cardiacs stent implants with another 10% drop. That, combined with more appropriate utilization, is going to continue to drive down our supply cost in cardiac interventions. So I think those are two examples of how we're continuing to drive our supply cost down.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","To Steve, to follow-up with what we've seen so far, I guess. If you are able to consolidate vendors, for example, in the spinal side or on the cardiac side, for the hospitals where you're doing MPI on a targeted DRGs right now, is it too soon to see the s",109,"To Steve, to follow-up with what we've seen so far, I guess. If you are able to consolidate vendors, for example, in the spinal side or on the cardiac side, for the hospitals where you're doing MPI on a targeted DRGs right now, is it too soon to see the supply cost savings in the results that came out today? So if you do consolidate vendors or limit your product selection, does that contracting take time to flow through, so we wouldn't see it until next quarter, six months from now? I mean, does it get push out like that? Or will we see some cost savings in realtime?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","I think to answer your question directly, Shelley, some of the savings you would've seen in the quarter in cardiac, especially those where we touched those first-wave hospitals and some of the cardiac DRGs in 2009, they would in fact show up in this quart",94,"I think to answer your question directly, Shelley, some of the savings you would've seen in the quarter in cardiac, especially those where we touched those first-wave hospitals and some of the cardiac DRGs in 2009, they would in fact show up in this quarter. Others, as we flow-through, take more time to develop. So it's both short- and longer-term cost savings in the supply area. Also, I should mention that we're working continuously on length of stay and driving down other variable costs, other than the supply cost, through the Medicare performance initiative.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","On the charity care, you're seeing less charity care in the quarter. Can you talk a little bit about what's driving that? Is that the Right Care Right Place initiative?",30,"On the charity care, you're seeing less charity care in the quarter. Can you talk a little bit about what's driving that? Is that the Right Care Right Place initiative?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, I think that it will be a combination of things. It would be the right care, right place initiative. Also our eligibility program where we have reps in all the hospitals working to get people qualify for Medicaid. So we're pretty confident that over",105,"Well, I think that it will be a combination of things. It would be the right care, right place initiative. Also our eligibility program where we have reps in all the hospitals working to get people qualify for Medicaid. So we're pretty confident that over the last couple of years, we've gotten more people qualify for Medicaid than we had previously. So those are the two primary drivers. There's also some evidence, anecdotal, that some undocumented immigrants are returning to their home economies due to job loss, that's, once again, harder to quantify our track. But all those things are having an effect, we believe.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Operator","Your next question comes from the line of Sheryl Skolnick of CRT Capital Group.",14,"Your next question comes from the line of Sheryl Skolnick of CRT Capital Group.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","The first thing is, I'm going to go back to MPI and I think that there was some interesting disclosures in the Q with respect to the supply cost, et cetera. But what I'm more interested in is, we saw, despite a significant increase in acuity that drove re",110,"The first thing is, I'm going to go back to MPI and I think that there was some interesting disclosures in the Q with respect to the supply cost, et cetera. But what I'm more interested in is, we saw, despite a significant increase in acuity that drove really, I think, perhaps even record rates of growth on outpatient revenue per visit, as well as strong growth on net revenue per adjusted admission. Despite that higher acuity, we saw a reduction in the average length of stay. Now that to me is fascinating. Is this proof of Medicare performance initiative beginning to take root? That's part one of the question.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","I think the short answer to your question is yes. And it is particularly noteworthy that the length of stay was down in the quarter, because our OB deliveries were down 4% or over 730 deliveries. Those, as you know, have a length of stay of between one an",126,"I think the short answer to your question is yes. And it is particularly noteworthy that the length of stay was down in the quarter, because our OB deliveries were down 4% or over 730 deliveries. Those, as you know, have a length of stay of between one and two days and tend to pull down the overall length of stay. So with the absence of those, you would have expected our length of stay to creep up. So I do think the effort that we're putting into the Medicare performance initiative and the rollout of our case management program aggressively to each hospital has made a difference in the length of stay, which then will affect our variable costs and our profitability for inpatient stay.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","The second question is, as we look at the Medicare performance initiative across the board, you addressed the issue of it being both a short-term and a long-term performance. But as you look at your pace at which you're rolling out, the degree to which ph",109,"The second question is, as we look at the Medicare performance initiative across the board, you addressed the issue of it being both a short-term and a long-term performance. But as you look at your pace at which you're rolling out, the degree to which physicians are accepting this, recognizing the changing -- you're not changing employee-physician behavior and as much as you're changing community-based physician behavior, which is the harder thing to do. What has been your experience in your track record to date? How many hospitals have it? How may hospitals are scheduled to get it? And I'll then stop there and let you answer that question.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","With respect to how many have completed Phase I of MPI, they're 20. We expect remaining hospitals to be completed with Phase I rollout by the end of the first quarter of '11. We've also begun Phase II at some of our early hospitals that would be the secon",186,"With respect to how many have completed Phase I of MPI, they're 20. We expect remaining hospitals to be completed with Phase I rollout by the end of the first quarter of '11. We've also begun Phase II at some of our early hospitals that would be the second five MS-DRGs with respect to loss related to excessive variable cost. Back to the issue of physicians, we continue to find physicians interested in learning more about the Medicare performance initiative. We kicked off MPI at one of our Houston hospitals yesterday. We had 30 physicians in attendance. Our Corporate Chief Medical Officer was there as well as our Regional Chief Medical Officer. And I think as the environment changes, as healthcare reform moves forward, as physicians understand their performance, both in their office as well as in-hospitals and outpatient facilities, is being measured by both commercial and governmental payers, with the potential for their pro fees to be affected, they are coming on board with the idea they should participate us. So I do believe that the embracing of MPI by physicians is increasing with time.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And pro fees are professional fees in the aspect of...",11,"And pro fees are professional fees in the aspect of...
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Sorry for the acronym.",4,"Sorry for the acronym.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Yes, and all of that makes a very good sense. I don't know of any doctor wants to stand up in front of it at court and say, ""I take pride and I'm providing lousy care at a high price."" And then if I can move on to another question, which is, given where t",193,"Yes, and all of that makes a very good sense. I don't know of any doctor wants to stand up in front of it at court and say, ""I take pride and I'm providing lousy care at a high price."" And then if I can move on to another question, which is, given where the performance is today -- I'm going to step back from the detail this quarter, given where the performance is today, would you describe the company as having moved out of the initial phases of the turnaround and into the middle innings, number one. Number two, if so, what is more crucial to do right now? And include in this, please, an update on your physician recruiting. Is it to recruit the right physicians in the right markets? Is it to -- as well as the Medicare performance initiative? Is it the control of costs? Is it expansion through acquisitions? Can you give us an idea of your strategic thought process about where the business is today and where it needs to go, say, in the next three years or pick a time frame, but where you are today?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Sheryl, this is Trevor. You know that sports analogies are not my forte, so the...",15,"Sheryl, this is Trevor. You know that sports analogies are not my forte, so the...
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Yes, well the only other thing was to second trimester pregnancy and I don't think people would appreciate either.",19,"Yes, well the only other thing was to second trimester pregnancy and I don't think people would appreciate either.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","No, that wouldn't be any better. So I'll defer on the innings question. I think we clearly put all of the clean up and all of the legacy issues behind us. And so we're just really operating the company in a way where we're focused on the basics of buildin",272,"No, that wouldn't be any better. So I'll defer on the innings question. I think we clearly put all of the clean up and all of the legacy issues behind us. And so we're just really operating the company in a way where we're focused on the basics of building volume, making sure that the pricing increases we are able to get are fair and appropriate and controlling cost. And driving cash through a variety of initiatives, we don't necessarily talk about it on this call, but we've done very well in bringing working capital out of the business. And even seemingly little things, I threw out that little factoid about the savings in rent on our headquarters move. But basically, every decision we make is made with the cost imperative in mind. So I would say that for some time, we've been operating in more of a stable environment. Clearly, volume remains our number one challenge. A few weeks ago, we had our 350 top hospitals and corporate managers here in Dallas for a conference, that was basically the entire topic. So the initiatives we have on volume, the initiatives we have around recruiting physicians, the MPI initiative, which is very directly focused on cost and quality and improving that, those are the engines that we are counting on to continue to drive improvements in the economics. And I think we're approaching a level where although our margins are still low relative to the industry peers, they're not orders of magnitude low like they were and we are within reach continuing to improve the levels that we can be proud of.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","As we look at your guidance for this year, and I think this is a question earlier for Biggs, you did nearly $300 million in EBITDA this quarter. It appears to be as clean an EBITDA number as we've generally seen, so accepting that. And as you've noted, vo",208,"As we look at your guidance for this year, and I think this is a question earlier for Biggs, you did nearly $300 million in EBITDA this quarter. It appears to be as clean an EBITDA number as we've generally seen, so accepting that. And as you've noted, volumes were especially weak, perhaps, affected by weather and lack of flu, the volume comps just simply get a little bit easier, given that weather may straighten itself out, the economy may improve, it just seems to me that if you've done better in the first quarter relative to the midpoint of your guidance, why would you then therefore be -- unless you thought you were going to do this all, why would you therefore be sort of apart from just generally being conservative, doesn't sort of stand to reason that the implied numbers from consensus don't give you enough credit for getting traction on all of the positive things you've identified, but do give you credit for not getting traction on the commercial managed care. Is it simply that given where you are today, it's just more appropriate to be conservative? Because when I look at your numbers and the way they work, I have trouble keeping them down.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, I think that there's a couple of points of conservatism or couple of points where mathematically, there's some cost increase remainder of the year, such as in healthcare IT where we haven't spent much in the first quarter and that's going to go up i",337,"Well, I think that there's a couple of points of conservatism or couple of points where mathematically, there's some cost increase remainder of the year, such as in healthcare IT where we haven't spent much in the first quarter and that's going to go up in the remainder of the year, so that sort of clearly identifiable as a variance in future quarters relative to this one. But having said that, your question is still a good one. I do think we're conservative with respect to cost performance otherwise. Malpractice expense, very low in the first quarter. We find that very challenging to forecast and won't give line item guidance. But in a nutshell, we presume the remainder of the year that it goes back up from this first quarter level to stay conservative along that point, and it's quite possible that we will be better than that. As I mentioned before just besides our efforts to control malpractice expense, the fact that there will be likely increasing discount rates into the future will cost that expense to be lower. But at this point in time, that's a difficult thing to forecast just like the economy, so we have left it at a conservative point. Same with our overall cost performance, I think, that we had a very good first quarter. Everything worked well even in a period where we had declining volumes. I think that we haven't fully extended that level of performance out for the remainder of the year to stay conservative as we watch the economy, but once again, we will see how that unfolds. In balance, as I said, we think that our outlook, we're very comfortable with it. I think that we're conservative on the cost, as I said. On the volume side, we still have some improvement to accomplish, so we've decided to leave it alone in the aggregate as far as the overall EBITDA outlook looks. But you're right to look at the cost and say, ""Gee, it appears conservative.""
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Operator","Your next question comes from the line of John Rex of JPMorgan.",12,"Your next question comes from the line of John Rex of JPMorgan.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Just picking up and continuing on kind of the cost commentary you just gave there. So I just want to focus particular on the op expense line. And we think about some of the elements you said that maybe that were running at lower levels than you expect for",100,"Just picking up and continuing on kind of the cost commentary you just gave there. So I just want to focus particular on the op expense line. And we think about some of the elements you said that maybe that were running at lower levels than you expect for the full year. Can you help us size -- if we're jumping off from the absolute dollar level that you reported in the 1Q, what do you think should be kind of more normalized quarterly run rate for that category when you think about some of the elements you just described?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","To be clear, there's nothing in the quarter which isn't repeatable. So I've mentioned malpractice expense and the fact that it could go up, we're very conservative with respect to that point. However it is possible that it will stay at a very low level th",101,"To be clear, there's nothing in the quarter which isn't repeatable. So I've mentioned malpractice expense and the fact that it could go up, we're very conservative with respect to that point. However it is possible that it will stay at a very low level throughout the year. Just difficult to forecast. So I want to resist the temptation, try to create some new run rate and suggest that empirically there's a number in there. It was just what you should multiply times four to get to a full year estimate, because I think that it doesn't quite work that cleanly.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So you wouldn't spike out anything all that unusual -- I mean, so let's take malpractice and set that kind of difficult forecast. Is there any other item you want to spike out and say kind of unusually low in the Q? Or x malpractice, is this a decent run",63,"So you wouldn't spike out anything all that unusual -- I mean, so let's take malpractice and set that kind of difficult forecast. Is there any other item you want to spike out and say kind of unusually low in the Q? Or x malpractice, is this a decent run rate to be thinking about for the stepping off here in 1Q?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","I think, as I said, everything is repeatable. There is good cost performance across the board. If you look at everything from utility, to contract labor, expenses, everything was running well. We managed very effectively all of our efforts over the last c",135,"I think, as I said, everything is repeatable. There is good cost performance across the board. If you look at everything from utility, to contract labor, expenses, everything was running well. We managed very effectively all of our efforts over the last couple of years to fine tune. Our cost management practices were evident. So I don't think there's anything else that I would pick at and say, ""Gee, there is a single event which would unwind or some trend that would unwind."" Malpractice, this is a single largest one in which it's relatively low in the quarter. It could stay low. But for the sake of the forecast, we haven't predicted that. And then HIT expense, we said, will go up over the remainder of the year as that's to more back-end loaded effort.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I appreciate the share data you gave. Just want to be clear on that, was that all in share, or was that managed care volume only?",26,"I appreciate the share data you gave. Just want to be clear on that, was that all in share, or was that managed care volume only?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","That's all payors. It's not possible for us to really get to universe, specifically, of the commercial managed care covered lives and utilization, so we used all payor data.",30,"That's all payors. It's not possible for us to really get to universe, specifically, of the commercial managed care covered lives and utilization, so we used all payor data.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","It would seem like just given where the volumes are running that there has been a share loss on the commercial side, and I know this is going to be way more of an art than a science, but if you think about kind of disaggregating kind of the economic impac",75,"It would seem like just given where the volumes are running that there has been a share loss on the commercial side, and I know this is going to be way more of an art than a science, but if you think about kind of disaggregating kind of the economic impact in your market from what you think the share loss impact might be, when we see kind of the commercial volumes where they're trending?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","So this is highly speculative. But if we look at corporate lives from Q1 '09 through the end of Q1 '10, there's about a 2.8% decrease in commercial managed care covered lives. In couple with that not only the decrease in covered lives but the utilization",98,"So this is highly speculative. But if we look at corporate lives from Q1 '09 through the end of Q1 '10, there's about a 2.8% decrease in commercial managed care covered lives. In couple with that not only the decrease in covered lives but the utilization rates of those covered lives that's still have commercial managed care coverage, then you'll have to say that our losses are pretty much about what the shrinkage in the coverage and utilization is and therefore, I would come to the conclusion, we're not losing commercial market share in most of our markets.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So your expectation right now would be a stabilizing economy would at least kind of bring you back to kind of more flattish performance on the commercial side? Is that all that would take to get there, I guess, to stabilize in those numbers? Or is that mo",61,"So your expectation right now would be a stabilizing economy would at least kind of bring you back to kind of more flattish performance on the commercial side? Is that all that would take to get there, I guess, to stabilize in those numbers? Or is that more so you have to achieve some progress on the physician recruiting targets also?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","We got to do both. First of all, you have to have job creation, get the enrollment numbers up. Presumably, there's some pent-up demand when people become re-employed and re-insured again and then of course, the physician. All of the efforts Steve talked a",52,"We got to do both. First of all, you have to have job creation, get the enrollment numbers up. Presumably, there's some pent-up demand when people become re-employed and re-insured again and then of course, the physician. All of the efforts Steve talked about earlier on the physician side are incredibly important.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'd give you one leading indicator to look at. And while our outpatient surgeries in aggregate across the company were down in three of the four regions, those outpatient surgeries were up for the quarter and outpatient surgeries are frequently more elect",63,"I'd give you one leading indicator to look at. And while our outpatient surgeries in aggregate across the company were down in three of the four regions, those outpatient surgeries were up for the quarter and outpatient surgeries are frequently more elective surgery, and that might be an early indication of the consumer deciding to move forward and have those procedures done.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","If I was taking the commentary you gave on your March and your April results, assuming that continues and a lot can happen, but would your expectation be the 2Q should show your meaningfully better commercial volume results?",38,"If I was taking the commentary you gave on your March and your April results, assuming that continues and a lot can happen, but would your expectation be the 2Q should show your meaningfully better commercial volume results?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","It's too early to make a prediction like that.",10,"It's too early to make a prediction like that.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Operator","Your next question comes from the line of Doug Simpson of Morgan Stanley.",13,"Your next question comes from the line of Doug Simpson of Morgan Stanley.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","If we try to strip out the cyclical factors and we just think about continued benefit buy downs and the pricing activity you've seen, how would you sort of set up a three-year trend line for commercial volumes if you could isolate some of the shorter-term",48,"If we try to strip out the cyclical factors and we just think about continued benefit buy downs and the pricing activity you've seen, how would you sort of set up a three-year trend line for commercial volumes if you could isolate some of the shorter-term dynamics?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'd say it's impossible to answer that question. It's probably a question more appropriate for somebody following managed care, one of the managed-care companies. But really hard for us to have visibility into that.",35,"I'd say it's impossible to answer that question. It's probably a question more appropriate for somebody following managed care, one of the managed-care companies. But really hard for us to have visibility into that.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then just to follow on the comments on the commercial volumes, are you thinking about potential -- looking into the second half of this year, as people start to hit the 18-month limit around the July, August time frame for the COBRA benefit, is that s",79,"And then just to follow on the comments on the commercial volumes, are you thinking about potential -- looking into the second half of this year, as people start to hit the 18-month limit around the July, August time frame for the COBRA benefit, is that something we should be thinking about in the second half of the year for any impact on volumes? Is that something that would show up, or does it not really move the needle?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","We've been asked so many times about COBRA. And as you realize, when patients come into our hospitals, they either have insurance or they don't. We don't know if they've obtained that insurance under COBRA. I suppose that expression of opinion seems to me",61,"We've been asked so many times about COBRA. And as you realize, when patients come into our hospitals, they either have insurance or they don't. We don't know if they've obtained that insurance under COBRA. I suppose that expression of opinion seems to me like COBRA benefit has become pretty popular. It is on the verge of becoming an entitlement.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","And we also tried to estimate the effects. And although we don't have empirical data based upon statistics provided by managed-care payors and others, we don't believe it has significant impact on us. That could be wrong. We don't believe so.",41,"And we also tried to estimate the effects. And although we don't have empirical data based upon statistics provided by managed-care payors and others, we don't believe it has significant impact on us. That could be wrong. We don't believe so.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Is there any directional commentary just in the second half cash flow seasonality just as we're thinking through the models?",21,"Is there any directional commentary just in the second half cash flow seasonality just as we're thinking through the models?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well the most significant element of cash flow seasonality is in the first quarter, we have a big usage in working capital related to the payment of 401(k), our incentive compensation plans and the normal pay down of payables that occurs after having a bu",89,"Well the most significant element of cash flow seasonality is in the first quarter, we have a big usage in working capital related to the payment of 401(k), our incentive compensation plans and the normal pay down of payables that occurs after having a build up at the end of the year. That effectively reverses itself over the remainder of the year. So if you look at our cash walk-forward, you'd see that working capital for the next three quarters is expected to be a significant source of cash.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","In each of the three quarters?",6,"In each of the three quarters?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Yes. Particularly, it builds up I think in the fourth quarter. Some of the things like incentive comp, 401(k) build more or less over the course of the year, but we talk about payables growth, that's more of a fourth quarter activity.",42,"Yes. Particularly, it builds up I think in the fourth quarter. Some of the things like incentive comp, 401(k) build more or less over the course of the year, but we talk about payables growth, that's more of a fourth quarter activity.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Operator","Your next question comes from the line of Whit Mayo of Robert Baird.",13,"Your next question comes from the line of Whit Mayo of Robert Baird.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","You've alluded recently to me what seems to be a more aggressive posture with regards to outpatient investments and service line development. Maybe, Trevor, can you talk a little bit about how you're thinking about in-market acquisitions now and how impor",50,"You've alluded recently to me what seems to be a more aggressive posture with regards to outpatient investments and service line development. Maybe, Trevor, can you talk a little bit about how you're thinking about in-market acquisitions now and how important that is to your overall strategy going forward?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","That's a very timely question because actually, last Friday, we closed on an outpatient acquisition, outpatient center acquisition in Nacogdoches, Texas. So acquiring outpatient centers is a key part of our outpatient development strategy. We are taking a",137,"That's a very timely question because actually, last Friday, we closed on an outpatient acquisition, outpatient center acquisition in Nacogdoches, Texas. So acquiring outpatient centers is a key part of our outpatient development strategy. We are taking a more aggressive position at least in terms of activity in looking at inpatient acquisitions. We're little reluctant to get involved in this acquisition. I might characterize that as turnaround where you've got a system in distress that's leading, and a lot of capital in some time is required to turn it around. But we've at least made it clear to brokers who are involved in the traffic of these types of transactions that people that they should talk to about it. We find the outpatient segment a more fertile opportunity but obviously small dollars and a smaller impact.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And maybe any way to maybe sort of size up expectations of maybe what we can expect to see over the course of the next 12 months or so?",29,"And maybe any way to maybe sort of size up expectations of maybe what we can expect to see over the course of the next 12 months or so?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","I don't think so. At this point, I've always been reluctant to give expectations around acquisition pipelines, because it can put undue pressure on the people inside the company try and make acquisitions work that otherwise we shouldn't make. But I think",56,"I don't think so. At this point, I've always been reluctant to give expectations around acquisition pipelines, because it can put undue pressure on the people inside the company try and make acquisitions work that otherwise we shouldn't make. But I think you can expect us to announce and disclose them as we do them.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Operator","Your next question comes from the line of John Ransom of Raymond James.",13,"Your next question comes from the line of John Ransom of Raymond James.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Just trying to get a little more behind the strong pricing, is that truly all pricing or was there some acuity in there as well?",25,"Just trying to get a little more behind the strong pricing, is that truly all pricing or was there some acuity in there as well?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","It's clearly both. We do have strong pricing increases, result of all the negotiation that have taken place over the last couple of years. But in addition, it is a fair amount of acuity in the quarter too, so that's one thing that you look through the rem",86,"It's clearly both. We do have strong pricing increases, result of all the negotiation that have taken place over the last couple of years. But in addition, it is a fair amount of acuity in the quarter too, so that's one thing that you look through the remainder of the year. We would expect the same year-over-year increase in per-unit revenue that we had in the first quarter on commercial. But it's still expected to be favorable and aligned with last year from negotiation standpoint.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","For example, what was your Medicare exchange quarter-over-quarter?",8,"For example, what was your Medicare exchange quarter-over-quarter?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","It went up a few percent.",6,"It went up a few percent.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So if you had a guess, is that 60/40 price acuity, 70/30, 80/20, 50/50. I mean, just some ballpark number?",20,"So if you had a guess, is that 60/40 price acuity, 70/30, 80/20, 50/50. I mean, just some ballpark number?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","I don't have the exact stats here and I don't want to guess.",14,"I don't have the exact stats here and I don't want to guess.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","The second question, just kind of going back, I'm always interested in when companies talk about things for a while and they try things to see how they work out. I know you had this big program under an old regime to have engage these footer positions and",98,"The second question, just kind of going back, I'm always interested in when companies talk about things for a while and they try things to see how they work out. I know you had this big program under an old regime to have engage these footer positions and you also had a big -- you were earlier than most in terms of focusing on quality. So now that we're kind of three to five years beyond that, can you look back on that and say what worked and what didn't worked and how we should think about it?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","Short answer, John, would be we're very happy we focused on quality. We continue to drive on quality. We're trying to improve patient safety. We've been continuously disappointed that we haven't been rewarded with both hard steerage and enough premium eve",117,"Short answer, John, would be we're very happy we focused on quality. We continue to drive on quality. We're trying to improve patient safety. We've been continuously disappointed that we haven't been rewarded with both hard steerage and enough premium even though we're getting incentive payments from commercial payers today for the effort that we put in, but we continue to believe long term, it's the right strategy. With respect to our Physician Relationship Program, we're continually refining that. We've recently changed the incentive comp of the PRP representatives, the organization of that comp. We're improving their targeting on a monthly basis and we continue to believe that we'll pay dividends and we're confident in those strategies.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Operator","And your last question comes from the line of Justin Lake of UBS.",13,"And your last question comes from the line of Justin Lake of UBS.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Just a quick follow-up on some of the commercial questions. I was wondering if you could -- you talk about the disparity between price there, obviously mix is improving. Can you talk about the differential between elective admissions or schedule admission",58,"Just a quick follow-up on some of the commercial questions. I was wondering if you could -- you talk about the disparity between price there, obviously mix is improving. Can you talk about the differential between elective admissions or schedule admissions versus admissions coming from the ER on the commercial side and how that might have changed?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","I think, the short answer would be, Justin, that we've seen weakness in our elective admissions and it seems to permeate preferentially the commercial line. As you might expect with their deductibles and co-pays and people not wanting to miss work, their",84,"I think, the short answer would be, Justin, that we've seen weakness in our elective admissions and it seems to permeate preferentially the commercial line. As you might expect with their deductibles and co-pays and people not wanting to miss work, their elective surgeries on the inpatient basis would be down. On the other hand, Medicare elective admissions are not down significantly and those people have annual co-pays deductibles that don't change dramatically year-for-year. And if they're on fixed incomes, neither do their incomes.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And does the average acuity of an elective admission, I would assume, is probably lower than something coming through the emergency room? Would that be driving some of the mix shift?",31,"And does the average acuity of an elective admission, I would assume, is probably lower than something coming through the emergency room? Would that be driving some of the mix shift?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","That's generally correct.",4,"That's generally correct.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Is there a way to, I mean, think about that from a market share standpoint? I would assume that the market share of emerging admissions is less tied to things like physician recruitment, and your capital spending, things like that, what others are doing i",83,"Is there a way to, I mean, think about that from a market share standpoint? I would assume that the market share of emerging admissions is less tied to things like physician recruitment, and your capital spending, things like that, what others are doing in the market, the ambulance is going to come to the closest hospital rather than an elective procedure? Is there a way to think about that from a market share perspective and kind of relate it versus the economy?
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'm not sure you could really interrelate those variables and draw our market share conclusion from that, Justin.",19,"I'm not sure you could really interrelate those variables and draw our market share conclusion from that, Justin.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'm sorry we're not able to take everyone's question, but we were determined to leave this call at a one-hour time length. If you have further questions, feel free to call us. Also, I'd like to remind everyone that we will be in New York next week present",69,"I'm sorry we're not able to take everyone's question, but we were determined to leave this call at a one-hour time length. If you have further questions, feel free to call us. Also, I'd like to remind everyone that we will be in New York next week presenting at the BofA Conference and we look forward to seeing many of you there. So operator, this concludes the call.
"
107911,100324930,59504,"Tenet Healthcare Corp., Q1 2010 Earnings Call, May 04, 2010",2010-05-04,"Earnings Calls","Tenet Healthcare Corporation","Operator","Ladies and gentlemen, thank you for your participation in today's conference. This concludes the presentation. You may now disconnect. Have a great day.",23,"Ladies and gentlemen, thank you for your participation in today's conference. This concludes the presentation. You may now disconnect. Have a great day.

"
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","Good day, ladies and gentlemen, and welcome to the Second Quarter 2010 Tenet's Healthcare Earnings Conference Call. My name is Larissa and I will be your operator for today's call. [Operator Instructions] I would now like to turn the conference over to yo",60,"Good day, ladies and gentlemen, and welcome to the Second Quarter 2010 Tenet's Healthcare Earnings Conference Call. My name is Larissa and I will be your operator for today's call. [Operator Instructions] I would now like to turn the conference over to your host for today's call, Mr. Thomas Rice, the Vice President of Investor Relations. You may proceed, sir."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, operator, and good morning, everyone. Tenet's management will be making forward-looking statements on this call. These statements are based on management's current expectations and are subject to risks and uncertainties that may cause those for",98,"Thank you, operator, and good morning, everyone. Tenet's management will be making forward-looking statements on this call. These statements are based on management's current expectations and are subject to risks and uncertainties that may cause those forward-looking statements to be materially incorrect. Management cautions you not to rely on and makes no promises to update any of the forward-looking statements. During the question-and-answer portion of the call, callers are requested to limit themselves to one question and one follow up question.
At this time, I will turn the call over to Trevor Fetter, Tenet's President and CEO. Trevor?"
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, Tom, and good morning, everyone. I'm very pleased with our solid performance in the second quarter. We generated $268 million of adjusted EBITDA, representing 9% growth over 2009 and a margin of 11.6%. We are in the midst of generating one of t",1178,"Thank you, Tom, and good morning, everyone. I'm very pleased with our solid performance in the second quarter. We generated $268 million of adjusted EBITDA, representing 9% growth over 2009 and a margin of 11.6%. We are in the midst of generating one of the strongest earnings trajectories in our recent history, and we faced a difficult comparison versus the second quarter of 2009, when EBITDA was up more than 50%. The 11.6% margin was the highest margin for a second quarter in the last seven years, and we achieved it in a difficult volume environment. 
The in-patient admissions picture was virtually identical to our first quarter, although there was a little more strength in our outpatient business in the second quarter relative to the first. When we released interim second quarter volumes on June 14, the volume picture for the quarter was stronger. Unfortunately, the final few weeks of June and all of July were soft, so we're off to a slow start for volumes in the third quarter. We also started the third quarter with a difficult comparison. Last year at this time, we were off to a strong start for Q3, with positive admissions growth in July.
Turning back to the second quarter, total admissions were down 2%. But that's before you take into account a decline in both flu and OB/GYN-related cases. Had it not been for these two categories, total admissions for the quarter would have been down less than 1%. But we are most disappointed by the 7.2% decline in commercial admissions and the 5.4% decline in commercial outpatient visits. 
Providing context for our commercial volumes relative to the industry continues to be difficult. There is really only one data point so far for the second quarter, namely HCA's negative 5.3% statistic for what they termed ""Managed Care and Other."" Our comparable statistic would have been negative 6.2%. 
While commercial volumes are a part of our story, they are not the whole story. I hope you noticed that our commercial revenues grew by 2%. So clearly, something is helping us mitigate these volume declines. Here's some insight into what's going on beneath the surface of our commercial volume trends.
First, there was a significant pickup in our commercial case mix index which increased 2.8%. Over a third of our decline in commercial admissions was OB/GYN-related. As many of you have written about the decline in U.S. birth rate, it's probably no surprise that the reduction in deliveries explains nearly 20% of our decline in commercial admissions in the second quarter. 
In addition, we had a favorable shift within the mix of our commercial payers from lower-paying to higher-paying health plans. The impact of these two factors, when combined with continuing increases in commercial pricing, resulted in commercial revenue growth of 2%. At the end of the day, it's this revenue growth and solid cost control which drove our 9% growth in EBITDA. 
Also, I don't want to overlook some areas of strength in the overall volume picture. Our outpatient business appears to be picking up after a weaker start to the year. Second quarter aggregate outpatient visits declined by less than 1%, while we saw positive growth in government outpatient of 2%.
Our admissions through the emergency department were equal to last year's statistic. This is further evidence that elective procedures are most directly impacted by a slow economy. And to complete the volume story, note that total government admissions were flat, and adjusted admissions declined by just 0.6%. 
We continue to show strong numbers in the area of cost control and rates. And importantly, the delta between these two variables continues to expand. Inpatient net revenue per admission and outpatient net revenue per visit grew by 4.6% and 5.3% respectively, significantly outpacing a 3.8% growth in controllable costs per adjusted patient day.
Collectively, these factors helped us to generate adjusted free cash flow of $121 million in Q2, bringing free cash flow for the first half to positive $21 million. That's a $23 million improvement on a year-to-date basis from last year and a significant achievement given the large cash consumption that's typical for our first quarter.
Speaking of cash, excluding cash and insurance subsidiaries, we had a corporate cash balance of $600 million at the end of Q2. Taking only into account capital expenditures, July repurchases of $40 million of debt and our planned investment in outpatient centers through the remainder of the year, our year-end outlook for corporate cash is $500 million to $575 million. Based on the improvement in our performance over the last several years and our credit line availability, we believe this amount of cash exceeds our liquidity requirements, even after considering the normal first quarter seasonal usage. Our liquidity will be even greater if we received the full California provider fee and complete the sale of some of our medical office buildings.
I want to spend a moment on two actions that will improve our financial flexibility. First, in order to improve cash flow and manage our debt maturities, today, we launched the refinancing of a portion of our $1 billion of 2013 debt. If we successfully complete this transaction as contemplated, our debt will drop by another $200 million to roughly $4.0 billion, our annual cash flow will improve by $11 million and our next significant maturity of debt will not occur until 2015.
Second, we are now beginning to negotiate a new credit line. Because our credit line is used to support letters of credit, which expire next year, it makes sense to replace that line in the third quarter of this year. Today, our facility is $800 million in size and after taking into account outstanding letters of credit and other limitations, we have undrawn capacity of approximately $500 million. 
We will seek to maintain a facility of $800 million with a five-year term. We also believe that based on our improved financial condition and the current bank market, we will be able to improve our capital allocation options, including lifting an existing limitation on stock repurchases. We think the combination of these actions, namely retiring $240 million of debt, extending $600 million of 2013 debt to 2020 and arranging a new credit line, will enable us to maintain an appropriately prudent capital structure and liquidity posture while adding new flexibility.
Please keep in mind that any further decisions to make investments in our business, make acquisitions, retire debt or repurchase stock, are conditional upon our outlook, as well as the opportunities and market conditions at the time. So I can't project a future capital deployment strategy with greater precision today. 
To summarize, I'm pleased with our effective response to the continued weak economy and soft volume environment in the first half. When confronted by these extraordinary challenges, our management teams responded quickly to maintain our positive earnings trajectory. And once we generate volume growth, I'm confident that we can achieve some truly outstanding bottom line performance. Let me now turn the floor over to Biggs Porter, our Chief Financial Officer. Biggs?"
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, Trevor, and good morning, everyone. As Trevor said, we are very pleased with our EBITDA and cash flow results for the quarter. There were two items we've pointed out in the release which could be characterized as non-recurring but they were ide",879,"Thank you, Trevor, and good morning, everyone. As Trevor said, we are very pleased with our EBITDA and cash flow results for the quarter. There were two items we've pointed out in the release which could be characterized as non-recurring but they were identical in size and therefore, fully offsetting.
The two items are a favorable Medicare bad debt settlement, offset by a reduction in revenue related to the Supplemental Security Income adjustment to Medicare reimbursement. I'll otherwise now give a little color on the other value drivers. 
First, as Trevor said on pricing, growth in per-unit revenues continues to make a solid contribution of profitability. We also have good visibility into future years' pricing. At this point, approximately 95% of our commercial contracting is complete for 2010, 75% for 2011 and 35% for 2012.
Attributable costs again reflect good cost discipline with an increase of 3.8% for adjusted patient day. Salaries, wages and benefits was well controlled with an increase of 3.4% also on a PAPD basis, demonstrating our ability to effectively flex our staffing in response to fluctuating volumes. 
Supply costs increased just 1.2% per adjusted patient day relative to last year's second quarter. The one area showing cost pressure is other controllable costs, which were up 6.8% per adjusted patient day. There were increases in various elements of costs, some of which are non-recurring by nature, including a contractual settlement on a lease, a credit in the prior year's results, provider taxes and IT maintenance costs.
Malpractice expense declined by $2 million or 7% relative to last year but increased by $14 million over the first quarter. Malpractice was negatively affected by a decrease in the discount rate and some individual claim adjustments. Otherwise, it would have been substantially less. If discount rates are stable or increase and we don't have the unusually large specific claim adjustments, there's opportunity for malpractice to decline in future quarters. However, since forecasting a malpractice expense is challenging, our outlook has been left conservative.
Our bad debt ratio was flat relative to last year at 7.5% but there were a number of moving pieces which contributed to that result. Reported bad debt for the quarter included the benefit of a $28 million favorable adjustment for Medicare bad debts. In a related item, we also recorded unfavorable contractual adjustments for Medicare of $8 million. Netting the $8 million from the $28 million results in a favorable $20 million. This $20 million offsets the unfavorable SSI adjustment of the same magnitude referred to earlier. We also expect any recurring effects from these items to offset. 
The sum of uninsured maturity admissions declined by 2.2% in the quarter. This decline helped control the costs of providing uncompensated care to an increase of only $5 million in the quarter. 
On a totally separate subject, there has been some positive movement on CMS's response to the California provider fee legislation. There have been comments received from CMS, which have prompted an adjustment to the program but moved it much closer to approval. At this time, we expect the benefit we will receive this year to be $70 million, $30 million of which would be applicable to 2009. Having said that, we are leaving the $30 million contribution in the middle of our 2010 outlook range unchanged until the program passes the last step of formal CMS approval.
Turning to our outlook. As you know, we raised our outlook for 2010 EBITDA by $50 million in early June. We remain confident with the new range of $1.035 billion to $1.1 billion as we expect acuity and shifts between commercial payers to continue to provide offset to aggregate volume statistical declines. This is consistent with the notion that the quality of commercial admits is better than what the unadjusted commercial volume statistic would suggest. To understand what the real impact of commercial volume losses is, one needs to add back the increase in acuity and the effects of payer shifts within commercial. This would bring the economic effects of commercial inpatient volume loss in the second quarter down to approximately 4%, rather than 7.2% and would put the effects of commercial pricing at around 7% to 7.5%. The details of our outlook are provided on Slide 12.
The walk forward of cash from June 30 to December 31, as reflected on Slide 13, breaks down second half cash flow into its major components, so that you can more clearly see the positive cash generated from operations and the planned deployment Trevor mentioned earlier. You will note that we have reduced our outlook for year-end cash to reflect the potential for outpatient acquisitions and the $40 million of debt we repurchased in July. Although not yet formally reflected in the outlook, we show the pro forma effect of the range of cash we would use in the refinancing and debt repurchase transaction which we launched today.
So to summarize. We have strong results for the quarter and earnings and cash flow. Commercial patient mix shifts continue to significantly offset gross statistical changes in volume. The potential upside of the California provider fee is nearing reality, and there is confirmation of our outlook for the year. I will now ask the operator to assemble the queue for Q&A. Operator?"
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","[Operator Instructions] You do have your first question from the line of Tom Gallucci from Lazard Capital.",17,"[Operator Instructions] You do have your first question from the line of Tom Gallucci from Lazard Capital."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","You mentioned that the end of June was soft sort of since your pre-announcement, I guess. And then July has been soft as well. Can you maybe give us a bit more color on the types of categories on the volume side that have been weaker? You mentioned during",74,"You mentioned that the end of June was soft sort of since your pre-announcement, I guess. And then July has been soft as well. Can you maybe give us a bit more color on the types of categories on the volume side that have been weaker? You mentioned during the quarter, your OB seemed to be a big piece of it. But I'm wondering if the drop-off was in other categories in particular."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","The trends are similar to what we've been seeing all year.",12,"The trends are similar to what we've been seeing all year."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Meaning OB dropped off significantly in late June and then July?",11,"Meaning OB dropped off significantly in late June and then July?"
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","You've got the same categories of weakness. And again, I think it's important not to focus too much on very short-term volumes. We're just trying to give some indication of trends here. But there are no trends that are unusual that are taking place that w",64,"You've got the same categories of weakness. And again, I think it's important not to focus too much on very short-term volumes. We're just trying to give some indication of trends here. But there are no trends that are unusual that are taking place that we haven't continued to see for the year inconsistent with what the comments are that I made earlier."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Okay. So similar categories that were weak, were just a little weaker. And then what about if you could just be...",21,"Okay. So similar categories that were weak, were just a little weaker. And then what about if you could just be..."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Actually, from the standpoint of being a little weaker, it is the same categories. But it's against a much tougher comp. So I don't know that sequentially, you would see it as weaker.",33,"Actually, from the standpoint of being a little weaker, it is the same categories. But it's against a much tougher comp. So I don't know that sequentially, you would see it as weaker."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Okay. And then my follow-up, I guess, is you mentioned more volume from higher-paying health plans. Is there any more color behind that and maybe why you're seeing that sort of a trend? Is there deductible differences or anything else that you might be ab",58,"Okay. And then my follow-up, I guess, is you mentioned more volume from higher-paying health plans. Is there any more color behind that and maybe why you're seeing that sort of a trend? Is there deductible differences or anything else that you might be able to identify that would cause the better utilization from one type from another?"
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","I don't think so. I mean that comment was made to help explain how you take a negative 7% volume number, which I think that the audience may pay too much attention to, and generate growth in the revenue number of our overall commercial book of business, w",82,"I don't think so. I mean that comment was made to help explain how you take a negative 7% volume number, which I think that the audience may pay too much attention to, and generate growth in the revenue number of our overall commercial book of business, which is the important statistic that drives earnings ultimately. And that is one component of it. It can be due to many things including growth or relative lack of growth in different health plans."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","And your next question comes from the line of Brendan Strong from Barclays Capital.",14,"And your next question comes from the line of Brendan Strong from Barclays Capital."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","When we look at the commercial trends, I mean, they are very similar to what they were in the first quarter. So really, no big change here. I guess, as you think about the rest of the year, I mean, do you think if the unemployment rate stays similar to wh",72,"When we look at the commercial trends, I mean, they are very similar to what they were in the first quarter. So really, no big change here. I guess, as you think about the rest of the year, I mean, do you think if the unemployment rate stays similar to where we're at today, do you think we'll be looking at similar declines in commercial trends for the rest of the year?"
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","I would be speculative to answer the question directly but this is driven by the things that we've talked about. So employment is key. It creates more people that could potentially be covered under commercial insurance. You've got the shifts among payers.",134,"I would be speculative to answer the question directly but this is driven by the things that we've talked about. So employment is key. It creates more people that could potentially be covered under commercial insurance. You've got the shifts among payers. That's very important in driving the revenue number. And you've got this issue with elective procedures, most importantly, OB. And I think what we're trying to do is highlight a more important economic trend, which is again, similar to the first quarter. The volumes that we've been losing the most that are contributing to those volume loss numbers are the ones with the least value associated with them. And that is in part how we've been able to continue to grow revenues even in the face of those weak volume numbers."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","I would just add that certainly we think our actions will help drive commercial volumes in the future. And, as you say, the economy improving, will drive commercial volumes more favorably in the future. But having said that, for the sake of conservatism,",104,"I would just add that certainly we think our actions will help drive commercial volumes in the future. And, as you say, the economy improving, will drive commercial volumes more favorably in the future. But having said that, for the sake of conservatism, the middle of our range in the outlook presumes that the trends through the first half are sustained through the year. So for purposes of the outlook, we have presumed that the economy does not turn, and that there's no other windfall that would change the current trend. But obviously, we're working to operate in a different direction and create growth."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Okay, sure. And then, I don't know if there's any other color you guys can provide on the Medicare side as well. I mean, that's part of the business that you'd think would be kind of stable, but there's some declines there on the admission side too. So I",68,"Okay, sure. And then, I don't know if there's any other color you guys can provide on the Medicare side as well. I mean, that's part of the business that you'd think would be kind of stable, but there's some declines there on the admission side too. So I presume part of that's because of some procedures being delayed because of co-pays possibly but any color around that?"
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Steve, do you want add some color on that?",9,"Steve, do you want add some color on that?"
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Sure. Brendon, I think you're right. I think we are beginning to see some increase in elective surgeries of Medicare patients. That too has been impacted by the downturn in the general economy. But, for example, orthopedic surgery and Medicare was up 1% i",70,"Sure. Brendon, I think you're right. I think we are beginning to see some increase in elective surgeries of Medicare patients. That too has been impacted by the downturn in the general economy. But, for example, orthopedic surgery and Medicare was up 1% in the quarter compared to the same quarter prior year. So I think we're beginning to see that. But it's only a small glimmer at this point."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","And your next question comes from the line of Gary Lieberman from Wells Fargo.",14,"And your next question comes from the line of Gary Lieberman from Wells Fargo."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I was hoping that maybe you could talk a little bit about what you're continuing to do in terms of attracting physicians and maybe some other measures that you're taking to try to reverse the trend or at least ameliorate the trend on the commercial manage",50,"I was hoping that maybe you could talk a little bit about what you're continuing to do in terms of attracting physicians and maybe some other measures that you're taking to try to reverse the trend or at least ameliorate the trend on the commercial managed care admission front?"
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","First of all, the number for the quarter, 245 active staff, net of attrition, added to staff. That's consistent with the forecast we made at the previous quarter for the year. But above and beyond that, we've accelerated our physician alignment activities",179,"First of all, the number for the quarter, 245 active staff, net of attrition, added to staff. That's consistent with the forecast we made at the previous quarter for the year. But above and beyond that, we've accelerated our physician alignment activities. And each of our hospitals now has a customized physician alignment plan. And we've added a number of tactics to that particular plan, including the rollout of office-based Health Information Technology through our joint venture partner Med3000. We are tying our doctors more closely to our facilities through this HIT set of products and that will make a difference longer term. Additionally, we are reactivating a number of organizations that we had 10 or 12 years ago that are called Physician Hospital Organizations. These are entities that are jointly owned by physicians and hospitals, and allow for contracting on a single signature, whether it be with a commercial payer or a governmental payer. So we're doing a number of things, Gary, to increase our physician alignment that should translate into growing our volumes, especially our commercial volume."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Okay. And then one follow-up. There's a lot of focus this quarter on one particular acquisition that you guys indicated you were looking at. Could you bring us up to speed on what your current thoughts are in terms of potential acquisitions and kind of wh",57,"Okay. And then one follow-up. There's a lot of focus this quarter on one particular acquisition that you guys indicated you were looking at. Could you bring us up to speed on what your current thoughts are in terms of potential acquisitions and kind of where you might be looking and where you might not be looking?"
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Sure. I think first of all, it's important to understand, we don't need to make acquisitions to meet our goals. So we believe we continue to have significant margin upside in the current portfolio. And we spent a lot of time in June and July in Investor R",183,"Sure. I think first of all, it's important to understand, we don't need to make acquisitions to meet our goals. So we believe we continue to have significant margin upside in the current portfolio. And we spent a lot of time in June and July in Investor Relations activities, talking to people about those sources of margin expansion. We are actively pursuing acquisitions in the outpatient imaging space. These are small dollars but they're very accretive and they generate very high IRR. I'd like to make acquisitions in our Service business in order to expand our scale but those tend to be very expensive, and they're hard to find the right fit. And then on acute acquisitions, it does seem as though the supply side of that market is increasing very steadily. But we're going to continue to be very careful in that area, looking for selective acquisitions where we would have a high degree of confidence in generating returns that would be well above our cost of capital. And other than that, I really can't be more specific. It'll be very situation-dependent."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","And your next question comes from the line of Doug Simpson from Morgan Stanley.",14,"And your next question comes from the line of Doug Simpson from Morgan Stanley."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Trevor, could you just talk a little bit. Just stepping back, if we look at the unit price increases the industry's seeing, they're above GDP. And then we've got this dynamic where we're seeing a sluggish commercial utilization. I mean, is there a broader",99,"Trevor, could you just talk a little bit. Just stepping back, if we look at the unit price increases the industry's seeing, they're above GDP. And then we've got this dynamic where we're seeing a sluggish commercial utilization. I mean, is there a broader sort of question looking out two years? I mean do you foresee any change in strategy relative to pricing to try to get volumes back up just sort of an affordability issue? Or is it more just when the economy rebounds, we should get some pickup from that? I mean, can you separate the two?"
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","It's a very tough question. Because we have examined this question quite extensively here. I think there's several ways to approach it. So first of all, I think we are still in an environment where there is not a direct correlation between pricing and vol",377,"It's a very tough question. Because we have examined this question quite extensively here. I think there's several ways to approach it. So first of all, I think we are still in an environment where there is not a direct correlation between pricing and volume. There just doesn't seem to be any evidence of that. I think that volume is driven by all of the strategies that we outlined about physician alignment and about competitive positioning within markets and the local economies. And again, you get into these micro-localities where really the particular employment position in a very small market makes a difference. I think going forward, in terms of changing strategies, we have employed for some time a differentiating strategy on clinical quality. We thought that, that would generate differentiated volumes. And there were quarters when it appeared to be doing so but I'm not sure you can make a blanket statement on that. I think that as transparency increases and as health plans focus more on delivering value to their customers, the quality differentiation will have to play an important part. I want to make sure, even though we have generated strong increases in per unit revenues over the past several years, we still believe that our pricing positions us very effectively in terms of delivering value in the markets. Rarely are we the high-priced provider in a market. That position is usually held by a large not-for-profit system in a particular market. And then in terms of dealing with us from a health plan perspective, we have a very efficient revenue cycle, a very efficient back office. We have very few disputes with the payers. And so, we try to point out to them that as they look at the overall cost of doing business with providers, we tend to be positioned very effectively. I think the strategies will continue to be legitimate and valuable for the foreseeable future. When you get into several years from now into tiering of networks and more restrictive networks and so forth, I think we're also well positioned for that. And that is where you may begin to see opportunities to link price and volume. But I don't think it's -- the industry's just not there today."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Okay. And is there any, as you look back to prior slowdowns, either regionally or nationally, a sense of timing with utilization slowdowns and relative to downturns in the economy, how long that may take to play out in terms of a lag effect?",44,"Okay. And is there any, as you look back to prior slowdowns, either regionally or nationally, a sense of timing with utilization slowdowns and relative to downturns in the economy, how long that may take to play out in terms of a lag effect?"
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","It's really hard. We haven't seen one this long. And I don't think anybody -- I mean, I've talked to all sorts of people in the industry, I don't think anyone has seen one this widespread or this pervasive.",40,"It's really hard. We haven't seen one this long. And I don't think anybody -- I mean, I've talked to all sorts of people in the industry, I don't think anyone has seen one this widespread or this pervasive."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","And you have your next question from the line of Sheryl Skolnick from CRT Capital Group.",16,"And you have your next question from the line of Sheryl Skolnick from CRT Capital Group."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I want to probe on the change in acuity a little bit more if I could. And perhaps if you look at those remaining, for lack of a better word, heads in the beds ex the OB/GYN, ex the respiratory/flu. And you look at your ER visits, is there any link or any",76,"I want to probe on the change in acuity a little bit more if I could. And perhaps if you look at those remaining, for lack of a better word, heads in the beds ex the OB/GYN, ex the respiratory/flu. And you look at your ER visits, is there any link or any indication that patients being admitted for treatment or surgery through the ER are of higher acuity today than they were a year ago?"
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Sheryl, I think we have a couple of data points that would tend to suggest that the patients are more acute that are being admitted. If you look at the commercial managed care patients that get admitted through our ER and compare the Q2 '10 results to Q2",161,"Sheryl, I think we have a couple of data points that would tend to suggest that the patients are more acute that are being admitted. If you look at the commercial managed care patients that get admitted through our ER and compare the Q2 '10 results to Q2 '09, the case mix index is 3% higher than it was in '09. So it would suggest that the commercial patients coming in through the ER are indeed sicker than they were a year ago. The other point is that Trevor mentioned that our overall ED admissions are flat compared to the same quarter prior year. The fact that we had 2,000 fewer visits for influenza would, in fact, increase the overall case mix index of patients we're seeing in the ED. And therefore, those admitted would be higher acuity. So I think those two data points reinforce the observation that our ED is admitting sicker patients than it was a year ago."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Yes. Because I'm wondering if we're seeing the showing up later and sicker effect of delaying what's elective, let it become urgent, then let it become emergency and whether that might be the very early stages of an interesting trend that could further of",51,"Yes. Because I'm wondering if we're seeing the showing up later and sicker effect of delaying what's elective, let it become urgent, then let it become emergency and whether that might be the very early stages of an interesting trend that could further offset from the headwinds in commercial managed care."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well certainly, we have been concerned about that from a theoretical point of view. It's a little early to call that. But that's the sort of activity we would expect to escalate if, in fact, that bolus of pent-up demand is coming forward, we would see it",53,"Well certainly, we have been concerned about that from a theoretical point of view. It's a little early to call that. But that's the sort of activity we would expect to escalate if, in fact, that bolus of pent-up demand is coming forward, we would see it through the ED as you suggest."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And I can count on you all to have that data at your fingertips. Thank you. And then as a follow-up. Trevor, the refinancing and reduction of debt that you're doing is, I think, timely and interesting, as well as the -- and a good thing as well as look at",109,"And I can count on you all to have that data at your fingertips. Thank you. And then as a follow-up. Trevor, the refinancing and reduction of debt that you're doing is, I think, timely and interesting, as well as the -- and a good thing as well as look at the credit facility. But you intrigued me with one of your comments, which is having the flexibility to do share repurchases. Rather than read anything into that, could you share with us your thoughts on once you have that flexibility, whether or not you would be inclined to do it assuming, for example, you had that flexibility today?"
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well after intriguing you with that comment, I went on to say that I wouldn't say anything more about those kinds of activities at this time because it would be dependent on the situation at the time after we have gained that flexibility. The situation me",74,"Well after intriguing you with that comment, I went on to say that I wouldn't say anything more about those kinds of activities at this time because it would be dependent on the situation at the time after we have gained that flexibility. The situation meaning what are the market conditions, what's our outlook, what opportunities have we had to deploy the capital and what at that time is the best use of capital."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","You have the next question from the line of Darren Lehrich from Deutsche Bank.",14,"You have the next question from the line of Darren Lehrich from Deutsche Bank."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I guess I just wanted to go back to the M&A strategy question that was asked previously. And I think Trevor, you've laid out maybe three things that are on the table that you're really kind of focusing on: imaging; some things in the services side of the",128,"I guess I just wanted to go back to the M&A strategy question that was asked previously. And I think Trevor, you've laid out maybe three things that are on the table that you're really kind of focusing on: imaging; some things in the services side of the business, I guess, that would be more revenue cycle oriented; and then selectively acute care. I guess, just given what's unfolded over the last three to four months, is there anything that you've brought up to your board that you would firmly say is off the table from here? Can you just help us think a little bit more clearly about capital deployment on the acquisition side and whether you've made any firm decisions about what's off the table?"
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","I don't really have anything to add to what I said earlier. And no, I don't think anything is particularly off the table. But by our actions, I think you can gain insights into what we're thinking.",38,"I don't really have anything to add to what I said earlier. And no, I don't think anything is particularly off the table. But by our actions, I think you can gain insights into what we're thinking."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Okay. And you mentioned that the medical office building's sale was something you're still working through. Can you just give us an update about that and any other asset sales that might be contemplated from here?",36,"Okay. And you mentioned that the medical office building's sale was something you're still working through. Can you just give us an update about that and any other asset sales that might be contemplated from here?"
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Sure, Biggs, do you want to give the updated office building?",11,"Sure, Biggs, do you want to give the updated office building?"
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Sure. It's been a long process but we have continued to look to sell medical office buildings. You may recall in a prior call, I commented that rather than try to sell them all in one large transaction, we've broken them up into smaller transactions by ma",128,"Sure. It's been a long process but we have continued to look to sell medical office buildings. You may recall in a prior call, I commented that rather than try to sell them all in one large transaction, we've broken them up into smaller transactions by market or by region in order to make financing more readily available for purchasers. And we presently do have a number of them under contract, but having said that, a real estate contract isn't done until it closes. And so it's premature to say that there is definitively any additional cash coming in. But we're certainly hopeful that we will have at least some of them get to the point of close this year. If not this year, then into next year."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And is there a range of, I guess, either numbers of assets, square footage that's sort on the block? Can you just help size what you're working on at this point?",31,"And is there a range of, I guess, either numbers of assets, square footage that's sort on the block? Can you just help size what you're working on at this point?"
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Yes. The total opportunity that remains in front of us, for those that we're still trying to market, I'd put in the range of $100 million. But once again, there can be no assurance that we will ultimately close on all those or that that's the amount that",69,"Yes. The total opportunity that remains in front of us, for those that we're still trying to market, I'd put in the range of $100 million. But once again, there can be no assurance that we will ultimately close on all those or that that's the amount that would be received. But just for the sake of sizing what the opportunity is, that's a reasonable number to work with."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And the EBITDA loss relative to that $100 million would be what?",12,"And the EBITDA loss relative to that $100 million would be what?"
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","It's nominal. As we said before, these are properties which don't generate a lot of earnings for us. We think that quite frankly, another owner that's a professional real estate manager will be able to operate them more efficiently, number one. And second",66,"It's nominal. As we said before, these are properties which don't generate a lot of earnings for us. We think that quite frankly, another owner that's a professional real estate manager will be able to operate them more efficiently, number one. And secondly, to the benefit of our physician tenants. And so it makes sense for these to change hands in just about all respects."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","And your next question comes from the line of A.J. Rice of Susquehanna.",14,"And your next question comes from the line of A.J. Rice of Susquehanna."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Maybe first off, you just gave us your update and if there is any update on thoughts on things like the managed care contracting outlook for next year. Your thoughts on how the FMAP extension and the COBRA state of play, those payer dynamics looking into",59,"Maybe first off, you just gave us your update and if there is any update on thoughts on things like the managed care contracting outlook for next year. Your thoughts on how the FMAP extension and the COBRA state of play, those payer dynamics looking into the forward year might -- what's your thinking on those at this point?"
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","And actually, I would like to thank you on the issues of COBRA and FMAP for injecting some rational thought into the hysteria that seems to surround those topics. I guess, I'll take FMAP first. I don't think I'm telling anybody on the call something they",157,"And actually, I would like to thank you on the issues of COBRA and FMAP for injecting some rational thought into the hysteria that seems to surround those topics. I guess, I'll take FMAP first. I don't think I'm telling anybody on the call something they don't already know. But the Senate appears to be willing to continue to work on this. I can understand why they would not have necessarily wanted to pass something before the recess. But it's important to the governors. We have tried to estimate what an effect on us would be if the FMAP incremental money were not continued, and it hit directly and only to the Medicaid budgets of every state. And if we proportionally were hit directly. So I don't know if you should call that a worst-case analysis but it's a direct flow-through directly to us of eliminating those funds, and the total would be what, Biggs, it was..."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","It'd be just under $70 million but I emphasize, that is kind of the worst-case number because we don't think that it would flow directly in that case.",29,"It'd be just under $70 million but I emphasize, that is kind of the worst-case number because we don't think that it would flow directly in that case."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","It is inconceivable it would actually work that way. But seems to me that people are sort of pricing in fears that are far greater than that. On COBRA...",29,"It is inconceivable it would actually work that way. But seems to me that people are sort of pricing in fears that are far greater than that. On COBRA..."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","I should point, that's the annual number.",7,"I should point, that's the annual number."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","So on COBRA, it's been very difficult for us, as we've said repeatedly for a long time, to identify which patients are affected by that and so forth. And it maybe that we're seeing the results of that COBRA roll-off now. I don't know but I still think tha",125,"So on COBRA, it's been very difficult for us, as we've said repeatedly for a long time, to identify which patients are affected by that and so forth. And it maybe that we're seeing the results of that COBRA roll-off now. I don't know but I still think that one's just totally amorphous. And then with respect to the pricing environment, it's obviously never easy, but the fact that we are essentially done for 2010 and 75% contracted for '11 and into the mid-30s in terms of percentage of our managed care business done for 2012 gives us an extraordinary amount of visibility into what we think pricing trends are into 2011 and 2012. And it's obviously considered in the comments that we've made today."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Okay. And then just maybe a follow-up on that. One thing that I encounter, I guess, and I'd be interested in your perspective on it is the sustainability of the cost trends. Obviously in the face of the weak commercial volumes and the other dynamics aroun",167,"Okay. And then just maybe a follow-up on that. One thing that I encounter, I guess, and I'd be interested in your perspective on it is the sustainability of the cost trends. Obviously in the face of the weak commercial volumes and the other dynamics around this economic downturn, you've been able to have very good cost controls on key items like labor and supplies. But I think there's sort of this concern that if these payer pressures continue to exert themselves out there, at some point, you sort of hit a wall on that cost savings. I guess, I'm trying to get my arms around and wonder if you've thought about the issue of whether -- does all of this go hand-in-hand if the cost opportunities you're realizing are hand-in-hand with some of the banks that are driving the commercial volume pressures, for example? Or do you see a point of time where some of the sustainability of some of these things gets called into question?"
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","As you face a declining volume environment, it does get more difficult to continue to reduce staffing because you run into certain core and minimum staffing. But that's why we really some time ago turned our attention to more creative approaches to cost r",155,"As you face a declining volume environment, it does get more difficult to continue to reduce staffing because you run into certain core and minimum staffing. But that's why we really some time ago turned our attention to more creative approaches to cost reduction, such as those that are part of the Medicare performance initiative. And that really gets to a whole different range of cost opportunities in the utilization of supplies and length of stay and even the clinical practice of medicine. That, together with the investments we're making in technology, should open up new opportunities for us in cost management beyond the traditional levers that were largely oriented towards labor. And again, I also should point out how really outstanding our performance has been in the revenue cycle. I mean, that's an important cost driver, and we have been very effective in managing that, both from an expense and a cash flow perspective."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","And you have your next question from the line of Kemp Dolliver from Avondale Partners.",15,"And you have your next question from the line of Kemp Dolliver from Avondale Partners."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Questions are on volumes. First on your volume outlook for the year, it looks like you are expecting some improvement in the second half versus the first half. And just wanted to get your rationale behind that, given that Q1 likely had some weather disrup",73,"Questions are on volumes. First on your volume outlook for the year, it looks like you are expecting some improvement in the second half versus the first half. And just wanted to get your rationale behind that, given that Q1 likely had some weather disruption, which would leave one to think that Q2 would have shown better trends. But they look very similar in many regards. So that's what's behind my thought process."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Okay. So I may ask Biggs to speak to the outlook for volumes for the second half.",17,"Okay. So I may ask Biggs to speak to the outlook for volumes for the second 
half."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Sure. I think that you're right. We are expecting, if you're looking at it from a year-over-year trend standpoint, some improvement in the second half. It's our belief that our actions will drive volume. Plus on the outpatient side, the acquisitions that",143,"Sure. I think that you're right. We are expecting, if you're looking at it from a year-over-year trend standpoint, some improvement in the second half. It's our belief that our actions will drive volume. Plus on the outpatient side, the acquisitions that we're making that will fall under our hospital licenses will add volume on outpatient. But I think it's a moderate level of growth that's projected second half over first half, from a trending standpoint. At a gross level, it may prove to be relatively flat to the first half because of seasonality. But from a year-over-year trending standpoint, yes, we're expecting some improvement as a result of our actions, be it physician recruitment, redirection, the outpatient acquisitions and everything else we're doing to drive volume. But it's a very modest amount of growth that we're expecting relative to the first half."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","That's fine. And also several years ago, you all changed your admission criteria to eliminate a lot of short-term stays. And with the rack audits and I think other payer pressures, there appears to be intensified industry pressure, increasing observation",62,"That's fine. And also several years ago, you all changed your admission criteria to eliminate a lot of short-term stays. And with the rack audits and I think other payer pressures, there appears to be intensified industry pressure, increasing observation stays, et cetera. What are you seeing in terms of your very short-stay cases as it relates to the commercial book?"
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, as you point out, we made these changes several years ago. So we've really gone through anniversary dates already of those changes. The good news has been we've done really well in the rack audits. The bad news has been we've probably depressed our",59,"Well, as you point out, we made these changes several years ago. So we've really gone through anniversary dates already of those changes. The good news has been we've done really well in the rack audits. The bad news has been we've probably depressed our admissions intentionally for some period of time. But that's really washed out before now."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So no new pressures from there then?",7,"So no new pressures from there then?"
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","No, not to us. If we had not implemented those different criteria, which principally involve using the [ph] (1:01:12) interquell system which is a method essentially of providing the same screening to admissions that the payers ultimately provide and that",72,"No, not to us. If we had not implemented those different criteria, which principally involve using the [ph] (1:01:12) interquell system which is a method essentially of providing the same screening to admissions that the payers ultimately provide and that the rack auditors are using. So if we hadn't done that, probably we'd be in a position of seeing many admissions denied and overturned and rack audits coming up with big claims."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","Your next question comes from the line of Justin Lake from UBS.",12,"Your next question comes from the line of Justin Lake from UBS."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Just a follow up question on the operating cost side. I'm just trying to get some perspective on obviously, you've done a great job there over the last few years. If you could think back maybe three to five years ago, what your kind of core operating cost",63,"Just a follow up question on the operating cost side. I'm just trying to get some perspective on obviously, you've done a great job there over the last few years. If you could think back maybe three to five years ago, what your kind of core operating cost inflation trend look like and compare it to where you are now, I'd be curious."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","That's a hard one. I can't remember what the inflationary trends were but I can tell you that our cost base wasn't nearly as good. If you go back a few years, we were having volume losses and we were staffing at levels that were too high for the volumes w",118,"That's a hard one. I can't remember what the inflationary trends were but I can tell you that our cost base wasn't nearly as good. If you go back a few years, we were having volume losses and we were staffing at levels that were too high for the volumes we were experiencing and constantly trying to chase that sort of after the fact and get our cost base right-sized. But the processes we have in place now enable us to flex routinely on a daily basis now with great tools in place. And so that's not core inflation but certainly from the standpoint of our ability to manage cost growth, it is a big value driver."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Sure. I guess what I was trying to get to was obviously you've done -- the second question was just -- or the follow-up there was just I'm trying to get from a core perspective what you've been able to drive yourself, which has obviously been a lot versus",65,"Sure. I guess what I was trying to get to was obviously you've done -- the second question was just -- or the follow-up there was just I'm trying to get from a core perspective what you've been able to drive yourself, which has obviously been a lot versus what you've kind of benefited from just on lower typical nursing inflation and things like that."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","I see what you're saying. Well look, we have really driven this improvement in productivity and this better performance on labor. The outside factors have been mixed on that. We've had pressures from labor unions. We've had continued competitive wage pres",196,"I see what you're saying. Well look, we have really driven this improvement in productivity and this better performance on labor. The outside factors have been mixed on that. We've had pressures from labor unions. We've had continued competitive wage pressures. And then we had some benefits from lower turnover, that was really caused in large part by the economy but also by a series of initiatives we undertook. So I guess you want that sort of macro rundown. I'd say there have been net probably neutral to slightly positive factors from the environment on labor but huge positive factors from our own management techniques and the implementation of systems to manage that. On supplies, we've had sort of relentless upward pressure on the high-value supplies and fairly benign pricing pressure on commodity supplies. But once again, our efforts to manage utilization, to substitute and use equivalent but less expensive drugs and supplies, and to be more conscious of the waste of supplies, the whole series of initiatives in the supply chain have really driven outstanding performance there. And then I've mentioned revenue cycle earlier and those, of course, are the huge drivers that cost."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Right. So you think these are replicable though looking forward, as the reimbursement environment gets tougher. I guess that's the real key.",22,"Right. So you think these are replicable though looking forward, as the reimbursement environment gets tougher. I guess that's the real key."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well I think independent of the reimbursement environment, as I said a few minutes ago, we continue to find new opportunities and new ways of being more efficient and saving money.",31,"Well I think independent of the reimbursement environment, as I said a few minutes ago, we continue to find new opportunities and new ways of being more efficient and saving money."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","And your next question comes from the line of Ralph Giacobbe from Credit Suisse.",14,"And your next question comes from the line of Ralph Giacobbe from Credit Suisse."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I just wanted to go back to volume and just kind of reconciling the pre-announcement down 1.2% on the volume side and in the quarter down 2% sort of implies that the last several weeks of the quarter obviously you were down kind of 4% to 5%. And I know it",116,"I just wanted to go back to volume and just kind of reconciling the pre-announcement down 1.2% on the volume side and in the quarter down 2% sort of implies that the last several weeks of the quarter obviously you were down kind of 4% to 5%. And I know it's hard to sort of extrapolate just those last three weeks but I guess, first, I mean, is there nothing in those results that are meaningfully different other than just a sharper decline within admission trends across-the-board? And then two, when you said that July remains soft, is that in the context of the full 2Q results or the last three weeks of the quarter?"
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","The July was pretty consistent with the end of June. So it's softer than the second quarter. But don't forget, the really tough comp for last year's July. So I think it's again, when you get into these really short-term periods where you're analyzing volu",132,"The July was pretty consistent with the end of June. So it's softer than the second quarter. But don't forget, the really tough comp for last year's July. So I think it's again, when you get into these really short-term periods where you're analyzing volumes, the prior year performance is important. The current year, if there's something from a service line perspective is important. And I think it's too limiting of a period to draw any broader conclusion than that, except just as a point of disclosure, we wanted to make sure we said look we're off to a slow start for the third quarter on volumes. As Biggs points out, we've taken into account in our outlook for the year that there's no dramatic recovery in volumes in the second half."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Okay. That's helpful. Thanks. And then I just want to go back to the managed care side. I may have missed this. I know you gave sort of the percentages of the business that's locked in for the next couple of few years. I just want to make sure the rates o",84,"Okay. That's helpful. Thanks. And then I just want to go back to the managed care side. I may have missed this. I know you gave sort of the percentages of the business that's locked in for the next couple of few years. I just want to make sure the rates on that. Have you sort of talked about what, kind of, the average rates are and/or maybe whether they're anything meaningfully different than the rates we've seen over the last couple of years?"
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","No, we haven't talked about it. We just find that it gets played right back to us. It's relatively consistent with what we've been able to do to date but we're working hard to get it.",36,"No, we haven't talked about it. We just find that it gets played right back to us. It's relatively consistent with what we've been able to do to date but we're working hard to get it."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","And we do have our last question from the line of John Rex.",13,"And we do have our last question from the line of John Rex."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","So with that, I think I'll just proceed to make a couple of closing comments. This quarter, we took a decline of 2% at admissions. We turned it into 3.3% growth in revenues and almost tripled that rate of growth in EBITDA. And we should be able to do a lo",160,"So with that, I think I'll just proceed to make a couple of closing comments. This quarter, we took a decline of 2% at admissions. We turned it into 3.3% growth in revenues and almost tripled that rate of growth in EBITDA. And we should be able to do a lot better than that once we begin growing volumes again. We achieved new milestones in margins and free cash flows. Ad those are very important to keep in mind. We're taking excess cash and we're reducing debt. We're reducing the company's risk by extending maturities of our 2013 debt. And we plan to increase our flexibility by arranging a new credit line. During June and July, we engaged in an extensive amount of Investor Relations activity. We're going to resume this in September by attending the Morgan Stanley conference and continuing to do one-on-one meetings in a few cities. And with that, operator, thank you and this concludes our call."
107911,109241320,71637,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","Ladies and gentlemen, that concludes our presentation. Thank you for your participation in today's conference. You may now disconnect. Have a great day.",23,"Ladies and gentlemen, that concludes our presentation. Thank you for your participation in today's conference. You may now disconnect. Have a great day."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","Good day, ladies and gentlemen, and welcome to the Second Quarter 2010 Tenet's Healthcare Earnings Conference Call. My name is Larissa and I will be your operator for today's call. [Operator Instructions] I would now like to turn the conference over to yo",60,"Good day, ladies and gentlemen, and welcome to the Second Quarter 2010 Tenet's Healthcare Earnings Conference Call. My name is Larissa and I will be your operator for today's call. [Operator Instructions] I would now like to turn the conference over to your host for today's call, Mr. Thomas Rice, the Vice President of Investor Relations. You may proceed, sir."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, operator, and good morning, everyone. Tenet's management will be making forward-looking statements on this call. These statements are based on management's current expectations and are subject to risks and uncertainties that may cause those for",98,"Thank you, operator, and good morning, everyone. Tenet's management will be making forward-looking statements on this call. These statements are based on management's current expectations and are subject to risks and uncertainties that may cause those forward-looking statements to be materially incorrect. Management cautions you not to rely on and makes no promises to update any of the forward-looking statements. During the question-and-answer portion of the call, callers are requested to limit themselves to one question and one follow up question.
At this time, I will turn the call over to Trevor Fetter, Tenet's President and CEO. Trevor?"
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, Tom, and good morning, everyone. I'm very pleased with our solid performance in the second quarter. We generated $268 million of adjusted EBITDA, representing 9% growth over 2009 and a margin of 11.6%. We are in the midst of generating one of t",1178,"Thank you, Tom, and good morning, everyone. I'm very pleased with our solid performance in the second quarter. We generated $268 million of adjusted EBITDA, representing 9% growth over 2009 and a margin of 11.6%. We are in the midst of generating one of the strongest earnings trajectories in our recent history, and we faced a difficult comparison versus the second quarter of 2009, when EBITDA was up more than 50%. The 11.6% margin was the highest margin for a second quarter in the last seven years, and we achieved it in a difficult volume environment. 
The in-patient admissions picture was virtually identical to our first quarter, although there was a little more strength in our outpatient business in the second quarter relative to the first. When we released interim second quarter volumes on June 14, the volume picture for the quarter was stronger. Unfortunately, the final few weeks of June and all of July were soft, so we're off to a slow start for volumes in the third quarter. We also started the third quarter with a difficult comparison. Last year at this time, we were off to a strong start for Q3, with positive admissions growth in July.
Turning back to the second quarter, total admissions were down 2%. But that's before you take into account a decline in both flu and OB/GYN-related cases. Had it not been for these two categories, total admissions for the quarter would have been down less than 1%. But we are most disappointed by the 7.2% decline in commercial admissions and the 5.4% decline in commercial outpatient visits. 
Providing context for our commercial volumes relative to the industry continues to be difficult. There is really only one data point so far for the second quarter, namely HCA's negative 5.3% statistic for what they termed ""Managed Care and Other."" Our comparable statistic would have been negative 6.2%. 
While commercial volumes are a part of our story, they are not the whole story. I hope you noticed that our commercial revenues grew by 2%. So clearly, something is helping us mitigate these volume declines. Here's some insight into what's going on beneath the surface of our commercial volume trends.
First, there was a significant pickup in our commercial case mix index which increased 2.8%. Over a third of our decline in commercial admissions was OB/GYN-related. As many of you have written about the decline in U.S. birth rate, it's probably no surprise that the reduction in deliveries explains nearly 20% of our decline in commercial admissions in the second quarter. 
In addition, we had a favorable shift within the mix of our commercial payers from lower-paying to higher-paying health plans. The impact of these two factors, when combined with continuing increases in commercial pricing, resulted in commercial revenue growth of 2%. At the end of the day, it's this revenue growth and solid cost control which drove our 9% growth in EBITDA. 
Also, I don't want to overlook some areas of strength in the overall volume picture. Our outpatient business appears to be picking up after a weaker start to the year. Second quarter aggregate outpatient visits declined by less than 1%, while we saw positive growth in government outpatient of 2%.
Our admissions through the emergency department were equal to last year's statistic. This is further evidence that elective procedures are most directly impacted by a slow economy. And to complete the volume story, note that total government admissions were flat, and adjusted admissions declined by just 0.6%. 
We continue to show strong numbers in the area of cost control and rates. And importantly, the delta between these two variables continues to expand. Inpatient net revenue per admission and outpatient net revenue per visit grew by 4.6% and 5.3% respectively, significantly outpacing a 3.8% growth in controllable costs per adjusted patient day.
Collectively, these factors helped us to generate adjusted free cash flow of $121 million in Q2, bringing free cash flow for the first half to positive $21 million. That's a $23 million improvement on a year-to-date basis from last year and a significant achievement given the large cash consumption that's typical for our first quarter.
Speaking of cash, excluding cash and insurance subsidiaries, we had a corporate cash balance of $600 million at the end of Q2. Taking only into account capital expenditures, July repurchases of $40 million of debt and our planned investment in outpatient centers through the remainder of the year, our year-end outlook for corporate cash is $500 million to $575 million. Based on the improvement in our performance over the last several years and our credit line availability, we believe this amount of cash exceeds our liquidity requirements, even after considering the normal first quarter seasonal usage. Our liquidity will be even greater if we receive the full California provider fee and complete the sale of some of our medical office buildings.
I want to spend a moment on two actions that will improve our financial flexibility. First, in order to improve cash flow and manage our debt maturities, today, we launched the refinancing of a portion of our $1 billion of 2013 debt. If we successfully complete this transaction as contemplated, our debt will drop by another $200 million to roughly $4.0 billion, our annual cash flow will improve by $11 million and our next significant maturity of debt will not occur until 2015.
Second, we are now beginning to negotiate a new credit line. Because our credit line is used to support letters of credit, which expire next year, it makes sense to replace that line in the third quarter of this year. Today, our facility is $800 million in size and after taking into account outstanding letters of credit and other limitations, we have undrawn capacity of approximately $500 million. 
We will seek to maintain a facility of $800 million with a five-year term. We also believe that based on our improved financial condition and the current bank market, we will be able to improve our capital allocation options, including lifting an existing limitation on stock repurchases. We think the combination of these actions, namely retiring $240 million of debt, extending $600 million of 2013 debt to 2020 and arranging a new credit line, will enable us to maintain an appropriately prudent capital structure and liquidity posture while adding new flexibility.
Please keep in mind that any further decisions to make investments in our business, make acquisitions, retire debt or repurchase stock, are conditional upon our outlook, as well as the opportunities and market conditions at the time. So I can't project a future capital deployment strategy with greater precision today. 
To summarize, I'm pleased with our effective response to the continued weak economy and soft volume environment in the first half. When confronted by these extraordinary challenges, our management teams responded quickly to maintain our positive earnings trajectory. And once we generate volume growth, I'm confident that we can achieve some truly outstanding bottom line performance. Let me now turn the floor over to Biggs Porter, our Chief Financial Officer. Biggs?"
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, Trevor, and good morning, everyone. As Trevor said, we are very pleased with our EBITDA and cash flow results for the quarter. There were two items we've pointed out in the release which could be characterized as non-recurring but they were ide",879,"Thank you, Trevor, and good morning, everyone. As Trevor said, we are very pleased with our EBITDA and cash flow results for the quarter. There were two items we've pointed out in the release which could be characterized as non-recurring but they were identical in size and therefore, fully offsetting.
The two items are a favorable Medicare bad debt settlement, offset by a reduction in revenue related to the Supplemental Security Income adjustment to Medicare reimbursement. I'll otherwise now give a little color on the other value drivers. 
First, as Trevor said on pricing, growth in per-unit revenues continues to make a solid contribution of profitability. We also have good visibility into future years' pricing. At this point, approximately 95% of our commercial contracting is complete for 2010, 75% for 2011 and 35% for 2012.
Attributable costs again reflect good cost discipline with an increase of 3.8% for adjusted patient day. Salaries, wages and benefits was well controlled with an increase of 3.4% also on a PAPD basis, demonstrating our ability to effectively flex our staffing in response to fluctuating volumes. 
Supply costs increased just 1.2% per adjusted patient day relative to last year's second quarter. The one area showing cost pressure is other controllable costs, which were up 6.8% per adjusted patient day. There were increases in various elements of costs, some of which are non-recurring by nature, including a contractual settlement on a lease, a credit in the prior year's results, provider taxes and IT maintenance costs.
Malpractice expense declined by $2 million or 7% relative to last year but increased by $14 million over the first quarter. Malpractice was negatively affected by a decrease in the discount rate and some individual claim adjustments. Otherwise, it would have been substantially less. If discount rates are stable or increase and we don't have the unusually large specific claim adjustments, there's opportunity for malpractice to decline in future quarters. However, since forecasting a malpractice expense is challenging, our outlook has been left conservative.
Our bad debt ratio was flat relative to last year at 7.5% but there were a number of moving pieces which contributed to that result. Reported bad debt for the quarter included the benefit of a $28 million favorable adjustment for Medicare bad debts. In a related item, we also recorded unfavorable contractual adjustments for Medicare of $8 million. Netting the $8 million from the $28 million results in a favorable $20 million. This $20 million offsets the unfavorable SSI adjustment of the same magnitude referred to earlier. We also expect any recurring effects from these items to offset. 
The sum of uninsured maturity admissions declined by 2.2% in the quarter. This decline helped control the costs of providing uncompensated care to an increase of only $5 million in the quarter. 
On a totally separate subject, there has been some positive movement on CMS's response to the California provider fee legislation. There have been comments received from CMS, which have prompted an adjustment to the program but moved it much closer to approval. At this time, we expect the benefit we will receive this year to be $70 million, $30 million of which would be applicable to 2009. Having said that, we are leaving the $30 million contribution in the middle of our 2010 outlook range unchanged until the program passes the last step of formal CMS approval.
Turning to our outlook. As you know, we raised our outlook for 2010 EBITDA by $50 million in early June. We remain confident with the new range of $1.035 billion to $1.1 billion as we expect acuity and shifts between commercial payers to continue to provide offset to aggregate volume statistical declines. This is consistent with the notion that the quality of commercial admits is better than what the unadjusted commercial volume statistic would suggest. To understand what the real impact of commercial volume losses is, one needs to add back the increase in acuity and the effects of payer shifts within commercial. This would bring the economic effects of commercial inpatient volume loss in the second quarter down to approximately 4%, rather than 7.2% and would put the effects of commercial pricing at around 7% to 7.5%. The details of our outlook are provided on Slide 12.
The walk forward of cash from June 30 to December 31, as reflected on Slide 13, breaks down second half cash flow into its major components, so that you can more clearly see the positive cash generated from operations and the planned deployment Trevor mentioned earlier. You will note that we have reduced our outlook for year-end cash to reflect the potential for outpatient acquisitions and the $40 million of debt we repurchased in July. Although not yet formally reflected in the outlook, we show the pro forma effect of the range of cash we would use in the refinancing and debt repurchase transaction which we launched today.
So to summarize. We have strong results for the quarter and earnings and cash flow. Commercial patient mix shifts continue to significantly offset gross statistical changes in volume. The potential upside of the California provider fee is nearing reality, and there is confirmation of our outlook for the year. I will now ask the operator to assemble the queue for Q&A. Operator?"
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","[Operator Instructions] You do have your first question from the line of Tom Gallucci from Lazard Capital.",17,"[Operator Instructions] You do have your first question from the line of Tom Gallucci from Lazard Capital."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","You mentioned that the end of June was soft sort of since your pre-announcement, I guess. And then July has been soft as well. Can you maybe give us a bit more color on the types of categories on the volume side that have been weaker? You mentioned during",74,"You mentioned that the end of June was soft sort of since your pre-announcement, I guess. And then July has been soft as well. Can you maybe give us a bit more color on the types of categories on the volume side that have been weaker? You mentioned during the quarter, your OB seemed to be a big piece of it. But I'm wondering if the drop-off was in other categories in particular."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","The trends are similar to what we've been seeing all year.",12,"The trends are similar to what we've been seeing all year."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Meaning OB dropped off significantly in late June and then July?",11,"Meaning OB dropped off significantly in late June and then July?"
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","You've got the same categories of weakness. And again, I think it's important not to focus too much on very short-term volumes. We're just trying to give some indication of trends here. But there are no trends that are unusual that are taking place that w",64,"You've got the same categories of weakness. And again, I think it's important not to focus too much on very short-term volumes. We're just trying to give some indication of trends here. But there are no trends that are unusual that are taking place that we haven't continued to see for the year inconsistent with what the comments are that I made earlier."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Okay. So similar categories that were weak, were just a little weaker. And then what about if you could just be...",21,"Okay. So similar categories that were weak, were just a little weaker. And then what about if you could just be..."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Actually, from the standpoint of being a little weaker, it is the same categories. But it's against a much tougher comp. So I don't know that sequentially, you would see it as weaker.",33,"Actually, from the standpoint of being a little weaker, it is the same categories. But it's against a much tougher comp. So I don't know that sequentially, you would see it as weaker."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Okay. And then my follow-up, I guess, is you mentioned more volume from higher-paying health plans. Is there any more color behind that and maybe why you're seeing that sort of a trend? Is there deductible differences or anything else that you might be ab",58,"Okay. And then my follow-up, I guess, is you mentioned more volume from higher-paying health plans. Is there any more color behind that and maybe why you're seeing that sort of a trend? Is there deductible differences or anything else that you might be able to identify that would cause the better utilization from one type from another?"
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","I don't think so. I mean that comment was made to help explain how you take a negative 7% volume number, which I think that the audience may pay too much attention to, and generate growth in the revenue number of our overall commercial book of business, w",82,"I don't think so. I mean that comment was made to help explain how you take a negative 7% volume number, which I think that the audience may pay too much attention to, and generate growth in the revenue number of our overall commercial book of business, which is the important statistic that drives earnings ultimately. And that is one component of it. It can be due to many things including growth or relative lack of growth in different health plans."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","And your next question comes from the line of Brendan Strong from Barclays Capital.",14,"And your next question comes from the line of Brendan Strong from Barclays Capital."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","When we look at the commercial trends, I mean, they are very similar to what they were in the first quarter. So really, no big change here. I guess, as you think about the rest of the year, I mean, do you think if the unemployment rate stays similar to wh",72,"When we look at the commercial trends, I mean, they are very similar to what they were in the first quarter. So really, no big change here. I guess, as you think about the rest of the year, I mean, do you think if the unemployment rate stays similar to where we're at today, do you think we'll be looking at similar declines in commercial trends for the rest of the year?"
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","I would be speculative to answer the question directly but this is driven by the things that we've talked about. So employment is key. It creates more people that could potentially be covered under commercial insurance. You've got the shifts among payers.",134,"I would be speculative to answer the question directly but this is driven by the things that we've talked about. So employment is key. It creates more people that could potentially be covered under commercial insurance. You've got the shifts among payers. That's very important in driving the revenue number. And you've got this issue with elective procedures, most importantly, OB. And I think what we're trying to do is highlight a more important economic trend, which is again, similar to the first quarter. The volumes that we've been losing the most that are contributing to those volume loss numbers are the ones with the least value associated with them. And that is in part how we've been able to continue to grow revenues even in the face of those weak volume numbers."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","I would just add that certainly we think our actions will help drive commercial volumes in the future. And, as you say, the economy improving, will drive commercial volumes more favorably in the future. But having said that, for the sake of conservatism,",104,"I would just add that certainly we think our actions will help drive commercial volumes in the future. And, as you say, the economy improving, will drive commercial volumes more favorably in the future. But having said that, for the sake of conservatism, the middle of our range in the outlook presumes that the trends through the first half are sustained through the year. So for purposes of the outlook, we have presumed that the economy does not turn, and that there's no other windfall that would change the current trend. But obviously, we're working to operate in a different direction and create growth."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Okay, sure. And then, I don't know if there's any other color you guys can provide on the Medicare side as well. I mean, that's part of the business that you'd think would be kind of stable, but there's some declines there on the admission side too. So I",68,"Okay, sure. And then, I don't know if there's any other color you guys can provide on the Medicare side as well. I mean, that's part of the business that you'd think would be kind of stable, but there's some declines there on the admission side too. So I presume part of that's because of some procedures being delayed because of co-pays possibly but any color around that?"
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Steve, do you want add some color on that?",9,"Steve, do you want add some color on that?"
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Sure. Brendon, I think you're right. I think we are beginning to see some increase in elective surgeries of Medicare patients. That too has been impacted by the downturn in the general economy. But, for example, orthopedic surgery and Medicare was up 1% i",70,"Sure. Brendon, I think you're right. I think we are beginning to see some increase in elective surgeries of Medicare patients. That too has been impacted by the downturn in the general economy. But, for example, orthopedic surgery and Medicare was up 1% in the quarter compared to the same quarter prior year. So I think we're beginning to see that. But it's only a small glimmer at this point."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","And your next question comes from the line of Gary Lieberman from Wells Fargo.",14,"And your next question comes from the line of Gary Lieberman from Wells Fargo."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I was hoping that maybe you could talk a little bit about what you're continuing to do in terms of attracting physicians and maybe some other measures that you're taking to try to reverse the trend or at least ameliorate the trend on the commercial manage",50,"I was hoping that maybe you could talk a little bit about what you're continuing to do in terms of attracting physicians and maybe some other measures that you're taking to try to reverse the trend or at least ameliorate the trend on the commercial managed care admission front?"
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","First of all, the number for the quarter, 245 active staff, net of attrition, added to staff. That's consistent with the forecast we made at the previous quarter for the year. But above and beyond that, we've accelerated our physician alignment activities",179,"First of all, the number for the quarter, 245 active staff, net of attrition, added to staff. That's consistent with the forecast we made at the previous quarter for the year. But above and beyond that, we've accelerated our physician alignment activities. And each of our hospitals now has a customized physician alignment plan. And we've added a number of tactics to that particular plan, including the rollout of office-based Health Information Technology through our joint venture partner Med3000. We are tying our doctors more closely to our facilities through this HIT set of products and that will make a difference longer term. Additionally, we are reactivating a number of organizations that we had 10 or 12 years ago that are called Physician Hospital Organizations. These are entities that are jointly owned by physicians and hospitals, and allow for contracting on a single signature, whether it be with a commercial payer or a governmental payer. So we're doing a number of things, Gary, to increase our physician alignment that should translate into growing our volumes, especially our commercial volume."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Okay. And then one follow-up. There's a lot of focus this quarter on one particular acquisition that you guys indicated you were looking at. Could you bring us up to speed on what your current thoughts are in terms of potential acquisitions and kind of wh",57,"Okay. And then one follow-up. There's a lot of focus this quarter on one particular acquisition that you guys indicated you were looking at. Could you bring us up to speed on what your current thoughts are in terms of potential acquisitions and kind of where you might be looking and where you might not be looking?"
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Sure. I think first of all, it's important to understand, we don't need to make acquisitions to meet our goals. So we believe we continue to have significant margin upside in the current portfolio. And we spent a lot of time in June and July in Investor R",183,"Sure. I think first of all, it's important to understand, we don't need to make acquisitions to meet our goals. So we believe we continue to have significant margin upside in the current portfolio. And we spent a lot of time in June and July in Investor Relations activities, talking to people about those sources of margin expansion. We are actively pursuing acquisitions in the outpatient imaging space. These are small dollars but they're very accretive and they generate very high IRR. I'd like to make acquisitions in our Service business in order to expand our scale but those tend to be very expensive, and they're hard to find the right fit. And then on acute acquisitions, it does seem as though the supply side of that market is increasing very steadily. But we're going to continue to be very careful in that area, looking for selective acquisitions where we would have a high degree of confidence in generating returns that would be well above our cost of capital. And other than that, I really can't be more specific. It'll be very situation-dependent."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","And your next question comes from the line of Doug Simpson from Morgan Stanley.",14,"And your next question comes from the line of Doug Simpson from Morgan Stanley."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Trevor, could you just talk a little bit. Just stepping back, if we look at the unit price increases the industry's seeing, they're above GDP. And then we've got this dynamic where we're seeing a sluggish commercial utilization. I mean, is there a broader",100,"Trevor, could you just talk a little bit. Just stepping back, if we look at the unit price increases the industry's seeing, they're above GDP. And then we've got this dynamic where we're seeing a sluggish commercial utilization. I mean, is there a broader sort of question looking out two years? I mean do you foresee any change in strategy relative to pricing to try to get volumes back up just as sort of an affordability issue? Or is it more just when the economy rebounds, we should get some pickup from that? I mean, can you separate the two?"
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","It's a very tough question because we have examined this question quite extensively here. I think there is several ways to approach it. So first of all, I think we are still in an environment where there is not a direct correlation between pricing and vol",378,"It's a very tough question because we have examined this question quite extensively here. I think there is several ways to approach it. So first of all, I think we are still in an environment where there is not a direct correlation between pricing and volume. There just doesn't seem to be any evidence of that. I think that volume is driven by all of the strategies that we outlined about physician alignment and about competitive positioning within markets and the local economies. And again, you get into these micro-localities where really the particular employment position in a very small market makes a difference. I think going forward, in terms of changing strategies, we have employed for some time a differentiating strategy on clinical quality. We thought that, that would generate differentiated volumes. And there were quarters when it appeared to be doing so but I'm not sure you can make a blanket statement on that. I think that as transparency increases and as health plans focus more on delivering value to their customers, the quality differentiation will have to play an important part. I want to make sure, even though we have generated strong increases in per unit revenues over the past several years, we still believe that our pricing positions us very effectively in terms of delivering value in the markets. Rarely are we the high-priced provider in a market. That position is usually held by a large not-for-profit system in a particular market. And then in terms of dealing with us from a health plan perspective, we have a very efficient revenue cycle, a very efficient back office. We have very few disputes with the payers. And so, we try to point out to them that as they look at the overall cost of doing business with providers, we tend to be positioned very effectively. I think those strategies will continue to be legitimate and valuable for the foreseeable future. When you get into several years from now into tiering of networks and more restrictive networks and so forth, I think we're also well positioned for that. And that is where you may begin to see opportunities to link price and volume. But I don't think it's -- the industry's just not there today."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Okay. And is there any, as you look back to prior slowdowns, either regionally or nationally, a sense of timing with utilization slowdowns and relative to downturns in the economy, how long that may take to play out in terms of a lag effect?",44,"Okay. And is there any, as you look back to prior slowdowns, either regionally or nationally, a sense of timing with utilization slowdowns and relative to downturns in the economy, how long that may take to play out in terms of a lag effect?"
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","It's really hard. We haven't seen one this long. And I don't think anybody -- I mean, I've talked to all sorts of people in the industry, I don't think anyone has seen one this widespread or this pervasive.",40,"It's really hard. We haven't seen one this long. And I don't think anybody -- I mean, I've talked to all sorts of people in the industry, I don't think anyone has seen one this widespread or this pervasive."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","And you have your next question from the line of Sheryl Skolnick from CRT Capital Group.",16,"And you have your next question from the line of Sheryl Skolnick from CRT Capital Group."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I want to probe on the change in acuity a little bit more if I could. And perhaps if you look at those remaining, for lack of a better word, heads in the beds x the OB/GYN, x the respiratory/flu and you look at your ER visits, is there any link or any ind",76,"I want to probe on the change in acuity a little bit more if I could. And perhaps if you look at those remaining, for lack of a better word, heads in the beds x the OB/GYN, x the respiratory/flu and you look at your ER visits, is there any link or any indication that patients being admitted for treatment or surgery through the ER are of higher acuity today than they were a year ago?"
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Sheryl, I think we have a couple of data points that would tend to suggest that the patients are more acute that are being admitted. If you look at the commercial managed care patients that get admitted through our ER and compare the Q2 '10 results to Q2",161,"Sheryl, I think we have a couple of data points that would tend to suggest that the patients are more acute that are being admitted. If you look at the commercial managed care patients that get admitted through our ER and compare the Q2 '10 results to Q2 '09, the case mix index is 3% higher than it was in '09. So it would suggest that the commercial patients coming in through the ER are indeed sicker than they were a year ago. The other point is that Trevor mentioned that our overall ED admissions are flat compared to the same quarter prior year. The fact that we had 2,000 fewer visits for influenza would, in fact, increase the overall case mix index of patients we're seeing in the ED. And therefore, those admitted would be higher acuity. So I think those two data points reinforce the observation that our ED is admitting sicker patients than it was a year ago."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Yes. Because I'm wondering if we're seeing the showing up later and sicker effect of delaying what's elective, let it become urgent, then let it become emergency and whether that might be the very early stages of an interesting trend that could further of",51,"Yes. Because I'm wondering if we're seeing the showing up later and sicker effect of delaying what's elective, let it become urgent, then let it become emergency and whether that might be the very early stages of an interesting trend that could further offset from the headwinds in commercial managed care."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well certainly, we have been concerned about that from a theoretical point of view. It's a little early to call that. But that's the sort of activity we would expect to escalate if, in fact, that bolus of pent-up demand is coming forward, we would see it",53,"Well certainly, we have been concerned about that from a theoretical point of view. It's a little early to call that. But that's the sort of activity we would expect to escalate if, in fact, that bolus of pent-up demand is coming forward, we would see it through the ED as you suggest."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And I can count on you all to have that data at your fingertips. Thank you. And then as a follow-up. Trevor, the refinancing and reduction of debt that you're doing is, I think, timely and interesting, as well as the -- and a good thing as well as look at",109,"And I can count on you all to have that data at your fingertips. Thank you. And then as a follow-up. Trevor, the refinancing and reduction of debt that you're doing is, I think, timely and interesting, as well as the -- and a good thing as well as look at the credit facility. But you intrigued me with one of your comments, which is having the flexibility to do share repurchases. Rather than read anything into that, could you share with us your thoughts on once you have that flexibility, whether or not you would be inclined to do it assuming, for example, you had that flexibility today?"
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well after intriguing you with that comment, I went on to say that I wouldn't say anything more about those kinds of activities at this time because it would be dependent on the situation at the time after we have gained that flexibility. The situation me",74,"Well after intriguing you with that comment, I went on to say that I wouldn't say anything more about those kinds of activities at this time because it would be dependent on the situation at the time after we have gained that flexibility. The situation meaning what are the market conditions, what's our outlook, what opportunities have we had to deploy the capital and what at that time is the best use of capital."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","You have the next question from the line of Darren Lehrich from Deutsche Bank.",14,"You have the next question from the line of Darren Lehrich from Deutsche Bank."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I guess I just wanted to go back to the M&A strategy question that was asked previously. And I think Trevor, you've laid out maybe three things that are on the table that you're really kind of focusing on: imaging; some things in the services side of the",128,"I guess I just wanted to go back to the M&A strategy question that was asked previously. And I think Trevor, you've laid out maybe three things that are on the table that you're really kind of focusing on: imaging; some things in the services side of the business, I guess, that would be more revenue cycle oriented; and then selectively acute care. I guess, just given what's unfolded over the last three to four months, is there anything that you've brought up to your board that you would firmly say is off the table from here? Can you just help us think a little bit more clearly about capital deployment on the acquisition side and whether you've made any firm decisions about what's off the table?"
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","I don't really have anything to add to what I said earlier. And no, I don't think anything is particularly off the table. But by our actions, I think you can gain insights into what we're thinking.",38,"I don't really have anything to add to what I said earlier. And no, I don't think anything is particularly off the table. But by our actions, I think you can gain insights into what we're thinking."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Okay. And you mentioned that the medical office building's sale was something you're still working through. Can you just give us an update about that and any other asset sales that might be contemplated from here?",36,"Okay. And you mentioned that the medical office building's sale was something you're still working through. Can you just give us an update about that and any other asset sales that might be contemplated from here?"
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Sure, Biggs, do you want to give the updated office building?",11,"Sure, Biggs, do you want to give the updated office building?"
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Sure. It's been a long process but we have continued to look to sell medical office buildings. You may recall in a prior call, I commented that rather than try to sell them all in one large transaction, we've broken them up into smaller transactions by ma",128,"Sure. It's been a long process but we have continued to look to sell medical office buildings. You may recall in a prior call, I commented that rather than try to sell them all in one large transaction, we've broken them up into smaller transactions by market or by region in order to make financing more readily available for purchasers. And we presently do have a number of them under contract, but having said that, a real estate contract isn't done until it closes. And so it's premature to say that there is definitively any additional cash coming in. But we're certainly hopeful that we will have at least some of them get to the point of close this year. If not this year, then into next year."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And is there a range of, I guess, either numbers of assets, square footage that's sort on the block? Can you just help size what you're working on at this point?",31,"And is there a range of, I guess, either numbers of assets, square footage that's sort on the block? Can you just help size what you're working on at this point?"
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Yes. The total opportunity that remains in front of us, for those that we're still trying to market, I'd put in the range of $100 million. But once again, there can be no assurance that we will ultimately close on all those or that that's the amount that",69,"Yes. The total opportunity that remains in front of us, for those that we're still trying to market, I'd put in the range of $100 million. But once again, there can be no assurance that we will ultimately close on all those or that that's the amount that would be received. But just for the sake of sizing what the opportunity is, that's a reasonable number to work with."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And the EBITDA loss relative to that $100 million would be what?",12,"And the EBITDA loss relative to that $100 million would be what?"
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","It's nominal. As we said before, these are properties which don't generate a lot of earnings for us. We think that quite frankly, another owner that's a professional real estate manager will be able to operate them more efficiently, number one. And second",66,"It's nominal. As we said before, these are properties which don't generate a lot of earnings for us. We think that quite frankly, another owner that's a professional real estate manager will be able to operate them more efficiently, number one. And secondly, to the benefit of our physician tenants. And so it makes sense for these to change hands in just about all respects."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","And your next question comes from the line of A.J. Rice of Susquehanna.",14,"And your next question comes from the line of A.J. Rice of Susquehanna."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Maybe first off, you just gave us your update and if there is any update on thoughts on things like the managed care contracting outlook for next year. Your thoughts on how the FMAP extension and the COBRA state of play, those payer dynamics looking into",59,"Maybe first off, you just gave us your update and if there is any update on thoughts on things like the managed care contracting outlook for next year. Your thoughts on how the FMAP extension and the COBRA state of play, those payer dynamics looking into the forward year might -- what's your thinking on those at this point?"
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","And actually, I would like to thank you on the issues of COBRA and FMAP for injecting some rational thought into the hysteria that seems to surround those topics. I guess, I'll take FMAP first. I don't think I'm telling anybody on the call something they",157,"And actually, I would like to thank you on the issues of COBRA and FMAP for injecting some rational thought into the hysteria that seems to surround those topics. I guess, I'll take FMAP first. I don't think I'm telling anybody on the call something they don't already know. But the Senate appears to be willing to continue to work on this. I can understand why they would not have necessarily wanted to pass something before the recess. But it's important to the governors. We have tried to estimate what an effect on us would be if the FMAP incremental money were not continued, and it hit directly and only to the Medicaid budgets of every state. And if we proportionally were hit directly. So I don't know if you should call that a worst-case analysis but it's a direct flow-through directly to us of eliminating those funds, and the total would be what, Biggs, it was..."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","It'd be just under $70 million but I emphasize, that is kind of the worst-case number because we don't think that it would flow directly in that case.",29,"It'd be just under $70 million but I emphasize, that is kind of the worst-case number because we don't think that it would flow directly in that case."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","It is inconceivable it would actually work that way. But seems to me that people are sort of pricing in fears that are far greater than that. On COBRA...",29,"It is inconceivable it would actually work that way. But seems to me that people are sort of pricing in fears that are far greater than that. On COBRA..."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","I should point, that's the annual number.",7,"I should point, that's the annual number."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","So on COBRA, it's been very difficult for us, as we've said repeatedly for a long time, to identify which patients are affected by that and so forth. And it maybe that we're seeing the results of that COBRA roll-off now. I don't know but I still think tha",125,"So on COBRA, it's been very difficult for us, as we've said repeatedly for a long time, to identify which patients are affected by that and so forth. And it maybe that we're seeing the results of that COBRA roll-off now. I don't know but I still think that one's just totally amorphous. And then with respect to the pricing environment, it's obviously never easy, but the fact that we are essentially done for 2010 and 75% contracted for '11 and into the mid-30s in terms of percentage of our managed care business done for 2012 gives us an extraordinary amount of visibility into what we think pricing trends are into 2011 and 2012. And it's obviously considered in the comments that we've made today."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Okay. And then just maybe a follow-up on that. One thing that I encounter, I guess, and I'd be interested in your perspective on it is the sustainability of the cost trends. Obviously in the face of the weak commercial volumes and the other dynamics aroun",167,"Okay. And then just maybe a follow-up on that. One thing that I encounter, I guess, and I'd be interested in your perspective on it is the sustainability of the cost trends. Obviously in the face of the weak commercial volumes and the other dynamics around this economic downturn, you've been able to have very good cost controls on key items like labor and supplies. But I think there's sort of this concern that if these payer pressures continue to exert themselves out there, at some point, you sort of hit a wall on that cost savings. I guess, I'm trying to get my arms around and wonder if you've thought about the issue of whether -- does all of this go hand-in-hand if the cost opportunities you're realizing are hand-in-hand with some of the things that are driving the commercial volume pressures, for example? Or do you see a point of time where some of the sustainability of some of these things gets called into question?"
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","As you face a declining volume environment, it does get more difficult to continue to reduce staffing because you run into certain core and minimum staffing. But that's why we really some time ago turned our attention to more creative approaches to cost r",155,"As you face a declining volume environment, it does get more difficult to continue to reduce staffing because you run into certain core and minimum staffing. But that's why we really some time ago turned our attention to more creative approaches to cost reductions, such as those that are part of the Medicare performance initiative. And that really gets to a whole different range of cost opportunities in the utilization of supplies and length of stay and even the clinical practice of medicine. That, together with the investments we're making in technology, should open up new opportunities for us in cost management beyond the traditional levers that were largely oriented towards labor. And again, I also should point out how really outstanding our performance has been in the revenue cycle. I mean, that's an important cost driver, and we have been very effective in managing that, both from an expense and a cash flow perspective."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","And you have your next question from the line of Kemp Dolliver from Avondale Partners.",15,"And you have your next question from the line of Kemp Dolliver from Avondale Partners."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Questions are on volumes. First on your volume outlook for the year, it looks like you are expecting some improvement in the second half versus the first half. And just wanted to get your rationale behind that, given that Q1 likely had some weather disrup",73,"Questions are on volumes. First on your volume outlook for the year, it looks like you are expecting some improvement in the second half versus the first half. And just wanted to get your rationale behind that, given that Q1 likely had some weather disruption, which would lead one to think that Q2 would have shown better trends but they look very similar in many regards. So that's what's behind my thought process."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Okay. So I'm going to ask Biggs to speak to the outlook for volumes for the second half.",18,"Okay. So I'm going to ask Biggs to speak to the outlook for volumes for the second half."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Sure. I think that you're right. We are expecting, if you're looking at it from a year-over-year trend standpoint, some improvement in the second half. It's our belief that our actions will drive volume. Plus on the outpatient side, the acquisitions that",143,"Sure. I think that you're right. We are expecting, if you're looking at it from a year-over-year trend standpoint, some improvement in the second half. It's our belief that our actions will drive volume. Plus on the outpatient side, the acquisitions that we're making that will fall under our hospital licenses will add volume on outpatient. But I think it's a moderate level of growth that's projected second half over first half, from a trending standpoint. At a gross level, it may prove to be relatively flat to the first half because of seasonality. But from a year-over-year trending standpoint, yes, we're expecting some improvement as a result of our actions, be it physician recruitment, redirection, the outpatient acquisitions and everything else we're doing to drive volume. But it's a very modest amount of growth that we're expecting relative to the first half."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","That's fine. And also several years ago, you all changed your admission criteria to eliminate a lot of short-term stays. And with the rack audits and I think other payer pressures, there appears to be intensified industry pressure, increasing observation",62,"That's fine. And also several years ago, you all changed your admission criteria to eliminate a lot of short-term stays. And with the rack audits and I think other payer pressures, there appears to be intensified industry pressure, increasing observation stays, et cetera. What are you seeing in terms of your very short-stay cases as it relates to the commercial book?"
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, as you point out, we made these changes several years ago. So we've really gone through anniversary dates already of those changes. The good news has been we've done really well in the rack audits. The bad news has been we've probably depressed our",59,"Well, as you point out, we made these changes several years ago. So we've really gone through anniversary dates already of those changes. The good news has been we've done really well in the rack audits. The bad news has been we've probably depressed our admissions intentionally for some period of time. But that's really washed out before now."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So no new pressures from there then?",7,"So no new pressures from there then?"
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","No, not to us. If we had not implemented those different criteria, which principally involve using the INTERQUAL system, which is a method essentially of providing the same screening to admissions that the payers ultimately provide and that the rack audit",71,"No, not to us. If we had not implemented those different criteria, which principally involve using the INTERQUAL system, which is a method essentially of providing the same screening to admissions that the payers ultimately provide and that the rack auditors are using. So if we hadn't done that, we probably would be in a position of seeing many admissions denied and overturned and rack audits coming up with big claims."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","Your next question comes from the line of Justin Lake from UBS.",12,"Your next question comes from the line of Justin Lake from UBS."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Just a follow up question on the operating cost side. I'm just trying to get some perspective on obviously, you've done a great job there over the last few years. If you could think back maybe three to five years ago, what your kind of core operating cost",63,"Just a follow up question on the operating cost side. I'm just trying to get some perspective on obviously, you've done a great job there over the last few years. If you could think back maybe three to five years ago, what your kind of core operating cost inflation trend look like and compare it to where you are now, I'd be curious."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","That's a hard one. I can't remember what the inflationary trends were but I can tell you that our cost base wasn't nearly as good. If you go back a few years, we were having volume losses and we were staffing at levels that were too high for the volumes w",118,"That's a hard one. I can't remember what the inflationary trends were but I can tell you that our cost base wasn't nearly as good. If you go back a few years, we were having volume losses and we were staffing at levels that were too high for the volumes we were experiencing and constantly trying to chase that sort of after the fact and get our cost base right-sized. But the processes we have in place now enable us to flex routinely on a daily basis now with great tools in place. And so that's not core inflation but certainly from the standpoint of our ability to manage cost growth, it is a big value driver."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Sure. I guess what I was trying to get to was obviously you've done -- the second question was just -- or the follow-up there was just I'm trying to get from a core perspective what you've been able to drive yourself, which has obviously been a lot versus",65,"Sure. I guess what I was trying to get to was obviously you've done -- the second question was just -- or the follow-up there was just I'm trying to get from a core perspective what you've been able to drive yourself, which has obviously been a lot versus what you've kind of benefited from just on lower typical nursing inflation and things like that."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","I see what you're saying. Well look, we have really driven this improvement in productivity and this better performance on labor. The outside factors have been mixed on that. We've had pressures from labor unions. We've had continued competitive wage pres",196,"I see what you're saying. Well look, we have really driven this improvement in productivity and this better performance on labor. The outside factors have been mixed on that. We've had pressures from labor unions. We've had continued competitive wage pressures. And then we had some benefits from lower turnover, that was really caused in large part by the economy but also by a series of initiatives we undertook. So I guess you want that sort of macro rundown. I'd say there have been net probably neutral to slightly positive factors from the environment on labor but huge positive factors from our own management techniques and the implementation of systems to manage that. On supplies, we've had sort of relentless upward pressure on the high-value supplies and fairly benign pricing pressure on commodity supplies. But once again, our efforts to manage utilization, to substitute and use equivalent but less expensive drugs and supplies, and to be more conscious of the waste of supplies, the whole series of initiatives in the supply chain have really driven outstanding performance there. And then I've mentioned revenue cycle earlier and those, of course, are the huge drivers that cost."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Right. So you think these are replicable though looking forward, as the reimbursement environment gets tougher. I guess that's the real key.",22,"Right. So you think these are replicable though looking forward, as the reimbursement environment gets tougher. I guess that's the real key."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well I think independent of the reimbursement environment, as I said a few minutes ago, we continue to find new opportunities and new ways of being more efficient and saving money.",31,"Well I think independent of the reimbursement environment, as I said a few minutes ago, we continue to find new opportunities and new ways of being more efficient and saving money."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","And your next question comes from the line of Ralph Giacobbe from Credit Suisse.",14,"And your next question comes from the line of Ralph Giacobbe from Credit Suisse."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I just wanted to go back to volume and just kind of reconciling the pre-announcement down 1.2% on the volume side and in the quarter down 2% sort of implies that the last several weeks of the quarter obviously you were down kind of 4% to 5%. And I know it",116,"I just wanted to go back to volume and just kind of reconciling the pre-announcement down 1.2% on the volume side and in the quarter down 2% sort of implies that the last several weeks of the quarter obviously you were down kind of 4% to 5%. And I know it's hard to sort of extrapolate just those last three weeks but I guess, first, I mean, is there nothing in those results that are meaningfully different other than just a sharper decline within admission trends across-the-board? And then two, when you said that July remains soft, is that in the context of the full 2Q results or the last three weeks of the quarter?"
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","The July was pretty consistent with the end of June. So it's softer than the second quarter. But don't forget, the really tough comp for last year's July. So I think it's again, when you get into these really short-term periods where you're analyzing volu",132,"The July was pretty consistent with the end of June. So it's softer than the second quarter. But don't forget, the really tough comp for last year's July. So I think it's again, when you get into these really short-term periods where you're analyzing volumes, the prior year performance is important. The current year, if there's something from a service line perspective is important. And I think it's too limiting of a period to draw any broader conclusion than that, except just as a point of disclosure, we wanted to make sure we said look we're off to a slow start for the third quarter on volumes. As Biggs points out, we've taken into account in our outlook for the year that there's no dramatic recovery in volumes in the second half."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Okay. That's helpful. Thanks. And then I just want to go back to the managed care side. I may have missed this. I know you gave sort of the percentages of the business that's locked in for the next couple of few years. I just want to make sure the rates o",84,"Okay. That's helpful. Thanks. And then I just want to go back to the managed care side. I may have missed this. I know you gave sort of the percentages of the business that's locked in for the next couple of few years. I just want to make sure the rates on that. Have you sort of talked about what, kind of, the average rates are and/or maybe whether they're anything meaningfully different than the rates we've seen over the last couple of years?"
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","No, we haven't talked about it. We just find that it gets played right back to us. It's relatively consistent with what we've been able to do to date but we're working hard to get it.",36,"No, we haven't talked about it. We just find that it gets played right back to us. It's relatively consistent with what we've been able to do to date but we're working hard to get it."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","And we do have our last question from the line of John Rex.",13,"And we do have our last question from the line of John Rex."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","So with that, I think I'll just proceed to make a couple of closing comments. This quarter, we took a decline of 2% at admissions. We turned it into 3.3% growth in revenues and almost tripled that rate of growth in EBITDA. And we should be able to do a lo",160,"So with that, I think I'll just proceed to make a couple of closing comments. This quarter, we took a decline of 2% at admissions. We turned it into 3.3% growth in revenues and almost tripled that rate of growth in EBITDA. And we should be able to do a lot better than that once we begin growing volumes again. We achieved new milestones in margins and free cash flows. Ad those are very important to keep in mind. We're taking excess cash and we're reducing debt. We're reducing the company's risk by extending maturities of our 2013 debt. And we plan to increase our flexibility by arranging a new credit line. During June and July, we engaged in an extensive amount of Investor Relations activity. We're going to resume this in September by attending the Morgan Stanley conference and continuing to do one-on-one meetings in a few cities. And with that, operator, thank you and this concludes our call."
107911,109241320,73762,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","Ladies and gentlemen, that concludes our presentation. Thank you for your participation in today's conference. You may now disconnect. Have a great day.",23,"Ladies and gentlemen, that concludes our presentation. Thank you for your participation in today's conference. You may now disconnect. Have a great day."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","Good day, ladies and gentlemen, and welcome to the Second Quarter 2010 Tenet Healthcare Earnings Conference Call. My name is Marisa, and I'll be the operator for today's call. [Operator Instructions] I would now like to turn the conference over to your ho",59,"Good day, ladies and gentlemen, and welcome to the Second Quarter 2010 Tenet Healthcare Earnings Conference Call. My name is Marisa, and I'll be the operator for today's call. [Operator Instructions] I would now like to turn the conference over to your host for today's call, Mr. Thomas Rice, the Vice President of Investor Relations. You may proceed, sir."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, operator, and good morning, everyone.  Tenet's management will be making forward-looking statements on this call. These statements are based on management's current expectations and are subject to risks and uncertainties that may cause those fo",97,"Thank you, operator, and good morning, everyone.  Tenet's management will be making forward-looking statements on this call. These statements are based on management's current expectations and are subject to risks and uncertainties that may cause those forward-looking statements to be materially incorrect. Management cautions you not to rely on and makes no promises to update any of the forward-looking statements. During the question-and-answer portion of the call, callers are requested to limit themselves to one question and one follow-up question.
At this time, I will turn the call over to Trevor Fetter, Tenet's President and CEO. Trevor?"
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, Tom, and good morning, everyone. I'm very pleased with our solid performance in the second quarter. We generated $268 million of adjusted EBITDA, representing 9% growth over 2009 and a margin of 11.6%.We are in the midst of generating one of",1176,"Thank you, Tom, and good morning, everyone. I'm very pleased with our solid performance in the second quarter. We generated $268 million of adjusted EBITDA, representing 9% growth over 2009 and a margin of 11.6%.
We are in the midst of generating one of the strongest earning trajectories in our recent history. And we face a difficult comparison versus the second quarter of 2009 when EBITDA was up more than 50%. The 11.6% margin was the highest margin for a second quarter in the last seven years. And we achieved it in a difficult volume environment. 
The in-patient admissions picture was virtually identical to our first quarter, although there was a little more strength in our Outpatient business in the second quarter relative to the first.
When we released interim second quarter volumes on June 14th, the volume picture for the quarter was stronger. Unfortunately, the final few weeks of June and all of July were soft, so we're off to a slow start for volumes in the third quarter. We also started the third quarter with a difficult comparison. Last year at this time, we were off to a strong start for Q3 with positive admissions growth in July.
Turning back to the second quarter, total admissions were down 2%. But that's before you take into account a decline in both flu and OB/GYN-related cases. Had it not been for these two categories, total admissions for the quarter would have been down less than 1%. But we are most disappointed by the 7.2% decline in commercial admissions and the 5.4% decline in commercial outpatient visits. 
Providing context for our commercial volumes relative to the industry continues to be difficult. There is really only one data point so far for the second quarter, namely HCA's negative 5.3% statistic for what they termed, Managed Care and Other. Our comparable statistic would have been negative 6.2%.
While commercial volumes are a part of our story, they are not the whole story. I hope you noticed that our commercial revenues grew by 2%. So clearly, something is helping us mitigate these volume declines. Here's some insight into what's going on beneath the surface of our commercial volume trends.
First, there was a significant pickup in our commercial case mix index, which increased 2.8%. Over a third of our decline in commercial admissions was OB/GYN-related. As many of you have written about the declining U.S. birthrate, it's probably no surprise that the reduction in deliveries explained nearly 20% of our decline in commercial admissions in the second quarter.
In addition, we had a favorable shift within the mix of our commercial payers from lower-paying to higher-paying health plans. The impact of these two factors, when combined with continuing increases in commercial pricing, resulted in commercial revenue growth of 2%. At the end of the day, it's this revenue growth and solid cost control which drove our 9% growth in EBITDA.
Also, I don't want to overlook some areas of strength in the overall volume picture. Our Outpatient business appears to be picking up after a weaker start to the year. Second quarter aggregate Outpatient business declined by less than 1%, while we saw positive growth in government outpatient of 2%. Our admissions through the emergency department were equal to last year's statistic. This is further evidence that elective procedures are most directly impacted by a slow economy. And to complete the volume story, note that total government admissions were flat and adjusted admissions declined by just 0.6%.
We continue to show strong numbers in the area of cost control and rates. And importantly, the delta between these two variables continues to expand. Inpatient net revenue per admission and outpatient net revenue per visit grew by 4.6% and 5.3%, respectively, significantly outpacing a 3.8% growth in controllable cost per adjusted patient day. 
Collectively, these factors helped us to generate adjusted free cash flow of $121 million in Q2, bringing free cash flow for the first half to positive $21 million. That's a $23 million improvement on a year-to-date basis from last year and a significant achievement given the large cash consumption that's typical for our first quarter.
Speaking of cash, excluding cash and insurance subsidiaries, we had a corporate cash balance of $600 million at the end of Q2. Taking only into account capital expenditures, July repurchases of $40 million of debt and our planned investment in outpatient centers through the remainder of the year, our year-end outlook for corporate cash is $500 million to $575 million. 
Based on the improvement in our performance over the last several years and our credit line availability, we believe this amount of cash exceeds our liquidity requirements even after considering the normal first quarter seasonal usage. Our liquidity will be even greater if we receive the full California provider fee and complete the sale of some of our medical office buildings. 
I want to spend a moment on two actions that will improve our financial flexibility. First, in order to improve cash flow and manage our debt maturities, today, we launched the refinancing of a portion of our $1 billion of 2013 debt. If we successfully complete this transaction as contemplated, our debt will drop by another $200 million to roughly $4.0 billion, our annual cash flow will improve by $11 million and our next significant maturity of debt will not occur until 2015. 
Second, we are now beginning to negotiate a new credit line. Because our credit line is used to support letters of credit which expire next year, it makes sense to replace that line in the third quarter of this year. Today, our facility is $800 million in size and after taking into account outstanding letters of credit and other limitations, we have undrawn capacity of approximately $500 million. We will seek to maintain a facility of $800 million with a five-year term. We also believe that based on our improved financial condition and the current bank market, we will be able to improve our capital allocation option, including lifting an existing limitation on stock repurchases.
We think the combination of these actions, namely, retiring $240 million of debt, extending $600 million of 2013 debt to 2020, and arranging a new credit line will enable us to maintain an appropriately prudent capital structure and liquidity posture while adding new flexibility.
Please keep in mind that any further decisions to make investments in our business, make acquisitions, retire debt or repurchase stock are conditional upon our outlook, as well as the opportunities and market conditions at the time, so I can't project a future capital deployment strategy with greater precision today. 
To summarize, I'm pleased with our effective response to the continued weak economy and soft volume environment in the first half. When confronted by these extraordinary challenges, our management teams responded quickly to maintain our positive earnings trajectory. And once we generate volume growth, I'm confident that we can achieve some truly outstanding bottom line performance. Let me now turn the floor over to Biggs Porter, our Chief Financial Officer. Biggs?"
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, Trevor, and good morning, everyone. As Trevor said, we are very pleased with our EBITDA and cash flow results for the quarter. There were two items we pointed out in the release, which could be characterized as non-recurring, but they were iden",883,"Thank you, Trevor, and good morning, everyone. As Trevor said, we are very pleased with our EBITDA and cash flow results for the quarter. There were two items we pointed out in the release, which could be characterized as non-recurring, but they were identical in size and therefore fully offsetting. The two items are a favorable Medicare bad debt settlement, offset by a reduction in revenue related to the supplemental security income adjustment to Medicare reimbursement. 
I will otherwise now give a little color on the other value drivers. First, as Trevor said, on pricing, growth and per unit revenues continues to make a solid contribution to profitability. We also have good visibility into future years pricing. At this point, approximately 95% of our commercial contracting is complete for 2010, 75% for 2011 and 35% for 2012.
Controllable costs again reflect good cost discipline, with an increase of 3.8% per adjusted patient day. Salaries, wages and benefits was well-controlled, with an increase of 3.4%, also on a PAPD basis, demonstrating our ability to effectively flex our staffing in response to fluctuating volumes. Supply cost increased just 1.2% per adjusted patient day relative to last year's second quarter.
The one area showing cost pressure is other controllable costs, which were up 6.8% per adjusted patient day. There were increases in various elements of cost, some of which are non-recurring by nature, including a contractual settlement on a lease, a credit in the prior year's results, provider taxes and IT maintenance costs. 
Malpractice expense declined by $2 million or 7% relative to last year, but increased by $14 million over the first quarter. Malpractice was negatively affected by a decrease in the discount rate and some individual claim adjustments. Otherwise, it would have been substantially less. If discount rates are stable or increase and we don't have the unusually large specific claim adjustments, there is opportunity for malpractice to decline in future quarters. However, since forecasting a malpractice expense is challenging, our outlook has been left conservative.
Our bad debt ratio was flat relative to last year at 7.5%, but there were a number of moving pieces which contributed to that result. Reported bad debt for the quarter included the benefit of a $28 million favorable adjustment for Medicare bad debt. In a related item, we also recorded unfavorable contractual adjustments for Medicare of $8 million. Netting the $8 million from the $28 million results in a favorable $20 million. This $20 million offsets the unfavorable SSI adjustment of the same magnitude referred to earlier. 
We also expect any recurring effects from these items to offset. The sum of uninsured and charity admissions declined by 2.2% in the quarter. This decline helped control the cost of providing uncompensated care to an increase of only $5 million in the quarter. 
On a totally separate subject, there has been some positive movement on CMS's response to the California provider fee legislation. There have been comments received from CMS which have prompted an adjustment to the program, but moved it much closer to approval. At this time, we expect the benefit we will receive this year to be $70 million, $30 million of which would be applicable to 2009. Having said that, we are leaving the $30 million contribution in the middle of our 2010 outlook range unchanged until the program passes the last step of formal CMS approval.
Turning to our outlook. As you know, we raised our outlook for 2010 EBITDA by $50 million in early June. We remain confident with the new range of $1.035 billion to $1.1 billion, as we expect acuity and shifts between commercial payers to continue to provide offset to aggregate volume statistical declines. This is consistent with the notion that the quality of commercial admits is better than what the unadjusted commercial volume statistic would suggest. 
To understand what the real impact of commercial volume losses is, one needs to add back the increase in acuity and the effects of payer shifts within commercial. This would bring the economic effects of commercial inpatient volume loss in the second quarter down to approximately 4% rather than 7.2%, and will put the effects of commercial pricing at around 7% to 7 1/2%. The details of our outlook are provided on Slide 12.
The walk forward of cash from June 30 to December 31 as reflected on Slide 13 breaks down second half cash flow into its major components, so that you can more clearly see the positive cash generated from operations and the planned deployment Trevor mentioned earlier. You will note that we have reduced our outlook for year-end cash to reflect the potential for outpatient acquisitions and the $40 million of debt we repurchased in July. Although not yet formally reflected in the outlook, we show the pro forma effect of the range of cash we would use in the refinancing and debt repurchase transaction, which we launched today.
So to summarize. We have strong results for the quarter in earnings and cash flow. Commercial patient mix shifts continue to significantly offset growth statistical changes in volume. The potential upside of the California provider fee is nearing reality and there is confirmation of our outlook for the year. I will now ask the operator to assemble the queue for Q&A. Operator?"
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","[Operator Instructions]  You do have your first question from the line of Tom Gallucci from Lazard Capital.",17,"[Operator Instructions]  You do have your first question from the line of Tom Gallucci from Lazard Capital."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","You mentioned that the end of June was soft sort of since your pre-announcement I guess. And then July has been soft as well. Can you maybe give us a little more color on the types of categories on the volume side that have been weaker? You mentioned duri",73,"You mentioned that the end of June was soft sort of since your pre-announcement I guess. And then July has been soft as well. Can you maybe give us a little more color on the types of categories on the volume side that have been weaker? You mentioned during the quarter, OB seemed to be a big piece of it. But I'm wondering if the drop-off was in other categories in particular."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","The trends are similar to what we've been seeing all year.",12,"The trends are similar to what we've been seeing all year."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Meaning OB dropped off significantly in late June and July?",10,"Meaning OB dropped off significantly in late June and July?"
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","You've got the same categories of weakness. And again, I think it's important not to focus too much on very short term volumes. We're just trying to give some indication of trends here. But there are no trends that are unusual that are taking place that w",65,"You've got the same categories of weakness. And again, I think it's important not to focus too much on very short term volumes. We're just trying to give some indication of trends here. But there are no trends that are unusual that are taking place that we haven't continued to see for the year inconsistent with what the comments are that I made earlier."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So similar categories that were weak were just a little weaker. And then what about if you could...",18,"So similar categories that were weak were just a little weaker. And then what about if you could..."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","From the standpoint of being a little weaker, it is the same categories, but it's against a much tougher comp. So I don't know that sequentially, you would see it as weaker.",32,"From the standpoint of being a little weaker, it is the same categories, but it's against a much tougher comp. So I don't know that sequentially, you would see it as weaker."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then my follow-up is I guess is you mentioned more volume from higher-paying health plans. Is there any more color behind that and maybe why you're seeing that sort of a trend? Is there deductible differences or anything else that you might be able to",59,"And then my follow-up is I guess is you mentioned more volume from higher-paying health plans. Is there any more color behind that and maybe why you're seeing that sort of a trend? Is there deductible differences or anything else that you might be able to identify that would cause the better utilization from one type from another?"
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","I don't think so. That comment was made to help explain how you take a negative 7% volume number, which I think that the audience may pay too much attention to, and generate growth in the revenue number of our overall Commercial book of business, which is",80,"I don't think so. That comment was made to help explain how you take a negative 7% volume number, which I think that the audience may pay too much attention to, and generate growth in the revenue number of our overall Commercial book of business, which is the important statistic that drives earnings ultimately, and that is one component of it. It can be due to many things, including growth or relative lack of growth in different health plans."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","And your next question comes from the line of Brendan Strong from Barclays Capital.",14,"And your next question comes from the line of Brendan Strong from Barclays Capital."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","When we look at the commercial trends, I mean, they are very similar to what they were in the first quarter. So really no big change here. I guess, as you think about the rest of the year, I mean, do you think if the unemployment rates stays similar to wh",72,"When we look at the commercial trends, I mean, they are very similar to what they were in the first quarter. So really no big change here. I guess, as you think about the rest of the year, I mean, do you think if the unemployment rates stays similar to where we're at today, do you think we'll be looking at similar declines in commercial trends for the rest of the year?"
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","It would be speculative to answer the question directly, but this is driven by the things that we've talked about. So employment is key. It creates more people that could potentially be covered under commercial insurance. You've got the shifts among payer",135,"It would be speculative to answer the question directly, but this is driven by the things that we've talked about. So employment is key. It creates more people that could potentially be covered under commercial insurance. You've got the shifts among payers that's very important in driving the revenue number. And you've got this issue with elective procedures, most importantly OB. And I think what we're trying to do is highlight a more important economic trend, which is very -- again similar to the first quarter, the volumes that we've been losing the most that are contributing to those volume loss numbers are the ones with the least value associated with them. And that is in part how we've been able to continue to grow revenues even in the face of those weak volume numbers."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","I would just add that certainly, we think our actions will help drive commercial volumes in the future. And as you say, the economy improving will drive commercial volumes more favorably in the future. But having said that for the sake of conservatism, th",104,"I would just add that certainly, we think our actions will help drive commercial volumes in the future. And as you say, the economy improving will drive commercial volumes more favorably in the future. But having said that for the sake of conservatism, the middle of our range in the outlook presumes that the trends through the first half are sustained through the year. So for purposes of the outlook, we have presumed that the economy does not turn and that there's no other windfall that would change the current trend. But obviously, we're working to operate in a different direction and create growth."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then, I don't know if there's any other color you guys can provide on the Medicare side as well; that's part of the business that you think would be kind of stable. But theres some declines there on the admission side, too. So I presume part of tha",64,"And then, I don't know if there's any other color you guys can provide on the Medicare side as well; that's part of the business that you think would be kind of stable. But theres some declines there on the admission side, too. So I presume part of thats because of some procedures being delayed, because of co-pays possibly. But any color around that?"
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Steve, do you want to add some color on that?",10,"Steve, do you want to add some color on that?"
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Sure. Brendan, I think you're right. I think we are beginning to see some increase in elective surgeries of Medicare patients. That too has been impacted by the downturn in the general economy. But for example, orthopedic surgery in Medicare was up 1% in",70,"Sure. Brendan, I think you're right. I think we are beginning to see some increase in elective surgeries of Medicare patients. That too has been impacted by the downturn in the general economy. But for example, orthopedic surgery in Medicare was up 1% in the quarter compared to the same quarter prior year. So I think we're beginning to see that. But it's only a small glimmer at this point."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","And your next question comes from the line of Gary Lieberman from Wells Fargo.",14,"And your next question comes from the line of Gary Lieberman from Wells Fargo."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I was hoping that maybe you could talk a little bit about what you're continuing to do in terms of attracting physicians and maybe some other measures that you're taking to try to reverse the trend or at least ameliorate the trend on a commercial managed",50,"I was hoping that maybe you could talk a little bit about what you're continuing to do in terms of attracting physicians and maybe some other measures that you're taking to try to reverse the trend or at least ameliorate the trend on a commercial managed care admission front?"
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Gary, we've been doing a lot. And Stephen, you want to answer that?",13,"Gary, we've been doing a lot. And Stephen, you want to answer that?"
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","First of all, the number for the quarter, 245 active staff net of attrition added to staff, that's consistent with the forecast we made at the previous quarter for the year. But above and beyond that, we've accelerated our physician alignment activities a",179,"First of all, the number for the quarter, 245 active staff net of attrition added to staff, that's consistent with the forecast we made at the previous quarter for the year. But above and beyond that, we've accelerated our physician alignment activities and each of our hospitals now has a customized physician alignment plan. And we've added a number of tactics to that particular plan, including the roll-out of office-based Health Information Technology through our joint venture partner, Med3000. We are tying our doctors more closely to our facilities through this HIT set of products and that will make a difference longer term. Additionally, we are reactivating a number of organizations that we had 10 or 12 years ago that are called Physician Hospital Organizations. These are entities that are jointly owned by physicians and hospitals, and allow for contracting on a single signature, whether it be with a commercial payer or a governmental payer. So we're doing a number of things, Gary, to increase our physician alignment that should translate into growing our volumes, especially our commercial volume."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","There's a lot of focus this quarter on one particular acquisition that you guys indicated you were looking at. Could you just bring us up to speed on what your current thoughts are in terms of potential acquisitions? And kind of where you might be looking",54,"There's a lot of focus this quarter on one particular acquisition that you guys indicated you were looking at. Could you just bring us up to speed on what your current thoughts are in terms of potential acquisitions? And kind of where you might be looking and where you might not be looking?"
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","I think first of all, it's important to understand we don't need to make acquisitions to meet our goals. So we believe we continue to have significant margin upside in the current portfolio, and we spent a lot of time in June and July in Investor Relation",183,"I think first of all, it's important to understand we don't need to make acquisitions to meet our goals. So we believe we continue to have significant margin upside in the current portfolio, and we spent a lot of time in June and July in Investor Relations activities talking to people about those sources of margin expansion. We are actively pursuing acquisitions in the outpatient imaging space. These are small dollars, but they're very accretive and they generate very high IR. I'd like to make acquisitions in our Service business in order to expand our scale, but those tend to be very expensive and they're hard to find the right fit. And then on acute acquisitions, it does seem as though the supply side of that market is increasing very steadily, but we're going to continue to be very careful in that area looking for selective acquisitions where we would have a high degree of confidence in generating returns that would be well above our cost of capital. And other than that, I really can't be more specific. Itll be very situation dependent."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","And your next question comes from the line of Doug Simpson from Morgan Stanley.",14,"And your next question comes from the line of Doug Simpson from Morgan Stanley."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Trevor, could you just talk a little bit -- just stepping back, if we look at the enterprise increase that the industrys seeing, they're above GDP and then we've got this dynamic where we're seeing a sluggish commercial utilization. Is there a broader",95,"Trevor, could you just talk a little bit -- just stepping back, if we look at the enterprise increase that the industrys seeing, they're above GDP and then we've got this dynamic where we're seeing a sluggish commercial utilization. Is there a broader sort of question, looking out two years, do you foresee any change in strategy relative to pricing to try to get volumes back up just as sort of an affordability issue or is it more just when the economy rebounds, we should get some pickup from that? Can you separate the two?"
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","It's a very tough question because we have examined this question quite extensively here. I think there are several ways to approach it. So first of all, I think we are still in an environment where there is not a direct correlation between pricing and vo",380,"It's a very tough question because we have examined this question quite extensively here. I think there are several ways to approach it. So first of all, I think we are still in an environment where there is not a direct correlation between pricing and volume. There just doesn't seem to be any evidence of that. I think that volume is driven by all of the strategies that we outlined about physician alignment and about competitive positioning within markets and the local economies. And again, you get into these micro localities where it really, the particular employment position in a very small market makes a difference. I think going forward, is in terms of changing strategies, we have employed for some time a differentiating strategy on clinical quality. We thought that, that would generate differentiated volumes and there were quarters when it appeared to be doing so. But I'm not sure you can make a blanket statement on that. I think that as transparency increases and as health plans focus more on delivering value to their customers, the quality differentiation will have to play an important part. I want to make sure that even though we have generated strong increases in per unit revenues over the past several years, we still believe that our pricing positions us very effectively in terms of delivering value in the markets. Rarely are we the high-priced provider in a market. That position is usually held by a large not-for-profit system in a particular market. And then in terms of dealing with us from a health plan perspective, we have a very efficient revenue cycle, a very efficient back office, we have very few disputes with the payers. And so we try to point out to them that as they look at the overall cost of doing business with providers, we tend to be positioned very effectively. I think those strategies will continue to be legitimate and valuable for the foreseeable future. When you get into several years from now into tiering of networks and more restrictive networks and so forth, I think we're also well positioned for that. And that is where you may begin to see opportunities to link price and volume. But I don't think the industrys just not there today."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","As you look back to prior slowdowns, either regionally or nationally, any sense of timing with utilization slowdowns and relative to downturns in the economy, how long that may take to play out in terms of the lag effect?",39,"As you look back to prior slowdowns, either regionally or nationally, any sense of timing with utilization slowdowns and relative to downturns in the economy, how long that may take to play out in terms of the lag effect?"
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","It's really hard. We haven't seen one this long. And I don't think anybody, Ive talked to all sorts of people in the industry; I don't think anyone has seen one this widespread or this pervasive.",37,"It's really hard. We haven't seen one this long. And I don't think anybody, Ive talked to all sorts of people in the industry; I don't think anyone has seen one this widespread or this pervasive."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","And you have your next question from the line of Sheryl Skolnick from CRT Capital Group.",16,"And you have your next question from the line of Sheryl Skolnick from CRT Capital Group."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I want to probe on the change in acuity a little bit more if I could. And perhaps if you look at those remaining, for lack of a better word, heads in the beds, x the OB/GYN, x the respiratory/flu, and you look at your ER visits, is there any link or any i",76,"I want to probe on the change in acuity a little bit more if I could. And perhaps if you look at those remaining, for lack of a better word, heads in the beds, x the OB/GYN, x the respiratory/flu, and you look at your ER visits, is there any link or any indication that patients being admitted for treatment or surgery through the ER are of higher acuity today than they were a year ago?"
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Sheryl, I think we have a couple of data points that would tend to suggest that the patients are more acute that are being admitted. If you look at the commercial managed care patients that get admitted through our ER and compare the Q2 '10 results to Q2",161,"Sheryl, I think we have a couple of data points that would tend to suggest that the patients are more acute that are being admitted. If you look at the commercial managed care patients that get admitted through our ER and compare the Q2 '10 results to Q2 '09, the case mix index is 3% higher than it was in '09. So it would suggest that the commercial patients coming in through the ER are indeed sicker than they were a year ago. The other point is that Trevor mentioned that our overall ED admissions are flat compared to the same quarter prior year. The fact that we had 2,000 fewer visits for influenza would in fact increase the overall case mix index of patients we're seeing in the ED and, therefore, those admitted would be higher acuity. So I think those two data points reinforce the observation that our ED is admitting sicker patients than it was a year ago."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Yes, because I'm wondering if we're seeing the showing up later and sicker effect of delaying whats elective, let it become urgent, then let it become emergency and whether that might be the very early stages of an interesting trend that could further",52,"Yes, because I'm wondering if we're seeing the showing up later and sicker effect of delaying whats elective, let it become urgent, then let it become emergency and whether that might be the very early stages of an interesting trend that could further offset some of the headwinds in commercial managed care."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, certainly, we have been concerned about that from a theoretical point of view. It's a little early to call that. But that's the sort of activity we would expect to escalate if, in fact, that bolus of pent-up demand is coming forward, we would see it",53,"Well, certainly, we have been concerned about that from a theoretical point of view. It's a little early to call that. But that's the sort of activity we would expect to escalate if, in fact, that bolus of pent-up demand is coming forward, we would see it through the EDs as you suggested."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And I can count on you all to have that data at your fingertips. As then as a follow-up, Trevor, the refinancing and reduction of debt that you're doing is I think timely and interesting, as well as the -- and a good thing, as well as looking at the credi",107,"And I can count on you all to have that data at your fingertips. As then as a follow-up, Trevor, the refinancing and reduction of debt that you're doing is I think timely and interesting, as well as the -- and a good thing, as well as looking at the credit facility but you intrigued me with one of your comments, which is having the flexibility to do share repurchases. Rather than read anything into that, could you share with us your thoughts on once you have that flexibility, whether or not you would be inclined to do it, assuming for example you had that flexibility today?"
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","After intriguing you with that comment, I went on to say that I wouldn't say anything more about those kinds of activities at this time, because it would be dependent on the situation at the time after we have gained that flexibility. The situation meanin",73,"After intriguing you with that comment, I went on to say that I wouldn't say anything more about those kinds of activities at this time, because it would be dependent on the situation at the time after we have gained that flexibility. The situation meaning what are the market conditions, whats our outlook, what opportunities have we had to deploy the capital and what at that time is the best use of capital?"
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","You have the next question from the line of Darren Lehrich from Deutsche Bank.",14,"You have the next question from the line of Darren Lehrich from Deutsche Bank."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I guess I just wanted to go back to the M&A strategy question that was asked previously. I think Trevor, you've laid out maybe three things that are on the table that you're really kind of focusing on, imaging some things in the services side of the busin",126,"I guess I just wanted to go back to the M&A strategy question that was asked previously. I think Trevor, you've laid out maybe three things that are on the table that you're really kind of focusing on, imaging some things in the services side of the business. I guess that would be more revenue-cycle oriented and then selectively acute care. I guess just given what's unfolded over the last three to four months, is there anything that youve brought up to your board that you would firmly say is off the table from here? Can you just help us think a little bit more clearly about capital deployment on the acquisition side and whether you've made any firm decisions about what's off the table?"
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","I don't really have anything to add to what I said earlier. And no, I don't think anything is particularly off the table. But by our actions, I think you can gain insights into what we're thinking.",38,"I don't really have anything to add to what I said earlier. And no, I don't think anything is particularly off the table. But by our actions, I think you can gain insights into what we're thinking."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And you mentioned that the medical office building sale was something you're still working through. Can you just give us an update about that and any other asset sales that might be contemplated from here?",36,"And you mentioned that the medical office building sale was something you're still working through. Can you just give us an update about that and any other asset sales that might be contemplated from here?"
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","It's been a long process, but we have continued to look to sell medical office buildings. You may recall in the prior call, I commented that rather than trying to sell them all in one large transaction, we've broken them up into smaller transactions by ma",128,"It's been a long process, but we have continued to look to sell medical office buildings. You may recall in the prior call, I commented that rather than trying to sell them all in one large transaction, we've broken them up into smaller transactions by market or by region in order to make financing more readily available for purchasers. And we presently do have a number of them under contract. But having said that, our real estate contract isn't done until it closes, and so it's premature to say that there is definitively any additional cash coming in. But we're certainly hopeful that we will have at least some of them get to the point of close this year. If not this year, then into next year."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And is there a range of either numbers of assets, square footage thats sort of on the block? Can you just help size what you're working on at this point?",30,"And is there a range of either numbers of assets, square footage thats sort of on the block? Can you just help size what you're working on at this point?"
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","The total opportunity that remains in front of us for those that we're still trying to market, I'd put it in the range of $100 million. But once again, there can be no assurance that we will ultimately close on all those or that's the amount that would be",69,"The total opportunity that remains in front of us for those that we're still trying to market, I'd put it in the range of $100 million. But once again, there can be no assurance that we will ultimately close on all those or that's the amount that would be received. But just for the sake of sizing what the opportunity is, that's a reasonable number to work with."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And the EBITDA loss relative to that $100 million would be what?",12,"And the EBITDA loss relative to that $100 million would be what?"
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","It's nominal. As we said before, these are properties which don't generate a lot of earnings for us. We think that quite frankly another owner that's a professional real estate manager will be able to operate them more efficiently, number one. And secondl",66,"It's nominal. As we said before, these are properties which don't generate a lot of earnings for us. We think that quite frankly another owner that's a professional real estate manager will be able to operate them more efficiently, number one. And secondly, to the benefit of our physician tenants. And so, it makes sense for these to change hands in just about all respects."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","And your next question comes from the line of A.J. Rice from Susquehanna.",14,"And your next question comes from the line of A.J. Rice from Susquehanna."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Can you just give us your update in -- if there is any update on thoughts on things like the managed care contracting outlook for next year? Your thoughts on how the FMAP extension and the COBRA state of play, those payer dynamics, who will get into the f",59,"Can you just give us your update in -- if there is any update on thoughts on things like the managed care contracting outlook for next year? Your thoughts on how the FMAP extension and the COBRA state of play, those payer dynamics, who will get into the forward year  whats your thinking on those at this point?"
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","I would like to thank you on the issues of COBRA and FMAP for injecting some rational thought into the hysteria that seems to surround those topics. I guess, I'll take FMAP first. I don't think I'm telling anybody on the call something they don't already",153,"I would like to thank you on the issues of COBRA and FMAP for injecting some rational thought into the hysteria that seems to surround those topics. I guess, I'll take FMAP first. I don't think I'm telling anybody on the call something they don't already know. But the Senate appears to be willing to continue to work on this. I can understand why they would not have necessarily wanted to pass something before the recess, but it's important to the governors. We have tried to estimate what an effect on us would be if the FMAP incremental money were not continued, and it hit directly and only to the Medicaid budget of every state and if we proportionately were hit directly. So I don't if you should call that a worst-case analysis. But it's a direct flow through directly to us of eliminating those funds and the total would be what, Biggs?"
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","It would be just under $70 million. But Ill emphasize, that is kind of a worst-case number, because I dont think",21,"It would be just under $70 million. But Ill emphasize, that is kind of a worst-case number, because I dont think"
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Its sort of inconceivable that it would actually work that way. But seems to me that people are sort of pricing in fears that are far greater than that. On COBRA",32,"Its sort of inconceivable that it would actually work that way. But seems to me that people are sort of pricing in fears that are far greater than that. On COBRA"
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","I should point out, that's the annual number.",8,"I should point out, that's the annual number."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Yes, annual numbers. So in COBRA, it's been very difficult for us, as we've said repeatedly for a long time, to identify which patients are affected by that and so forth. And it may be that we're seeing the results of that COBRA roll-off now, I don't know",129,"Yes, annual numbers. So in COBRA, it's been very difficult for us, as we've said repeatedly for a long time, to identify which patients are affected by that and so forth. And it may be that we're seeing the results of that COBRA roll-off now, I don't know. But I still think that ones just totally amorphous. And then with respect to the pricing environment, its, obviously, never easy. But the fact that we are essentially done for 2010 and 75% contracted for '11 and into the mid-30s in terms of percentage of our Managed Care business done for 2012, gives us an extraordinary amount of visibility into what we think pricing trends are into 2011 and 2012, and it's obviously considered in the comments that we've made today."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then just maybe a follow-up on that. One thing that I encounter, I guess, and I'd be interested in your perspective on it, is the sustainability of the cost trends. Obviously, in the face of the weak commercial volumes and the other dynamics around th",167,"And then just maybe a follow-up on that. One thing that I encounter, I guess, and I'd be interested in your perspective on it, is the sustainability of the cost trends. Obviously, in the face of the weak commercial volumes and the other dynamics around this economic downturn, you've been able to have very good cost controls on key items like labor and supplies. But I think theres sort of this concern that if these payer pressures continue to exert themselves out there, at some point you sort of hit a wall on that cost savings. I guess I'm trying to get my arms around, I wonder if you've thought about the issue of whether -- does all of this go hand-in-hand, that the cost opportunities youre realizing are hand-in-hand with some of the things that are driving the commercial volume pressures, for example? Or do you see a point in time where some of the sustainability of some of these things gets called into question?"
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","As you face a declining volume environment, it does get more difficult to continue to reduce staffing because you run into certain core and minimum staffing. But that's why we really sometime ago turned our attention to more creative approaches to cost re",153,"As you face a declining volume environment, it does get more difficult to continue to reduce staffing because you run into certain core and minimum staffing. But that's why we really sometime ago turned our attention to more creative approaches to cost reduction, such as those that are part of the Medicare performance initiative. And that really gets to a whole different range of cost opportunities in the utilization of supplies and length of stay and even the clinical practice of medicine. That together with the investments we're making in technology should open up new opportunities for us in cost management beyond the traditional levers that were largely oriented towards labor. And again, I also should point out how really outstanding our performance has been in the revenue cycle. And that's an important cost driver and we have been very effective in managing that, both from an expense and a cash flow perspective."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","And you have your next question from the line of Kemp Dolliver from Avondale Partners.",15,"And you have your next question from the line of Kemp Dolliver from Avondale Partners."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Questions are on volumes. First, on your volume outlook for the year, it looks like you are expecting some improvement in the second half versus the first half, and just wanted to get your rationale behind that, given that Q1 likely had some weather disru",73,"Questions are on volumes. First, on your volume outlook for the year, it looks like you are expecting some improvement in the second half versus the first half, and just wanted to get your rationale behind that, given that Q1 likely had some weather disruption, which would lead one to think that Q2 would have shown better trends but they looked very similar in many regards, so that's what's behind my thought process."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'm going to ask Biggs to speak to the outlook for volumes in the second half.",17,"I'm going to ask Biggs to speak to the outlook for volumes in the second half."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","I think that you're right. We are expecting, if you're looking at it from a year-over-year trend standpoint, some improvement in the second half. It's our belief that our actions will drive volume, plus on the outpatient side, the acquisitions that we're",143,"I think that you're right. We are expecting, if you're looking at it from a year-over-year trend standpoint, some improvement in the second half. It's our belief that our actions will drive volume, plus on the outpatient side, the acquisitions that we're making that will fall under our hospital licenses will add volume on outpatient. But I think it's a moderate level of growth that's projected second half over first half from a trending standpoint. At a gross level, it may prove to be relatively flat for the first half because of seasonality. But from a year-over-year trending standpoint, yes, we're expecting some improvement as a result of our actions, be it physician recruitment, redirection, the outpatient acquisitions and everything else we're doing to drive volume. But it's a very modest amount of growth that we're expecting relative to the first half."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And also, several years ago, you all changed your admission criteria to eliminate a lot of short-term stays, and with the RAC Audits and I think other payer pressures, there appears to be intensified industry pressure, increasing observation stays, et cet",60,"And also, several years ago, you all changed your admission criteria to eliminate a lot of short-term stays, and with the RAC Audits and I think other payer pressures, there appears to be intensified industry pressure, increasing observation stays, et cetera. What are you seeing in terms of your very short stay cases as it relates to the Commercial book?"
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","As you point out, we made these changes several years ago, so weve really gone through anniversary dates already of the changes. The good news has been we've done really well on the RAC Audits. The bad news has been we probably depressed our admissions",58,"As you point out, we made these changes several years ago, so weve really gone through anniversary dates already of the changes. The good news has been we've done really well on the RAC Audits. The bad news has been we probably depressed our admissions intentionally for some period of time. But that's really washed out before now."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","But no new pressures from there then.",7,"But no new pressures from there then."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","No, not to us. If we had not implemented those different criteria, which principally involved using the InterQual system, which is a method essentially of providing the same screening to admissions that the payers ultimately provide and that the RAC audit",70,"No, not to us. If we had not implemented those different criteria, which principally involved using the InterQual system, which is a method essentially of providing the same screening to admissions that the payers ultimately provide and that the RAC auditors are using. If we hadnt done that, probably would be in a position of seeing many admissions denied and overturned, and RAC Audits coming up with the big claims."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","Your next question comes from the line of Justin Lake from UBS.",12,"Your next question comes from the line of Justin Lake from UBS."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Just a follow-up question on the operating cost side. I'm just trying to get some perspective on -- obviously, you've done a great job there over the last few years. If you could think over the last -- think back maybe three to five years ago what your ki",70,"Just a follow-up question on the operating cost side. I'm just trying to get some perspective on -- obviously, you've done a great job there over the last few years. If you could think over the last -- think back maybe three to five years ago what your kind of core and operating cost inflation trends look like, then compare it to where you are now, I'd be curious."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","That's a hard one.",5,"That's a hard one."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","I can't remember what the inflationary trends were, but I can tell you that our cost management wasn't nearly as good. If you go back a few years, we were having volume losses. And we were staffing at levels that were too high for the volumes they were ex",115,"I can't remember what the inflationary trends were, but I can tell you that our cost management wasn't nearly as good. If you go back a few years, we were having volume losses. And we were staffing at levels that were too high for the volumes they were experiencing and constantly trying to chase that sort of after the fact and get our cost base right sized. But the processes we have in place now enable us to flex routinely on a daily basis. We have great tools in place and so that's not core inflation but certainly from the standpoint of our ability to manage cost growth, it is a big value driver."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I guess what I was trying to get to was obviously you've done -- The second question was just sort of a follow-up. I'm trying to get from a core perspective the -- what you've been able to drive yourself, which obviously have been a lot versus what you've",63,"I guess what I was trying to get to was obviously you've done -- The second question was just sort of a follow-up. I'm trying to get from a core perspective the -- what you've been able to drive yourself, which obviously have been a lot versus what you've kind of benefited from just on lower typical nursing inflation, things like that."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","I see what you're saying. Look, we have really driven this improvement in productivity and this better performance on labor. The outside factors have been mixed on that. We've had pressures from labor unions. We've had continued competitive wage pressures",198,"I see what you're saying. Look, we have really driven this improvement in productivity and this better performance on labor. The outside factors have been mixed on that. We've had pressures from labor unions. We've had continued competitive wage pressures. And then, we had some benefit from lower turnover that was really caused in large part by the economy but also by a series of initiatives we undertook. So I guess if you want that sort of macro run own, I'd say there have been net probably neutral to slightly positive factors from the environment on labor, but huge positive factors from our own management techniques and the implementation of systems to manage that. On supplies, we've had sort of relentless upward pressure on the high-value supplies and fairly benign pricing pressure on commodity supplies. So once again, our efforts to manage utilization, to substitute and use equivalent but less expensive drugs and supplies and to be more conscious of the waste of supplies, the whole series of initiatives in the supply chain have really driven an outstanding performance there. And then I've mentioned revenue cycle earlier, and those, of course, are the huge drivers of cost."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So you think these are replicable looking forward as the reimbursement environment gets tougher. I guess thats the real key.",20,"So you think these are replicable looking forward as the reimbursement environment gets tougher. I guess thats the real key."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, I think independent of the reimbursement environment, as I said a few minutes ago, we continue to find new opportunities and new ways of being more efficient and saving money.",31,"Well, I think independent of the reimbursement environment, as I said a few minutes ago, we continue to find new opportunities and new ways of being more efficient and saving money."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","And your next question comes from the line of Ralph Giacobbe from Credit Suisse.",14,"And your next question comes from the line of Ralph Giacobbe from Credit Suisse."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I just want to go back to volume and just kind of reconciling the pre-announcement down 1.2% on the volume side then the quarter down 2% sort of implies that the last several weeks of the quarter obviously were down kind of 4% to 5%. And I know it's hard",115,"I just want to go back to volume and just kind of reconciling the pre-announcement down 1.2% on the volume side then the quarter down 2% sort of implies that the last several weeks of the quarter obviously were down kind of 4% to 5%. And I know it's hard to sort of extrapolate just those last three weeks, but I guess first, is there nothing in those results that are meaningfully different other than just a sharper decline within admission trends across the board. And then, two, when you said that July remained soft, it is that in the context of the full 2Q results or the last three weeks of the quarter?"
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","The July was pretty consistent with the end of June. So it's softer than the second quarter but don't forget the really tough comps for last years July. So I think it's -- again, when you get into these really short-term periods where you're analyzing",133,"The July was pretty consistent with the end of June. So it's softer than the second quarter but don't forget the really tough comps for last years July. So I think it's -- again, when you get into these really short-term periods where you're analyzing volumes, the prior year performance is important. The current year, if there's something from a service line perspective is important, and I think it's too limiting of a period to draw any broader conclusions than that, except just as a point of disclosure, we wanted to make sure we said, Look, we're off to a slow start for the third quarter on volume. As Biggs points out, we've taken into account in our outlook for the year that there's no dramatic recovery in volumes in the second half."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then, I just wanted to go back to managed care, I may have missed this. I know you gave sort of the percentages of the business that's locked in for the next couple, few years. I just want to make sure the rates on that, if you sort of talked about wh",77,"And then, I just wanted to go back to managed care, I may have missed this. I know you gave sort of the percentages of the business that's locked in for the next couple, few years. I just want to make sure the rates on that, if you sort of talked about what kind of the average rates are and/or maybe where therere anything meaningfully different than the rates we've seen over the last couple of years."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","No, we haven't talked about it. We just find that it gets played right back to us. It's relatively consistent with what we've been able to do to date, but we're working hard to get it.",36,"No, we haven't talked about it. We just find that it gets played right back to us. It's relatively consistent with what we've been able to do to date, but we're working hard to get it."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Executives","With that, I think, I'll just proceed to make a couple of closing comments. This quarter, we took a decline of 2% admissions. We turned it into 3.3% growth in revenues and almost tripled that rate of growth in EBITDA. And we should be able to do a lot bet",158,"With that, I think, I'll just proceed to make a couple of closing comments. This quarter, we took a decline of 2% admissions. We turned it into 3.3% growth in revenues and almost tripled that rate of growth in EBITDA. And we should be able to do a lot better than that once we begin growing volumes again. We achieved new milestones in margins and free cash flows, and those are very important to keep in mind. We're taking excess cash and we're reducing debt. We're reducing the company's risk by extending maturities of our 2013 debt. And we plan to increase our flexibility by arranging a new credit line. During June and July, we engaged in an extensive amount of Investor Relations activity. We're going to resume this in September by attending the Morgan Stanley Conference and continuing to do one-on-one meeting in a few cities. And with that, operator, thank you. And this concludes our call."
107911,109241320,79563,"Tenet Healthcare Corp., Q2 2010 Earnings Call, Aug-03-2010",2010-08-03,"Earnings Calls","Tenet Healthcare Corporation","Operator","Ladies and gentlemen, that concludes our presentation. Thank you for participation in today's conference. You may now disconnect. Have a great day.",22,"Ladies and gentlemen, that concludes our presentation. Thank you for participation in today's conference. You may now disconnect. Have a great day."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Good day, ladies and gentlemen, and welcome to the Third Quarter 2010 Tenet Healthcare Earnings Conference Call. My name is Jeff, and I'll be your operator for today. [Operator Instructions] I would now like to turn the conference over to your host for to",57,"Good day, ladies and gentlemen, and welcome to the Third Quarter 2010 Tenet Healthcare Earnings Conference Call. My name is Jeff, and I'll be your operator for today. [Operator Instructions] I would now like to turn the conference over to your host for today, Mr. Thomas Rice, Senior Vice President of Investor Relations. Please proceed, Mr. Rice."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, operator, and good morning, everyone. Tenet's management will be making forward-looking statements on this call. These statements are based on management's current expectations and are subject to risk and uncertainties that may cause those forw",97,"Thank you, operator, and good morning, everyone. Tenet's management will be making forward-looking statements on this call. These statements are based on management's current expectations and are subject to risk and uncertainties that may cause those forward-looking statements to be materially incorrect. Management cautions you not to rely on and makes no promises to update any of the forward-looking statements. During the question-and-answer portion of the call, callers are requested to limit themselves to one question and one follow-up question.
At this time, I will turn the call over to Trevor Fetter, Tenet's President and CEO. Trevor?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, Tom, and good morning, everyone. Well, I will blame you if you write report saying that this is a noisy quarter. In summary, our earnings number was huge and we're raising the bottom end of our 2010 outlook. The volumes were soft, and the EBITD",1672,"Thank you, Tom, and good morning, everyone. Well, I will blame you if you write report saying that this is a noisy quarter. In summary, our earnings number was huge and we're raising the bottom end of our 2010 outlook. The volumes were soft, and the EBITDA is flat to 2009, if you make appropriate adjustments. 
We generated over $900 million in net income due to the accounting recognition of the value of our tax loss carryforward. Biggs will explain this further, but the key point is that while existence of the NOL has been well known it should be more tangible to investors now that it's on the books.
Looking beyond net income, we were challenged by soft volumes in the quarter. We reacted to a particularly weak July by implementing a reduction in force in August. The impact of these actions to reduce costs along with improved volume trends after July led to a positive earnings trend in the quarter, in which EBITDA grew steadily from July to August to September. 
It's worth noting that we face the very tough comparison this year as adjusted EBITDA was up 50% in the third quarter last year. Once you allow for year-over-year variability, our longer-term EBITDA trend remains strong. You can see the variability and the clear long-term trend demonstrated on Slide 4.
Clearly, our growth has been very strong but not a steady as I'd like. When you make your assessment of our growth in EBITDA in the quarter, please consider the items on Slide 5. The third quarter of 2009 included three favorable items contributing a total of $20 million. We called out these items in last year's third quarter call, and nearly all of you noted them when assessing our performance. 
In contrast, this year's third quarter includes items with a net unfavorable impact of $16 million. In total, these items created a $36 million unfavorable swing from the third quarter of 2009 to this year's quarter. Net of these items, this quarter was essentially unchanged.
As I mentioned earlier, we're raising the bottom end of our outlook for 2010 EBITDA to a new range of $1,050,000,000 to $1.1 billion. This is the second time this year we've increased one or both ends of the range. Volumes were certainly weaker than we originally anticipated, but this has been offset by stronger pricing, enhanced acuity and excellent cost control. We're also benefiting from the California provider fee being larger than we forecast and health IT spending being less than we anticipated.
Soft volumes were a dominant theme across the industry last quarter, so I'd like to give you some color on our experience. The overall takeaways that the volume declines were contained to a small number of hospitals, and once again a single service line. OB accounted for a full third of our volume loss.
Total admissions declined 3.5%, and commercial admissions declined 8.6% in the quarter. July was by far our weakest month for patient volumes. The trend was more encouraging in August and through mid-September. Through the first 28 days of October, commercial admissions trended slightly better than in Q3 but total admissions were slightly weaker.
As you can see on Slide 7, outpatient visits were down 2% in the third quarter. Emergency department outpatient visits were down 1.7% in the quarter, but just over 70% of that decline is due to a reduction in flu, so non-flu ED visits are basically flat year-over-year. Outpatient surgeries were up modestly, increasing by 0.1% and adjusted admissions were down only 1.8%.
The volume losses this quarter and this year have been confined to a small number of hospitals. In fact, just seven hospitals comprise more than 70% of our total admissions declines in the third quarter. But while these seven hospitals cost the majority of our volume losses, the other 42 hospitals in the aggregate are performing better than the industry average. 
The seven hospitals are widely dispersed. There are two in Texas, but they're not in the same market. The other five are each in different states. Interestingly, although California is challenged by extremely high unemployment in some of our markets, none of our California hospitals are among the seven.
There is no single theme for the volume losses at these seven hospitals. One of the hospitals are having a solid and growing year but facing extremely tough comparison on volumes in Q3. Another one lost the unprofitable volume. Those two, plus three others, grew EBITDA significantly despite their volume losses. 
The two others saw challenges with their physician channels. These are instances where physicians have gone into direct competition with the hospitals, where we're competing hospitals have engaged in very aggressive and sudden physician employment strategies. No matter the reason for the volume declines, we're responding appropriately, and we believe that we're already turning the losses around. In October, in these seven hospitals, while still down, the volumes were down by a lower percentage than in the third quarter.
Turning to service lines. I already mentioned that the third of the total volume decline was in OB. Looking beyond OB, there's some elective service lines, I'd like to share some interesting insights with you. As we're deep into the recession, it's very clear that patients who have a significant personal financial responsibility are behaving very differently than patients who don't. We've known all along that this was driving reductions in our commercial elective surgical volumes. But let me give you some facts that our other orthopedic surgery as an example.
If you look at Slide 10, you'll see that total admissions for orthopedic surgeries declined by 2.5%. Commercially insured orthopedic surgeries declined by 9%. Orthopedic surgeries for all other patients, most of whom are covered by Medicare and Medicaid, actually increased 0.2%. 
The same pattern is true with spinal fusions. Commercially insured spinal fusions declined by 160 admissions or 15% in the third quarter, but noncommercial spinal fusions increased by 17% or over 150 admissions in the quarter. Since the same physicians are doing these surgeries for both payer classes, the loss of commercial volumes and the growth of noncommercial volumes to just this behavior is being driven by the patient not the physicians. We believe this patient behavior is largely related to economic uncertainty on the part of the patients, commercial enrollment losses and rising co-pays and deductibles for those who remain insured.
Again, on Slide 10, you can see this pattern holds through across several service lines that we would consider as elective and easy to defer. Slide 11 illustrates that when the procedure is harder to defer, like in the case of OB, the changes in volumes in other commercial and noncommercial populations are very similar. 
Despite the challenges to volume growth, favorable pricing and acuity continue to drive a stable picture for revenues. Commercial pricing remains particularly strong. We also had a 2.4% increase in commercial acuity. The result was positive commercial revenue growth of nearly 1% for the quarter. Collectively, this helped us generate adjusted free cash flow of $53 million in Q3, bringing year-to-date free cash flow deposit of $74 million. 
We've made a lot of progress on other front in the quarter. We continue to improve and de-risk our capital structure, pushing out the majority of our 2013 maturities to 2020, while retiring $229 million face value of debt. This brings our total debt slightly more than $4 billion with no meaningful maturities for five years. We also entered into a new $800 million credit line with new flexibility with regard to our capital allocation options, including lifting an existing limitation on stock repurchases.
Earlier this year, we drew your attention to the seven items on Slide 14, which we believe can drive significant margin expansion and earnings growth over the next few years. While some of these items depends on a recovering economy, three of these initiatives, Outpatient, Medicare Performance Initiative and Conifer, were more directly under our control and less dependent on an economic recovery.
Just walking down the list for a minute, our newly acquired outpatient centers are already coming online. We expect to have invested about $70 million in outpatient acquisitions by the end of 2010 and believe there are enough great opportunities that we could do that again in 2011. We anticipate these acquisitions will add $100 million to $150 million to revenues in 2011, and given the much higher margins in this business, contribute as much as $30 million to $40 million in 2011 EBITDA.
Turning to MPI, we are very much on track with our 2010 objective of a $30 million incremental EBITDA contribution. While we have not yet completed our MPI plan for 2011, our preliminary view is for another $30 million. Conifer will take longer to gain visibility, but we remain very excited about its prospects. Conifer's contributions from outside clients to 2011's EBITDA growth will exceed $10 million.
Our healthcare information technology initiative will again create incremental expenses in 2011. And as previously disclosed, we're not planning on a net positive net financial contribution from the initiative prior to 2012. Earlier last month, we went live at four hospitals, and the rollout went smoothly. We're going live in an additional three hospitals this month.
In addition, we continue to achieve solid commercial pricing that's consistent with the trends of recent years. To make major progress on margin expansion and EBITDA growth, we need volume growth and to go back towards prerecession bad debt expense levels. But it's still clear there's much we can achieve even in the absence of recovery.
So to wrap-up, I believe we demonstrated once again that we have the appropriate and effective leverage to pull in the short term to keep us on track relative to our longer-term performance milestone. I also believe our long-term growth strategy have us well positioned to face the myriad challenges that 2011 will bring. 
And with that, let me turn the floor over to Biggs Porter, our Chief Financial Officer. Biggs?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, Trevor, and good morning, everyone. The biggest item impacting our net income for the quarter is a recognition of the tax benefit or our net operating loss carry forward. This recognition resulted from our reversal of the previously-established",2154,"Thank you, Trevor, and good morning, everyone. The biggest item impacting our net income for the quarter is a recognition of the tax benefit or our net operating loss carry forward. This recognition resulted from our reversal of the previously-established valuation allowance and added $981 million to our net income or $1.75 per diluted share. 
Under generally accepted accounting principles, which arguably are conservative on this point and in recognition of our sustained and sustainable return to profitability, the realization of this tax benefits has become sufficiently likely as to require its recognition in our financial statements. Given the conservative criteria applied in our GAAP, this makes a strong statement about the expectations of our future profitability and the value of the NOL.
As a result of this recognition, our income statement tax rate in future quarters will approximate a normalized tax rate of approximately 40%. From a cash perspective, however, we will continue to benefit from the tax shield, and our tax payments on future income will be primarily limited to state taxes, and will continue at the low level of recent years. It will remain low until our loss carry forward is fully utilized, which is still a number of years out.
The biggest item not impacting either net income or adjusted EBITDA in the third quarter was the $64 million net receipt of revenues related to the California provider fee. Due to delays in a very complex approval process, this materially favorable event was not recognized in the third quarter. The portion of the plan related to direct medical payments was approved after the end of the quarter, with the Managed Care portion still pending. We had expected that up to $55 million would be recognized in the third quarter. This delay has no affect on full year income but will cost some of the cash receipts to slip out of this year into next, which we estimate at a net $36 million.
Looking forward to next year, the California provider fee may be renewed for a half year, and a new fee in Pennsylvania worth approximately $25 million is in the process of development. Other states are also working on these types of arrangements. Just as food for thought, if you put the normalized 2010 value of the California provider fee at $37 million, but Pennsylvania fee and a partial extension of the California fee could more than replace that. So you should not think of the revenue from the California provider fee as being entirely non-recurring and looking at next year. For a cash basis, the cash received from provider fees could actually go up next year.
Adjusting both quarters for prior cost quarter adjustments, revenues grew slightly in the third quarter as a result of strong commercial pricing and case mix, offset by adverse payer mix in aggregate declines in paying volumes. As in the prior quarters of this year, case mix on commercial Managed Care was strong relative to last year reflecting about a 3% increase. As I said in last quarter's comments, this increase in acuity has to be considered in understanding the economic effect of lower volume.
Our overall pricing picture remains positive. Even with the commercial volume declines we experienced in the quarter, commercial pricing gains were sufficient to drive growth of 0.9% in commercial revenues in the quarter. Because of the payer mix shift, however, net inpatient revenue per admission increased by only 1.1%, and net outpatient revenue per visit increased by 5.6%. 
The strong increase in outpatient pricing reflects the loss of H1N1 volumes from last year, which had generated lower revenues per outpatient visit. The absence of flu volumes in this year's third quarter drove average pricing higher. Once again, this demonstrates the necessity of understanding acuity and patient mix when assessing the economic effects of volume fluctuations.
While among the topic of pricing, I will comment that we continue to have very good visibility with regard to our forward pricing. At this point, approximately 80% of our commercial contracting is complete for 2011 and 40% for 2012. 
Turning to cost. Although the benefits weren't fully visible in the third quarter, we successfully took action to flex our cost structure. As Trevor mentioned, July's volumes were particularly weak. We responded very quickly to reduce our staffing and implemented the significant reduction for us in August. We incurred a couple of million in severance costs as part of this, but this August, the action left us well positioned for the balance of the quarter.  Those cut should also have full visibility in our fourth quarter. 
In addition, we have delayed our annual merit increases for the general population from October 1 to January 1. This takes us a step closer to timing our merit increases for all employees in the April time period where they used to be.
The result of these actions are merely evident in our internal measures of productivity, which looks at FTEs per adjusted average daily census. Despite the soft volumes in the quarter, this productivity measure actually improved in the third quarter as FTEs per adjusted average daily census declined in September by 1.2%.
Supplies cost were essentially flat in the quarter. On a per-adjusted patient-day basis, the increase in supplies cost was 2.6% as adverse operating leverage and the increase in acuity offset the effects of our supply cost initiatives. Because we recorded within other controllable cost line were more of a challenge. Many of the costs recorded in this heading are more heavily fixed or semi-variable in nature and as a result are more difficult to flex in response to soft volumes. 
We also recorded some incremental expense from items whose actual early determine impact is adversely influenced by declining interest rates. While now practice expenses increased by only $1 million relative to last year's third quarter, the decline in interest and therefore discount rates at $11 million to malpractice expense in the current quarter. Combined with an increase of $3 million in workers comp expense, lower discount rates added $14 million to operating expense in the quarter. This discount rate adjustment should be considered unusual at this point given low rates we were already seeing on U.S. Treasuries and can be expected to more than reversed itself in the future when interest rates rise to normal levels, thereby creating earnings upside of up to $40 million at some point in the future.
In addition, we recorded an incremental $4 million of HIT expense. As Trevor mentioned, we successfully went live on the first phase of the system of four of our hospitals in the month of October, and we now expect the internal effects of these expenses to be down to $11 million in 2010. We expect this incremental expense to increase in 2011 prior to being offset in 2012 by the recognition of federal incentive payments. This increase is now a deferral of 2010 expenses, but is reflective of the increase and number of implementations in 2011.
Our bad debt ratio declined to 8.3% in the quarter, a 20 basis point decline relative to 8.5% a year ago. This decline includes the recurring benefits of federal Medicare bad debt recoveries, as well as declines in uninsured volumes. We view the size of this quarter's Medicare bad debt recovery as representative of ongoing sustainable impacts that can be expected in future quarters.
We had $398 million in cash and cash equivalents at quarter end, a decrease of $313 million from June 30. The largest driver of the cash decline was the use of $274 million to reduce debt. Cash provided from continuing operations was $160 million, and adjusted free cash flow was $53 million after capital expenditures of $107 million in the quarter. 
In the third quarter year-to-date, our cash from operations has been held back by lower levels of accounts payable and in the prior year. Some of this is due to the timing of expenditures or aggressive disbursements. We've not changed policy or contractual arrangements however, and we expect payables to expand again by year end.
Subsequent to the end of the quarter, we completed the sale of a number of our Florida medical office buildings, generating cash of $46 million. As a part of the sale, the buyers committed to certain capital improvements to facilities, which will benefit our position Tenet's. These MOBs had immaterial annual ends and EBITDA. 
We continue to actually market additional MOBs, and we believe a number of these transactions could be completed in the next few quarters. At this point, we have other MOB sales contracts pending worth approximately $50 million, but in real estate, nothing is done until it closes so there's not reflected in our outlook.
Turning to our outlook. We have raised the lower end of our outlook to a new range of $1.05 billion to $1.1 billion. We raised both ends of the range of pretax income, reflecting lower depreciation and interest expense. Our revised assumptions are detailed on Slide 24. This revision includes the lowering of our volume and revenue estimates, which are tied to a later reductions in our cost estimates for the balance of the year. 
There's been speculation that volumes will grow in the fourth quarter of more than a seasonal basis due to the effects of co-pays and deductibles. At this point, we're going to be conservative and not count on that in our outlook. The walk forward of cash from September 30 to December 31 is provided on Slide 25 breaks down fourth quarter cash flow into its major components. 
It's too early to give an outlook for 2011, but I do think it's appropriate to give a little balance to what the headwinds and opportunities are going into next year. First, the biggest challenge remains on the volume side, but some of the effects of the economy and flu should have average rate by the end of this year. Economic stability followed by recovery would presumably create upside. Second, we expect the full year benefit on the outpatient acquisition we're completing on the second half of this year and a partial benefit of those we're targeting for next year.
Third, we're already seeing improvement in the yield on our physician additions the last couple of years, and we expect expansion of that benefit in 2011 and beyond. Fourth, commercial pricing is almost completely negotiated with reasonable existent price increases expected next year. Medicare, all in, is basically flat as outpatient increases offset inpatient decreases. I've already talked about state signing and potentially new provider fees with the 2009 retroactive portion of the California provider fee being the one element most challenging to replace.
Finally on the cost side, we will increase our investment in our physician base and HIT both of which will yield improvements for the future. And we will continue to drive on our Medicare performance and related initiatives to reduce link to stay in supply costs. 
In the aggregate, we will continue to drive toward industry margins. We have confidence in the path we have laid out. The only gating consideration in what the near-term timing and slow for progress is going to be is the degree of economic headwinds we must offset. On the positive side for 2011, we expect to drive value in the outpatient investments, position base initiatives, commercial pricing and the Medicare performance initiative. The big potential near-term negative, longer-term appositive is, as I just said, the effect of economic conditions. It is not clear and therefore remains subject to continuing evaluation by us as to what extent economic conditions will offset the net positive drivers of growth in 2011.
So to summarize. The value of our NOL carryforwards has been confirmed from accounting standpoint. We have raised our outlook for EBITDA and pretax and net income for the year. We approved cost efficiencies in the quarter, as we were able to react quickly to significant volume declines in the first month of the quarter. This will be fully visible in the fourth quarter. 
Free cash flow came under pressure due to the timing of disbursements in rising CapEx. But because of the timing effects on accounts payable will reverse themselves, we have retained our free cash flow outlook for the year. Pricing continued as the source of strength. Commercial case mix remained favorable compared to the prior year. California provider fee, has been partially approved while full approval expected this quarter. 
And one last point. From a volume and payer mix standpoint, this was the weakest quarter we've experienced, clearly reflective of the economic headwinds. However, the fact that we held earnings flat on a normalized basis and even in this harsh environment demonstrates that we are well positioned to grow earnings as the economy moderates and/or as our volume initiatives yield increasing results. 
Let me now ask the operator to assemble the queue for Q&A. Operator?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","[Operator Instructions] Our first question comes from the line of John Rex with JPMorgan.",14,"[Operator Instructions] Our first question comes from the line of John Rex with JPMorgan."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And the issue here for me is when we look at the share, the erosion in commercial, and it's just been persistent now as many quarters in terms of actually kind of seeing accelerating losses. So my question is, it looks like you're losing share when that c",98,"And the issue here for me is when we look at the share, the erosion in commercial, and it's just been persistent now as many quarters in terms of actually kind of seeing accelerating losses. So my question is, it looks like you're losing share when that compared to what I'm seeing from others and when I even think about what I'm seeing is kind of more stabilizing trends in just commercial coverage broadly. So can you tell us how you look at that in terms of the potential share losses you might be seeing in the markets?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Yes, John. This is Trevor. That's a good question. I have to comment first and I'm going to turn it over to Steve Newman, because we've done extensive analysis of this share question. But first, we'd have to make the comment that it is very difficult to c",135,"Yes, John. This is Trevor. That's a good question. I have to comment first and I'm going to turn it over to Steve Newman, because we've done extensive analysis of this share question. But first, we'd have to make the comment that it is very difficult to compare the commercial statistics that we've been disclosing in any kind of context to the industry at large or even the peer companies, because you're not getting that same type of disclosure. So not that everybody should do it and not to say that we don't regret starting with disclosure. But you really can't look at these commercial numbers and draw any conclusion about share from them. Now having said that, we've done a lot of work on shares so I'll ask Steve to comment on that. Steve?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","John, I think it's an excellent point, and we've got a great deal of evidence that we're not losing commercial managed care or market share except in the markets of the hospitals that Trevor mentioned in his comments. Our evidence comes from three separat",100,"John, I think it's an excellent point, and we've got a great deal of evidence that we're not losing commercial managed care or market share except in the markets of the hospitals that Trevor mentioned in his comments. Our evidence comes from three separate sources: First, our statewide all-payer database; second, our large statewide Blue Cross plants, where we have significant penetration in those markets; the third is a review of our market share with three of the largest national commercial payers. In summary, these studies also guess, except in a few isolated instances, our commercial market share is stable."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","And I think, John, we triangulated on that question. As Steve said, there's several different approaches to it. But very hard to do with precision. So this quarter, we did something we haven't done before, which was essentially go to the payers who would",107,"And I think, John, we triangulated on that question. As Steve said, there's several different approaches to it. But very hard to do with precision. So this quarter, we did something we haven't done before, which was essentially go to the payers who would give us this information to say, ""Look, this is our change in volume with you in this particular market. Tell us, because you have access to it, what is the share change and was very reassuring in all cases with the exception of a few, where it's clear that we're losing share because there's, some new competitors some different dynamic in the market."""
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And my follow-up, if you look at the seven hospitals that you spiked out, what percent of company revenues were they representing? I'm trying to compare, I think about your top seven hospitals and percentage revenue there. Group this seven, where would th",45,"And my follow-up, if you look at the seven hospitals that you spiked out, what percent of company revenues were they representing? I'm trying to compare, I think about your top seven hospitals and percentage revenue there. Group this seven, where would they fall?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","They do tend to be some of our larger hospitals. So we have a portfolio that ranges in size, but does have some large ones. And I think, when you have a quarter where the large hospitals are underperforming at any given statistics, it tends to drive the c",88,"They do tend to be some of our larger hospitals. So we have a portfolio that ranges in size, but does have some large ones. And I think, when you have a quarter where the large hospitals are underperforming at any given statistics, it tends to drive the company in that direction and vice versa. And unfortunately, this is one of those quarters and I've seen other ones over the time that I've been with Tenet, where the largest hospitals with exceptions were moving in the wrong direction."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","So these are not our seven largest hospitals but amongst them are [indiscernible] hospitals.",14,"So these are not our seven largest hospitals but amongst them are [indiscernible] hospitals."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So I'd find some of that in that category then. And does stabilizing coverage levels, do you think there's going to have impact or what you're seeing at this point, is it less about erosion and just commercial coverage and more just about avoidance of the",52,"So I'd find some of that in that category then. And does stabilizing coverage levels, do you think there's going to have impact or what you're seeing at this point, is it less about erosion and just commercial coverage and more just about avoidance of the carenstein [ph] at all ?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, you've got the baseline high-shrinking issue of the commercial enrollment losses that's been running around 4% among the big payers. You start with that. And then you add to it some utilization issue that potentially is driven by the economic incent",166,"Well, you've got the baseline high-shrinking issue of the commercial enrollment losses that's been running around 4% among the big payers. You start with that. And then you add to it some utilization issue that potentially is driven by the economic incentive that are inherent in higher deductible health plans. And now the enrollment losses you could see turnaround in a stronger economy, the shift towards a higher deductible plans and whatever's depression of consumption exist that could be a longer-term trend. But like just this morning, I'm encouraged to see in the newspaper the results of the Kaiser survey that among very small employers, coverage is going way up to these tax incentives that they've been provided with. So among firms with something like nine to 13 employees or five to 13 employees. But the average percentage is up like nine points. I may have sound of that a little bit wrong but it's an encouraging trend among the smallest segment of the employer population."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Shelley Gnall with Goldman Sachs.",13,"Our next question comes from the line of Shelley Gnall with Goldman Sachs."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I'm wondering, is it possible to generalize across your markets those that are hardest hit? So for example, in California, you've got a number of markets where you got unemployment north of 15% and 16%. And then, you've got healthier markets, like those i",79,"I'm wondering, is it possible to generalize across your markets those that are hardest hit? So for example, in California, you've got a number of markets where you got unemployment north of 15% and 16%. And then, you've got healthier markets, like those in Texas that are 8% to 10% unemployment. Is it possible to generalize where you are able to take share and where you just don't see a market share opportunity across all of payer classes?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","So hard to generalize and one of the reasons I mentioned that among the seven hospitals generating 70% of the admissions decline is none in our California, because we did not see in terms of the volume performance of our hospitals, a correlation with unem",217,"So hard to generalize and one of the reasons I mentioned that among the seven hospitals generating 70% of the admissions decline is none in our California, because we did not see in terms of the volume performance of our hospitals, a correlation with unemployment. And our highest unemployment market were really not having a volume problem. And conversely, where we've seen these physician competition phenomenon that has really created new capacity and a new entrant into a market that's very aggressive owned by physicians were they have the ability to direct patients, that in some of our markets with the lowest unemployment are the best trends in unemployment. So I would set aside the unemployment correlation. We've also seen some very strong volume performance in Florida, which is a market that's struggled for a long time. And that I think can be attributed to strong management actions and market working to see sizeably on business development activity. So you really -- at the risk of having added two paragraphs to my script on this volume side, I'm trying to convey an impression that there is not an overall trend, one way or another that you can point to or some correlation that it's really more one-off issues. And that's the way we've had to manage them."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Other than the cost shifting that you're seeing from the commercial payers, are there any other specific actions that they're taking to limit utilization specifically on the inpatient side?",30,"Other than the cost shifting that you're seeing from the commercial payers, are there any other specific actions that they're taking to limit utilization specifically on the inpatient side?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, one thing that's causing a lot of noise in the statistics is this trend towards observation status, which originally was contemplated to something only to be used in Medicare and now it's widely used in the payers. And I think other companies have t",63,"Well, one thing that's causing a lot of noise in the statistics is this trend towards observation status, which originally was contemplated to something only to be used in Medicare and now it's widely used in the payers. And I think other companies have talked about that. We didn't break it out specifically but it's of course the contributor to weak inpatient admissions."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Tom Gallucci with Lazard Capital.",13,"Our next question comes from the line of Tom Gallucci with Lazard Capital."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","First, the Slides 10 and 11 that you offered the commercial versus noncommercial admission trends, very interesting data. Curious if you look back is the discrepancy between those two payer classes growing or moderating? Or how would you consider that tre",41,"First, the Slides 10 and 11 that you offered the commercial versus noncommercial admission trends, very interesting data. Curious if you look back is the discrepancy between those two payer classes growing or moderating? Or how would you consider that trend?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","For the time being, that it's a new slide. We didn't really look back on it. We don't have a trend for you on that. We've looked for quite a long time at what we would consider discretionary versus last discretionary service lines. And have had more press",106,"For the time being, that it's a new slide. We didn't really look back on it. We don't have a trend for you on that. We've looked for quite a long time at what we would consider discretionary versus last discretionary service lines. And have had more pressure in the discretionary. And obviously, when you're in a quarter that's as tough as the one that we just emerged from, you dig a lot harder for explanations and this was a very interesting one that came through, but we didn't go back up and run at historically, it's actually not that difficult to do so we could."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then you mentioned Managed Care 80% of your contracting, I guess you're done for next year, 40% the following year. Could you just remind us of sort of the average rates that you're expecting and also maybe more importantly, comment sort of on the ton",85,"And then you mentioned Managed Care 80% of your contracting, I guess you're done for next year, 40% the following year. Could you just remind us of sort of the average rates that you're expecting and also maybe more importantly, comment sort of on the tone of discussion I guess there have been some suggestions out there that obviously the Managed Care environment is getting a little more difficult for the payers. I'm wondering if that's leaking into the tone of conversation with you all?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","This is Biggs. First of all, to address the rate question, the rates that we've negotiated for next year are pretty much in-line with what we've budgeted as negotiated rates for 2010. It ultimately, the yield, we get on those will determined by patient mi",74,"This is Biggs. First of all, to address the rate question, the rates that we've negotiated for next year are pretty much in-line with what we've budgeted as negotiated rates for 2010. It ultimately, the yield, we get on those will determined by patient mix index and any payer shifts between the plants, but the negotiation are very much in line with what we've budgeted and achieved this year from a peer-rate negotiation standpoint."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And the tone of discussions, as you're looking further out, maybe one or two years out?",16,"And the tone of discussions, as you're looking further out, maybe one or two years out?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","As for tone, Steve, you want to add anything to that?",11,"As for tone, Steve, you want to add anything to that?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'd just say that negotiations are taking a little bit longer than they have in the past, and we're pushing for more pay for performance to be added to those contracts as we move toward a valued base purchasing environment.",41,"I'd just say that negotiations are taking a little bit longer than they have in the past, and we're pushing for more pay for performance to be added to those contracts as we move toward a valued base purchasing environment."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I guess the only thing I would add is, I've made an effort to stay close to the senior executives, some of our largest customers and to remind them that we provide a very good value solution for them. We have demonstrated high quality. They assess that th",192,"I guess the only thing I would add is, I've made an effort to stay close to the senior executives, some of our largest customers and to remind them that we provide a very good value solution for them. We have demonstrated high quality. They assess that themselves. I don't need to convince them of that. And our price point relative to our competitors in virtually all of our markets is certainly not the highest, and sometimes it's on the low end of the market pricing. And typically with a large prominent successful not-for-profit system leading the way on pricing. So I feel that we are well positioned with the national payers from a value point of view. We're also exceedingly well positioned when they look at the total cost to doing business with us because we have streamlined and automated the revenue cycle process with them. So we have lowered -- they tell us, we have lowered lower-than-average denials. We have better-than-average electronic connectivity and we offer a total solution that I think is very effective as they start to look harder at price sensitivity and narrow networks in their markets."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Adam Feinstein with Barclays Capital.",13,"Our next question comes from the line of Adam Feinstein with Barclays Capital."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I guess to follow-up a few thoughts here. I guess the volume weakness is something that everyone was talking about throughout the quarter. So I do think that really caught people that of off-guard. I guess it was just throughout the year with the volume w",173,"I guess to follow-up a few thoughts here. I guess the volume weakness is something that everyone was talking about throughout the quarter. So I do think that really caught people that of off-guard. I guess it was just throughout the year with the volume weakness you guys have able to offset it through better unit pricing growth, as well as just cost cutting. So I guess the question is, as you look back on the quarter, Trevor, just maybe talk about -- and you guys called out a few things like the discount rate and some of the issues around cost there, but I guess just in terms of the ability to offset the volume weakness and not even the most recent quarter but going forward as well maybe just to go back through and talk about some of the initiatives there and certainly, you have the great slide deck here with that, but to just get some more clarity in terms of just visibility around the ability to offset volumes."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I think, Adam, in the beginning of your question, you touched on a topic that I think is important just to be very clear about in case it wasn't clear enough in the scripts. But we were trying to make the point that although I think the industry-wide volu",357,"I think, Adam, in the beginning of your question, you touched on a topic that I think is important just to be very clear about in case it wasn't clear enough in the scripts. But we were trying to make the point that although I think the industry-wide volume weakness was well known throughout the quarter. There were plenty of surveys and other indicators that, that was taking place. What was surprisingly negative was July. And so, I mentioned that July was particularly weak and then we took actions to reduce cost. Of course, these actions couldn't be taken in July, they were taken in August and have that effect of creating a positive trajectory in EBITDA from July to August to September. And as volume losses moderated from July through August through mid-September, then they did turn down in late September, that's the implication of saying that they were strong through mid-September. So I think one way -- the thing I would characterize as being unusual in the third quarter at least for us was how negative the first month was and then the fact that although many in the industry anticipated some snap back in August was encouraging, that, that encouraging trend at least in terms of volume did not persist through the entire quarter. And then based on our comments about October, it didn't persist into October. but I think to answer your question about what we can do and how we've been able to offset weak volumes, obviously, it's very hard on a month-to-month basis, because it's easier on a quarterly basis and it gets easier to accomplish. I shouldn't use the word easy. That's not easy but it's less difficult to accomplish on a yearly basis. And so, if you look at the quarter as a whole, we really overcame a lot of challenge that we had right out of the box in July. But it's difficult to do more in a short period of time. I think we have positioned ourselves well going into the fourth quarter. But again, we don't even have the first month of results on that yet."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Just on the unit pricing, the 1.1% you talked about mix having some impact there, maybe just go back some of that. I guess, the commercial piece you talked about but just within the other categories just maybe a quick update there in terms of -- and I gue",75,"Just on the unit pricing, the 1.1% you talked about mix having some impact there, maybe just go back some of that. I guess, the commercial piece you talked about but just within the other categories just maybe a quick update there in terms of -- and I guess, what are you guys thinking about in terms of being normalized revenue per admin number if you try to clean up some of the noise there?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, what's normal at this point will depend largely upon whether the OB admissions stayed down or not for an extended period because one of the reasons why case mix is up is because obstetrics are down. Obstetrics supply stayed down for quite a while. S",143,"Well, what's normal at this point will depend largely upon whether the OB admissions stayed down or not for an extended period because one of the reasons why case mix is up is because obstetrics are down. Obstetrics supply stayed down for quite a while. So I would expect on that basis case mix do not changed radically over the near term. As I said, case mix on commercial Managed Care was up about 3%. It was up about 1% on a Medicare Managed Care and up almost 5% on Medicaid Managed Care. So in most of the categories, it was up in the quarter. We'll see, of course, with that was a longer term but there's nothing right now that indicates that, that would change. So we'll just have to watch it but I think is reflective of the economics of today."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I just point, Adam, that we had a 5.6% increase in revenue per outpatient visit. That's largely driven by increases relatively speaking about patient surgery and high-end imaging like CT and MRI.",32,"I just point, Adam, that we had a 5.6% increase in revenue per outpatient visit. That's largely driven by increases relatively speaking about patient surgery and high-end imaging like CT and MRI."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'm going to add a response to, I think it was John's question earlier on the revenue from the seven hospitals. We want to pull the statistic and from the period of merit standpoint is the seven hospitals are 14% of our hospital count from a revenue stand",94,"I'm going to add a response to, I think it was John's question earlier on the revenue from the seven hospitals. We want to pull the statistic and from the period of merit standpoint is the seven hospitals are 14% of our hospital count from a revenue standpoint, they comprise 18% of the revenues in the quarter. So a little more heavily weighted than the peer hospital account but not, as I said, because there's not all the largest hospitals that are in there. It's not a real disproportionate share of the revenue."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Ralph Giacobbe with Credit Suisse.",13,"Our next question comes from the line of Ralph Giacobbe with Credit Suisse."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","In the release, you mentioned increased physician employment. And I think in the past, you've talked about not necessarily wanting to employ. Can you maybe talk about what's changed to your strategy there and maybe just give us a sense of the base that's",50,"In the release, you mentioned increased physician employment. And I think in the past, you've talked about not necessarily wanting to employ. Can you maybe talk about what's changed to your strategy there and maybe just give us a sense of the base that's employed currently where that can go?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Biggs, you want to take that?",6,"Biggs, you want to take that?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Sure. Ralph, we've got a number of things to affect physician recruitment. First thing we've done is expanded the number of staff focused at the hospital level, as well as at the regional corporate level on physician recruiting. Another thing we've done i",120,"Sure. Ralph, we've got a number of things to affect physician recruitment. First thing we've done is expanded the number of staff focused at the hospital level, as well as at the regional corporate level on physician recruiting. Another thing we've done is we've reassessed our community need and revised the medical staff development plan for each of our hospitals. The third thing, and I think we've done at significant is we revised the process for targeting redirection of our local physicians, and we've improved that on-boarding process, as well as orientation for these successfully recruited or redirected physicians. Finally, we believe that this will improve the productivity and retention rate of the physicians that we've been able to recruit."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And I guess I'm just trying to get a sense of, is this sort of in reaction to what's going on in your markets, where there perhaps was a reluctance to employ in the past, but now you need to because others are doing it and perhaps that can explain some of",60,"And I guess I'm just trying to get a sense of, is this sort of in reaction to what's going on in your markets, where there perhaps was a reluctance to employ in the past, but now you need to because others are doing it and perhaps that can explain some of the weaker volume trends that you see?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, look, I will be the first to say that I had a particularly bad attitude about jumping into the employment trend having experienced first hand the disasters of the late 90s when hospitals rapidly purchased practices and employed physicians and lost o",435,"Well, look, I will be the first to say that I had a particularly bad attitude about jumping into the employment trend having experienced first hand the disasters of the late 90s when hospitals rapidly purchased practices and employed physicians and lost on a tremendous amount of money. But this is a trend that is inexorable. It started with the large most prosperous, not for profits. We compete against a lot of this in our markets and we have completely adopted, I think new and improved way to do this. So just to go in order of sort of the promise that we're doing about it. Purchasing practices is really not market practice anymore. It's employing physicians. So you don't have the problem from the 90s of spending a lot of capital on purchasing something that turns out to not be worth of what you paid for. So it's really hiring talent. And then in terms of hiring talent, we've become very sophisticated about how to do it in terms of providing incentives for productivity so we don't experience the next problem that was characteristic for the 90s, which is hiring physicians, which essentially was enabling them to retire at the expense of the hospital. So we're incentivizing productivity. And we've also experienced some churn of the employed physicians based on those who failed to meet the productivity target leaving and those who are succeeding in the productivity target staying and enjoying the benefits of that. We've also been very selective in terms of the credentials of the physicians that we've been hiring. So just as if you undertook to hire a cadre of 200 MBA students you want to go to the top schools and hire the best students, we're doing the same thing when it comes to physicians. We're also being very selective about filling certain holes and specialties or building primary-care networks, where that strategy is right. And then finally, rather than attempting to manage all these practices ourselves, we've employed in a joint venture format a practice management company that's an expert in doing this and running them at economic results that are superior to what hospitals generally experience. So I think, all of these things together and I didn't mention the EMR solution that we're offering for physicians, I think it's a better solution, and we probably got started later than we should have. And perhaps it's because of historic bias, at least on my part, against that as a strategy. But we are well into it now and have a very strong pipeline of physicians that we are employing."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And just my follow-up, I'm wondering sort of revisit capital structure. You talked about sort of refinancing, pushing out debt maturities. Are you kind of happy with where the company sits from that perspective? Is there anything else you would contemplat",63,"And just my follow-up, I'm wondering sort of revisit capital structure. You talked about sort of refinancing, pushing out debt maturities. Are you kind of happy with where the company sits from that perspective? Is there anything else you would contemplate? Obviously, you mentioned share repo in your commentary, just given where the credit markets are in just the overall rate environment?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, I think, I'll answer and if there's anything left, Biggs, you can chime in. But as I mentioned, there are no significant maturities for five years. That's a long time. I don't think it would make any sense to push it up farther. That's actually quit",139,"Well, I think, I'll answer and if there's anything left, Biggs, you can chime in. But as I mentioned, there are no significant maturities for five years. That's a long time. I don't think it would make any sense to push it up farther. That's actually quite a conservative approach to a capital structure, which I think is appropriate given the risk in the business and the historic leverage that we've had. We've also obviously brought down the leverage ratios substantially, this new credit line offers us a lot of flexibility. We obviously not commenting today on the potential for share buybacks, but it's obviously something we couldn't even consider prior to this new credit line. So we'll just have to see depending on circumstances what we decide to do there. Biggs, is there anything you want to add?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","No, I think there's some small amounts of the '11 and '12 maturities still outstanding, so obviously, over time if not at maturity, we will retire those in due course. And otherwise, if the capital structure are big drivers to keep driving on improving fr",68,"No, I think there's some small amounts of the '11 and '12 maturities still outstanding, so obviously, over time if not at maturity, we will retire those in due course. And otherwise, if the capital structure are big drivers to keep driving on improving free cash flow, drive up earnings and drive free cash flow along with it. And further improve all of the statistics and the ratios."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Darren Lehrich with Deutsche Bank.",13,"Our next question comes from the line of Darren Lehrich with Deutsche Bank."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So maybe I'll just follow-on to that point a little bit more just to round capital and deployment of capital. If you include some value of your NOL, you're probably trading just a little under 5x your guidance for 2010 on an EBITDA basis. So I guess, I'd",107,"So maybe I'll just follow-on to that point a little bit more just to round capital and deployment of capital. If you include some value of your NOL, you're probably trading just a little under 5x your guidance for 2010 on an EBITDA basis. So I guess, I'd be curious to hear your thoughts what kind of assets you can buy that are out there that are more favorable than that type of valuation. So are you seeing any acute-care assets? You've commented a little bit more about your interest in getting aggressive on the outpatient side? Maybe just update us generally on capital deployment priorities."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Obviously, if you employ a rule of thumb that says you should only acquire things to trade a lower multiple than your own multiple. It's very limiting. Based on my comments about outpatient, it appears that we are doing that, and we're very pleased to out",317,"Obviously, if you employ a rule of thumb that says you should only acquire things to trade a lower multiple than your own multiple. It's very limiting. Based on my comments about outpatient, it appears that we are doing that, and we're very pleased to outpatient acquisitions that we're making. I would say that the potential acquisitions of the acute care hospitals that would be of interest to us or of the greatest interest to us, there are certainly more hospitals considering selling themselves or seeking partnerships of some kind. And we're spending more time than we ever have exploring those types of things. I think it's premature to talk about value and whether we would actually proceed and devote our capital in that way. What we haven't been doing, you obviously noticed is we have not been competing in the auctions that has been out there for standalone hospitals or possibles that or -- whatever other acute-care transactions are out there. I don't think we are necessarily the best potential acquirers for those kinds of things. Where we have been focused is more in our markets and things that have some degree of synergy, where we understand the market, we understand the dynamics and the future trends. And obviously, given the uncertainties around healthcare reforms something you have to take into consideration when you evaluate the hospitals. So for that reason, we've been most focused on the outpatient side. I think that you'll agree since we gave some disclosure on those numbers that those are incrementally very helpful acquisitions for us. We like that business and will continue to do that as much as possible. And then, with -- there maybe opportunities in the future within our Services business, which we're also very excited about, the multiple issue tends to present a barrier there, but we have to keep our eyes open on that as well."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And if I could just follow-up maybe clarify a point you made earlier about the cost savings actions in Q3. I guess just putting some rough numbers on the FTE figures you provided, Biggs, it would seem like that's about maybe a $20 million, $30 million typ",67,"And if I could just follow-up maybe clarify a point you made earlier about the cost savings actions in Q3. I guess just putting some rough numbers on the FTE figures you provided, Biggs, it would seem like that's about maybe a $20 million, $30 million type of annualized savings run rate. Is that a good range to work off of what we'll see in Q4?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Like I said it's 1.2% improvement in productivity. So it's quite a little north of that approaching $40 million on an annual basis. Real near term depending on third quarter, the fourth quarter other improvements we expect on the malpractice and workers c",193,"Like I said it's 1.2% improvement in productivity. So it's quite a little north of that approaching $40 million on an annual basis. Real near term depending on third quarter, the fourth quarter other improvements we expect on the malpractice and workers comp side really took the hits in the third quarter for the discount rate. We expect those to not occur in the fourth quarter and possibly will have improvement again in the first quarter as a result of what continues to be good claims experience. Another thing looking at the third quarter was it was a couple of million dollars of severance costs in there, so that was that was the cost of achieving the reductions and we don't expect that to occur in the fourth quarter of the future. So there's a number of things going on in addition to just appear FTE reductions to be considered looking at or maybe this year and on to the future. And of course, we're still driving on the MediCare performance initiatives, which is worth $30 million this year and expect to do similar amount next year in terms of incremental savings."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Gary Lieberman with Wells Fargo.",13,"Our next question comes from the line of Gary Lieberman with Wells Fargo."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I was wondering if you just maybe elaborate a little bit more on the line in the slide about the Managed Care portion of the provider taxes still awaiting approval from CMS and what that involves?",36,"I was wondering if you just maybe elaborate a little bit more on the line in the slide about the Managed Care portion of the provider taxes still awaiting approval from CMS and what that involves?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Sure. The way it has been approved is in pieces. The fee for service portion of it was a little simpler, and it only involves the hospitals, the state and the CMS. And so, that approval came first. The Managed Care portion of this has to flow through the",137,"Sure. The way it has been approved is in pieces. The fee for service portion of it was a little simpler, and it only involves the hospitals, the state and the CMS. And so, that approval came first. The Managed Care portion of this has to flow through the Managed Care payers. And so, contracts and structures have to be adjusted in order to allow for that money to flow through the Managed Care payers. And until that it's totally defined, CMS basically that holds our approval on that portion of it. And so it should be seen as largely administrative in our mind, and that's why we're counting on the entire $64 million in our outlook. But it is a step that has yet to be completed between the states, the Managed Care payers and CMS."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And I guess just the Managed Care portion have to be put to bed before the  entire plan can take place? Or is it should we view it kind of separate by some chance the Managed Care portion gets approved?",40,"And I guess just the Managed Care portion have to be put to bed before the  entire plan can take place? Or is it should we view it kind of separate by some chance the Managed Care portion gets approved?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","It's happening in pieces. And In fact, the direct payment portion of it, the fee-for-service portion, has already been implemented. And we've been invoiced and also receiving funds on that portion of it, which is about half of the total, near half the Man",59,"It's happening in pieces. And In fact, the direct payment portion of it, the fee-for-service portion, has already been implemented. And we've been invoiced and also receiving funds on that portion of it, which is about half of the total, near half the Managed Care piece will happen separately. But as I said, we expect it to happen."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then one quick follow-up, Trevor, I know you mentioned that there wasn't any data on volumes for October. Any initial thoughts just in terms of where it might going to stand up?",34,"And then one quick follow-up, Trevor, I know you mentioned that there wasn't any data on volumes for October. Any initial thoughts just in terms of where it might going to stand up?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I actually commented on the volumes on October. I'm not sure what you mean by your question.",17,"I actually commented on the volumes on October. I'm not sure what you mean by your question."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Just in terms of any picture or service lines that look like they've been reversing trend or so continuation in trend.",22,"Just in terms of any picture or service lines that look like they've been reversing trend or so continuation in trend."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","No, it's too early for that. Usually, we have the volume data daily. And then at the close of the month but then to get clean service line and payer data takes a little longer.",35,"No, it's too early for that. Usually, we have the volume data daily. And then at the close of the month but then to get clean service line and payer data takes a little longer."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Whit Mayo with Robert W. Baird.",14,"Our next question comes from the line of Whit Mayo with Robert W. Baird."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Trevor, can you go back and talk about the delay in merit paid? Did you say that, that was going to be pushed to January? I guess, I didn't follow you.",31,"Trevor, can you go back and talk about the delay in merit paid? Did you say that, that was going to be pushed to January? I guess, I didn't follow you."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Let me just tell you conceptually what we decided to do. We had multiple employee populations with an expectation of annual inflation/merit-oriented salary increases at different times in the year. So we've had for a long time a desire to standardize that",159,"Let me just tell you conceptually what we decided to do. We had multiple employee populations with an expectation of annual inflation/merit-oriented salary increases at different times in the year. So we've had for a long time a desire to standardize that all at the same time of the year, which is really the spring being the best time. And so, given the sort of rapidly decreasing expectations of inflation and also the observations we made of competitive practice declining in terms of the increases that competitors appear to be giving to people, what we've decided to do was to implement the program effective January 1, but to tell people in advance what they would get. So I think it's a very good solution from a cost management perspective. It also administratively will simplify our administration of these programs in the future. And it obviously, was a prudent move to save costs in the second half of this year."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Is there any chance that, that may be delayed further in between '11? I guess I'm just wondering if that's a concrete start in January or whether or not?",29,"Is there any chance that, that may be delayed further in between '11? I guess I'm just wondering if that's a concrete start in January or whether or not?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","No, that's concrete for January.",5,"No, that's concrete for January."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And any other benefit design changes, anything that's meaningful as we look out to 2011?",15,"And any other benefit design changes, anything that's meaningful as we look out to 2011?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Not that we're contemplating at this moment.",8,"Not that we're contemplating at this moment."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","My last question, Biggs, I was just curious if we could get the P&L expense and the cash CapEx numbers for your electronic health records been this year at least year-to-date and maybe a peek into what those two numbers may look like in 2011?",45,"My last question, Biggs, I was just curious if we could get the P&L expense and the cash CapEx numbers for your electronic health records been this year at least year-to-date and maybe a peek into what those two numbers may look like in 2011?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'll do the second part first. On 2011, we're still in the planning process. We've completed, as we said four implementations here in the last couple of weeks. We have three more that are going live shortly among other things. We have to look at that expe",199,"I'll do the second part first. On 2011, we're still in the planning process. We've completed, as we said four implementations here in the last couple of weeks. We have three more that are going live shortly among other things. We have to look at that experience what it's cost us what lessons learned are as a part of fully defining next year's budget and expectations that we would communicate as a part of our outlook. But in any event -- but we do expect it to go up as I said earlier. And maybe that's not so much, an increase off of what we originally expected for this year as it is just an increase in where we actually landed for this year. So the comparative number for this year has come down as opposed to saying next year is increased off of what might we have expected before. This year, we're spending around $90 million in incremental spend. It's actually that total spend -- it's about $66 million of that is CapEx and about $23 million is expense. And like I said, the expense of $23 million represents an $11 million increase over the prior year."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","On the P&L?",4,"On the P&L?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","We do expect that number in total both on CapEx and expense to go up next year. But as I said, it's still early to give a hard number.",29,"We do expect that number in total both on CapEx and expense to go up next year. But as I said, it's still early to give a hard number."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Justin Lake with UBS.",12,"Our next question comes from the line of Justin Lake with UBS."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","First question just on the outpatient side, specifically, you look at that as being opportunity. Talk about outpatient margin being significantly greater than inpatient. I'm just wondering if you can give us some color there in terms of a magnitude of dif",45,"First question just on the outpatient side, specifically, you look at that as being opportunity. Talk about outpatient margin being significantly greater than inpatient. I'm just wondering if you can give us some color there in terms of a magnitude of differential between those margins?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, I think it tend to be more than double. And the comments that I made in the opening suggest that we're buying this at very attractive multiples and that they have very high margins relative to the overall business. And so, it's a very attractive for",49,"Well, I think it tend to be more than double. And the comments that I made in the opening suggest that we're buying this at very attractive multiples and that they have very high margins relative to the overall business. And so, it's a very attractive form of acquisition."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Are you just talking about surgical centers at this point on the margin side because if that will all -- I think it's pretty clear those out margins that are much better than in in-patient hospital or acute care hospital.",40,"Are you just talking about surgical centers at this point on the margin side because if that will all -- I think it's pretty clear those out margins that are much better than in in-patient hospital or acute care hospital."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Most of what we've been doing is imaging centers we have bought some surgery centers. But this year, not exactly clear how many will be able to close, but it'll be on the magnitude of 22-plus-ish imaging centers and three to four surgery centers. So far m",52,"Most of what we've been doing is imaging centers we have bought some surgery centers. But this year, not exactly clear how many will be able to close, but it'll be on the magnitude of 22-plus-ish imaging centers and three to four surgery centers. So far more on the imaging side."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then just a little bit of the cleanup on some of the 2011 moving parts. Can you give us any specifics on how much of the headwind healthcare IT is going to be next year? And then just to confirm, I think, I heard you say that the provider taxes would",58,"And then just a little bit of the cleanup on some of the 2011 moving parts. Can you give us any specifics on how much of the headwind healthcare IT is going to be next year? And then just to confirm, I think, I heard you say that the provider taxes would be a $36 million headwind year-over-year?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I think, actually, the latter one on the provider fee, the amount of the provider fee attributable to 2009 is what I said the most challenging of the care provider fee and that's actually about $27 million of the $64 million. The amount, which is carrying",58,"I think, actually, the latter one on the provider fee, the amount of the provider fee attributable to 2009 is what I said the most challenging of the care provider fee and that's actually about $27 million of the $64 million. The amount, which is carrying over to next year from a cash standpoint is about $36 million."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Any other kind of provider fees or provider tax benefit you're getting this year that you don't expect? So you expect the other $37 million of the $64 million to reoccur again in 2011? Or that you would expect to guide to?",43,"Any other kind of provider fees or provider tax benefit you're getting this year that you don't expect? So you expect the other $37 million of the $64 million to reoccur again in 2011? Or that you would expect to guide to?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Yes, well, what I've said was if you take the California fee, the current year portion of it, will be replaced by in part a half year extension on California, we would expect not yet done, but we would expect that plus $25 million from Pennsylvania and al",72,"Yes, well, what I've said was if you take the California fee, the current year portion of it, will be replaced by in part a half year extension on California, we would expect not yet done, but we would expect that plus $25 million from Pennsylvania and also not yet done but in works and the sum of those two, yes, would offset the $37 million of current year California provider fee."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then just healthcare IT increase year-over-year?",8,"And then just healthcare IT increase year-over-year?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","As I said, it's a little early to say. I think that this year, we've underrun significantly based upon not as occurring as much in a way of start-up costs and also being very efficient in the implementations that we have successfully completed here in the",124,"As I said, it's a little early to say. I think that this year, we've underrun significantly based upon not as occurring as much in a way of start-up costs and also being very efficient in the implementations that we have successfully completed here in the last few weeks. So we've got to assess, if you will, what that means with respect to the implementation for next year have or we do have more implementations next year than this year. More hospitals will be in process, so we do expect the number to go up. It's probably in the say low tens of millions kind of number not a radical change in overall profitability associated with it, but we just have to finalize that."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So is that like $10 million to $30 million or is that $10 million to $15 million?",17,"So is that like $10 million to $30 million or is that $10 million to $15 million?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","$10 million to $30 million would be in the low. Low tens is very [indiscernible]. But as I said, it's early yet to put a hard number out there.",29,"$10 million to $30 million would be in the low. Low tens is very [indiscernible]. But as I said, it's early yet to put a hard number out there."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Sheryl Skolnick with CRT Capital Group.",14,"Our next question comes from the line of Sheryl Skolnick with CRT Capital Group."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","First, I want to complement you on the extensive diligence you've done on all the key questions that I would have had about the composition of the volume shortfall in trying to get comforted guidance in bridging, where we are from third quarter and the di",131,"First, I want to complement you on the extensive diligence you've done on all the key questions that I would have had about the composition of the volume shortfall in trying to get comforted guidance in bridging, where we are from third quarter and the difficulties here versus the fourth quarter and then to 2011. So it's extremely helpful, and I think it was fair to do. But I'm going to turn to sort of a more conceptual question about the fourth quarter guidance if I could. If I take out the provider fee, anticipated impact in fourth quarter, which I believe you said was $64 million, and I look at that -- first of all, would it be correct to assume that, that would drop 100% to the EBITDA line?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Yes.",1,"Yes."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","The answer to that I think is yes. And then second, if that's the case, then your guidance sort of implies something on the order of a quarter to flat on the EBITDA line with third quarter to something that is would be up around the sort of $270 million t",130,"The answer to that I think is yes. And then second, if that's the case, then your guidance sort of implies something on the order of a quarter to flat on the EBITDA line with third quarter to something that is would be up around the sort of $270 million to $280 million in order to achieve the $10.50 million to $1.1 billion if my math is correct. So if I look at those numbers, I'm still not sure how you get to the upper end of the range. So my question then becomes, what really has to go right for us to be optimistic that you can get back on the path of exceeding not only consensus but achieving the high end of your guidance or even exceeding it?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'll try to answer the first batch. Obviously, we've taken cost out. We've talked about that. And if you look at this from adjusted patient-day basis in Q3, our experience was around $2,050. Q3 year-to-date was $1,995. So clearly, Q3 jumped up. Q4, we loo",311,"I'll try to answer the first batch. Obviously, we've taken cost out. We've talked about that. And if you look at this from adjusted patient-day basis in Q3, our experience was around $2,050. Q3 year-to-date was $1,995. So clearly, Q3 jumped up. Q4, we look at being back around that $1,995 kind of levels. So based upon the reductions in staff, the improvements we forecast on mid now, severance is not recurring as I talked about some of other initiatives to drive down costs. We think we get back down to that $1,995 kind of level. So it's at the middle of the range. And of course, there's opportunity, they'll beyond with that to help drive towards the end of the range as well. From a revenue standpoint, we've just looked at what's real recent experience on volumes. And as I said, we didn't presume many kind of a hockey stick in the last two months of the year. But from an overall admit standpoint, at the middle of the range, we could be at a negative 4% to 5% and still hit the middle of the range and commercial still be in that 6% to 7% kind of range where we were at for the first half. Once again, be in the middle of the race. So those seem like based on everything we know, still some recent very conservative positions to be taken as we look at the underlying trends. So there's opportunity in my mind for us to do better than those of both on the cost side and on the volume side but as you know, we didn't take up the upper end of the range because we wanted to stay conservative and not presume that we're going to do better than those and left ourselves, I'd say to build a range based on those stats."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then with, I think with all of these questions, I think you're getting around the point of just for how long is the pattern we've been seeing in your earnings as well as others, for how long will the cost savings continue to save the day as it were as",117,"And then with, I think with all of these questions, I think you're getting around the point of just for how long is the pattern we've been seeing in your earnings as well as others, for how long will the cost savings continue to save the day as it were as volume continues to deteriorate? I mean that's not an issue unique to Tenet. And I guess the answer to that is nobody really knows, but how much more do you have left on the cost? And it seems like you've been doing just about everything you can on that score. You found another 800 FTEs. But at what point do you have to stop doing that?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well staff reductions, it's the only place for reducing cost to make our performance initiatives driving cost out and supply cost were basically flat and have very low inflationary rate even with higher acuity. So there is success in our efforts there, an",127,"Well staff reductions, it's the only place for reducing cost to make our performance initiatives driving cost out and supply cost were basically flat and have very low inflationary rate even with higher acuity. So there is success in our efforts there, and they'll be continuing in success. But cost is also not the only way we're going to drive value. Even if we don't have increasing inpatient volumes over the near future because we have the outpatient acquisition is driving value. We have our investments in Conifer yield increasing value. The price negotiation, the commercially still favorable, the price on government, pretty much flat. So there's plenty of things we're operating on to create value besides just driving our cost but there's more cost opportunity too."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I would just add to what Biggs said, Sheryl, opportunity on longer term is the clinical standardization, where we really get in on more and more of the BRGs both inpatient, as well as our outpatient care standardized that, eliminate some redundancy, drive",104,"I would just add to what Biggs said, Sheryl, opportunity on longer term is the clinical standardization, where we really get in on more and more of the BRGs both inpatient, as well as our outpatient care standardized that, eliminate some redundancy, drive down that variable costs, and really affect the cost metrics and something outside necessarily of the salary wages and benefits or direct supply cost. We're also working on length of stay. We're working on readmission rates as we look at more was prospective payments. So there are lots of opportunities to drive on the cost side of the equation going forward."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And just finally, on your commercial Managed Care negotiations, we've begun to see some more, shall we say, innovative almost back to the future kinds of tactics at the Main Street level on the part of some of the Managed Care companies with their relatio",177,"And just finally, on your commercial Managed Care negotiations, we've begun to see some more, shall we say, innovative almost back to the future kinds of tactics at the Main Street level on the part of some of the Managed Care companies with their relationship with physicians, with restructuring their contract for payment, for example, United with an oncology we've heard about the potential force some of the company's to have more direct even ownership relationship with providers, physicians, hospitals, outpatient, et cetera to have them do the rationing rather than the health plan, but the health plan gets the benefits thereof. But is there anything that you can see in your negotiations with the commercial Managed Care plans that might get more creative i.e., contracting for guaranteed volume within a disease or within a procedure or service lines where you might give a dominant or best quality provider in the market that could assure you some commercial Managed Care share in those markets and help you even to take share rather than just to maintain share?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","So the short answer is, every creative structure that you can imagine and probably more are under discussion. But still, it is today an environment that's all about costs and access and companies obtaining benefits with the sort of least amount of frictio",137,"So the short answer is, every creative structure that you can imagine and probably more are under discussion. But still, it is today an environment that's all about costs and access and companies obtaining benefits with the sort of least amount of friction for their employees and all that. But I think, we're well positioned on those creative types of structures because of quality, because of our visibility and ability to understand what it is that we're actually doing in terms of the provision of the service. And then we have this little secret weapon that we've used for decades in California that as of unit that assesses risk and helps us on capitated types of arrangement and serves clients beyond Tenet. And so, I think we're very well positioned when risk-taking enters the question as well."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our final question comes from the line of A.J. Rice with Susquehanna.",13,"Our final question comes from the line of A.J. Rice with Susquehanna."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","First of all, I ask one that's sort of a long shot, but I think, Biggs, you alluded to the idea that people may have been managing their deductibles this year [indiscernible] more aggressively and therefore speculation get into Q4, you might see some pent",89,"First of all, I ask one that's sort of a long shot, but I think, Biggs, you alluded to the idea that people may have been managing their deductibles this year [indiscernible] more aggressively and therefore speculation get into Q4, you might see some pent-up demands so as deductibles hit. I guess my question first off would be, you guys have anyway to measure that? Can you see whether people are taking longer to hit their deductibles this year than they did last there or anything along those lines?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","There really isn't any clear way for us to see that. We don't have that kind of visibility as to patient comes in or as we send the bill to the payers, so not great insight.",37,"There really isn't any clear way for us to see that. We don't have that kind of visibility as to patient comes in or as we send the bill to the payers, so not great insight."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I have heard the theories as spouse payers, they have obviously much more insight, but I don't think that evidence at least as I mentioned earlier through the first 28 days of October that, that demand wave was ready to hit the beach.",43,"I have heard the theories as spouse payers, they have obviously much more insight, but I don't think that evidence at least as I mentioned earlier through the first 28 days of October that, that demand wave was ready to hit the beach."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","The $100 million to $150 million that acquired outpatient revenues that you're looking for this year, is this year in your mind unusual with the focus on acquiring things like outpatient imaging? Do you think you can run at that rate of acquisitions for a",48,"The $100 million to $150 million that acquired outpatient revenues that you're looking for this year, is this year in your mind unusual with the focus on acquiring things like outpatient imaging? Do you think you can run at that rate of acquisitions for a couple of years?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, we said we think we can do it for next year. I mean, obviously, we've been very sensitive about doing this, where we have the ability to put the centers within a hospital structure. So you run out of opportunities just geographically over time. But",97,"Well, we said we think we can do it for next year. I mean, obviously, we've been very sensitive about doing this, where we have the ability to put the centers within a hospital structure. So you run out of opportunities just geographically over time. But there are other ones where the sellers -- we've seen somewhere the sellers initially said they don't want to sell their price expectation or unrealistic and they're coming back to us now. So that's way we made the comment with respect to 2011. I wouldn't speculate on 2012 at this point."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I don't think you quantify to how much benefit you get from delaying the merit increase, maybe I missed it if you did for the extra quarters. How much would that benefit you in the fourth quarter? And then if you could just maybe I'm curious, when do you",81,"I don't think you quantify to how much benefit you get from delaying the merit increase, maybe I missed it if you did for the extra quarters. How much would that benefit you in the fourth quarter? And then if you could just maybe I'm curious, when do you guys think you would offer -- we're talking around the 2011 outlook a lot, have you given some thoughts exactly when you're likely to actually give a formal outlook for 2011?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","On the benefit of deferral of the merit increases, it's in the neighborhood of $15 million for the quarter. And that would be similar to numbers we've given in the past. And we've talked about what the effect of the merit increases were in the fourth quar",110,"On the benefit of deferral of the merit increases, it's in the neighborhood of $15 million for the quarter. And that would be similar to numbers we've given in the past. And we've talked about what the effect of the merit increases were in the fourth quarter when we gave them by example last year? In terms of when we were given outlook, I mean, our baseline is we will look at results, we complete our planning process otherwise in December, we look at results through December ultimately and sort of re-evaluate and validate our expectations based upon that and then give you outlook when we released fourth quarter earnings."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So in February, at some point?",6,"So in February, at some point?"
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Yes.",1,"Yes."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thanks AJ and thanks, everybody, for joining the call. And see you on the next one.",16,"Thanks AJ and thanks, everybody, for joining the call. And see you on the next one."
107911,114307236,84333,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Ladies and gentlemen, that concludes today's conference. Thank you for your participation. You may now disconnect. Have a wonderful day.",20,"Ladies and gentlemen, that concludes today's conference. Thank you for your participation. You may now disconnect. Have a wonderful day."
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Good day, ladies and gentlemen, and welcome to the Third Quarter 2010 Tenet Healthcare Earnings Conference Call. My name is Jeff, and I'll be your operator for today. [Operator Instructions] I would now like to turn the conference over to your host for to",57,"Good day, ladies and gentlemen, and welcome to the Third Quarter 2010 Tenet Healthcare Earnings Conference Call. My name is Jeff, and I'll be your operator for today. [Operator Instructions] I would now like to turn the conference over to your host for today, Mr. Thomas Rice, Senior Vice President of Investor Relations. Please proceed, Mr. Rice.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, operator, and good morning, everyone. Tenet's management will be making forward-looking statements on this call. These statements are based on management's current expectations and are subject to risk and uncertainties that may cause those forw",97,"Thank you, operator, and good morning, everyone. Tenet's management will be making forward-looking statements on this call. These statements are based on management's current expectations and are subject to risk and uncertainties that may cause those forward-looking statements to be materially incorrect. Management cautions you not to rely on and makes no promises to update any of the forward-looking statements. During the question-and-answer portion of the call, callers are requested to limit themselves to one question and one follow-up question.
At this time, I will turn the call over to Trevor Fetter, Tenet's President and CEO. Trevor?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, Tom, and good morning, everyone. Well, I will blame you if you write report saying that this is a noisy quarter. In summary, our earnings number was huge and we're raising the bottom end of our 2010 outlook. The volumes were soft, and the EBITD",1672,"Thank you, Tom, and good morning, everyone. Well, I will blame you if you write report saying that this is a noisy quarter. In summary, our earnings number was huge and we're raising the bottom end of our 2010 outlook. The volumes were soft, and the EBITDA is flat to 2009, if you make appropriate adjustments. 
We generated over $900 million in net income due to the accounting recognition of the value of our tax loss carryforward. Biggs will explain this further, but the key point is that while existence of the NOL has been well known it should be more tangible to investors now that it's on the books.
Looking beyond net income, we were challenged by soft volumes in the quarter. We reacted to a particularly weak July by implementing a reduction in force in August. The impact of these actions to reduce costs along with improved volume trends after July led to a positive earnings trend in the quarter, in which EBITDA grew steadily from July to August to September. 
It's worth noting that we face the very tough comparison this year as adjusted EBITDA was up 50% in the third quarter last year. Once you allow for year-over-year variability, our longer-term EBITDA trend remains strong. You can see the variability and the clear long-term trend demonstrated on Slide 4.
Clearly, our growth has been very strong but not a steady as I'd like. When you make your assessment of our growth in EBITDA in the quarter, please consider the items on Slide 5. The third quarter of 2009 included three favorable items contributing a total of $20 million. We called out these items in last year's third quarter call, and nearly all of you noted them when assessing our performance. 
In contrast, this year's third quarter includes items with a net unfavorable impact of $16 million. In total, these items created a $36 million unfavorable swing from the third quarter of 2009 to this year's quarter. Net of these items, this quarter was essentially unchanged.
As I mentioned earlier, we're raising the bottom end of our outlook for 2010 EBITDA to a new range of $1,050,000,000 to $1.1 billion. This is the second time this year we've increased one or both ends of the range. Volumes were certainly weaker than we originally anticipated, but this has been offset by stronger pricing, enhanced acuity and excellent cost control. We're also benefiting from the California provider fee being larger than we forecast and health IT spending being less than we anticipated.
Soft volumes were a dominant theme across the industry last quarter, so I'd like to give you some color on our experience. The overall takeaways that the volume declines were contained to a small number of hospitals, and once again a single service line. OB accounted for a full third of our volume loss.
Total admissions declined 3.5%, and commercial admissions declined 8.6% in the quarter. July was by far our weakest month for patient volumes. The trend was more encouraging in August and through mid-September. Through the first 28 days of October, commercial admissions trended slightly better than in Q3 but total admissions were slightly weaker.
As you can see on Slide 7, outpatient visits were down 2% in the third quarter. Emergency department outpatient visits were down 1.7% in the quarter, but just over 70% of that decline is due to a reduction in flu, so non-flu ED visits are basically flat year-over-year. Outpatient surgeries were up modestly, increasing by 0.1% and adjusted admissions were down only 1.8%.
The volume losses this quarter and this year have been confined to a small number of hospitals. In fact, just seven hospitals comprise more than 70% of our total admissions declines in the third quarter. But while these seven hospitals cost the majority of our volume losses, the other 42 hospitals in the aggregate are performing better than the industry average. 
The seven hospitals are widely dispersed. There are two in Texas, but they're not in the same market. The other five are each in different states. Interestingly, although California is challenged by extremely high unemployment in some of our markets, none of our California hospitals are among the seven.
There is no single theme for the volume losses at these seven hospitals. One of the hospitals are having a solid and growing year but facing extremely tough comparison on volumes in Q3. Another one lost the unprofitable volume. Those two, plus three others, grew EBITDA significantly despite their volume losses. 
The two others saw challenges with their physician channels. These are instances where physicians have gone into direct competition with the hospitals, where we're competing hospitals have engaged in very aggressive and sudden physician employment strategies. No matter the reason for the volume declines, we're responding appropriately, and we believe that we're already turning the losses around. In October, in these seven hospitals, while still down, the volumes were down by a lower percentage than in the third quarter.
Turning to service lines. I already mentioned that the third of the total volume decline was in OB. Looking beyond OB, there's some elective service lines, I'd like to share some interesting insights with you. As we're deep into the recession, it's very clear that patients who have a significant personal financial responsibility are behaving very differently than patients who don't. We've known all along that this was driving reductions in our commercial elective surgical volumes. But let me give you some facts that our other orthopedic surgery as an example.
If you look at Slide 10, you'll see that total admissions for orthopedic surgeries declined by 2.5%. Commercially insured orthopedic surgeries declined by 9%. Orthopedic surgeries for all other patients, most of whom are covered by Medicare and Medicaid, actually increased 0.2%. 
The same pattern is true with spinal fusions. Commercially insured spinal fusions declined by 160 admissions or 15% in the third quarter, but noncommercial spinal fusions increased by 17% or over 150 admissions in the quarter. Since the same physicians are doing these surgeries for both payer classes, the loss of commercial volumes and the growth of noncommercial volumes to just this behavior is being driven by the patient not the physicians. We believe this patient behavior is largely related to economic uncertainty on the part of the patients, commercial enrollment losses and rising co-pays and deductibles for those who remain insured.
Again, on Slide 10, you can see this pattern holds through across several service lines that we would consider as elective and easy to defer. Slide 11 illustrates that when the procedure is harder to defer, like in the case of OB, the changes in volumes in other commercial and noncommercial populations are very similar. 
Despite the challenges to volume growth, favorable pricing and acuity continue to drive a stable picture for revenues. Commercial pricing remains particularly strong. We also had a 2.4% increase in commercial acuity. The result was positive commercial revenue growth of nearly 1% for the quarter. Collectively, this helped us generate adjusted free cash flow of $53 million in Q3, bringing year-to-date free cash flow deposit of $74 million. 
We've made a lot of progress on other front in the quarter. We continue to improve and de-risk our capital structure, pushing out the majority of our 2013 maturities to 2020, while retiring $229 million face value of debt. This brings our total debt slightly more than $4 billion with no meaningful maturities for five years. We also entered into a new $800 million credit line with new flexibility with regard to our capital allocation options, including lifting an existing limitation on stock repurchases.
Earlier this year, we drew your attention to the seven items on Slide 14, which we believe can drive significant margin expansion and earnings growth over the next few years. While some of these items depends on a recovering economy, three of these initiatives, Outpatient, Medicare Performance Initiative and Conifer, were more directly under our control and less dependent on an economic recovery.
Just walking down the list for a minute, our newly acquired outpatient centers are already coming online. We expect to have invested about $70 million in outpatient acquisitions by the end of 2010 and believe there are enough great opportunities that we could do that again in 2011. We anticipate these acquisitions will add $100 million to $150 million to revenues in 2011, and given the much higher margins in this business, contribute as much as $30 million to $40 million in 2011 EBITDA.
Turning to MPI, we are very much on track with our 2010 objective of a $30 million incremental EBITDA contribution. While we have not yet completed our MPI plan for 2011, our preliminary view is for another $30 million. Conifer will take longer to gain visibility, but we remain very excited about its prospects. Conifer's contributions from outside clients to 2011's EBITDA growth will exceed $10 million.
Our healthcare information technology initiative will again create incremental expenses in 2011. And as previously disclosed, we're not planning on a net positive net financial contribution from the initiative prior to 2012. Earlier last month, we went live at four hospitals, and the rollout went smoothly. We're going live in an additional three hospitals this month.
In addition, we continue to achieve solid commercial pricing that's consistent with the trends of recent years. To make major progress on margin expansion and EBITDA growth, we need volume growth and to go back towards prerecession bad debt expense levels. But it's still clear there's much we can achieve even in the absence of recovery.
So to wrap-up, I believe we demonstrated once again that we have the appropriate and effective leverage to pull in the short term to keep us on track relative to our longer-term performance milestone. I also believe our long-term growth strategy have us well positioned to face the myriad challenges that 2011 will bring. 
And with that, let me turn the floor over to Biggs Porter, our Chief Financial Officer. Biggs?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, Trevor, and good morning, everyone. The biggest item impacting our net income for the quarter is a recognition of the tax benefit or our net operating loss carry forward. This recognition resulted from our reversal of the previously-established",2154,"Thank you, Trevor, and good morning, everyone. The biggest item impacting our net income for the quarter is a recognition of the tax benefit or our net operating loss carry forward. This recognition resulted from our reversal of the previously-established valuation allowance and added $981 million to our net income or $1.75 per diluted share. 
Under generally accepted accounting principles, which arguably are conservative on this point and in recognition of our sustained and sustainable return to profitability, the realization of this tax benefits has become sufficiently likely as to require its recognition in our financial statements. Given the conservative criteria applied in our GAAP, this makes a strong statement about the expectations of our future profitability and the value of the NOL.
As a result of this recognition, our income statement tax rate in future quarters will approximate a normalized tax rate of approximately 40%. From a cash perspective, however, we will continue to benefit from the tax shield, and our tax payments on future income will be primarily limited to state taxes, and will continue at the low level of recent years. It will remain low until our loss carry forward is fully utilized, which is still a number of years out.
The biggest item not impacting either net income or adjusted EBITDA in the third quarter was the $64 million net receipt of revenues related to the California provider fee. Due to delays in a very complex approval process, this materially favorable event was not recognized in the third quarter. The portion of the plan related to direct medical payments was approved after the end of the quarter, with the Managed Care portion still pending. We had expected that up to $55 million would be recognized in the third quarter. This delay has no affect on full year income but will cost some of the cash receipts to slip out of this year into next, which we estimate at a net $36 million.
Looking forward to next year, the California provider fee may be renewed for a half year, and a new fee in Pennsylvania worth approximately $25 million is in the process of development. Other states are also working on these types of arrangements. Just as food for thought, if you put the normalized 2010 value of the California provider fee at $37 million, but Pennsylvania fee and a partial extension of the California fee could more than replace that. So you should not think of the revenue from the California provider fee as being entirely non-recurring and looking at next year. For a cash basis, the cash received from provider fees could actually go up next year.
Adjusting both quarters for prior cost quarter adjustments, revenues grew slightly in the third quarter as a result of strong commercial pricing and case mix, offset by adverse payer mix in aggregate declines in paying volumes. As in the prior quarters of this year, case mix on commercial Managed Care was strong relative to last year reflecting about a 3% increase. As I said in last quarter's comments, this increase in acuity has to be considered in understanding the economic effect of lower volume.
Our overall pricing picture remains positive. Even with the commercial volume declines we experienced in the quarter, commercial pricing gains were sufficient to drive growth of 0.9% in commercial revenues in the quarter. Because of the payer mix shift, however, net inpatient revenue per admission increased by only 1.1%, and net outpatient revenue per visit increased by 5.6%. 
The strong increase in outpatient pricing reflects the loss of H1N1 volumes from last year, which had generated lower revenues per outpatient visit. The absence of flu volumes in this year's third quarter drove average pricing higher. Once again, this demonstrates the necessity of understanding acuity and patient mix when assessing the economic effects of volume fluctuations.
While among the topic of pricing, I will comment that we continue to have very good visibility with regard to our forward pricing. At this point, approximately 80% of our commercial contracting is complete for 2011 and 40% for 2012. 
Turning to cost. Although the benefits weren't fully visible in the third quarter, we successfully took action to flex our cost structure. As Trevor mentioned, July's volumes were particularly weak. We responded very quickly to reduce our staffing and implemented the significant reduction for us in August. We incurred a couple of million in severance costs as part of this, but this August, the action left us well positioned for the balance of the quarter.  Those cut should also have full visibility in our fourth quarter. 
In addition, we have delayed our annual merit increases for the general population from October 1 to January 1. This takes us a step closer to timing our merit increases for all employees in the April time period where they used to be.
The result of these actions are merely evident in our internal measures of productivity, which looks at FTEs per adjusted average daily census. Despite the soft volumes in the quarter, this productivity measure actually improved in the third quarter as FTEs per adjusted average daily census declined in September by 1.2%.
Supplies cost were essentially flat in the quarter. On a per-adjusted patient-day basis, the increase in supplies cost was 2.6% as adverse operating leverage and the increase in acuity offset the effects of our supply cost initiatives. Because we recorded within other controllable cost line were more of a challenge. Many of the costs recorded in this heading are more heavily fixed or semi-variable in nature and as a result are more difficult to flex in response to soft volumes. 
We also recorded some incremental expense from items whose actual early determine impact is adversely influenced by declining interest rates. While now practice expenses increased by only $1 million relative to last year's third quarter, the decline in interest and therefore discount rates at $11 million to malpractice expense in the current quarter. Combined with an increase of $3 million in workers comp expense, lower discount rates added $14 million to operating expense in the quarter. This discount rate adjustment should be considered unusual at this point given low rates we were already seeing on U.S. Treasuries and can be expected to more than reversed itself in the future when interest rates rise to normal levels, thereby creating earnings upside of up to $40 million at some point in the future.
In addition, we recorded an incremental $4 million of HIT expense. As Trevor mentioned, we successfully went live on the first phase of the system of four of our hospitals in the month of October, and we now expect the internal effects of these expenses to be down to $11 million in 2010. We expect this incremental expense to increase in 2011 prior to being offset in 2012 by the recognition of federal incentive payments. This increase is now a deferral of 2010 expenses, but is reflective of the increase and number of implementations in 2011.
Our bad debt ratio declined to 8.3% in the quarter, a 20 basis point decline relative to 8.5% a year ago. This decline includes the recurring benefits of federal Medicare bad debt recoveries, as well as declines in uninsured volumes. We view the size of this quarter's Medicare bad debt recovery as representative of ongoing sustainable impacts that can be expected in future quarters.
We had $398 million in cash and cash equivalents at quarter end, a decrease of $313 million from June 30. The largest driver of the cash decline was the use of $274 million to reduce debt. Cash provided from continuing operations was $160 million, and adjusted free cash flow was $53 million after capital expenditures of $107 million in the quarter. 
In the third quarter year-to-date, our cash from operations has been held back by lower levels of accounts payable and in the prior year. Some of this is due to the timing of expenditures or aggressive disbursements. We've not changed policy or contractual arrangements however, and we expect payables to expand again by year end.
Subsequent to the end of the quarter, we completed the sale of a number of our Florida medical office buildings, generating cash of $46 million. As a part of the sale, the buyers committed to certain capital improvements to facilities, which will benefit our position Tenet's. These MOBs had immaterial annual ends and EBITDA. 
We continue to actually market additional MOBs, and we believe a number of these transactions could be completed in the next few quarters. At this point, we have other MOB sales contracts pending worth approximately $50 million, but in real estate, nothing is done until it closes so there's not reflected in our outlook.
Turning to our outlook. We have raised the lower end of our outlook to a new range of $1.05 billion to $1.1 billion. We raised both ends of the range of pretax income, reflecting lower depreciation and interest expense. Our revised assumptions are detailed on Slide 24. This revision includes the lowering of our volume and revenue estimates, which are tied to a later reductions in our cost estimates for the balance of the year. 
There's been speculation that volumes will grow in the fourth quarter of more than a seasonal basis due to the effects of co-pays and deductibles. At this point, we're going to be conservative and not count on that in our outlook. The walk forward of cash from September 30 to December 31 is provided on Slide 25 breaks down fourth quarter cash flow into its major components. 
It's too early to give an outlook for 2011, but I do think it's appropriate to give a little balance to what the headwinds and opportunities are going into next year. First, the biggest challenge remains on the volume side, but some of the effects of the economy and flu should have average rate by the end of this year. Economic stability followed by recovery would presumably create upside. Second, we expect the full year benefit on the outpatient acquisition we're completing on the second half of this year and a partial benefit of those we're targeting for next year.
Third, we're already seeing improvement in the yield on our physician additions the last couple of years, and we expect expansion of that benefit in 2011 and beyond. Fourth, commercial pricing is almost completely negotiated with reasonable existent price increases expected next year. Medicare, all in, is basically flat as outpatient increases offset inpatient decreases. I've already talked about state signing and potentially new provider fees with the 2009 retroactive portion of the California provider fee being the one element most challenging to replace.
Finally on the cost side, we will increase our investment in our physician base and HIT both of which will yield improvements for the future. And we will continue to drive on our Medicare performance and related initiatives to reduce link to stay in supply costs. 
In the aggregate, we will continue to drive toward industry margins. We have confidence in the path we have laid out. The only gating consideration in what the near-term timing and slow for progress is going to be is the degree of economic headwinds we must offset. On the positive side for 2011, we expect to drive value in the outpatient investments, position base initiatives, commercial pricing and the Medicare performance initiative. The big potential near-term negative, longer-term appositive is, as I just said, the effect of economic conditions. It is not clear and therefore remains subject to continuing evaluation by us as to what extent economic conditions will offset the net positive drivers of growth in 2011.
So to summarize. The value of our NOL carryforwards has been confirmed from accounting standpoint. We have raised our outlook for EBITDA and pretax and net income for the year. We approved cost efficiencies in the quarter, as we were able to react quickly to significant volume declines in the first month of the quarter. This will be fully visible in the fourth quarter. 
Free cash flow came under pressure due to the timing of disbursements in rising CapEx. But because of the timing effects on accounts payable will reverse themselves, we have retained our free cash flow outlook for the year. Pricing continued as the source of strength. Commercial case mix remained favorable compared to the prior year. California provider fee, has been partially approved while full approval expected this quarter. 
And one last point. From a volume and payer mix standpoint, this was the weakest quarter we've experienced, clearly reflective of the economic headwinds. However, the fact that we held earnings flat on a normalized basis and even in this harsh environment demonstrates that we are well positioned to grow earnings as the economy moderates and/or as our volume initiatives yield increasing results. 
Let me now ask the operator to assemble the queue for Q&A. Operator?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","[Operator Instructions] Our first question comes from the line of John Rex with JPMorgan.",14,"[Operator Instructions] Our first question comes from the line of John Rex with JPMorgan.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And the issue here for me is when we look at the share, the erosion in commercial, and it's just been persistent now as many quarters in terms of actually kind of seeing accelerating losses. So my question is, it looks like you're losing share when that c",98,"And the issue here for me is when we look at the share, the erosion in commercial, and it's just been persistent now as many quarters in terms of actually kind of seeing accelerating losses. So my question is, it looks like you're losing share when that compared to what I'm seeing from others and when I even think about what I'm seeing is kind of more stabilizing trends in just commercial coverage broadly. So can you tell us how you look at that in terms of the potential share losses you might be seeing in the markets?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Yes, John. This is Trevor. That's a good question. I have to comment first and I'm going to turn it over to Steve Newman, because we've done extensive analysis of this share question. But first, we'd have to make the comment that it is very difficult to c",135,"Yes, John. This is Trevor. That's a good question. I have to comment first and I'm going to turn it over to Steve Newman, because we've done extensive analysis of this share question. But first, we'd have to make the comment that it is very difficult to compare the commercial statistics that we've been disclosing in any kind of context to the industry at large or even the peer companies, because you're not getting that same type of disclosure. So not that everybody should do it and not to say that we don't regret starting with disclosure. But you really can't look at these commercial numbers and draw any conclusion about share from them. Now having said that, we've done a lot of work on shares so I'll ask Steve to comment on that. Steve?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","John, I think it's an excellent point, and we've got a great deal of evidence that we're not losing commercial managed care or market share except in the markets of the hospitals that Trevor mentioned in his comments. Our evidence comes from three separat",100,"John, I think it's an excellent point, and we've got a great deal of evidence that we're not losing commercial managed care or market share except in the markets of the hospitals that Trevor mentioned in his comments. Our evidence comes from three separate sources: First, our statewide all-payer database; second, our large statewide Blue Cross plants, where we have significant penetration in those markets; the third is a review of our market share with three of the largest national commercial payers. In summary, these studies also guess, except in a few isolated instances, our commercial market share is stable.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","And I think, John, we triangulated on that question. As Steve said, there's several different approaches to it. But very hard to do with precision. So this quarter, we did something we haven't done before, which was essentially go to the payers who would",107,"And I think, John, we triangulated on that question. As Steve said, there's several different approaches to it. But very hard to do with precision. So this quarter, we did something we haven't done before, which was essentially go to the payers who would give us this information to say, ""Look, this is our change in volume with you in this particular market. Tell us, because you have access to it, what is the share change and was very reassuring in all cases with the exception of a few, where it's clear that we're losing share because there's, some new competitors some different dynamic in the market.""
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And my follow-up, if you look at the seven hospitals that you spiked out, what percent of company revenues were they representing? I'm trying to compare, I think about your top seven hospitals and percentage revenue there. Group this seven, where would th",45,"And my follow-up, if you look at the seven hospitals that you spiked out, what percent of company revenues were they representing? I'm trying to compare, I think about your top seven hospitals and percentage revenue there. Group this seven, where would they fall?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","They do tend to be some of our larger hospitals. So we have a portfolio that ranges in size, but does have some large ones. And I think, when you have a quarter where the large hospitals are underperforming at any given statistics, it tends to drive the c",88,"They do tend to be some of our larger hospitals. So we have a portfolio that ranges in size, but does have some large ones. And I think, when you have a quarter where the large hospitals are underperforming at any given statistics, it tends to drive the company in that direction and vice versa. And unfortunately, this is one of those quarters and I've seen other ones over the time that I've been with Tenet, where the largest hospitals with exceptions were moving in the wrong direction.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","So these are not our seven largest hospitals but amongst them are [indiscernible] hospitals.",14,"So these are not our seven largest hospitals but amongst them are [indiscernible] hospitals.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So I'd find some of that in that category then. And does stabilizing coverage levels, do you think there's going to have impact or what you're seeing at this point, is it less about erosion and just commercial coverage and more just about avoidance of the",52,"So I'd find some of that in that category then. And does stabilizing coverage levels, do you think there's going to have impact or what you're seeing at this point, is it less about erosion and just commercial coverage and more just about avoidance of the carenstein [ph] at all ?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, you've got the baseline high-shrinking issue of the commercial enrollment losses that's been running around 4% among the big payers. You start with that. And then you add to it some utilization issue that potentially is driven by the economic incent",166,"Well, you've got the baseline high-shrinking issue of the commercial enrollment losses that's been running around 4% among the big payers. You start with that. And then you add to it some utilization issue that potentially is driven by the economic incentive that are inherent in higher deductible health plans. And now the enrollment losses you could see turnaround in a stronger economy, the shift towards a higher deductible plans and whatever's depression of consumption exist that could be a longer-term trend. But like just this morning, I'm encouraged to see in the newspaper the results of the Kaiser survey that among very small employers, coverage is going way up to these tax incentives that they've been provided with. So among firms with something like nine to 13 employees or five to 13 employees. But the average percentage is up like nine points. I may have sound of that a little bit wrong but it's an encouraging trend among the smallest segment of the employer population.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Shelley Gnall with Goldman Sachs.",13,"Our next question comes from the line of Shelley Gnall with Goldman Sachs.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I'm wondering, is it possible to generalize across your markets those that are hardest hit? So for example, in California, you've got a number of markets where you got unemployment north of 15% and 16%. And then, you've got healthier markets, like those i",79,"I'm wondering, is it possible to generalize across your markets those that are hardest hit? So for example, in California, you've got a number of markets where you got unemployment north of 15% and 16%. And then, you've got healthier markets, like those in Texas that are 8% to 10% unemployment. Is it possible to generalize where you are able to take share and where you just don't see a market share opportunity across all of payer classes?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","So hard to generalize and one of the reasons I mentioned that among the seven hospitals generating 70% of the admissions decline is none in our California, because we did not see in terms of the volume performance of our hospitals, a correlation with unem",217,"So hard to generalize and one of the reasons I mentioned that among the seven hospitals generating 70% of the admissions decline is none in our California, because we did not see in terms of the volume performance of our hospitals, a correlation with unemployment. And our highest unemployment market were really not having a volume problem. And conversely, where we've seen these physician competition phenomenon that has really created new capacity and a new entrant into a market that's very aggressive owned by physicians were they have the ability to direct patients, that in some of our markets with the lowest unemployment are the best trends in unemployment. So I would set aside the unemployment correlation. We've also seen some very strong volume performance in Florida, which is a market that's struggled for a long time. And that I think can be attributed to strong management actions and market working to see sizeably on business development activity. So you really -- at the risk of having added two paragraphs to my script on this volume side, I'm trying to convey an impression that there is not an overall trend, one way or another that you can point to or some correlation that it's really more one-off issues. And that's the way we've had to manage them.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Other than the cost shifting that you're seeing from the commercial payers, are there any other specific actions that they're taking to limit utilization specifically on the inpatient side?",30,"Other than the cost shifting that you're seeing from the commercial payers, are there any other specific actions that they're taking to limit utilization specifically on the inpatient side?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, one thing that's causing a lot of noise in the statistics is this trend towards observation status, which originally was contemplated to something only to be used in Medicare and now it's widely used in the payers. And I think other companies have t",63,"Well, one thing that's causing a lot of noise in the statistics is this trend towards observation status, which originally was contemplated to something only to be used in Medicare and now it's widely used in the payers. And I think other companies have talked about that. We didn't break it out specifically but it's of course the contributor to weak inpatient admissions.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Tom Gallucci with Lazard Capital.",13,"Our next question comes from the line of Tom Gallucci with Lazard Capital.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","First, the Slides 10 and 11 that you offered the commercial versus noncommercial admission trends, very interesting data. Curious if you look back is the discrepancy between those two payer classes growing or moderating? Or how would you consider that tre",41,"First, the Slides 10 and 11 that you offered the commercial versus noncommercial admission trends, very interesting data. Curious if you look back is the discrepancy between those two payer classes growing or moderating? Or how would you consider that trend?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","For the time being, that it's a new slide. We didn't really look back on it. We don't have a trend for you on that. We've looked for quite a long time at what we would consider discretionary versus last discretionary service lines. And have had more press",106,"For the time being, that it's a new slide. We didn't really look back on it. We don't have a trend for you on that. We've looked for quite a long time at what we would consider discretionary versus last discretionary service lines. And have had more pressure in the discretionary. And obviously, when you're in a quarter that's as tough as the one that we just emerged from, you dig a lot harder for explanations and this was a very interesting one that came through, but we didn't go back up and run at historically, it's actually not that difficult to do so we could.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then you mentioned Managed Care 80% of your contracting, I guess you're done for next year, 40% the following year. Could you just remind us of sort of the average rates that you're expecting and also maybe more importantly, comment sort of on the ton",85,"And then you mentioned Managed Care 80% of your contracting, I guess you're done for next year, 40% the following year. Could you just remind us of sort of the average rates that you're expecting and also maybe more importantly, comment sort of on the tone of discussion I guess there have been some suggestions out there that obviously the Managed Care environment is getting a little more difficult for the payers. I'm wondering if that's leaking into the tone of conversation with you all?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","This is Biggs. First of all, to address the rate question, the rates that we've negotiated for next year are pretty much in-line with what we've budgeted as negotiated rates for 2010. It ultimately, the yield, we get on those will determined by patient mi",74,"This is Biggs. First of all, to address the rate question, the rates that we've negotiated for next year are pretty much in-line with what we've budgeted as negotiated rates for 2010. It ultimately, the yield, we get on those will determined by patient mix index and any payer shifts between the plants, but the negotiation are very much in line with what we've budgeted and achieved this year from a peer-rate negotiation standpoint.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And the tone of discussions, as you're looking further out, maybe one or two years out?",16,"And the tone of discussions, as you're looking further out, maybe one or two years out?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","As for tone, Steve, you want to add anything to that?",11,"As for tone, Steve, you want to add anything to that?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'd just say that negotiations are taking a little bit longer than they have in the past, and we're pushing for more pay for performance to be added to those contracts as we move toward a valued base purchasing environment.",41,"I'd just say that negotiations are taking a little bit longer than they have in the past, and we're pushing for more pay for performance to be added to those contracts as we move toward a valued base purchasing environment.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I guess the only thing I would add is, I've made an effort to stay close to the senior executives, some of our largest customers and to remind them that we provide a very good value solution for them. We have demonstrated high quality. They assess that th",192,"I guess the only thing I would add is, I've made an effort to stay close to the senior executives, some of our largest customers and to remind them that we provide a very good value solution for them. We have demonstrated high quality. They assess that themselves. I don't need to convince them of that. And our price point relative to our competitors in virtually all of our markets is certainly not the highest, and sometimes it's on the low end of the market pricing. And typically with a large prominent successful not-for-profit system leading the way on pricing. So I feel that we are well positioned with the national payers from a value point of view. We're also exceedingly well positioned when they look at the total cost to doing business with us because we have streamlined and automated the revenue cycle process with them. So we have lowered -- they tell us, we have lowered lower-than-average denials. We have better-than-average electronic connectivity and we offer a total solution that I think is very effective as they start to look harder at price sensitivity and narrow networks in their markets.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Adam Feinstein with Barclays Capital.",13,"Our next question comes from the line of Adam Feinstein with Barclays Capital.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I guess to follow-up a few thoughts here. I guess the volume weakness is something that everyone was talking about throughout the quarter. So I do think that really caught people that of off-guard. I guess it was just throughout the year with the volume w",173,"I guess to follow-up a few thoughts here. I guess the volume weakness is something that everyone was talking about throughout the quarter. So I do think that really caught people that of off-guard. I guess it was just throughout the year with the volume weakness you guys have able to offset it through better unit pricing growth, as well as just cost cutting. So I guess the question is, as you look back on the quarter, Trevor, just maybe talk about -- and you guys called out a few things like the discount rate and some of the issues around cost there, but I guess just in terms of the ability to offset the volume weakness and not even the most recent quarter but going forward as well maybe just to go back through and talk about some of the initiatives there and certainly, you have the great slide deck here with that, but to just get some more clarity in terms of just visibility around the ability to offset volumes.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I think, Adam, in the beginning of your question, you touched on a topic that I think is important just to be very clear about in case it wasn't clear enough in the scripts. But we were trying to make the point that although I think the industry-wide volu",357,"I think, Adam, in the beginning of your question, you touched on a topic that I think is important just to be very clear about in case it wasn't clear enough in the scripts. But we were trying to make the point that although I think the industry-wide volume weakness was well known throughout the quarter. There were plenty of surveys and other indicators that, that was taking place. What was surprisingly negative was July. And so, I mentioned that July was particularly weak and then we took actions to reduce cost. Of course, these actions couldn't be taken in July, they were taken in August and have that effect of creating a positive trajectory in EBITDA from July to August to September. And as volume losses moderated from July through August through mid-September, then they did turn down in late September, that's the implication of saying that they were strong through mid-September. So I think one way -- the thing I would characterize as being unusual in the third quarter at least for us was how negative the first month was and then the fact that although many in the industry anticipated some snap back in August was encouraging, that, that encouraging trend at least in terms of volume did not persist through the entire quarter. And then based on our comments about October, it didn't persist into October. but I think to answer your question about what we can do and how we've been able to offset weak volumes, obviously, it's very hard on a month-to-month basis, because it's easier on a quarterly basis and it gets easier to accomplish. I shouldn't use the word easy. That's not easy but it's less difficult to accomplish on a yearly basis. And so, if you look at the quarter as a whole, we really overcame a lot of challenge that we had right out of the box in July. But it's difficult to do more in a short period of time. I think we have positioned ourselves well going into the fourth quarter. But again, we don't even have the first month of results on that yet.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Just on the unit pricing, the 1.1% you talked about mix having some impact there, maybe just go back some of that. I guess, the commercial piece you talked about but just within the other categories just maybe a quick update there in terms of -- and I gue",75,"Just on the unit pricing, the 1.1% you talked about mix having some impact there, maybe just go back some of that. I guess, the commercial piece you talked about but just within the other categories just maybe a quick update there in terms of -- and I guess, what are you guys thinking about in terms of being normalized revenue per admin number if you try to clean up some of the noise there?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, what's normal at this point will depend largely upon whether the OB admissions stayed down or not for an extended period because one of the reasons why case mix is up is because obstetrics are down. Obstetrics supply stayed down for quite a while. S",143,"Well, what's normal at this point will depend largely upon whether the OB admissions stayed down or not for an extended period because one of the reasons why case mix is up is because obstetrics are down. Obstetrics supply stayed down for quite a while. So I would expect on that basis case mix do not changed radically over the near term. As I said, case mix on commercial Managed Care was up about 3%. It was up about 1% on a Medicare Managed Care and up almost 5% on Medicaid Managed Care. So in most of the categories, it was up in the quarter. We'll see, of course, with that was a longer term but there's nothing right now that indicates that, that would change. So we'll just have to watch it but I think is reflective of the economics of today.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I just point, Adam, that we had a 5.6% increase in revenue per outpatient visit. That's largely driven by increases relatively speaking about patient surgery and high-end imaging like CT and MRI.",32,"I just point, Adam, that we had a 5.6% increase in revenue per outpatient visit. That's largely driven by increases relatively speaking about patient surgery and high-end imaging like CT and MRI.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'm going to add a response to, I think it was John's question earlier on the revenue from the seven hospitals. We want to pull the statistic and from the period of merit standpoint is the seven hospitals are 14% of our hospital count from a revenue stand",94,"I'm going to add a response to, I think it was John's question earlier on the revenue from the seven hospitals. We want to pull the statistic and from the period of merit standpoint is the seven hospitals are 14% of our hospital count from a revenue standpoint, they comprise 18% of the revenues in the quarter. So a little more heavily weighted than the peer hospital account but not, as I said, because there's not all the largest hospitals that are in there. It's not a real disproportionate share of the revenue.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Ralph Giacobbe with Credit Suisse.",13,"Our next question comes from the line of Ralph Giacobbe with Credit Suisse.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","In the release, you mentioned increased physician employment. And I think in the past, you've talked about not necessarily wanting to employ. Can you maybe talk about what's changed to your strategy there and maybe just give us a sense of the base that's",50,"In the release, you mentioned increased physician employment. And I think in the past, you've talked about not necessarily wanting to employ. Can you maybe talk about what's changed to your strategy there and maybe just give us a sense of the base that's employed currently where that can go?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Biggs, you want to take that?",6,"Biggs, you want to take that?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Sure. Ralph, we've got a number of things to affect physician recruitment. First thing we've done is expanded the number of staff focused at the hospital level, as well as at the regional corporate level on physician recruiting. Another thing we've done i",120,"Sure. Ralph, we've got a number of things to affect physician recruitment. First thing we've done is expanded the number of staff focused at the hospital level, as well as at the regional corporate level on physician recruiting. Another thing we've done is we've reassessed our community need and revised the medical staff development plan for each of our hospitals. The third thing, and I think we've done at significant is we revised the process for targeting redirection of our local physicians, and we've improved that on-boarding process, as well as orientation for these successfully recruited or redirected physicians. Finally, we believe that this will improve the productivity and retention rate of the physicians that we've been able to recruit.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And I guess I'm just trying to get a sense of, is this sort of in reaction to what's going on in your markets, where there perhaps was a reluctance to employ in the past, but now you need to because others are doing it and perhaps that can explain some of",60,"And I guess I'm just trying to get a sense of, is this sort of in reaction to what's going on in your markets, where there perhaps was a reluctance to employ in the past, but now you need to because others are doing it and perhaps that can explain some of the weaker volume trends that you see?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, look, I will be the first to say that I had a particularly bad attitude about jumping into the employment trend having experienced first hand the disasters of the late 90s when hospitals rapidly purchased practices and employed physicians and lost o",435,"Well, look, I will be the first to say that I had a particularly bad attitude about jumping into the employment trend having experienced first hand the disasters of the late 90s when hospitals rapidly purchased practices and employed physicians and lost on a tremendous amount of money. But this is a trend that is inexorable. It started with the large most prosperous, not for profits. We compete against a lot of this in our markets and we have completely adopted, I think new and improved way to do this. So just to go in order of sort of the promise that we're doing about it. Purchasing practices is really not market practice anymore. It's employing physicians. So you don't have the problem from the 90s of spending a lot of capital on purchasing something that turns out to not be worth of what you paid for. So it's really hiring talent. And then in terms of hiring talent, we've become very sophisticated about how to do it in terms of providing incentives for productivity so we don't experience the next problem that was characteristic for the 90s, which is hiring physicians, which essentially was enabling them to retire at the expense of the hospital. So we're incentivizing productivity. And we've also experienced some churn of the employed physicians based on those who failed to meet the productivity target leaving and those who are succeeding in the productivity target staying and enjoying the benefits of that. We've also been very selective in terms of the credentials of the physicians that we've been hiring. So just as if you undertook to hire a cadre of 200 MBA students you want to go to the top schools and hire the best students, we're doing the same thing when it comes to physicians. We're also being very selective about filling certain holes and specialties or building primary-care networks, where that strategy is right. And then finally, rather than attempting to manage all these practices ourselves, we've employed in a joint venture format a practice management company that's an expert in doing this and running them at economic results that are superior to what hospitals generally experience. So I think, all of these things together and I didn't mention the EMR solution that we're offering for physicians, I think it's a better solution, and we probably got started later than we should have. And perhaps it's because of historic bias, at least on my part, against that as a strategy. But we are well into it now and have a very strong pipeline of physicians that we are employing.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And just my follow-up, I'm wondering sort of revisit capital structure. You talked about sort of refinancing, pushing out debt maturities. Are you kind of happy with where the company sits from that perspective? Is there anything else you would contemplat",63,"And just my follow-up, I'm wondering sort of revisit capital structure. You talked about sort of refinancing, pushing out debt maturities. Are you kind of happy with where the company sits from that perspective? Is there anything else you would contemplate? Obviously, you mentioned share repo in your commentary, just given where the credit markets are in just the overall rate environment?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, I think, I'll answer and if there's anything left, Biggs, you can chime in. But as I mentioned, there are no significant maturities for five years. That's a long time. I don't think it would make any sense to push it up farther. That's actually quit",139,"Well, I think, I'll answer and if there's anything left, Biggs, you can chime in. But as I mentioned, there are no significant maturities for five years. That's a long time. I don't think it would make any sense to push it up farther. That's actually quite a conservative approach to a capital structure, which I think is appropriate given the risk in the business and the historic leverage that we've had. We've also obviously brought down the leverage ratios substantially, this new credit line offers us a lot of flexibility. We obviously not commenting today on the potential for share buybacks, but it's obviously something we couldn't even consider prior to this new credit line. So we'll just have to see depending on circumstances what we decide to do there. Biggs, is there anything you want to add?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","No, I think there's some small amounts of the '11 and '12 maturities still outstanding, so obviously, over time if not at maturity, we will retire those in due course. And otherwise, if the capital structure are big drivers to keep driving on improving fr",68,"No, I think there's some small amounts of the '11 and '12 maturities still outstanding, so obviously, over time if not at maturity, we will retire those in due course. And otherwise, if the capital structure are big drivers to keep driving on improving free cash flow, drive up earnings and drive free cash flow along with it. And further improve all of the statistics and the ratios.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Darren Lehrich with Deutsche Bank.",13,"Our next question comes from the line of Darren Lehrich with Deutsche Bank.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So maybe I'll just follow-on to that point a little bit more just to round capital and deployment of capital. If you include some value of your NOL, you're probably trading just a little under 5x your guidance for 2010 on an EBITDA basis. So I guess, I'd",107,"So maybe I'll just follow-on to that point a little bit more just to round capital and deployment of capital. If you include some value of your NOL, you're probably trading just a little under 5x your guidance for 2010 on an EBITDA basis. So I guess, I'd be curious to hear your thoughts what kind of assets you can buy that are out there that are more favorable than that type of valuation. So are you seeing any acute-care assets? You've commented a little bit more about your interest in getting aggressive on the outpatient side? Maybe just update us generally on capital deployment priorities.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Obviously, if you employ a rule of thumb that says you should only acquire things to trade a lower multiple than your own multiple. It's very limiting. Based on my comments about outpatient, it appears that we are doing that, and we're very pleased to out",317,"Obviously, if you employ a rule of thumb that says you should only acquire things to trade a lower multiple than your own multiple. It's very limiting. Based on my comments about outpatient, it appears that we are doing that, and we're very pleased to outpatient acquisitions that we're making. I would say that the potential acquisitions of the acute care hospitals that would be of interest to us or of the greatest interest to us, there are certainly more hospitals considering selling themselves or seeking partnerships of some kind. And we're spending more time than we ever have exploring those types of things. I think it's premature to talk about value and whether we would actually proceed and devote our capital in that way. What we haven't been doing, you obviously noticed is we have not been competing in the auctions that has been out there for standalone hospitals or possibles that or -- whatever other acute-care transactions are out there. I don't think we are necessarily the best potential acquirers for those kinds of things. Where we have been focused is more in our markets and things that have some degree of synergy, where we understand the market, we understand the dynamics and the future trends. And obviously, given the uncertainties around healthcare reforms something you have to take into consideration when you evaluate the hospitals. So for that reason, we've been most focused on the outpatient side. I think that you'll agree since we gave some disclosure on those numbers that those are incrementally very helpful acquisitions for us. We like that business and will continue to do that as much as possible. And then, with -- there maybe opportunities in the future within our Services business, which we're also very excited about, the multiple issue tends to present a barrier there, but we have to keep our eyes open on that as well.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And if I could just follow-up maybe clarify a point you made earlier about the cost savings actions in Q3. I guess just putting some rough numbers on the FTE figures you provided, Biggs, it would seem like that's about maybe a $20 million, $30 million typ",67,"And if I could just follow-up maybe clarify a point you made earlier about the cost savings actions in Q3. I guess just putting some rough numbers on the FTE figures you provided, Biggs, it would seem like that's about maybe a $20 million, $30 million type of annualized savings run rate. Is that a good range to work off of what we'll see in Q4?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Like I said it's 1.2% improvement in productivity. So it's quite a little north of that approaching $40 million on an annual basis. Real near term depending on third quarter, the fourth quarter other improvements we expect on the malpractice and workers c",193,"Like I said it's 1.2% improvement in productivity. So it's quite a little north of that approaching $40 million on an annual basis. Real near term depending on third quarter, the fourth quarter other improvements we expect on the malpractice and workers comp side really took the hits in the third quarter for the discount rate. We expect those to not occur in the fourth quarter and possibly will have improvement again in the first quarter as a result of what continues to be good claims experience. Another thing looking at the third quarter was it was a couple of million dollars of severance costs in there, so that was that was the cost of achieving the reductions and we don't expect that to occur in the fourth quarter of the future. So there's a number of things going on in addition to just appear FTE reductions to be considered looking at or maybe this year and on to the future. And of course, we're still driving on the MediCare performance initiatives, which is worth $30 million this year and expect to do similar amount next year in terms of incremental savings.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Gary Lieberman with Wells Fargo.",13,"Our next question comes from the line of Gary Lieberman with Wells Fargo.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I was wondering if you just maybe elaborate a little bit more on the line in the slide about the Managed Care portion of the provider taxes still awaiting approval from CMS and what that involves?",36,"I was wondering if you just maybe elaborate a little bit more on the line in the slide about the Managed Care portion of the provider taxes still awaiting approval from CMS and what that involves?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Sure. The way it has been approved is in pieces. The fee for service portion of it was a little simpler, and it only involves the hospitals, the state and the CMS. And so, that approval came first. The Managed Care portion of this has to flow through the",137,"Sure. The way it has been approved is in pieces. The fee for service portion of it was a little simpler, and it only involves the hospitals, the state and the CMS. And so, that approval came first. The Managed Care portion of this has to flow through the Managed Care payers. And so, contracts and structures have to be adjusted in order to allow for that money to flow through the Managed Care payers. And until that it's totally defined, CMS basically that holds our approval on that portion of it. And so it should be seen as largely administrative in our mind, and that's why we're counting on the entire $64 million in our outlook. But it is a step that has yet to be completed between the states, the Managed Care payers and CMS.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And I guess just the Managed Care portion have to be put to bed before the  entire plan can take place? Or is it should we view it kind of separate by some chance the Managed Care portion gets approved?",40,"And I guess just the Managed Care portion have to be put to bed before the  entire plan can take place? Or is it should we view it kind of separate by some chance the Managed Care portion gets approved?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","It's happening in pieces. And In fact, the direct payment portion of it, the fee-for-service portion, has already been implemented. And we've been invoiced and also receiving funds on that portion of it, which is about half of the total, near half the Man",59,"It's happening in pieces. And In fact, the direct payment portion of it, the fee-for-service portion, has already been implemented. And we've been invoiced and also receiving funds on that portion of it, which is about half of the total, near half the Managed Care piece will happen separately. But as I said, we expect it to happen.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then one quick follow-up, Trevor, I know you mentioned that there wasn't any data on volumes for October. Any initial thoughts just in terms of where it might going to stand up?",34,"And then one quick follow-up, Trevor, I know you mentioned that there wasn't any data on volumes for October. Any initial thoughts just in terms of where it might going to stand up?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I actually commented on the volumes on October. I'm not sure what you mean by your question.",17,"I actually commented on the volumes on October. I'm not sure what you mean by your question.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Just in terms of any picture or service lines that look like they've been reversing trend or so continuation in trend.",22,"Just in terms of any picture or service lines that look like they've been reversing trend or so continuation in trend.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","No, it's too early for that. Usually, we have the volume data daily. And then at the close of the month but then to get clean service line and payer data takes a little longer.",35,"No, it's too early for that. Usually, we have the volume data daily. And then at the close of the month but then to get clean service line and payer data takes a little longer.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Whit Mayo with Robert W. Baird.",14,"Our next question comes from the line of Whit Mayo with Robert W. Baird.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Trevor, can you go back and talk about the delay in merit paid? Did you say that, that was going to be pushed to January? I guess, I didn't follow you.",31,"Trevor, can you go back and talk about the delay in merit paid? Did you say that, that was going to be pushed to January? I guess, I didn't follow you.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Let me just tell you conceptually what we decided to do. We had multiple employee populations with an expectation of annual inflation/merit-oriented salary increases at different times in the year. So we've had for a long time a desire to standardize that",159,"Let me just tell you conceptually what we decided to do. We had multiple employee populations with an expectation of annual inflation/merit-oriented salary increases at different times in the year. So we've had for a long time a desire to standardize that all at the same time of the year, which is really the spring being the best time. And so, given the sort of rapidly decreasing expectations of inflation and also the observations we made of competitive practice declining in terms of the increases that competitors appear to be giving to people, what we've decided to do was to implement the program effective January 1, but to tell people in advance what they would get. So I think it's a very good solution from a cost management perspective. It also administratively will simplify our administration of these programs in the future. And it obviously, was a prudent move to save costs in the second half of this year.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Is there any chance that, that may be delayed further in between '11? I guess I'm just wondering if that's a concrete start in January or whether or not?",29,"Is there any chance that, that may be delayed further in between '11? I guess I'm just wondering if that's a concrete start in January or whether or not?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","No, that's concrete for January.",5,"No, that's concrete for January.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And any other benefit design changes, anything that's meaningful as we look out to 2011?",15,"And any other benefit design changes, anything that's meaningful as we look out to 2011?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Not that we're contemplating at this moment.",8,"Not that we're contemplating at this moment.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","My last question, Biggs, I was just curious if we could get the P&L expense and the cash CapEx numbers for your electronic health records been this year at least year-to-date and maybe a peek into what those two numbers may look like in 2011?",45,"My last question, Biggs, I was just curious if we could get the P&L expense and the cash CapEx numbers for your electronic health records been this year at least year-to-date and maybe a peek into what those two numbers may look like in 2011?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'll do the second part first. On 2011, we're still in the planning process. We've completed, as we said four implementations here in the last couple of weeks. We have three more that are going live shortly among other things. We have to look at that expe",199,"I'll do the second part first. On 2011, we're still in the planning process. We've completed, as we said four implementations here in the last couple of weeks. We have three more that are going live shortly among other things. We have to look at that experience what it's cost us what lessons learned are as a part of fully defining next year's budget and expectations that we would communicate as a part of our outlook. But in any event -- but we do expect it to go up as I said earlier. And maybe that's not so much, an increase off of what we originally expected for this year as it is just an increase in where we actually landed for this year. So the comparative number for this year has come down as opposed to saying next year is increased off of what might we have expected before. This year, we're spending around $90 million in incremental spend. It's actually that total spend -- it's about $66 million of that is CapEx and about $23 million is expense. And like I said, the expense of $23 million represents an $11 million increase over the prior year.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","On the P&L?",4,"On the P&L?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","We do expect that number in total both on CapEx and expense to go up next year. But as I said, it's still early to give a hard number.",29,"We do expect that number in total both on CapEx and expense to go up next year. But as I said, it's still early to give a hard number.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Justin Lake with UBS.",12,"Our next question comes from the line of Justin Lake with UBS.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","First question just on the outpatient side, specifically, you look at that as being opportunity. Talk about outpatient margin being significantly greater than inpatient. I'm just wondering if you can give us some color there in terms of a magnitude of dif",45,"First question just on the outpatient side, specifically, you look at that as being opportunity. Talk about outpatient margin being significantly greater than inpatient. I'm just wondering if you can give us some color there in terms of a magnitude of differential between those margins?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, I think it tend to be more than double. And the comments that I made in the opening suggest that we're buying this at very attractive multiples and that they have very high margins relative to the overall business. And so, it's a very attractive for",49,"Well, I think it tend to be more than double. And the comments that I made in the opening suggest that we're buying this at very attractive multiples and that they have very high margins relative to the overall business. And so, it's a very attractive form of acquisition.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Are you just talking about surgical centers at this point on the margin side because if that will all -- I think it's pretty clear those out margins that are much better than in in-patient hospital or acute care hospital.",40,"Are you just talking about surgical centers at this point on the margin side because if that will all -- I think it's pretty clear those out margins that are much better than in in-patient hospital or acute care hospital.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Most of what we've been doing is imaging centers we have bought some surgery centers. But this year, not exactly clear how many will be able to close, but it'll be on the magnitude of 22-plus-ish imaging centers and three to four surgery centers. So far m",52,"Most of what we've been doing is imaging centers we have bought some surgery centers. But this year, not exactly clear how many will be able to close, but it'll be on the magnitude of 22-plus-ish imaging centers and three to four surgery centers. So far more on the imaging side.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then just a little bit of the cleanup on some of the 2011 moving parts. Can you give us any specifics on how much of the headwind healthcare IT is going to be next year? And then just to confirm, I think, I heard you say that the provider taxes would",58,"And then just a little bit of the cleanup on some of the 2011 moving parts. Can you give us any specifics on how much of the headwind healthcare IT is going to be next year? And then just to confirm, I think, I heard you say that the provider taxes would be a $36 million headwind year-over-year?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I think, actually, the latter one on the provider fee, the amount of the provider fee attributable to 2009 is what I said the most challenging of the care provider fee and that's actually about $27 million of the $64 million. The amount, which is carrying",58,"I think, actually, the latter one on the provider fee, the amount of the provider fee attributable to 2009 is what I said the most challenging of the care provider fee and that's actually about $27 million of the $64 million. The amount, which is carrying over to next year from a cash standpoint is about $36 million.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Any other kind of provider fees or provider tax benefit you're getting this year that you don't expect? So you expect the other $37 million of the $64 million to reoccur again in 2011? Or that you would expect to guide to?",43,"Any other kind of provider fees or provider tax benefit you're getting this year that you don't expect? So you expect the other $37 million of the $64 million to reoccur again in 2011? Or that you would expect to guide to?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Yes, well, what I've said was if you take the California fee, the current year portion of it, will be replaced by in part a half year extension on California, we would expect not yet done, but we would expect that plus $25 million from Pennsylvania and al",72,"Yes, well, what I've said was if you take the California fee, the current year portion of it, will be replaced by in part a half year extension on California, we would expect not yet done, but we would expect that plus $25 million from Pennsylvania and also not yet done but in works and the sum of those two, yes, would offset the $37 million of current year California provider fee.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then just healthcare IT increase year-over-year?",8,"And then just healthcare IT increase year-over-year?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","As I said, it's a little early to say. I think that this year, we've underrun significantly based upon not as occurring as much in a way of start-up costs and also being very efficient in the implementations that we have successfully completed here in the",124,"As I said, it's a little early to say. I think that this year, we've underrun significantly based upon not as occurring as much in a way of start-up costs and also being very efficient in the implementations that we have successfully completed here in the last few weeks. So we've got to assess, if you will, what that means with respect to the implementation for next year have or we do have more implementations next year than this year. More hospitals will be in process, so we do expect the number to go up. It's probably in the say low tens of millions kind of number not a radical change in overall profitability associated with it, but we just have to finalize that.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So is that like $10 million to $30 million or is that $10 million to $15 million?",17,"So is that like $10 million to $30 million or is that $10 million to $15 million?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","$10 million to $30 million would be in the low. Low tens is very [indiscernible]. But as I said, it's early yet to put a hard number out there.",29,"$10 million to $30 million would be in the low. Low tens is very [indiscernible]. But as I said, it's early yet to put a hard number out there.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Sheryl Skolnick with CRT Capital Group.",14,"Our next question comes from the line of Sheryl Skolnick with CRT Capital Group.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","First, I want to complement you on the extensive diligence you've done on all the key questions that I would have had about the composition of the volume shortfall in trying to get comforted guidance in bridging, where we are from third quarter and the di",131,"First, I want to complement you on the extensive diligence you've done on all the key questions that I would have had about the composition of the volume shortfall in trying to get comforted guidance in bridging, where we are from third quarter and the difficulties here versus the fourth quarter and then to 2011. So it's extremely helpful, and I think it was fair to do. But I'm going to turn to sort of a more conceptual question about the fourth quarter guidance if I could. If I take out the provider fee, anticipated impact in fourth quarter, which I believe you said was $64 million, and I look at that -- first of all, would it be correct to assume that, that would drop 100% to the EBITDA line?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Yes.",1,"Yes.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","The answer to that I think is yes. And then second, if that's the case, then your guidance sort of implies something on the order of a quarter to flat on the EBITDA line with third quarter to something that is would be up around the sort of $270 million t",130,"The answer to that I think is yes. And then second, if that's the case, then your guidance sort of implies something on the order of a quarter to flat on the EBITDA line with third quarter to something that is would be up around the sort of $270 million to $280 million in order to achieve the $10.50 million to $1.1 billion if my math is correct. So if I look at those numbers, I'm still not sure how you get to the upper end of the range. So my question then becomes, what really has to go right for us to be optimistic that you can get back on the path of exceeding not only consensus but achieving the high end of your guidance or even exceeding it?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'll try to answer the first batch. Obviously, we've taken cost out. We've talked about that. And if you look at this from adjusted patient-day basis in Q3, our experience was around $2,050. Q3 year-to-date was $1,995. So clearly, Q3 jumped up. Q4, we loo",311,"I'll try to answer the first batch. Obviously, we've taken cost out. We've talked about that. And if you look at this from adjusted patient-day basis in Q3, our experience was around $2,050. Q3 year-to-date was $1,995. So clearly, Q3 jumped up. Q4, we look at being back around that $1,995 kind of levels. So based upon the reductions in staff, the improvements we forecast on mid now, severance is not recurring as I talked about some of other initiatives to drive down costs. We think we get back down to that $1,995 kind of level. So it's at the middle of the range. And of course, there's opportunity, they'll beyond with that to help drive towards the end of the range as well. From a revenue standpoint, we've just looked at what's real recent experience on volumes. And as I said, we didn't presume many kind of a hockey stick in the last two months of the year. But from an overall admit standpoint, at the middle of the range, we could be at a negative 4% to 5% and still hit the middle of the range and commercial still be in that 6% to 7% kind of range where we were at for the first half. Once again, be in the middle of the race. So those seem like based on everything we know, still some recent very conservative positions to be taken as we look at the underlying trends. So there's opportunity in my mind for us to do better than those of both on the cost side and on the volume side but as you know, we didn't take up the upper end of the range because we wanted to stay conservative and not presume that we're going to do better than those and left ourselves, I'd say to build a range based on those stats.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then with, I think with all of these questions, I think you're getting around the point of just for how long is the pattern we've been seeing in your earnings as well as others, for how long will the cost savings continue to save the day as it were as",117,"And then with, I think with all of these questions, I think you're getting around the point of just for how long is the pattern we've been seeing in your earnings as well as others, for how long will the cost savings continue to save the day as it were as volume continues to deteriorate? I mean that's not an issue unique to Tenet. And I guess the answer to that is nobody really knows, but how much more do you have left on the cost? And it seems like you've been doing just about everything you can on that score. You found another 800 FTEs. But at what point do you have to stop doing that?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well staff reductions, it's the only place for reducing cost to make our performance initiatives driving cost out and supply cost were basically flat and have very low inflationary rate even with higher acuity. So there is success in our efforts there, an",127,"Well staff reductions, it's the only place for reducing cost to make our performance initiatives driving cost out and supply cost were basically flat and have very low inflationary rate even with higher acuity. So there is success in our efforts there, and they'll be continuing in success. But cost is also not the only way we're going to drive value. Even if we don't have increasing inpatient volumes over the near future because we have the outpatient acquisition is driving value. We have our investments in Conifer yield increasing value. The price negotiation, the commercially still favorable, the price on government, pretty much flat. So there's plenty of things we're operating on to create value besides just driving our cost but there's more cost opportunity too.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I would just add to what Biggs said, Sheryl, opportunity on longer term is the clinical standardization, where we really get in on more and more of the BRGs both inpatient, as well as our outpatient care standardized that, eliminate some redundancy, drive",104,"I would just add to what Biggs said, Sheryl, opportunity on longer term is the clinical standardization, where we really get in on more and more of the BRGs both inpatient, as well as our outpatient care standardized that, eliminate some redundancy, drive down that variable costs, and really affect the cost metrics and something outside necessarily of the salary wages and benefits or direct supply cost. We're also working on length of stay. We're working on readmission rates as we look at more was prospective payments. So there are lots of opportunities to drive on the cost side of the equation going forward.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And just finally, on your commercial Managed Care negotiations, we've begun to see some more, shall we say, innovative almost back to the future kinds of tactics at the Main Street level on the part of some of the Managed Care companies with their relatio",177,"And just finally, on your commercial Managed Care negotiations, we've begun to see some more, shall we say, innovative almost back to the future kinds of tactics at the Main Street level on the part of some of the Managed Care companies with their relationship with physicians, with restructuring their contract for payment, for example, United with an oncology we've heard about the potential force some of the company's to have more direct even ownership relationship with providers, physicians, hospitals, outpatient, et cetera to have them do the rationing rather than the health plan, but the health plan gets the benefits thereof. But is there anything that you can see in your negotiations with the commercial Managed Care plans that might get more creative i.e., contracting for guaranteed volume within a disease or within a procedure or service lines where you might give a dominant or best quality provider in the market that could assure you some commercial Managed Care share in those markets and help you even to take share rather than just to maintain share?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","So the short answer is, every creative structure that you can imagine and probably more are under discussion. But still, it is today an environment that's all about costs and access and companies obtaining benefits with the sort of least amount of frictio",137,"So the short answer is, every creative structure that you can imagine and probably more are under discussion. But still, it is today an environment that's all about costs and access and companies obtaining benefits with the sort of least amount of friction for their employees and all that. But I think, we're well positioned on those creative types of structures because of quality, because of our visibility and ability to understand what it is that we're actually doing in terms of the provision of the service. And then we have this little secret weapon that we've used for decades in California that as of unit that assesses risk and helps us on capitated types of arrangement and serves clients beyond Tenet. And so, I think we're very well positioned when risk-taking enters the question as well.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our final question comes from the line of A.J. Rice with Susquehanna.",13,"Our final question comes from the line of A.J. Rice with Susquehanna.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","First of all, I ask one that's sort of a long shot, but I think, Biggs, you alluded to the idea that people may have been managing their deductibles this year [indiscernible] more aggressively and therefore speculation get into Q4, you might see some pent",89,"First of all, I ask one that's sort of a long shot, but I think, Biggs, you alluded to the idea that people may have been managing their deductibles this year [indiscernible] more aggressively and therefore speculation get into Q4, you might see some pent-up demands so as deductibles hit. I guess my question first off would be, you guys have anyway to measure that? Can you see whether people are taking longer to hit their deductibles this year than they did last there or anything along those lines?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","There really isn't any clear way for us to see that. We don't have that kind of visibility as to patient comes in or as we send the bill to the payers, so not great insight.",37,"There really isn't any clear way for us to see that. We don't have that kind of visibility as to patient comes in or as we send the bill to the payers, so not great insight.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I have heard the theories as spouse payers, they have obviously much more insight, but I don't think that evidence at least as I mentioned earlier through the first 28 days of October that, that demand wave was ready to hit the beach.",43,"I have heard the theories as spouse payers, they have obviously much more insight, but I don't think that evidence at least as I mentioned earlier through the first 28 days of October that, that demand wave was ready to hit the beach.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","The $100 million to $150 million that acquired outpatient revenues that you're looking for this year, is this year in your mind unusual with the focus on acquiring things like outpatient imaging? Do you think you can run at that rate of acquisitions for a",48,"The $100 million to $150 million that acquired outpatient revenues that you're looking for this year, is this year in your mind unusual with the focus on acquiring things like outpatient imaging? Do you think you can run at that rate of acquisitions for a couple of years?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, we said we think we can do it for next year. I mean, obviously, we've been very sensitive about doing this, where we have the ability to put the centers within a hospital structure. So you run out of opportunities just geographically over time. But",97,"Well, we said we think we can do it for next year. I mean, obviously, we've been very sensitive about doing this, where we have the ability to put the centers within a hospital structure. So you run out of opportunities just geographically over time. But there are other ones where the sellers -- we've seen somewhere the sellers initially said they don't want to sell their price expectation or unrealistic and they're coming back to us now. So that's way we made the comment with respect to 2011. I wouldn't speculate on 2012 at this point.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I don't think you quantify to how much benefit you get from delaying the merit increase, maybe I missed it if you did for the extra quarters. How much would that benefit you in the fourth quarter? And then if you could just maybe I'm curious, when do you",81,"I don't think you quantify to how much benefit you get from delaying the merit increase, maybe I missed it if you did for the extra quarters. How much would that benefit you in the fourth quarter? And then if you could just maybe I'm curious, when do you guys think you would offer -- we're talking around the 2011 outlook a lot, have you given some thoughts exactly when you're likely to actually give a formal outlook for 2011?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","On the benefit of deferral of the merit increases, it's in the neighborhood of $15 million for the quarter. And that would be similar to numbers we've given in the past. And we've talked about what the effect of the merit increases were in the fourth quar",110,"On the benefit of deferral of the merit increases, it's in the neighborhood of $15 million for the quarter. And that would be similar to numbers we've given in the past. And we've talked about what the effect of the merit increases were in the fourth quarter when we gave them by example last year? In terms of when we were given outlook, I mean, our baseline is we will look at results, we complete our planning process otherwise in December, we look at results through December ultimately and sort of re-evaluate and validate our expectations based upon that and then give you outlook when we released fourth quarter earnings.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So in February, at some point?",6,"So in February, at some point?
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Yes.",1,"Yes.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thanks AJ and thanks, everybody, for joining the call. And see you on the next one.",16,"Thanks AJ and thanks, everybody, for joining the call. And see you on the next one.
"
107911,114307236,84347,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Ladies and gentlemen, that concludes today's conference. Thank you for your participation. You may now disconnect. Have a wonderful day.",20,"Ladies and gentlemen, that concludes today's conference. Thank you for your participation. You may now disconnect. Have a wonderful day.

"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Good day, ladies and gentlemen, and welcome to the Third Quarter 2010 Tenet Healthcare Earnings Conference Call. My name is Jeff, and I'll be your operator for today. [Operator Instructions] I would now like to turn the conference over to your host for to",57,"Good day, ladies and gentlemen, and welcome to the Third Quarter 2010 Tenet Healthcare Earnings Conference Call. My name is Jeff, and I'll be your operator for today. [Operator Instructions] I would now like to turn the conference over to your host for today, Mr. Thomas Rice, Senior Vice President of Investor Relations. Please proceed, Mr. Rice."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, operator, and good morning, everyone. Tenet's management will be making forward-looking statements on this call. These statements are based on management's current expectations and are subject to risk and uncertainties that may cause those forw",97,"Thank you, operator, and good morning, everyone. Tenet's management will be making forward-looking statements on this call. These statements are based on management's current expectations and are subject to risk and uncertainties that may cause those forward-looking statements to be materially incorrect. Management cautions you not to rely on and makes no promises to update any of the forward-looking statements. During the question-and-answer portion of the call, callers are requested to limit themselves to one question and one follow-up question.
At this time, I will turn the call over to Trevor Fetter, Tenet's President and CEO. Trevor?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, Tom, and good morning, everyone. Well, I wont blame you if you write reports saying that this is a noisy quarter. In summary, our earnings number was huge and we're raising the bottom end of our 2010 outlook. The volumes were soft, and the E",1675,"Thank you, Tom, and good morning, everyone. Well, I wont blame you if you write reports saying that this is a noisy quarter. In summary, our earnings number was huge and we're raising the bottom end of our 2010 outlook. The volumes were soft, and the EBITDA is flat to 2009 if you make appropriate adjustments. 
We generated over $900 million in net income due to the accounting recognition of the value of our tax loss carryforward. Biggs will explain this further, but the key point is that while existence of the NOL has been well known, it should be more tangible to investors now that it's on the books.
Looking beyond net income, we were challenged by soft volumes in the quarter. We reacted to a particularly weak July by implementing a reduction in force in August. The impact of this action to reduce costs along with improved volume trends after July led to a positive earnings trend in the quarter in which EBITDA grew steadily from July to August to September. 
It's worth noting that we faced a very tough comparison this year as adjusted EBITDA was up 50% in the third quarter last year. Once you allow for year-over-year variability, our longer-term EBITDA trend remains strong. You can see the variability and the clear long-term trend demonstrated on Slide 4.
Clearly, our growth has been very strong but not as steady as I'd like. When you make your assessment of our growth in EBITDA in the quarter, please consider the items on Slide 5. The third quarter of 2009 included three favorable items contributing a total of $20 million. We called out these items on last year's third quarter call, and nearly all of you noted them when assessing our performance. 
In contrast, this year's third quarter includes items with a net unfavorable impact of $16 million. In total, these items created a $36 million unfavorable swing from the third quarter of 2009 to this year's quarter. Net of these items, this quarter was essentially unchanged.
As I mentioned earlier, we're raising the bottom end of our outlook for 2010 EBITDA to a new range of $1,050,000,000 to $1.1 billion. This is the second time this year we've increased one or both ends of the range. Volumes were certainly weaker than we originally anticipated, but this has been offset by stronger pricing, enhanced acuity and excellent cost control. We're also benefiting from the California provider fee being larger than we forecast and health IT spending being less than we anticipated.
Soft volumes were a dominant theme across the industry last quarter, so I'd like to give you some color on our experience. The overall takeaways that the volume declines were contained to a small number of hospitals, and once again a single service line. OB accounted for a full third of our volume loss.
Total admissions declined 3.5%, and commercial admissions declined 8.6% in the quarter. July was by far our weakest month for patient volumes. The trend was more encouraging in August and through mid-September. Through the first 28 days of October, commercial admissions trended slightly better than in Q3 but total admissions were slightly weaker.
As you can see on Slide 7, outpatient visits were down 2% in the third quarter. Emergency department outpatient visits were down 1.7% in the quarter, but just over 70% of that decline is due to a reduction in flu, so non-flu ED visits are basically flat year-over-year. Outpatient surgeries were up modestly, increasing by 0.1% and adjusted admissions were down only 1.8%.
The volume losses this quarter and this year have been confined to a small number of hospitals. In fact, just seven hospitals comprise more than 70% of our total admissions declines in the third quarter. So while these seven hospitals cost the majority of our volume losses, the other 42 hospitals in the aggregate are performing better than the industry average. 
The seven hospitals are widely dispersed. There are two in Texas, but they're not in the same market. The other five are each in different states. Interestingly, although California is challenged by extremely high unemployment in some of our markets, none of our California hospitals are among the seven.
There is no single theme for the volume losses at these seven hospitals. One of the hospitals is having a solid and growing year, but faced an extremely tough comparison on volumes in Q3. Another one lost to unprofitable volume. Those two, plus three others, grew EBITDA significantly despite their volume losses. 
The two others saw challenges with their physician channels. These are instances where physicians have gone into direct competition with the hospitals, or where competing hospitals have engaged in very aggressive and sudden physician employment strategies. No matter the reason for the volume declines, we're responding appropriately, and we believe that we are already turning the losses around. In October, in these seven hospitals, while still down, the volumes were down by a lower percentage than in the third quarter.
Turning to service lines. I already mentioned that a third of the total volume decline was in OB. Looking beyond OB to some elective service lines, I'd like to share some interesting insights with you. As we're deep into the recession, it's very clear that patients who have a significant personal financial responsibility are behaving very differently than patients who don't. We've known all along that this was driving reductions in our commercial elective surgical volumes. But let me give you some facts that our orthopedic surgeries as an example.
If you look at Slide 10, you'll see that total admissions for orthopedic surgeries declined by 2.5%. Commercially insured orthopedic surgeries declined by 9%. Orthopedic surgeries for all other patients, most of whom are covered by Medicare or Medicaid, actually increased 0.2%. 
The same pattern is true with spinal fusions. Commercially insured spinal fusions declined by 160 admissions or 15% in the third quarter, but noncommercial spinal fusions increased by 17% or over 150 admissions in the quarter. Since the same physicians are doing these surgeries for both payer classes, the loss of commercial volumes and the growth of noncommercial volumes suggests this behavior is being driven by the patients, not the physicians. We believe this patient behavior is largely related to economic uncertainty on the part of the patients, commercial enrollment losses and rising co-pays and deductibles for those who remain insured.
Again, on Slide 10, you can see this pattern holds true across several service lines that we would consider as elective and easy to defer. Slide 11 illustrates that when a procedure is harder to defer, like in the case of OB, the changes in volumes in the commercial and noncommercial populations are very similar. 
Despite the challenges to volume growth, favorable pricing and acuity continue to drive a stable picture for revenues. Commercial pricing remains particularly strong. We also had a 2.4% increase in commercial acuity. The result was positive commercial revenue growth of nearly 1% for the quarter. Collectively, this helped us generate adjusted free cash flow of $53 million in Q3, bringing year-to-date free cash flow to positive $74 million. 
We've made a lot of progress on other fronts in the quarter. We continue to improve and de-risk our capital structure, pushing out the majority of our 2013 maturities to 2020, while retiring $229 million face value of debt. This brings our total debt to slightly more than $4 billion with no meaningful maturities for five years. We also entered into a new $800 million credit line with new flexibility with regard to our capital allocation options, including lifting an existing limitation on stock repurchases.
Earlier this year, we drew your attention to the seven items on Slide 14, which we believe can drive significant expansion in earnings growth over the next few years. While some of these items depend on a recovering economy, three of these initiatives, Outpatient, Medicare Performance Initiative and Conifer, were more directly under our control and less dependent on an economic recovery.
Just walking down the list for a minute, our newly acquired outpatient centers are already coming online. We expect to have invested about $70 million in outpatient acquisitions by the end of 2010 and believe there are enough great opportunities that we could do that again in 2011. We anticipate these acquisitions will add $100 million to $150 million to revenues in 2011, and given the much higher margins in this business, contribute as much as $30 million to $40 million in 2011 EBITDA.
Turning to MPI, we are very much on track with our 2010 objective of a $30 million incremental EBITDA contribution. While we have not yet completed our MPI plan for 2011, our preliminary view is for another $30 million. Conifer will take longer to gain visibility, but we remain very excited about its prospects. Conifer's contributions from outside clients to 2011's EBITDA growth will exceed $10 million.
Our healthcare information technology initiative will again create incremental expenses in 2011. And as previously disclosed, we are not planning on a net positive net financial contribution from the initiative prior to 2012. Earlier last month, we went live at four hospitals, and the rollout went smoothly. We're going live at an additional three hospitals this month.
In addition, we continue to achieve solid commercial pricing that's consistent with the trends of recent years. To make major progress on margin expansion and EBITDA growth, we need volume growth and to go back towards prerecession bad debt expense levels. But it's still clear there's much we can achieve even in the absence of recovery.
So to wrap up, I believe we demonstrated once again that we have the appropriate and effective levers to pull in the short term to keep us on track relative to our longer-term performance milestone. I also believe our long-term growth strategies have us well positioned to face the myriad of challenges that 2011 will bring. 
And with that, let me turn the floor over to Biggs Porter, our Chief Financial Officer. Biggs?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, Trevor, and good morning, everyone. The biggest item impacting our net income for the quarter is a recognition of the tax benefit of our net operating loss carryforward. This recognition resulted from our reversal of the previously-established",2155,"Thank you, Trevor, and good morning, everyone. The biggest item impacting our net income for the quarter is a recognition of the tax benefit of our net operating loss carryforward. This recognition resulted from our reversal of the previously-established valuation allowance and added $981 million to our net income or $1.75 per diluted share. 
Under generally accepted accounting principles, which arguably are conservative on this point, and in recognition of our sustained and sustainable return to profitability, the realization of this tax benefits has become sufficiently likely as to require its recognition in our financial statements. Given the conservative criteria applied in our GAAP, this makes a strong statement about the expectations of our future profitability and the value of the NOL.
As a result of this recognition, our income statement tax rate in future quarters will approximate a normalized tax rate of approximately 40%. From a cash perspective, however, we will continue to benefit from the tax shield, and our cash tax payments on future income will be primarily limited to state taxes, and will continue at the low level of recent years. They will remain low until our loss carryforward is fully utilized, which is still a number of years out.
The biggest item not impacting either net income or adjusted EBITDA in the third quarter was the $64 million net receipt of revenues related to the California provider fee. Due to delays and a very complex approval process, this materially favorable event was not recognized in the third quarter. The portion of the plan related to direct medical payments was approved after the end of the quarter, with the Managed Care portion still pending. We had expected that up to $55 million would be recognized in the third quarter. This delay has no affect on full year income but will cause some of the cash receipts to slip out of this year into next, which we estimate at a net $36 million.
Looking forward to next year, the California provider fee may be renewed for a half year, and a new fee in Pennsylvania worth approximately $25 million is in the process of development. Other states are also working on these types of arrangements. Just as food for thought, if you put the normalized 2010 value of the California provider fee at $37 million, the Pennsylvania fee and a partial extension of the California fee could more than replace that. So you should not think of the revenue from the California provider fee as being entirely non-recurring in looking at next year. From a cash basis, the cash received from provider fees could actually go up next year.
Adjusting both quarters for prior-year cost report adjustments, revenues grew slightly in the third quarter as a result of strong commercial pricing and case mix, offset by adverse payer mix and aggregate declines in paying volumes. As in the prior quarters of this year, case mix on commercial Managed Care was strong relative to last year, reflecting about a 3% increase. As I said in last quarter's comments, this increase in acuity has to be considered in understanding the economic effect of lower volume.
Our overall pricing picture remains positive. Even with the commercial volume declines we experienced in the quarter, commercial pricing gains were sufficient to drive growth of 0.9% in commercial revenues in the quarter. Because of the payer mix shift, however, net inpatient revenue per admission increased by only 1.1%, and net outpatient revenue per visit increased by 5.6%. 
The strong increase in outpatient pricing reflects the loss of H1N1 volumes from last year, which had generated lower revenues per outpatient visit. The absence of flu volumes in this year's third quarter drove average pricing higher. Once again, this demonstrates the necessity of understanding acuity and patient mix when assessing the economic effects of volume fluctuations.
While Im on the topic of pricing, I will comment that we continue to have very good visibility with regard to our forward pricing. At this point, approximately 80% of our commercial contracting is complete for 2011 and 40% for 2012. 
Turning to cost. Although the benefits weren't fully visible in the third quarter, we successfully took action to flex our cost structure. As Trevor mentioned, July's volumes were particularly weak. We responded very quickly to reduce our staffing and implemented a significant reduction in force in August. We incurred a couple of million in severance costs as part of this, but this August action left us well positioned for the balance of the quarter. Those cuts should also have full visibility in our fourth quarter. 
In addition, we have delayed our annual merit increases for the general population from October 1 to January 1. This takes us a step closer to timing our merit increases for all employees in the April time period where they used to be.
The result of these actions are immediately evident in our internal measures of productivity, which looks at FTEs per adjusted average daily census. Despite the soft volumes in the quarter, this productivity measure actually improved in the third quarter as FTEs per adjusted average daily census declined in September by 1.2%.
Supplies cost were essentially flat in the quarter. On a per-adjusted patient-day basis, the increase in supplies cost was 2.6% as adverse operating leverage and the increase in acuity offset the effects of our supply cost initiatives. The costs we recorded within other controllable costs line were more of a challenge. Many of the costs recorded under this heading are more heavily fixed or semi-variable in nature and, as a result, are more difficult to flex in response to soft volumes. 
We also recorded some incremental expense from items whose actuarially determined impact is adversely influenced by declining interest rates. While malpractice expenses increased by only $1 million relative to last year's third quarter, the decline in interest and therefore discount rates added $11 million to malpractice expense in the current quarter. Combined with an increase of $3 million in workers comp expense, lower discount rates added $14 million to operating expense in the quarter. This discount rate adjustment should be considered unusual at this point given the low rates we were already seeing on U.S. Treasuries and can be expected to more than reverse itself in the future when interest rates rise to normal levels, thereby creating earnings upside of up to $40 million at some point in the future.
In addition, we recorded an incremental $4 million in HIT expense. As Trevor mentioned, we successfully went live on the first phase of these systems at four of our hospitals in the month of October, and we now expect the incremental effects of these expenses to be down to $11 million in 2010. We expect this incremental expense to increase in 2011 prior to being offset in 2012 by the recognition of federal incentive payments. This increase is not a deferral of 2010 expenses, but is reflective of the increase in a number of implementations in 2011.
Our bad debt ratio declined to 8.3% in the quarter, a 20 basis point decline relative to 8.5% a year ago. This decline includes the recurring benefits of federal Medicare bad debt recoveries as well as declines in uninsured volumes. We view the size of this quarter's Medicare bad debt recovery as representative of ongoing sustainable impacts that can be expected in future quarters.
We had $398 million in cash and cash equivalents at quarter end, a decrease of $313 million from June 30. The largest driver of the cash decline was the use of $274 million to reduce debt. Cash provided from continuing operations was $160 million, and adjusted free cash flow was $53 million after capital expenditures of $107 million in the quarter. 
In the third quarter year-to-date, our cash from operations has been held back by lower levels of accounts payable than in the prior year. Some of this is due to the timing of expenditures, overdrafts and disbursements. We've not changed policy or contractual arrangements, however, and we expect payables to expand again by year end.
Subsequent to the end of the quarter, we completed the sale of a number of our Florida medical office buildings, generating cash of $46 million. As a part of the sale, the buyers committed to certain capital improvements to the facilities, which will benefit our physician tenants. These MOBs had immaterial annual rents and EBITDA. 
We continue to actively market additional MOBs, and we believe a number of these transactions could be completed in the next few quarters. At this point, we have other MOB contracts pending worth approximately $50 million, but in real estate, nothing is done until it closes, so it is not reflected in our outlook.
Turning to our outlook. We have raised the low end of our outlook to a new range of $1.05 billion to $1.1 billion. We raised both ends of the range on pretax income, reflecting lower depreciation and interest expense. Our revised assumptions are detailed on Slide 24. These revision includes the lowering of our volume and revenue estimates, which are tied to related reductions in our cost estimates for the balance of the year. 
There's been speculation that volumes will grow in the fourth quarter on more than a seasonal basis due to the effects of co-pays and deductibles. At this point, we're going to be conservative and not count on that in our outlook. The walk-forward of cash from September 30 to December 31 is provided on Slide 25 breaks down fourth quarter cash flow into its major components. 
It's too early to give an outlook for 2011, but I do think it's appropriate to give a little balance to what the headwinds and opportunities are going into next year. First, the biggest challenge remains on the volume side, but some of the effects of the economy and flu should have anniversaried by the end of this year. Economic stability followed by recovery would presumably create upside. Second, we expect the full year benefit on the outpatient acquisitions we're completing on the second half of this year and a partial benefit of those we are targeting for next year.
Third, we're already seeing improvement in the yield on our physician additions the last couple of years, and we expect expansion of that benefit in 2011 and beyond. Fourth, commercial pricing is almost completely negotiated with reasonable consistent price increases expected next year. Medicare, all in, is basically flat as outpatient increases offset inpatient decreases. I've already talked about state funding and potential new provider fees with the 2009 retroactive portion of the California provider fee being the one element most challenging to replace.
Finally on the cost side, we will increase our investment in our physician base and HIT, both of which will yield improvements for the future. And we will continue to drive on our Medicare Performance and related initiatives to reduce length of stay and supply costs. 
In the aggregate, we will continue to drive toward industry margins. We have confidence in the path we have laid out. The only gating consideration in what the near-term timing and slope of progress is going to be is the degree of economic headwinds we must offset. On the positive side for 2011, we expect to drive value in outpatient investments, physician base initiatives, commercial pricing and the Medicare Performance Initiative. The big potential near-term negative, longer-term a positive is, as I just said, the effect of economic conditions. It is not clear and therefore remains subject to continuing evaluation by us, as to what extent economic conditions will offset the net positive drivers of growth in 2011.
So to summarize. The value of our NOL carryforward has been confirmed from an accounting standpoint. We have raised our outlook for EBITDA at pretax and net income for the year. We approved cost efficiencies in the quarter, as we were able to react quickly to significant volume declines in the first months of the quarter. This will be fully visible in the fourth quarter. 
Free cash flow came under pressure due to the timing of disbursements in rising CapEx. But because of the timing effects on accounts payable will reverse themselves, we have retained our free cash flow outlook for the year. Pricing continued as a source of strength. Commercial case mix remained favorable compared to the prior year. California provider fee has been partially approved while full approval expected this quarter. 
And one last point. From a volume and payer mix standpoint, this was the weakest quarter we've experienced, clearly reflective of the economic headwinds. However, the fact that we held earnings flat on a normalized basis and even in this harsh an environment demonstrates that we are well positioned to grow earnings as the economy moderates and/or as our volume initiatives yield increasing results. 
Let me now ask the operator to assemble the queue for Q&A. Operator?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","[Operator Instructions] Our first question comes from the line of John Rex with JP Morgan.",15,"[Operator Instructions] Our first question comes from the line of John Rex with JP Morgan."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And the issue here for me is when we look at the share, the erosion in commercial, and it's just been persistent now over the past many quarters in terms of actually kind of seeing accelerating losses. So my question is, it looks like you're losing share",101,"And the issue here for me is when we look at the share, the erosion in commercial, and it's just been persistent now over the past many quarters in terms of actually kind of seeing accelerating losses. So my question is, it looks like you're losing share when I compare it to what I'm seeing from others and when I even think about what I'm seeing as kind of more stabilizing trends in just commercial coverage broadly. So can you tell us how you look at that in terms of the potential share losses you might be seeing in you markets?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Yes, John. This is Trevor. That's a good question. I have to comment first, and I'm going to turn it over to Steve Newman, because we've done extensive analysis of this share question. But I first just have to make the comment that it is very difficult to",136,"Yes, John. This is Trevor. That's a good question. I have to comment first, and I'm going to turn it over to Steve Newman, because we've done extensive analysis of this share question. But I first just have to make the comment that it is very difficult to compare the commercial statistics that we've been disclosing in any kind of context to the industry at large or even the peer companies, because you're not getting that same type of disclosure. So not that everybody should do it and not to say that we don't regret starting with disclosure, but you really can't look at these commercial numbers and draw any conclusion about share from them. Now having said that, we've done a lot of work on shares, so I'll ask Steve to comment on that. Steve?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","John, I think it's an excellent point, and we've got a great deal of evidence that we're not losing commercial managed care market share except in the markets of the hospitals that Trevor mentioned in his comments. Our evidence comes from three separate s",99,"John, I think it's an excellent point, and we've got a great deal of evidence that we're not losing commercial managed care market share except in the markets of the hospitals that Trevor mentioned in his comments. Our evidence comes from three separate sources: First, our statewide all-payer database; second, our large statewide Blue Cross plants, where we have significant penetration in those markets; the third is a review of our market share with three of the largest national commercial payers. In summary, these studies all suggest, except in a few isolated instances, our commercial market share is stable."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","And I think, John, we triangulated on that question. As Steve said, there's several different approaches to it. But very hard to do with precision. So this quarter, we did something we hadn't done before, which was essentially go to the payers who would g",109,"And I think, John, we triangulated on that question. As Steve said, there's several different approaches to it. But very hard to do with precision. So this quarter, we did something we hadn't done before, which was essentially go to the payers who would give us this information to say, ""Look, this is our change in volume with you in this particular market. Tell us, because you have access to it, what is the share change, and it was very reassuring in all cases with the exception of a few, where it's clear that we're losing share because there's some new competitor or some different dynamic in the market."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","If you look at the seven hospitals that you spiked out, what percent of company revenues would they represent? I'm trying to compare, if I think about your top seven hospitals and percentage of revenue they represent. If you group these seven, where would",46,"If you look at the seven hospitals that you spiked out, what percent of company revenues would they represent? I'm trying to compare, if I think about your top seven hospitals and percentage of revenue they represent. If you group these seven, where would they fall?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","They do tend to be some of our larger hospitals. So we have a portfolio that ranges in size, but does have some large ones. And I think, when you have a quarter where the large hospitals are underperforming on any given statistic, it tends to drive the co",88,"They do tend to be some of our larger hospitals. So we have a portfolio that ranges in size, but does have some large ones. And I think, when you have a quarter where the large hospitals are underperforming on any given statistic, it tends to drive the company in that direction and vice versa. And unfortunately, this is one of those quarters and I've seen other ones over the time that I've been with Tenet, where the largest hospitals, with exceptions, were moving in the wrong direction."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","So these are not our seven largest hospitals, but amongst them are some of our largest hospitals.",17,"So these are not our seven largest hospitals, but amongst them are some of our largest hospitals."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So I'd find some of that in that category then. And does the stabilizing coverage levels, do you think that's going to have impact or what you're seeing at this point, is it less about erosion in just commercial coverage and more just about avoidance of t",53,"So I'd find some of that in that category then. And does the stabilizing coverage levels, do you think that's going to have impact or what you're seeing at this point, is it less about erosion in just commercial coverage and more just about avoidance of the carenstein [ph] (41:09) at all?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, you've got the baseline high-shrinking issue of the commercial enrollment losses that's been running around 4% among the big payers. You start with that. And then you add to it some utilization issue that potentially is driven by the economic incent",171,"Well, you've got the baseline high-shrinking issue of the commercial enrollment losses that's been running around 4% among the big payers. You start with that. And then you add to it some utilization issue that potentially is driven by the economic incentives that are inherent in higher deductible health plans. And now the enrollment losses you could see turn around in a stronger economy, the shift towards higher deductible plans and whatever's depression of consumption exist [ph] (41:46), that could be a longer-term trend. But like just this morning, I was encouraged to see in the newspaper the results of the Kaiser survey that, among very small employers, coverage is going way up due to these tax incentives that they've been provided with. So among firms with something like nine to 13 employees or five to 13 employees, but the coverage percentage was up like nine points. I may have sound of that a little bit wrong, but it was an encouraging trend among the smallest segment of the employer population."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Shelley Gnall with Goldman Sachs.",13,"Our next question comes from the line of Shelley Gnall with Goldman Sachs."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I'm wondering, is it possible to generalize across your markets those that are hardest hit? So for example, in California, you've got a number of markets where youve got unemployment north of 15% and 16%. And then you've got healthier markets, like tho",78,"I'm wondering, is it possible to generalize across your markets those that are hardest hit? So for example, in California, you've got a number of markets where youve got unemployment north of 15% and 16%. And then you've got healthier markets, like those in Texas that are 8% to 10% unemployment. Is it possible to generalize where you are able to take share and where you just don't see a market share opportunity across all payer classes?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","So hard to generalize, and one of the reasons I mentioned that among the seven hospitals generating 70% of the admissions decline, none are in California, because we did not see, in terms of the volume performance of our hospitals, a correlation with unem",215,"So hard to generalize, and one of the reasons I mentioned that among the seven hospitals generating 70% of the admissions decline, none are in California, because we did not see, in terms of the volume performance of our hospitals, a correlation with unemployment. And our highest unemployment markets were really not having a volume problem. And conversely, where we've seen this physician competition phenomenon that has really created new capacity and a new entrance into a market that's very aggressive, owned by physicians were they have the ability to direct patients, thats in some of our markets with the lowest unemployment or the best trends in unemployment. So I would set aside the unemployment correlation. We've also seen some very strong volume performance in Florida, which is a market that's struggled for a long time. And that I think can be attributed to strong management actions and a market working cohesively on business development activity. So you really -- at the risk of having added two paragraphs to my script on this volume stuff, I'm trying to convey an impression that there is not an overall trend one way or another that you can point to or some correlation, that it's really more one-off issues. And that's the way we've had to manage them."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Other than the cost shifting that you're seeing from the commercial payers, are there any other specific actions that they're taking to limit utilization specifically on the inpatient side?",30,"Other than the cost shifting that you're seeing from the commercial payers, are there any other specific actions that they're taking to limit utilization specifically on the inpatient side?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, one thing that's causing a lot of noise in the statistics is this trend towards observation status, which originally was contemplated as something only to be used in Medicare and now it's widely used in the payers. And I think other companies have t",63,"Well, one thing that's causing a lot of noise in the statistics is this trend towards observation status, which originally was contemplated as something only to be used in Medicare and now it's widely used in the payers. And I think other companies have talked about that. We didn't break it out specifically, but it's of course a contributor to weak inpatient admissions."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Tom Gallucci with Lazard Capital.",13,"Our next question comes from the line of Tom Gallucci with Lazard Capital."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","First, the Slides 10 and 11 that you offered on the commercial versus noncommercial admission trends, very interesting data. Curious if you look back, is the discrepancy between those two payer classes growing or moderating? Or how would you consider that",42,"First, the Slides 10 and 11 that you offered on the commercial versus noncommercial admission trends, very interesting data. Curious if you look back, is the discrepancy between those two payer classes growing or moderating? Or how would you consider that trend?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Tom, being that it's a new slide, we didn't really look back on it and don't have a trend for you on that. We've looked for quite a long time at what we would consider discretionary versus less discretionary service lines and have had more pressure in the",103,"Tom, being that it's a new slide, we didn't really look back on it and don't have a trend for you on that. We've looked for quite a long time at what we would consider discretionary versus less discretionary service lines and have had more pressure in the discretionary. And obviously, when you're in a quarter that's as tough as the one that we just emerged from, you dig a lot harder for explanations, and this was a very interesting one that came through, but we didn't go back and run it historically. It's actually not that difficult to do, so we could."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then you mentioned Managed Care, 80% of your contracting, I guess, are done for next year, 40% the following year. Could you just remind us of sort of the average rates that you're expecting and also maybe more importantly, comment sort of on the tone",85,"And then you mentioned Managed Care, 80% of your contracting, I guess, are done for next year, 40% the following year. Could you just remind us of sort of the average rates that you're expecting and also maybe more importantly, comment sort of on the tone of discussions? I guess there have been some suggestions out there that obviously the Managed Care environment is getting a little more difficult for the payers. I'm wondering if that's leaking into the tone of conversations with you all."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","This is Biggs. First of all, to address the rate question, the rates that we've negotiated for next year are pretty much in-line with what we've budgeted as negotiated rates for 2010. Ultimately, the yield we get on those will determined by case mix index",73,"This is Biggs. First of all, to address the rate question, the rates that we've negotiated for next year are pretty much in-line with what we've budgeted as negotiated rates for 2010. Ultimately, the yield we get on those will determined by case mix index and any payer shifts between the plans, but the negotiations are very much in line with what we've budgeted and achieved this year from a peer-rate negotiation standpoint."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And the tone of discussions, as you're looking further out, maybe one or two years out.",16,"And the tone of discussions, as you're looking further out, maybe one or two years out."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","As for tone, Steve, you want to add anything to that?",11,"As for tone, Steve, you want to add anything to that?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'd just say that negotiations are taking a little bit longer than they have in the past, and we're pushing for more pay for performance to be added to those contracts as we move toward a value-based purchasing environment.",40,"I'd just say that negotiations are taking a little bit longer than they have in the past, and we're pushing for more pay for performance to be added to those contracts as we move toward a value-based purchasing environment."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I guess the only thing I would add is I've made an effort to stay close to the senior executives, some of our largest customers, and to remind them that we provide a very good value solution for them. We have demonstrated high quality. They assess that th",193,"I guess the only thing I would add is I've made an effort to stay close to the senior executives, some of our largest customers, and to remind them that we provide a very good value solution for them. We have demonstrated high quality. They assess that themselves. So I don't need to convince them of that. And our price point relative to our competitors in virtually all of our markets is certainly not the highest, and sometimes it's on the low end of the market pricing, and typically with a large, prominent, successful, not-for-profit system leading the way on pricing. So I feel that we are well positioned with the national payers from a value point of view. We're also exceedingly well positioned when they look at the total cost of doing business with us because we have streamlined and automated the revenue cycle process with them. So we have lowered -- they tell us, we have lower-than-average denials. We have better-than-average electronic connectivity and we offer a total solution that I think is very effective as they start to look harder at price sensitivity and narrow networks in their markets."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Adam Feinstein with Barclays Capital.",13,"Our next question comes from the line of Adam Feinstein with Barclays Capital."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I guess the volume weakness is something that everyone was talking about throughout the quarter. So I dont think that really caught people that off-guard. I guess it was just throughout the year with the volume weakness, you guys have able to offset it",165,"I guess the volume weakness is something that everyone was talking about throughout the quarter. So I dont think that really caught people that off-guard. I guess it was just throughout the year with the volume weakness, you guys have able to offset it through better unit pricing growth as well as just cost cutting. So I guess the question is, as you look back on the quarter, Trevor, just maybe talk about -- and you guys called out a few things like the discount rate and some of the issues around cost there, but I guess just in terms of the ability to offset the volume weakness, and not even just for the most recent quarter but going forward as well, maybe just to go back through and talk about some of the initiatives there and certainly, you have the great slide deck here with that, but to just get some more clarity in terms of just visibility around the ability to offset volumes."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I think, Adam, in the beginning of your question, you touched on a topic that I think is important just to be very clear about in case it wasn't clear enough in the scripts. But we were trying to make the point that although I think the industry-wide volu",358,"I think, Adam, in the beginning of your question, you touched on a topic that I think is important just to be very clear about in case it wasn't clear enough in the scripts. But we were trying to make the point that although I think the industry-wide volume weakness was well known throughout the quarter, there were plenty of surveys and other indicators that, that was taking place; what was surprisingly negative was July. And so I mentioned that July was particularly weak and then we took actions to reduce cost. Of course, those actions couldn't be taken in July; they were taken in August and had that effect of creating a positive trajectory in EBITDA from July to August to September. And as volume losses moderated from July through August through mid-September, then they did turn down in late September; that's the implication of saying that they were strong through mid-September. So I think one way -- the thing I would characterize as being unusual in the third quarter at least for us was how negative the first month was and then the fact that although many in the industry anticipated some snap back and August was encouraging, that, that encouraging trend at least in terms of volume did not persist through the entire quarter. And then based on our comments about October, it didn't persist into October. But I think to answer your question about what we can do and how we've been able to offset weak volumes, obviously, it's very hard on a month-to-month basis; it gets easier on a quarterly basis and it gets easier to accomplish. I shouldn't use the word easy because its not easy, but it's less difficult to accomplish on a yearly basis. And so, if you look at the quarter as a whole, we really overcame a lot of challenge that we had right out of the box in July. But it's difficult to do more in a short period of time. I think we have positioned ourselves well going into the fourth quarter. But again, we don't even have the first month of results on that yet."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Just on the unit pricing, the 1.1%, you talked about mix having some impact there. So maybe just to get you to go back through some of that, I guess, the commercial piece you talked about but just within the other categories just maybe a quick update ther",81,"Just on the unit pricing, the 1.1%, you talked about mix having some impact there. So maybe just to get you to go back through some of that, I guess, the commercial piece you talked about but just within the other categories just maybe a quick update there in terms of -- and I guess, what are you guys thinking about in terms of a normalized revenue per admit number if you try to clean up some of the noise there?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, what's normal at this point will depend largely upon whether the OB admissions stay down or not for an extended period because one of the reasons why case mix is up is because obstetrics are down. Obstetrics will probably stay down for quite a while",145,"Well, what's normal at this point will depend largely upon whether the OB admissions stay down or not for an extended period because one of the reasons why case mix is up is because obstetrics are down. Obstetrics will probably stay down for quite a while. So I would expect on that basis, case mix to not changed radically over the near term. As I said, case mix on commercial Managed Care was up about 3%. It was up about 1% on a Medicare Managed Care and up almost 5% on Medicaid Managed Care. So in most of the categories, it was up in the quarter. We'll see, of course, with that was over a longer term but there's nothing right now that indicates that, that would change. So we'll just have to watch it but I think is reflective of the economics of today."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I just point, Adam, that we had a 5.6% increase in revenue per outpatient visit that was largely driven by increases relatively speaking of outpatient surgery and high-end imaging like CT and MRI.",33,"I just point, Adam, that we had a 5.6% increase in revenue per outpatient visit that was largely driven by increases relatively speaking of outpatient surgery and high-end imaging like CT and MRI."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'm going to add a response to, I think it was John's question earlier on the revenue from the seven hospitals. We went and pulled the statistic and from a pure numeric standpoint, the seven hospitals are 14% of our hospital count. From a revenue standpoi",92,"I'm going to add a response to, I think it was John's question earlier on the revenue from the seven hospitals. We went and pulled the statistic and from a pure numeric standpoint, the seven hospitals are 14% of our hospital count. From a revenue standpoint, they comprise 18% of the revenues in the quarter. So a little more heavily weighted than the peer hospital account but not, as I said, because it's not all the largest hospitals that are in there, it's not a real disproportionate share of the revenue."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Ralph Giacobbe with Credit Suisse.",13,"Our next question comes from the line of Ralph Giacobbe with Credit Suisse."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","In the release, you mentioned increased physician employment. And I think in the past, you've talked about not necessarily wanting to employ. Can you maybe talk about what's changed to your strategy there and maybe just give us a sense of the base that's",51,"In the release, you mentioned increased physician employment. And I think in the past, you've talked about not necessarily wanting to employ. Can you maybe talk about what's changed to your strategy there and maybe just give us a sense of the base that's employed currently and where that can go?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Steve, you want to take that?",6,"Steve, you want to take that?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Sure. Ralph, we've done a number of things to affect physician recruitment. First thing we've done is expanded the number of staff focused at the hospital level as well as at the regional corporate level on physician recruiting. Another thing we've done i",120,"Sure. Ralph, we've done a number of things to affect physician recruitment. First thing we've done is expanded the number of staff focused at the hospital level as well as at the regional corporate level on physician recruiting. Another thing we've done is we've reassessed our community need and revised the medical staff development plan for each of our hospitals. The third thing that I think we've done thats significant is we revised the process for targeting redirection of our local physicians, and we've improved that on-boarding process as well as orientation for these successfully recruited or redirected physicians. Finally, we believe that this will improve the productivity and retention rate of the physicians that we've been able to recruit."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I guess I'm just trying to get a sense of, is this sort of in reaction to what's going on in your markets, where there perhaps was a reluctance to employ in the past, but now you need to because others are doing it and perhaps that can explain some of the",59,"I guess I'm just trying to get a sense of, is this sort of in reaction to what's going on in your markets, where there perhaps was a reluctance to employ in the past, but now you need to because others are doing it and perhaps that can explain some of the weaker volume trends that youve seen?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, look, I will be the first to say that I had a particularly bad attitude about jumping into the employment trend having experienced firsthand the disasters of the late 90s when hospitals rapidly purchased practices and employed physicians and lost",434,"Well, look, I will be the first to say that I had a particularly bad attitude about jumping into the employment trend having experienced firsthand the disasters of the late 90s when hospitals rapidly purchased practices and employed physicians and lost tremendous amount of money. But this is a trend that is inexorable. It started with the large, most prosperous not-for-profits. We compete against a lot of those in our markets and we have completely adopted a, I think, new and improved way to do this. So just to go in order of sort of the problems and what we're doing about it, purchasing practices is really not market practice anymore. It's employing physicians. So you don't have the problem from the 90s of spending a lot of capital on purchasing something that turns out to not be worth of what you paid for it. So it's really hiring talent. And then in terms of hiring talent, we've become very sophisticated about how to do it in terms of providing incentives for productivity so we don't experience the next problem that was characteristic for the 90s, which is hiring physicians, which essentially was enabling them to retire at the expense of the hospital. So we're incentivizing productivity. And we've also experienced some churn of the employee physicians based on those who failed to meet the productivity targets leaving and those who are succeeding in the productivity targets staying and enjoying the benefits of that. We've also been very selective in terms of the credentials of the physicians that we've been hiring. So just as if you undertook to hire a cadre of 200 MBA students, youd want to go to the top schools and hire the best students; we're doing the same thing when it comes to physicians. We're also being very selective about filling certain holes in specialties or building primary-care networks, where that strategy is right. And then finally, rather than attempting to manage all these practices ourselves, we've employed in a joint venture format a practice management company that's an expert in doing this and running them at economic results that are superior to what hospitals generally experience. So I think all of those things together and I didn't mention the EMR solution that we're offering for physicians, so I think it's a better solution, and we probably got started later than we should have. And perhaps it's because of historic bias, at least on my part, against that as a strategy. But we are well into it now and have a very strong pipeline of physicians that we are employing."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I wanted to sort of revisit capital structure. You talked about sort of refinancing, pushing out debt maturities. Are you kind of happy where the company sits from that perspective? Is there anything else you would contemplate? Obviously, you mentioned sh",58,"I wanted to sort of revisit capital structure. You talked about sort of refinancing, pushing out debt maturities. Are you kind of happy where the company sits from that perspective? Is there anything else you would contemplate? Obviously, you mentioned share repo in your commentary, just given where the credit markets are and just the overall rate environment."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, I think, I'll answer and if there's anything left, Biggs can chime in. But as I mentioned, there are no significant maturities for five years. That's a long time. I don't think it would make any sense to push it out farther. That's actually quite a",136,"Well, I think, I'll answer and if there's anything left, Biggs can chime in. But as I mentioned, there are no significant maturities for five years. That's a long time. I don't think it would make any sense to push it out farther. That's actually quite a conservative approach to a capital structure, which I think is appropriate given the risks in the business and the historic leverage that we've had. We've also obviously brought down the leverage ratios substantially. This new credit line offers us a lot of flexibility. Were obviously not commenting today on the potential for share buybacks, but it's obviously something we couldn't even consider prior to this new credit line. So we'll just have to see depending on circumstances what we decide to do there. Biggs, did I leave anything out?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","No, I think there's some small amounts of the '11 and '12 maturities still outstanding, so obviously, over time if not at maturity, we will retire those in due course. And otherwise, with respect to capital structure, our big driver is to keep driving on",70,"No, I think there's some small amounts of the '11 and '12 maturities still outstanding, so obviously, over time if not at maturity, we will retire those in due course. And otherwise, with respect to capital structure, our big driver is to keep driving on improving free cash flow, drive up earnings and drive free cash flow along with it. And further improve all of the statistics and the ratios."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Darren Lehrich with Deutsche Bank.",13,"Our next question comes from the line of Darren Lehrich with Deutsche Bank."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Just around capital and deployment of capital, if you include some value of your NOL, you're probably trading just a little under 5x your guidance for 2010 on an EBITDA basis. So I guess, I'd be curious to hear your thoughts what kind of assets you can bu",93,"Just around capital and deployment of capital, if you include some value of your NOL, you're probably trading just a little under 5x your guidance for 2010 on an EBITDA basis. So I guess, I'd be curious to hear your thoughts what kind of assets you can buy that are out there that are more favorable than that type of valuation. So are you seeing any acute-care assets? You've commented a little bit more about your interest in getting aggressive on the outpatient side. Maybe just update us generally on capital deployment priorities."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Obviously, if you employ a rule of thumb that says you should only acquire things that trade at a lower multiple than your own multiple, it's very limiting. Based on my comments about outpatient, it appears that we are doing that, and we're very pleased w",321,"Obviously, if you employ a rule of thumb that says you should only acquire things that trade at a lower multiple than your own multiple, it's very limiting. Based on my comments about outpatient, it appears that we are doing that, and we're very pleased with the outpatient acquisitions that we're making. I would say that the potential acquisitions of acute care hospitals that would be of interest to us or of the greatest interest to us, there are certainly more hospitals considering selling themselves or seeking partnerships of some kind. And we're spending more time than we ever have exploring those types of things. I think it's premature to talk about value and whether we would actually proceed and devote our capital in that way. What we haven't been doing, you obviously noticed, is we have not been competing in the auctions that have been out there for standalone hospitals or hospitals that are distressed or whatever other acute-care transactions are out there. I don't think we are necessarily the best potential acquirers for those kinds of things. Where we have been focused is more in our markets of things that have some degree of synergy, where we understand the market, we understand the dynamics and the future trends. And obviously, given the uncertainties around healthcare reform, is something you have to take into consideration when you evaluate the hospitals. So for that reason, we've been most focused on the outpatient side. I think that you'll agree, since we gave some disclosure on those numbers, that those are incrementally very helpful acquisitions for us. We like that business and will continue to do that as much as possible. And then, with -- there may be opportunities in the future within our Services business, which we're also very excited about. The multiple issue tends to present a barrier there, but we have to keep our eyes open on that as well."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And if I could just follow-up maybe clarify a point you made earlier about the cost savings actions in Q3. I guess just putting some rough numbers on the FTE figures you provided us, Biggs, it would seem like that's about maybe a $20 million to $30 millio",70,"And if I could just follow-up maybe clarify a point you made earlier about the cost savings actions in Q3. I guess just putting some rough numbers on the FTE figures you provided us, Biggs, it would seem like that's about maybe a $20 million to $30 million type of annualized savings run rate. Is that a good range to work off of for what we'll see in Q4?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","As I said, it's 1.2% improvement in productivity. So it's probably a little north of that, approaching $40 million on an annual basis. Real near term, comparing third quarter to the fourth quarter, other improvements we expect are on the malpractice and w",197,"As I said, it's 1.2% improvement in productivity. So it's probably a little north of that, approaching $40 million on an annual basis. Real near term, comparing third quarter to the fourth quarter, other improvements we expect are on the malpractice and workers comp side where we took the hits in the third quarter for the discount rate. We expect those to not occur in the fourth quarter and possibly will have improvement again in the fourth quarter as a result of what continues to be good claims experience. Another thing looking at the third quarter, as I said, there was a couple million dollars of severance costs in there, so that was the cost of achieving the reductions and we don't expect that to occur in the fourth quarter in the future. So there's a number of things going on in addition to just the pure FTE reductions to be considered looking at or later [ph] (1:05:48) this year and on to the future. And of course, we're still driving on the Medicare Performance Initiative, which was worth $30 million this year and expect to do a similar amount next year in terms of incremental savings."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Gary Lieberman with Wells Fargo.",13,"Our next question comes from the line of Gary Lieberman with Wells Fargo."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I was wondering if youd just maybe elaborate a little bit more on the line in the slide about the Managed Care portion of the provider taxes still awaiting approval from CMS and what that involves.",37,"I was wondering if youd just maybe elaborate a little bit more on the line in the slide about the Managed Care portion of the provider taxes still awaiting approval from CMS and what that involves."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Sure. The way this has been approved is in pieces. The fee for service portion of it was a little simpler in that it only involves the hospitals, the state and CMS. And so, that approval came first. The Managed Care portion of this has to flow through the",136,"Sure. The way this has been approved is in pieces. The fee for service portion of it was a little simpler in that it only involves the hospitals, the state and CMS. And so, that approval came first. The Managed Care portion of this has to flow through the Managed Care payers. And so contracts and structures have to be adjusted in order to allow for that money to flow through the Managed Care payers. And until that is totally defined, CMS basically withholds their approval on that portion of it. And so it should be seen as largely administrative in our mind, and that's why we're counting on the entire $64 million in our outlook. But it is a step that has yet to be completed between the states, the Managed Care payers and CMS."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And I guess just does the Managed Care portion have to be put to bed before the entire plan can take place? Or should we view it kind of as separate, so if by some chance the Managed Care portion didnt get approved",43,"And I guess just does the Managed Care portion have to be put to bed before the entire plan can take place? Or should we view it kind of as separate, so if by some chance the Managed Care portion didnt get approved"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","It's happening in pieces. And in fact, the direct payment portion of it, the fee-for-service portion, has already been implemented. And we've been invoiced and also are receiving funds on that portion of it, which is about half of the total. The other hal",61,"It's happening in pieces. And in fact, the direct payment portion of it, the fee-for-service portion, has already been implemented. And we've been invoiced and also are receiving funds on that portion of it, which is about half of the total. The other half the Managed Care piece will happen separately. But as I said, we expect it to happen."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Trevor, I know you mentioned that there wasn't any data on volumes for October. Any initial thoughts just in terms of anything that might stand out?",26,"Trevor, I know you mentioned that there wasn't any data on volumes for October. Any initial thoughts just in terms of anything that might stand out?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I actually commented on the volumes on October. I'm not sure what you mean by your question.",17,"I actually commented on the volumes on October. I'm not sure what you mean by your question."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Just in terms of any picture of service lines that look like they've been reversing trend or sort of continuation in trend.",23,"Just in terms of any picture of service lines that look like they've been reversing trend or sort of continuation in trend."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, it's too early for that. Usually, we have the volume data daily and then at the close of the month, but then to get clean service line and payer data takes a little longer.",35,"Well, it's too early for that. Usually, we have the volume data daily and then at the close of the month, but then to get clean service line and payer data takes a little longer."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Whit Mayo with Robert W. Baird.",14,"Our next question comes from the line of Whit Mayo with Robert W. Baird."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Trevor, can you go back and talk about the delay in merit paid? Did you say that, that was going to be pushed to January? I guess I didn't follow you.",31,"Trevor, can you go back and talk about the delay in merit paid? Did you say that, that was going to be pushed to January? I guess I didn't follow you."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Let me just tell you conceptually what we decided to do. We had multiple employee populations with an expectation of annual inflation/merit-oriented salary increases at different times in the year. So we've had for a long time a desire to standardize that",159,"Let me just tell you conceptually what we decided to do. We had multiple employee populations with an expectation of annual inflation/merit-oriented salary increases at different times in the year. So we've had for a long time a desire to standardize that all at the same time of the year, which is really the spring being the best time. And so, given the sort of rapidly decreasing expectations of inflation and also the observations we made of competitive practice declining in terms of the increases that competitors appear to be giving to people, what we've decided to do was to implement the program effective January 1, but to tell people in advance what they would get. So I think it's a very good solution from a cost management perspective. It also administratively will simplify our administration of these programs in the future. And it obviously was a prudent move to save costs in the second half of this year."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Is there any chance that, that may be delayed further into 2011? I guess I'm just wondering if that's a concrete start in January or whether or not",28,"Is there any chance that, that may be delayed further into 2011? I guess I'm just wondering if that's a concrete start in January or whether or not"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","No, that's concrete for January.",5,"No, that's concrete for January."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And any other benefit design changes, anything that's meaningful as we look out to 2011?",15,"And any other benefit design changes, anything that's meaningful as we look out to 2011?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Not that we're contemplating at this moment.",8,"Not that we're contemplating at this moment."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Biggs, I was just curious if we could get the P&L expense and the cash CapEx numbers for your electronic health records spend this year, at least year-to-date, and maybe a peek into what those two numbers may look like in 2011.",42,"Biggs, I was just curious if we could get the P&L expense and the cash CapEx numbers for your electronic health records spend this year, at least year-to-date, and maybe a peek into what those two numbers may look like in 2011."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'll do the second part first. On 2011, we're still in the planning process. We've completed, as I said, four implementations here in the last couple weeks. We have three more that are going live shortly among other things. We have to look at that experie",196,"I'll do the second part first. On 2011, we're still in the planning process. We've completed, as I said, four implementations here in the last couple weeks. We have three more that are going live shortly among other things. We have to look at that experience, what it's cost us, what lessons learned are as a part of fully defining next year's budget and expectations that we would communicate as a part of our outlook. But in any event -- but we do expect it to go up, as I said earlier. And maybe that's not so much an increase off of what we originally expected for this year as it is just an increase on where we actually landed for this year. So the comparative number for this year has come down as opposed to saying next year is increased off of what we might have expected before. This year, we're spending around $90 million in incremental spend. Actually, thats total spend. It's about $66 million of that is CapEx and about $23 million is expense. And like I said, the expense of $23 million represents an $11 million increase over the prior year."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","On the P&L.",4,"On the P&L."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","We do expect that number in total both on CapEx and expense to go up next year. But as I said, it's a little early to give a hard number.",30,"We do expect that number in total both on CapEx and expense to go up next year. But as I said, it's a little early to give a hard number."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Justin Lake with UBS.",12,"Our next question comes from the line of Justin Lake with UBS."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","First question just on the outpatient side, specifically, you looked at that as being opportunity. Talked about outpatient margin being significantly greater than inpatient. I'm just wondering if you can give us some color there in terms of a magnitude of",46,"First question just on the outpatient side, specifically, you looked at that as being opportunity. Talked about outpatient margin being significantly greater than inpatient. I'm just wondering if you can give us some color there in terms of a magnitude of the differential between those margins."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, I think they tend to be more than double. And the comments that I made in the opening suggest that we're buying these at very attractive multiples and that they have very high margins relative to the overall business. And so it's a very attractive f",49,"Well, I think they tend to be more than double. And the comments that I made in the opening suggest that we're buying these at very attractive multiples and that they have very high margins relative to the overall business. And so it's a very attractive form of acquisition."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Are you just talking about surgical centers at this point on the margin side because I think we all -- I think it's pretty clear those have margins that are much better than in an-patient hospital or acute care hospital.",40,"Are you just talking about surgical centers at this point on the margin side because I think we all -- I think it's pretty clear those have margins that are much better than in an-patient hospital or acute care hospital."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Most of what we've been doing is imaging centers. We have bought some surgery centers. But this year, not exactly clear how many will be able to close, but it'll be in the magnitude of 22-plus-ish imaging centers and three to four surgery centers. So far",52,"Most of what we've been doing is imaging centers. We have bought some surgery centers. But this year, not exactly clear how many will be able to close, but it'll be in the magnitude of 22-plus-ish imaging centers and three to four surgery centers. So far more on the imaging side."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then just a little bit of a cleanup on some of the 2011 moving parts. Can you give us any specifics on how much of a headwind healthcare IT is going to be next year? And then just to confirm, I think I heard you say that the provider taxes would be a",58,"And then just a little bit of a cleanup on some of the 2011 moving parts. Can you give us any specifics on how much of a headwind healthcare IT is going to be next year? And then just to confirm, I think I heard you say that the provider taxes would be a $36 million headwind year-over-year."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I think, actually, the latter one on the provider fee, the amount of the provider fee attributable to 2009 is what I said was the most challenging of the California provider fee and that's actually about $27 million of the $64 million. The amount, which i",59,"I think, actually, the latter one on the provider fee, the amount of the provider fee attributable to 2009 is what I said was the most challenging of the California provider fee and that's actually about $27 million of the $64 million. The amount, which is carrying over to next year from a cash standpoint is about $36 million."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Is there other kind of provider fees or provider tax benefit you're getting this year that you don't expect? So you expect the other $37 million of the $64 million to reoccur again in 2011. Or is that something you would expect to guide to?",46,"Is there other kind of provider fees or provider tax benefit you're getting this year that you don't expect? So you expect the other $37 million of the $64 million to reoccur again in 2011. Or is that something you would expect to guide to?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Yes, well, what I've said was if you take the California fee, the current year portion of it will be replaced by in part a half year extension on California, we would expect, not yet done, but we would expect that plus $25 million from Pennsylvania and al",72,"Yes, well, what I've said was if you take the California fee, the current year portion of it will be replaced by in part a half year extension on California, we would expect, not yet done, but we would expect that plus $25 million from Pennsylvania and also not yet done but in works, and the sum of those two, yes, would offset the $37 million of current year California provider fee."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then just the healthcare IT increase year-over-year.",9,"And then just the healthcare IT increase year-over-year."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","As I just said, it's a little early to say. I think that this year, we've under-run significantly based upon incurring as much in the way of start-up costs and also being very efficient in the implementations that we have successfully completed here in th",122,"As I just said, it's a little early to say. I think that this year, we've under-run significantly based upon incurring as much in the way of start-up costs and also being very efficient in the implementations that we have successfully completed here in the last few weeks. So we've got to assess, if you will, what that means with respect to the implementation for next year. However, we do have more implementations next year than this year. More hospitals will be in process, so we do expect the number to go up. It's probably in the say low tens of millions kind of number, not a radical change in overall profitability associated with it, but we just have to finalize that."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So is that like $10 million to $30 million or is that $10 million to $15 million?",17,"So is that like $10 million to $30 million or is that $10 million to $15 million?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","$10 million to $30 million would be in the low tens territory I referred to. But as I said, it's early yet to put a hard number out there.",29,"$10 million to $30 million would be in the low tens territory I referred to. But as I said, it's early yet to put a hard number out there."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Sheryl Skolnick with CRT Capital Group.",14,"Our next question comes from the line of Sheryl Skolnick with CRT Capital Group."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","If I take out the provider fee anticipated impact in fourth quarter, which I believe you said was $64 million, and I look at that, first of all, would it be correct to assume that, that would drop 100% to the EBITDA line?",43,"If I take out the provider fee anticipated impact in fourth quarter, which I believe you said was $64 million, and I look at that, first of all, would it be correct to assume that, that would drop 100% to the EBITDA line?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Yes.",1,"Yes."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","The answer to that I think is yes. And then second, if that's the case, then your guidance sort of implies something on the order of a quarter thats flat on the EBITDA line with third quarter to something that is would be up around the sort of $270 mil",130,"The answer to that I think is yes. And then second, if that's the case, then your guidance sort of implies something on the order of a quarter thats flat on the EBITDA line with third quarter to something that is would be up around the sort of $270 million to $280 million in order to achieve the $1.050 billion to $1.1 billion if my math is correct. So if I look at those numbers, I'm still not sure how you get to the upper end of the range. So my question then becomes, what really has to go right for us to be optimistic that you can get back on the path of exceeding not only consensus but achieving the high end of your guidance or even exceeding it?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'll try to answer the first batch. Obviously, we've taken cost out. We've talked about that. And if you look at this from a per-adjusted patient-day basis in Q3, our experience was around $2,050. Q3 year-to-date was $1,995. So clearly, Q3 jumped up. Q4,",312,"I'll try to answer the first batch. Obviously, we've taken cost out. We've talked about that. And if you look at this from a per-adjusted patient-day basis in Q3, our experience was around $2,050. Q3 year-to-date was $1,995. So clearly, Q3 jumped up. Q4, we look at being back around that $1,995 kind of level. So based upon the reductions in staff, the improvements forecast on med mal, severance not recurring as I already talked about, some other initiatives to drive down costs, we think we get back down to that $1,995 kind of level. So that's at the middle of the range. And of course, there's opportunity to go beyond that to help drive towards the other end of the range as well. From a revenue standpoint, we've just looked at what's real recent experience on volumes. And as I said, we didn't presume any kind of a hockey stick in the last two months of the year. But from an overall admit standpoint, at the middle of the range, we could be at a negative 4% to 5% and still hit the middle of the range and commercial still be in that 6% to 7% kind of range that we were at in the first half. Once again, it would be at the middle of the range. So those seem like, based on everything we know, still some reasonably conservative positions to be taking as we look at the underlying trends. So there's opportunity in my mind for us to do better than those, both on the cost side and on the volume side, but as you know, we didn't take up the upper end of the range because we wanted to stay conservative and not presume that we were going to do better than those and lift ourselves, I'd say, to build a range based on those stats."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then with, because all of these questions, I think, are getting around the point of just for how long is the pattern we've been seeing in your earnings as well as others, for how long will the cost savings continue to save the day as it were as volume",115,"And then with, because all of these questions, I think, are getting around the point of just for how long is the pattern we've been seeing in your earnings as well as others, for how long will the cost savings continue to save the day as it were as volume continues to deteriorate? I mean that's not an issue unique to Tenet. And I guess the answer to that is nobody really knows, but how much more do you have left on the cost? And it seems like you've been doing just about everything you can on that score. You found another 800 FTEs. But at what point do you have to stop doing that?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well staff reductions arent the only place where were reducing cost. The Medicare Performance Initiative is driving cost out and supply costs were basically flat and had a very low inflationary rate, even with higher acuity. So there is success in o",129,"Well staff reductions arent the only place where were reducing cost. The Medicare Performance Initiative is driving cost out and supply costs were basically flat and had a very low inflationary rate, even with higher acuity. So there is success in our efforts there, and there'll be continuing success. But cost also isnt the only way we're going to drive value, even if we don't have increasing inpatient volumes over the near future, because we have the outpatient acquisition is driving value. We have our investments in Conifer yield increasing value. The price negotiations on commercial are still favorable; the price on government, pretty much flat. So there's plenty of things we're operating on to create value besides just driving out cost, but there's more cost opportunity too."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I would just add to what Biggs said, Sheryl; opportunity longer term is the clinical standardization, where we really get in on more and more of the DRGs, both inpatient as well as our outpatient care, standardize that, eliminate some redundancy, drive do",102,"I would just add to what Biggs said, Sheryl; opportunity longer term is the clinical standardization, where we really get in on more and more of the DRGs, both inpatient as well as our outpatient care, standardize that, eliminate some redundancy, drive down that variable cost, and really affect the cost metrics in something outside necessarily of the salary wages and benefits or direct supply cost. We're also working on length of stay. We're working on readmission rates as we look at more prospective payments. So there are lots of opportunities to drive on the cost side of the equation going forward."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And just finally, on your commercial Managed Care negotiations, we've begun to see some more, shall we say, innovative almost back to the future kinds of tactics at the Main Street level on the part of some of the Managed Care companies with their relatio",178,"And just finally, on your commercial Managed Care negotiations, we've begun to see some more, shall we say, innovative almost back to the future kinds of tactics at the Main Street level on the part of some of the Managed Care companies with their relationship with physicians, with restructuring their contract for payment, for example, United with oncology [ph] (1:24:19), we've heard about the potential for some of the companies to have more direct even ownership relationships with providers, physicians, hospitals, outpatients, et cetera, to have them do the rationing rather than the health plan, but the health plan gets the benefits thereof. But is there anything that you can see in your negotiations with the commercial Managed Care plans that might get more creative i.e., contracting for guaranteed volume within a disease or within a procedure or service line where you might be the dominant or best quality provider in the market that could assure you some commercial Managed Care share in those markets and help you even to take share rather than just to maintain share?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","So the short answer is, every creative structure that you can imagine and probably more are under discussion. But still, it is today an environment that's all about cost and access and companies obtaining benefits with the sort of least amount of friction",137,"So the short answer is, every creative structure that you can imagine and probably more are under discussion. But still, it is today an environment that's all about cost and access and companies obtaining benefits with the sort of least amount of friction for their employees and all that. But I think we're well positioned on those creative types of structures because of quality, because of our visibility and ability to understand what it is that we're actually doing in terms of the provision of the service. And then we have this little secret weapon that we've used for decades in California that is a unit that assesses risk and helps us on capitated types of arrangement and serves clients beyond Tenet. And so I think we're very well positioned when risk-taking enters the question as well."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our final question comes from the line of A.J. Rice with Susquehanna.",13,"Our final question comes from the line of A.J. Rice with Susquehanna."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","First of all, Ill ask one that's sort of a long shot, but I think, Biggs, you alluded to the idea that people may have been managing their deductibles this year with a weak economy more aggressively, and therefore speculation get into Q4, you might see",93,"First of all, Ill ask one that's sort of a long shot, but I think, Biggs, you alluded to the idea that people may have been managing their deductibles this year with a weak economy more aggressively, and therefore speculation get into Q4, you might see some pent-up demand as those deductibles hit. I guess my question first off would be, you guys have any way to measure that? Can you see whether people are taking longer to hit their deductibles this year than they did last year or anything along those lines?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","There really isn't any clear way for us to see that. We don't have that kind of visibility as the patient comes in or as we send the bill to the payers, so not great insight.",37,"There really isn't any clear way for us to see that. We don't have that kind of visibility as the patient comes in or as we send the bill to the payers, so not great insight."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I have heard the theory espoused by payers, they have obviously much more insight, but I don't think theres evidence, at least as I mentioned earlier, through the first 28 days of October that, that demand wave was ready to hit the beach.",43,"I have heard the theory espoused by payers, they have obviously much more insight, but I don't think theres evidence, at least as I mentioned earlier, through the first 28 days of October that, that demand wave was ready to hit the beach."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","The $100 million to $150 million of acquired outpatient revenues that you're looking for this year, is this year in your mind unusual with the focus on acquiring things like outpatient imaging? Do you think you can run at that rate of acquisitions for a c",47,"The $100 million to $150 million of acquired outpatient revenues that you're looking for this year, is this year in your mind unusual with the focus on acquiring things like outpatient imaging? Do you think you can run at that rate of acquisitions for a couple years?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, we said we think we can do it for next year. I mean, obviously, we've been very sensitive about doing this, where we have the ability to put these centers within the hospital structure. So you run out of opportunities just geographically over time.",98,"Well, we said we think we can do it for next year. I mean, obviously, we've been very sensitive about doing this, where we have the ability to put these centers within the hospital structure. So you run out of opportunities just geographically over time. But there are other ones where the sellers -- we've seen somewhere the sellers initially said they didn't want to sell or their price expectations were unrealistic and they're coming back to us now. So that's way we made the comment with respect to 2011. I wouldn't speculate on 2012 at this point."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I don't think you quantified how much benefit you get from delaying the merit increase, maybe I missed it if you did, for the extra quarter. How much will that benefit you in the fourth quarter? And then if you could just, maybe I made you curious, when d",82,"I don't think you quantified how much benefit you get from delaying the merit increase, maybe I missed it if you did, for the extra quarter. How much will that benefit you in the fourth quarter? And then if you could just, maybe I made you curious, when do you guys think you would offer -- we're talking around the 2011 outlook a lot; have you given some thoughts exactly when you're likely to actually give a formal outlook for 2011?"
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","On the benefit of deferral of the merit increases, it's in the neighborhood of $15 million for the quarter. And that would be similar to numbers we've given in the past. And we've talked about what the effect of merit increases were on the fourth quarter",110,"On the benefit of deferral of the merit increases, it's in the neighborhood of $15 million for the quarter. And that would be similar to numbers we've given in the past. And we've talked about what the effect of merit increases were on the fourth quarter when we gave them by example last year. In terms of when we would give an outlook, I mean, our baseline is we will look at results, we complete our planning process otherwise in December, we look at results through December ultimately and sort of re-evaluate and validate our expectation based upon that and then give the outlook when we release fourth quarter earnings."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So in February, at some point.",6,"So in February, at some point."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Yes.",1,"Yes."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thanks, everybody, for joining the call. And see you on the next one.",13,"Thanks, everybody, for joining the call. And see you on the next one."
107911,114307236,84399,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Ladies and gentlemen, that concludes today's conference. Thank you for your participation. You may now disconnect. Have a wonderful day.",20,"Ladies and gentlemen, that concludes today's conference. Thank you for your participation. You may now disconnect. Have a wonderful day."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Good day, ladies and gentlemen, and welcome to the Third Quarter 2010 Tenet Healthcare Earnings Conference Call. My name is Jeff, and I'll be your operator for today. [Operator Instructions] I would now like to turn the conference over to your host for to",57,"Good day, ladies and gentlemen, and welcome to the Third Quarter 2010 Tenet Healthcare Earnings Conference Call. My name is Jeff, and I'll be your operator for today. [Operator Instructions] I would now like to turn the conference over to your host for today, Mr. Thomas Rice, Senior Vice President of Investor Relations. Please proceed, Mr. Rice."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, operator, and good morning, everyone. Tenet's management will be making forward-looking statements on this call. These statements are based on management's current expectations and are subject to risk and uncertainties that may cause those forw",97,"Thank you, operator, and good morning, everyone. Tenet's management will be making forward-looking statements on this call. These statements are based on management's current expectations and are subject to risk and uncertainties that may cause those forward-looking statements to be materially incorrect. Management cautions you not to rely on and makes no promises to update any of the forward-looking statements. During the question-and-answer portion of the call, callers are requested to limit themselves to one question and one follow-up question.
At this time, I will turn the call over to Trevor Fetter, Tenet's President and CEO. Trevor?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, Tom, and good morning, everyone. Well, I wont blame you if you write reports saying that this is a noisy quarter. In summary, our earnings number was huge and we're raising the bottom end of our 2010 outlook. The volumes were soft, and the E",1675,"Thank you, Tom, and good morning, everyone. Well, I wont blame you if you write reports saying that this is a noisy quarter. In summary, our earnings number was huge and we're raising the bottom end of our 2010 outlook. The volumes were soft, and the EBITDA is flat to 2009 if you make appropriate adjustments. 
We generated over $900 million in net income due to the accounting recognition of the value of our tax loss carryforward. Biggs will explain this further, but the key point is that while existence of the NOL has been well known, it should be more tangible to investors now that it's on the books.
Looking beyond net income, we were challenged by soft volumes in the quarter. We reacted to a particularly weak July by implementing a reduction in force in August. The impact of this action to reduce costs along with improved volume trends after July led to a positive earnings trend in the quarter in which EBITDA grew steadily from July to August to September. 
It's worth noting that we faced a very tough comparison this year as adjusted EBITDA was up 50% in the third quarter last year. Once you allow for year-over-year variability, our longer-term EBITDA trend remains strong. You can see the variability and the clear long-term trend demonstrated on Slide 4.
Clearly, our growth has been very strong but not as steady as I'd like. When you make your assessment of our growth in EBITDA in the quarter, please consider the items on Slide 5. The third quarter of 2009 included three favorable items contributing a total of $20 million. We called out these items on last year's third quarter call, and nearly all of you noted them when assessing our performance. 
In contrast, this year's third quarter includes items with a net unfavorable impact of $16 million. In total, these items created a $36 million unfavorable swing from the third quarter of 2009 to this year's quarter. Net of these items, this quarter was essentially unchanged.
As I mentioned earlier, we're raising the bottom end of our outlook for 2010 EBITDA to a new range of $1,050,000,000 to $1.1 billion. This is the second time this year we've increased one or both ends of the range. Volumes were certainly weaker than we originally anticipated, but this has been offset by stronger pricing, enhanced acuity and excellent cost control. We're also benefiting from the California provider fee being larger than we forecast and health IT spending being less than we anticipated.
Soft volumes were a dominant theme across the industry last quarter, so I'd like to give you some color on our experience. The overall takeaways that the volume declines were contained to a small number of hospitals, and once again a single service line. OB accounted for a full third of our volume loss.
Total admissions declined 3.5%, and commercial admissions declined 8.6% in the quarter. July was by far our weakest month for patient volumes. The trend was more encouraging in August and through mid-September. Through the first 28 days of October, commercial admissions trended slightly better than in Q3 but total admissions were slightly weaker.
As you can see on Slide 7, outpatient visits were down 2% in the third quarter. Emergency department outpatient visits were down 1.7% in the quarter, but just over 70% of that decline is due to a reduction in flu, so non-flu ED visits are basically flat year-over-year. Outpatient surgeries were up modestly, increasing by 0.1% and adjusted admissions were down only 1.8%.
The volume losses this quarter and this year have been confined to a small number of hospitals. In fact, just seven hospitals comprise more than 70% of our total admissions declines in the third quarter. So while these seven hospitals cost the majority of our volume losses, the other 42 hospitals in the aggregate are performing better than the industry average. 
The seven hospitals are widely dispersed. There are two in Texas, but they're not in the same market. The other five are each in different states. Interestingly, although California is challenged by extremely high unemployment in some of our markets, none of our California hospitals are among the seven.
There is no single theme for the volume losses at these seven hospitals. One of the hospitals is having a solid and growing year, but faced an extremely tough comparison on volumes in Q3. Another one lost to unprofitable volume. Those two, plus three others, grew EBITDA significantly despite their volume losses. 
The two others saw challenges with their physician channels. These are instances where physicians have gone into direct competition with the hospitals, or where competing hospitals have engaged in very aggressive and sudden physician employment strategies. No matter the reason for the volume declines, we're responding appropriately, and we believe that we are already turning the losses around. In October, in these seven hospitals, while still down, the volumes were down by a lower percentage than in the third quarter.
Turning to service lines. I already mentioned that a third of the total volume decline was in OB. Looking beyond OB to some elective service lines, I'd like to share some interesting insights with you. As we're deep into the recession, it's very clear that patients who have a significant personal financial responsibility are behaving very differently than patients who don't. We've known all along that this was driving reductions in our commercial elective surgical volumes. But let me give you some facts that our orthopedic surgeries as an example.
If you look at Slide 10, you'll see that total admissions for orthopedic surgeries declined by 2.5%. Commercially insured orthopedic surgeries declined by 9%. Orthopedic surgeries for all other patients, most of whom are covered by Medicare or Medicaid, actually increased 0.2%. 
The same pattern is true with spinal fusions. Commercially insured spinal fusions declined by 160 admissions or 15% in the third quarter, but noncommercial spinal fusions increased by 17% or over 150 admissions in the quarter. Since the same physicians are doing these surgeries for both payer classes, the loss of commercial volumes and the growth of noncommercial volumes suggests this behavior is being driven by the patients, not the physicians. We believe this patient behavior is largely related to economic uncertainty on the part of the patients, commercial enrollment losses and rising co-pays and deductibles for those who remain insured.
Again, on Slide 10, you can see this pattern holds true across several service lines that we would consider as elective and easy to defer. Slide 11 illustrates that when a procedure is harder to defer, like in the case of OB, the changes in volumes in the commercial and noncommercial populations are very similar. 
Despite the challenges to volume growth, favorable pricing and acuity continue to drive a stable picture for revenues. Commercial pricing remains particularly strong. We also had a 2.4% increase in commercial acuity. The result was positive commercial revenue growth of nearly 1% for the quarter. Collectively, this helped us generate adjusted free cash flow of $53 million in Q3, bringing year-to-date free cash flow to positive $74 million. 
We've made a lot of progress on other fronts in the quarter. We continue to improve and de-risk our capital structure, pushing out the majority of our 2013 maturities to 2020, while retiring $229 million face value of debt. This brings our total debt to slightly more than $4 billion with no meaningful maturities for five years. We also entered into a new $800 million credit line with new flexibility with regard to our capital allocation options, including lifting an existing limitation on stock repurchases.
Earlier this year, we drew your attention to the seven items on Slide 14, which we believe can drive significant expansion in earnings growth over the next few years. While some of these items depend on a recovering economy, three of these initiatives, Outpatient, Medicare Performance Initiative and Conifer, were more directly under our control and less dependent on an economic recovery.
Just walking down the list for a minute, our newly acquired outpatient centers are already coming online. We expect to have invested about $70 million in outpatient acquisitions by the end of 2010 and believe there are enough great opportunities that we could do that again in 2011. We anticipate these acquisitions will add $100 million to $150 million to revenues in 2011, and given the much higher margins in this business, contribute as much as $30 million to $40 million in 2011 EBITDA.
Turning to MPI, we are very much on track with our 2010 objective of a $30 million incremental EBITDA contribution. While we have not yet completed our MPI plan for 2011, our preliminary view is for another $30 million. Conifer will take longer to gain visibility, but we remain very excited about its prospects. Conifer's contributions from outside clients to 2011's EBITDA growth will exceed $10 million.
Our healthcare information technology initiative will again create incremental expenses in 2011. And as previously disclosed, we are not planning on a net positive net financial contribution from the initiative prior to 2012. Earlier last month, we went live at four hospitals, and the rollout went smoothly. We're going live at an additional three hospitals this month.
In addition, we continue to achieve solid commercial pricing that's consistent with the trends of recent years. To make major progress on margin expansion and EBITDA growth, we need volume growth and to go back towards prerecession bad debt expense levels. But it's still clear there's much we can achieve even in the absence of recovery.
So to wrap up, I believe we demonstrated once again that we have the appropriate and effective levers to pull in the short term to keep us on track relative to our longer-term performance milestone. I also believe our long-term growth strategies have us well positioned to face the myriad of challenges that 2011 will bring. 
And with that, let me turn the floor over to Biggs Porter, our Chief Financial Officer. Biggs?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thank you, Trevor, and good morning, everyone. The biggest item impacting our net income for the quarter is a recognition of the tax benefit of our net operating loss carryforward. This recognition resulted from our reversal of the previously-established",2155,"Thank you, Trevor, and good morning, everyone. The biggest item impacting our net income for the quarter is a recognition of the tax benefit of our net operating loss carryforward. This recognition resulted from our reversal of the previously-established valuation allowance and added $981 million to our net income or $1.75 per diluted share. 
Under generally accepted accounting principles, which arguably are conservative on this point, and in recognition of our sustained and sustainable return to profitability, the realization of this tax benefits has become sufficiently likely as to require its recognition in our financial statements. Given the conservative criteria applied in our GAAP, this makes a strong statement about the expectations of our future profitability and the value of the NOL.
As a result of this recognition, our income statement tax rate in future quarters will approximate a normalized tax rate of approximately 40%. From a cash perspective, however, we will continue to benefit from the tax shield, and our cash tax payments on future income will be primarily limited to state taxes, and will continue at the low level of recent years. They will remain low until our loss carryforward is fully utilized, which is still a number of years out.
The biggest item not impacting either net income or adjusted EBITDA in the third quarter was the $64 million net receipt of revenues related to the California provider fee. Due to delays and a very complex approval process, this materially favorable event was not recognized in the third quarter. The portion of the plan related to direct medical payments was approved after the end of the quarter, with the Managed Care portion still pending. We had expected that up to $55 million would be recognized in the third quarter. This delay has no affect on full year income but will cause some of the cash receipts to slip out of this year into next, which we estimate at a net $36 million.
Looking forward to next year, the California provider fee may be renewed for a half year, and a new fee in Pennsylvania worth approximately $25 million is in the process of development. Other states are also working on these types of arrangements. Just as food for thought, if you put the normalized 2010 value of the California provider fee at $37 million, the Pennsylvania fee and a partial extension of the California fee could more than replace that. So you should not think of the revenue from the California provider fee as being entirely non-recurring in looking at next year. From a cash basis, the cash received from provider fees could actually go up next year.
Adjusting both quarters for prior-year cost report adjustments, revenues grew slightly in the third quarter as a result of strong commercial pricing and case mix, offset by adverse payer mix and aggregate declines in paying volumes. As in the prior quarters of this year, case mix on commercial Managed Care was strong relative to last year, reflecting about a 3% increase. As I said in last quarter's comments, this increase in acuity has to be considered in understanding the economic effect of lower volume.
Our overall pricing picture remains positive. Even with the commercial volume declines we experienced in the quarter, commercial pricing gains were sufficient to drive growth of 0.9% in commercial revenues in the quarter. Because of the payer mix shift, however, net inpatient revenue per admission increased by only 1.1%, and net outpatient revenue per visit increased by 5.6%. 
The strong increase in outpatient pricing reflects the loss of H1N1 volumes from last year, which had generated lower revenues per outpatient visit. The absence of flu volumes in this year's third quarter drove average pricing higher. Once again, this demonstrates the necessity of understanding acuity and patient mix when assessing the economic effects of volume fluctuations.
While Im on the topic of pricing, I will comment that we continue to have very good visibility with regard to our forward pricing. At this point, approximately 80% of our commercial contracting is complete for 2011 and 40% for 2012. 
Turning to cost. Although the benefits weren't fully visible in the third quarter, we successfully took action to flex our cost structure. As Trevor mentioned, July's volumes were particularly weak. We responded very quickly to reduce our staffing and implemented a significant reduction in force in August. We incurred a couple of million in severance costs as part of this, but this August action left us well positioned for the balance of the quarter. Those cuts should also have full visibility in our fourth quarter. 
In addition, we have delayed our annual merit increases for the general population from October 1 to January 1. This takes us a step closer to timing our merit increases for all employees in the April time period where they used to be.
The result of these actions are immediately evident in our internal measures of productivity, which looks at FTEs per adjusted average daily census. Despite the soft volumes in the quarter, this productivity measure actually improved in the third quarter as FTEs per adjusted average daily census declined in September by 1.2%.
Supplies cost were essentially flat in the quarter. On a per-adjusted patient-day basis, the increase in supplies cost was 2.6% as adverse operating leverage and the increase in acuity offset the effects of our supply cost initiatives. The costs we recorded within other controllable costs line were more of a challenge. Many of the costs recorded under this heading are more heavily fixed or semi-variable in nature and, as a result, are more difficult to flex in response to soft volumes. 
We also recorded some incremental expense from items whose actuarially determined impact is adversely influenced by declining interest rates. While malpractice expenses increased by only $1 million relative to last year's third quarter, the decline in interest and therefore discount rates added $11 million to malpractice expense in the current quarter. Combined with an increase of $3 million in workers comp expense, lower discount rates added $14 million to operating expense in the quarter. This discount rate adjustment should be considered unusual at this point given the low rates we were already seeing on U.S. Treasuries and can be expected to more than reverse itself in the future when interest rates rise to normal levels, thereby creating earnings upside of up to $40 million at some point in the future.
In addition, we recorded an incremental $4 million in HIT expense. As Trevor mentioned, we successfully went live on the first phase of these systems at four of our hospitals in the month of October, and we now expect the incremental effects of these expenses to be down to $11 million in 2010. We expect this incremental expense to increase in 2011 prior to being offset in 2012 by the recognition of federal incentive payments. This increase is not a deferral of 2010 expenses, but is reflective of the increase in a number of implementations in 2011.
Our bad debt ratio declined to 8.3% in the quarter, a 20 basis point decline relative to 8.5% a year ago. This decline includes the recurring benefits of federal Medicare bad debt recoveries as well as declines in uninsured volumes. We view the size of this quarter's Medicare bad debt recovery as representative of ongoing sustainable impacts that can be expected in future quarters.
We had $398 million in cash and cash equivalents at quarter end, a decrease of $313 million from June 30. The largest driver of the cash decline was the use of $274 million to reduce debt. Cash provided from continuing operations was $160 million, and adjusted free cash flow was $53 million after capital expenditures of $107 million in the quarter. 
In the third quarter year-to-date, our cash from operations has been held back by lower levels of accounts payable than in the prior year. Some of this is due to the timing of expenditures, overdrafts and disbursements. We've not changed policy or contractual arrangements, however, and we expect payables to expand again by year end.
Subsequent to the end of the quarter, we completed the sale of a number of our Florida medical office buildings, generating cash of $46 million. As a part of the sale, the buyers committed to certain capital improvements to the facilities, which will benefit our physician tenants. These MOBs had immaterial annual rents and EBITDA. 
We continue to actively market additional MOBs, and we believe a number of these transactions could be completed in the next few quarters. At this point, we have other MOB contracts pending worth approximately $50 million, but in real estate, nothing is done until it closes, so it is not reflected in our outlook.
Turning to our outlook. We have raised the low end of our outlook to a new range of $1.05 billion to $1.1 billion. We raised both ends of the range on pretax income, reflecting lower depreciation and interest expense. Our revised assumptions are detailed on Slide 24. These revision includes the lowering of our volume and revenue estimates, which are tied to related reductions in our cost estimates for the balance of the year. 
There's been speculation that volumes will grow in the fourth quarter on more than a seasonal basis due to the effects of co-pays and deductibles. At this point, we're going to be conservative and not count on that in our outlook. The walk-forward of cash from September 30 to December 31 is provided on Slide 25 breaks down fourth quarter cash flow into its major components. 
It's too early to give an outlook for 2011, but I do think it's appropriate to give a little balance to what the headwinds and opportunities are going into next year. First, the biggest challenge remains on the volume side, but some of the effects of the economy and flu should have anniversaried by the end of this year. Economic stability followed by recovery would presumably create upside. Second, we expect the full year benefit on the outpatient acquisitions we're completing on the second half of this year and a partial benefit of those we are targeting for next year.
Third, we're already seeing improvement in the yield on our physician additions the last couple of years, and we expect expansion of that benefit in 2011 and beyond. Fourth, commercial pricing is almost completely negotiated with reasonable consistent price increases expected next year. Medicare, all in, is basically flat as outpatient increases offset inpatient decreases. I've already talked about state funding and potential new provider fees with the 2009 retroactive portion of the California provider fee being the one element most challenging to replace.
Finally on the cost side, we will increase our investment in our physician base and HIT, both of which will yield improvements for the future. And we will continue to drive on our Medicare Performance and related initiatives to reduce length of stay and supply costs. 
In the aggregate, we will continue to drive toward industry margins. We have confidence in the path we have laid out. The only gating consideration in what the near-term timing and slope of progress is going to be is the degree of economic headwinds we must offset. On the positive side for 2011, we expect to drive value in outpatient investments, physician base initiatives, commercial pricing and the Medicare Performance Initiative. The big potential near-term negative, longer-term a positive is, as I just said, the effect of economic conditions. It is not clear and therefore remains subject to continuing evaluation by us, as to what extent economic conditions will offset the net positive drivers of growth in 2011.
So to summarize. The value of our NOL carryforward has been confirmed from an accounting standpoint. We have raised our outlook for EBITDA at pretax and net income for the year. We approved cost efficiencies in the quarter, as we were able to react quickly to significant volume declines in the first months of the quarter. This will be fully visible in the fourth quarter. 
Free cash flow came under pressure due to the timing of disbursements in rising CapEx. But because of the timing effects on accounts payable will reverse themselves, we have retained our free cash flow outlook for the year. Pricing continued as a source of strength. Commercial case mix remained favorable compared to the prior year. California provider fee has been partially approved while full approval expected this quarter. 
And one last point. From a volume and payer mix standpoint, this was the weakest quarter we've experienced, clearly reflective of the economic headwinds. However, the fact that we held earnings flat on a normalized basis and even in this harsh an environment demonstrates that we are well positioned to grow earnings as the economy moderates and/or as our volume initiatives yield increasing results. 
Let me now ask the operator to assemble the queue for Q&A. Operator?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","[Operator Instructions] Our first question comes from the line of John Rex with JP Morgan.",15,"[Operator Instructions] Our first question comes from the line of John Rex with JP Morgan."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And the issue here for me is when we look at the share, the erosion in commercial, and it's just been persistent now over the past many quarters in terms of actually kind of seeing accelerating losses. So my question is, it looks like you're losing share",101,"And the issue here for me is when we look at the share, the erosion in commercial, and it's just been persistent now over the past many quarters in terms of actually kind of seeing accelerating losses. So my question is, it looks like you're losing share when I compare it to what I'm seeing from others and when I even think about what I'm seeing as kind of more stabilizing trends in just commercial coverage broadly. So can you tell us how you look at that in terms of the potential share losses you might be seeing in you markets?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Yes, John. This is Trevor. That's a good question. I have to comment first, and I'm going to turn it over to Steve Newman, because we've done extensive analysis of this share question. But I first just have to make the comment that it is very difficult to",136,"Yes, John. This is Trevor. That's a good question. I have to comment first, and I'm going to turn it over to Steve Newman, because we've done extensive analysis of this share question. But I first just have to make the comment that it is very difficult to compare the commercial statistics that we've been disclosing in any kind of context to the industry at large or even the peer companies, because you're not getting that same type of disclosure. So not that everybody should do it and not to say that we don't regret starting with disclosure, but you really can't look at these commercial numbers and draw any conclusion about share from them. Now having said that, we've done a lot of work on shares, so I'll ask Steve to comment on that. Steve?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","John, I think it's an excellent point, and we've got a great deal of evidence that we're not losing commercial managed care market share except in the markets of the hospitals that Trevor mentioned in his comments. Our evidence comes from three separate s",99,"John, I think it's an excellent point, and we've got a great deal of evidence that we're not losing commercial managed care market share except in the markets of the hospitals that Trevor mentioned in his comments. Our evidence comes from three separate sources: First, our statewide all-payer database; second, our large statewide Blue Cross plants, where we have significant penetration in those markets; the third is a review of our market share with three of the largest national commercial payers. In summary, these studies all suggest, except in a few isolated instances, our commercial market share is stable."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","And I think, John, we triangulated on that question. As Steve said, there's several different approaches to it. But very hard to do with precision. So this quarter, we did something we hadn't done before, which was essentially go to the payers who would g",109,"And I think, John, we triangulated on that question. As Steve said, there's several different approaches to it. But very hard to do with precision. So this quarter, we did something we hadn't done before, which was essentially go to the payers who would give us this information to say, ""Look, this is our change in volume with you in this particular market. Tell us, because you have access to it, what is the share change, and it was very reassuring in all cases with the exception of a few, where it's clear that we're losing share because there's some new competitor or some different dynamic in the market."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","If you look at the seven hospitals that you spiked out, what percent of company revenues would they represent? I'm trying to compare, if I think about your top seven hospitals and percentage of revenue they represent. If you group these seven, where would",46,"If you look at the seven hospitals that you spiked out, what percent of company revenues would they represent? I'm trying to compare, if I think about your top seven hospitals and percentage of revenue they represent. If you group these seven, where would they fall?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","They do tend to be some of our larger hospitals. So we have a portfolio that ranges in size, but does have some large ones. And I think, when you have a quarter where the large hospitals are underperforming on any given statistic, it tends to drive the co",88,"They do tend to be some of our larger hospitals. So we have a portfolio that ranges in size, but does have some large ones. And I think, when you have a quarter where the large hospitals are underperforming on any given statistic, it tends to drive the company in that direction and vice versa. And unfortunately, this is one of those quarters and I've seen other ones over the time that I've been with Tenet, where the largest hospitals, with exceptions, were moving in the wrong direction."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","So these are not our seven largest hospitals, but amongst them are some of our largest hospitals.",17,"So these are not our seven largest hospitals, but amongst them are some of our largest hospitals."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So I'd find some of that in that category then. And does the stabilizing coverage levels, do you think that's going to have impact or what you're seeing at this point, is it less about erosion in just commercial coverage and more just about avoidance of t",53,"So I'd find some of that in that category then. And does the stabilizing coverage levels, do you think that's going to have impact or what you're seeing at this point, is it less about erosion in just commercial coverage and more just about avoidance of the carenstein [ph] (41:09) at all?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, you've got the baseline high-shrinking issue of the commercial enrollment losses that's been running around 4% among the big payers. You start with that. And then you add to it some utilization issue that potentially is driven by the economic incent",171,"Well, you've got the baseline high-shrinking issue of the commercial enrollment losses that's been running around 4% among the big payers. You start with that. And then you add to it some utilization issue that potentially is driven by the economic incentives that are inherent in higher deductible health plans. And now the enrollment losses you could see turn around in a stronger economy, the shift towards higher deductible plans and whatever's depression of consumption exist [ph] (41:46), that could be a longer-term trend. But like just this morning, I was encouraged to see in the newspaper the results of the Kaiser survey that, among very small employers, coverage is going way up due to these tax incentives that they've been provided with. So among firms with something like nine to 13 employees or five to 13 employees, but the coverage percentage was up like nine points. I may have sound of that a little bit wrong, but it was an encouraging trend among the smallest segment of the employer population."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Shelley Gnall with Goldman Sachs.",13,"Our next question comes from the line of Shelley Gnall with Goldman Sachs."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I'm wondering, is it possible to generalize across your markets those that are hardest hit? So for example, in California, you've got a number of markets where youve got unemployment north of 15% and 16%. And then you've got healthier markets, like tho",78,"I'm wondering, is it possible to generalize across your markets those that are hardest hit? So for example, in California, you've got a number of markets where youve got unemployment north of 15% and 16%. And then you've got healthier markets, like those in Texas that are 8% to 10% unemployment. Is it possible to generalize where you are able to take share and where you just don't see a market share opportunity across all payer classes?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","So hard to generalize, and one of the reasons I mentioned that among the seven hospitals generating 70% of the admissions decline, none are in California, because we did not see, in terms of the volume performance of our hospitals, a correlation with unem",215,"So hard to generalize, and one of the reasons I mentioned that among the seven hospitals generating 70% of the admissions decline, none are in California, because we did not see, in terms of the volume performance of our hospitals, a correlation with unemployment. And our highest unemployment markets were really not having a volume problem. And conversely, where we've seen this physician competition phenomenon that has really created new capacity and a new entrance into a market that's very aggressive, owned by physicians were they have the ability to direct patients, thats in some of our markets with the lowest unemployment or the best trends in unemployment. So I would set aside the unemployment correlation. We've also seen some very strong volume performance in Florida, which is a market that's struggled for a long time. And that I think can be attributed to strong management actions and a market working cohesively on business development activity. So you really -- at the risk of having added two paragraphs to my script on this volume stuff, I'm trying to convey an impression that there is not an overall trend one way or another that you can point to or some correlation, that it's really more one-off issues. And that's the way we've had to manage them."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Other than the cost shifting that you're seeing from the commercial payers, are there any other specific actions that they're taking to limit utilization specifically on the inpatient side?",30,"Other than the cost shifting that you're seeing from the commercial payers, are there any other specific actions that they're taking to limit utilization specifically on the inpatient side?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, one thing that's causing a lot of noise in the statistics is this trend towards observation status, which originally was contemplated as something only to be used in Medicare and now it's widely used in the payers. And I think other companies have t",63,"Well, one thing that's causing a lot of noise in the statistics is this trend towards observation status, which originally was contemplated as something only to be used in Medicare and now it's widely used in the payers. And I think other companies have talked about that. We didn't break it out specifically, but it's of course a contributor to weak inpatient admissions."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Tom Gallucci with Lazard Capital.",13,"Our next question comes from the line of Tom Gallucci with Lazard Capital."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","First, the Slides 10 and 11 that you offered on the commercial versus noncommercial admission trends, very interesting data. Curious if you look back, is the discrepancy between those two payer classes growing or moderating? Or how would you consider that",42,"First, the Slides 10 and 11 that you offered on the commercial versus noncommercial admission trends, very interesting data. Curious if you look back, is the discrepancy between those two payer classes growing or moderating? Or how would you consider that trend?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Tom, being that it's a new slide, we didn't really look back on it and don't have a trend for you on that. We've looked for quite a long time at what we would consider discretionary versus less discretionary service lines and have had more pressure in the",103,"Tom, being that it's a new slide, we didn't really look back on it and don't have a trend for you on that. We've looked for quite a long time at what we would consider discretionary versus less discretionary service lines and have had more pressure in the discretionary. And obviously, when you're in a quarter that's as tough as the one that we just emerged from, you dig a lot harder for explanations, and this was a very interesting one that came through, but we didn't go back and run it historically. It's actually not that difficult to do, so we could."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then you mentioned Managed Care, 80% of your contracting, I guess, are done for next year, 40% the following year. Could you just remind us of sort of the average rates that you're expecting and also maybe more importantly, comment sort of on the tone",85,"And then you mentioned Managed Care, 80% of your contracting, I guess, are done for next year, 40% the following year. Could you just remind us of sort of the average rates that you're expecting and also maybe more importantly, comment sort of on the tone of discussions? I guess there have been some suggestions out there that obviously the Managed Care environment is getting a little more difficult for the payers. I'm wondering if that's leaking into the tone of conversations with you all."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","This is Biggs. First of all, to address the rate question, the rates that we've negotiated for next year are pretty much in-line with what we've budgeted as negotiated rates for 2010. Ultimately, the yield we get on those will determined by case mix index",73,"This is Biggs. First of all, to address the rate question, the rates that we've negotiated for next year are pretty much in-line with what we've budgeted as negotiated rates for 2010. Ultimately, the yield we get on those will determined by case mix index and any payer shifts between the plans, but the negotiations are very much in line with what we've budgeted and achieved this year from a peer-rate negotiation standpoint."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And the tone of discussions, as you're looking further out, maybe one or two years out.",16,"And the tone of discussions, as you're looking further out, maybe one or two years out."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","As for tone, Steve, you want to add anything to that?",11,"As for tone, Steve, you want to add anything to that?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'd just say that negotiations are taking a little bit longer than they have in the past, and we're pushing for more pay for performance to be added to those contracts as we move toward a value-based purchasing environment.",40,"I'd just say that negotiations are taking a little bit longer than they have in the past, and we're pushing for more pay for performance to be added to those contracts as we move toward a value-based purchasing environment."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I guess the only thing I would add is I've made an effort to stay close to the senior executives, some of our largest customers, and to remind them that we provide a very good value solution for them. We have demonstrated high quality. They assess that th",193,"I guess the only thing I would add is I've made an effort to stay close to the senior executives, some of our largest customers, and to remind them that we provide a very good value solution for them. We have demonstrated high quality. They assess that themselves. So I don't need to convince them of that. And our price point relative to our competitors in virtually all of our markets is certainly not the highest, and sometimes it's on the low end of the market pricing, and typically with a large, prominent, successful, not-for-profit system leading the way on pricing. So I feel that we are well positioned with the national payers from a value point of view. We're also exceedingly well positioned when they look at the total cost of doing business with us because we have streamlined and automated the revenue cycle process with them. So we have lowered -- they tell us, we have lower-than-average denials. We have better-than-average electronic connectivity and we offer a total solution that I think is very effective as they start to look harder at price sensitivity and narrow networks in their markets."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Adam Feinstein with Barclays Capital.",13,"Our next question comes from the line of Adam Feinstein with Barclays Capital."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I guess the volume weakness is something that everyone was talking about throughout the quarter. So I dont think that really caught people that off-guard. I guess it was just throughout the year with the volume weakness, you guys have able to offset it",165,"I guess the volume weakness is something that everyone was talking about throughout the quarter. So I dont think that really caught people that off-guard. I guess it was just throughout the year with the volume weakness, you guys have able to offset it through better unit pricing growth as well as just cost cutting. So I guess the question is, as you look back on the quarter, Trevor, just maybe talk about -- and you guys called out a few things like the discount rate and some of the issues around cost there, but I guess just in terms of the ability to offset the volume weakness, and not even just for the most recent quarter but going forward as well, maybe just to go back through and talk about some of the initiatives there and certainly, you have the great slide deck here with that, but to just get some more clarity in terms of just visibility around the ability to offset volumes."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I think, Adam, in the beginning of your question, you touched on a topic that I think is important just to be very clear about in case it wasn't clear enough in the scripts. But we were trying to make the point that although I think the industry-wide volu",358,"I think, Adam, in the beginning of your question, you touched on a topic that I think is important just to be very clear about in case it wasn't clear enough in the scripts. But we were trying to make the point that although I think the industry-wide volume weakness was well known throughout the quarter, there were plenty of surveys and other indicators that, that was taking place; what was surprisingly negative was July. And so I mentioned that July was particularly weak and then we took actions to reduce cost. Of course, those actions couldn't be taken in July; they were taken in August and had that effect of creating a positive trajectory in EBITDA from July to August to September. And as volume losses moderated from July through August through mid-September, then they did turn down in late September; that's the implication of saying that they were strong through mid-September. So I think one way -- the thing I would characterize as being unusual in the third quarter at least for us was how negative the first month was and then the fact that although many in the industry anticipated some snap back and August was encouraging, that, that encouraging trend at least in terms of volume did not persist through the entire quarter. And then based on our comments about October, it didn't persist into October. But I think to answer your question about what we can do and how we've been able to offset weak volumes, obviously, it's very hard on a month-to-month basis; it gets easier on a quarterly basis and it gets easier to accomplish. I shouldn't use the word easy because its not easy, but it's less difficult to accomplish on a yearly basis. And so, if you look at the quarter as a whole, we really overcame a lot of challenge that we had right out of the box in July. But it's difficult to do more in a short period of time. I think we have positioned ourselves well going into the fourth quarter. But again, we don't even have the first month of results on that yet."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Just on the unit pricing, the 1.1%, you talked about mix having some impact there. So maybe just to get you to go back through some of that, I guess, the commercial piece you talked about but just within the other categories just maybe a quick update ther",81,"Just on the unit pricing, the 1.1%, you talked about mix having some impact there. So maybe just to get you to go back through some of that, I guess, the commercial piece you talked about but just within the other categories just maybe a quick update there in terms of -- and I guess, what are you guys thinking about in terms of a normalized revenue per admit number if you try to clean up some of the noise there?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, what's normal at this point will depend largely upon whether the OB admissions stay down or not for an extended period because one of the reasons why case mix is up is because obstetrics are down. Obstetrics will probably stay down for quite a while",145,"Well, what's normal at this point will depend largely upon whether the OB admissions stay down or not for an extended period because one of the reasons why case mix is up is because obstetrics are down. Obstetrics will probably stay down for quite a while. So I would expect on that basis, case mix to not changed radically over the near term. As I said, case mix on commercial Managed Care was up about 3%. It was up about 1% on a Medicare Managed Care and up almost 5% on Medicaid Managed Care. So in most of the categories, it was up in the quarter. We'll see, of course, with that was over a longer term but there's nothing right now that indicates that, that would change. So we'll just have to watch it but I think is reflective of the economics of today."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I just point, Adam, that we had a 5.6% increase in revenue per outpatient visit that was largely driven by increases relatively speaking of outpatient surgery and high-end imaging like CT and MRI.",33,"I just point, Adam, that we had a 5.6% increase in revenue per outpatient visit that was largely driven by increases relatively speaking of outpatient surgery and high-end imaging like CT and MRI."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'm going to add a response to, I think it was John's question earlier on the revenue from the seven hospitals. We went and pulled the statistic and from a pure numeric standpoint, the seven hospitals are 14% of our hospital count. From a revenue standpoi",92,"I'm going to add a response to, I think it was John's question earlier on the revenue from the seven hospitals. We went and pulled the statistic and from a pure numeric standpoint, the seven hospitals are 14% of our hospital count. From a revenue standpoint, they comprise 18% of the revenues in the quarter. So a little more heavily weighted than the peer hospital account but not, as I said, because it's not all the largest hospitals that are in there, it's not a real disproportionate share of the revenue."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Ralph Giacobbe with Credit Suisse.",13,"Our next question comes from the line of Ralph Giacobbe with Credit Suisse."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","In the release, you mentioned increased physician employment. And I think in the past, you've talked about not necessarily wanting to employ. Can you maybe talk about what's changed to your strategy there and maybe just give us a sense of the base that's",51,"In the release, you mentioned increased physician employment. And I think in the past, you've talked about not necessarily wanting to employ. Can you maybe talk about what's changed to your strategy there and maybe just give us a sense of the base that's employed currently and where that can go?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Steve, you want to take that?",6,"Steve, you want to take that?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Sure. Ralph, we've done a number of things to affect physician recruitment. First thing we've done is expanded the number of staff focused at the hospital level as well as at the regional corporate level on physician recruiting. Another thing we've done i",120,"Sure. Ralph, we've done a number of things to affect physician recruitment. First thing we've done is expanded the number of staff focused at the hospital level as well as at the regional corporate level on physician recruiting. Another thing we've done is we've reassessed our community need and revised the medical staff development plan for each of our hospitals. The third thing that I think we've done thats significant is we revised the process for targeting redirection of our local physicians, and we've improved that on-boarding process as well as orientation for these successfully recruited or redirected physicians. Finally, we believe that this will improve the productivity and retention rate of the physicians that we've been able to recruit."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I guess I'm just trying to get a sense of, is this sort of in reaction to what's going on in your markets, where there perhaps was a reluctance to employ in the past, but now you need to because others are doing it and perhaps that can explain some of the",59,"I guess I'm just trying to get a sense of, is this sort of in reaction to what's going on in your markets, where there perhaps was a reluctance to employ in the past, but now you need to because others are doing it and perhaps that can explain some of the weaker volume trends that youve seen?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, look, I will be the first to say that I had a particularly bad attitude about jumping into the employment trend having experienced firsthand the disasters of the late 90s when hospitals rapidly purchased practices and employed physicians and lost",434,"Well, look, I will be the first to say that I had a particularly bad attitude about jumping into the employment trend having experienced firsthand the disasters of the late 90s when hospitals rapidly purchased practices and employed physicians and lost tremendous amount of money. But this is a trend that is inexorable. It started with the large, most prosperous not-for-profits. We compete against a lot of those in our markets and we have completely adopted a, I think, new and improved way to do this. So just to go in order of sort of the problems and what we're doing about it, purchasing practices is really not market practice anymore. It's employing physicians. So you don't have the problem from the 90s of spending a lot of capital on purchasing something that turns out to not be worth of what you paid for it. So it's really hiring talent. And then in terms of hiring talent, we've become very sophisticated about how to do it in terms of providing incentives for productivity so we don't experience the next problem that was characteristic for the 90s, which is hiring physicians, which essentially was enabling them to retire at the expense of the hospital. So we're incentivizing productivity. And we've also experienced some churn of the employee physicians based on those who failed to meet the productivity targets leaving and those who are succeeding in the productivity targets staying and enjoying the benefits of that. We've also been very selective in terms of the credentials of the physicians that we've been hiring. So just as if you undertook to hire a cadre of 200 MBA students, youd want to go to the top schools and hire the best students; we're doing the same thing when it comes to physicians. We're also being very selective about filling certain holes in specialties or building primary-care networks, where that strategy is right. And then finally, rather than attempting to manage all these practices ourselves, we've employed in a joint venture format a practice management company that's an expert in doing this and running them at economic results that are superior to what hospitals generally experience. So I think all of those things together and I didn't mention the EMR solution that we're offering for physicians, so I think it's a better solution, and we probably got started later than we should have. And perhaps it's because of historic bias, at least on my part, against that as a strategy. But we are well into it now and have a very strong pipeline of physicians that we are employing."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I wanted to sort of revisit capital structure. You talked about sort of refinancing, pushing out debt maturities. Are you kind of happy where the company sits from that perspective? Is there anything else you would contemplate? Obviously, you mentioned sh",58,"I wanted to sort of revisit capital structure. You talked about sort of refinancing, pushing out debt maturities. Are you kind of happy where the company sits from that perspective? Is there anything else you would contemplate? Obviously, you mentioned share repo in your commentary, just given where the credit markets are and just the overall rate environment."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, I think, I'll answer and if there's anything left, Biggs can chime in. But as I mentioned, there are no significant maturities for five years. That's a long time. I don't think it would make any sense to push it out farther. That's actually quite a",136,"Well, I think, I'll answer and if there's anything left, Biggs can chime in. But as I mentioned, there are no significant maturities for five years. That's a long time. I don't think it would make any sense to push it out farther. That's actually quite a conservative approach to a capital structure, which I think is appropriate given the risks in the business and the historic leverage that we've had. We've also obviously brought down the leverage ratios substantially. This new credit line offers us a lot of flexibility. Were obviously not commenting today on the potential for share buybacks, but it's obviously something we couldn't even consider prior to this new credit line. So we'll just have to see depending on circumstances what we decide to do there. Biggs, did I leave anything out?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","No, I think there's some small amounts of the '11 and '12 maturities still outstanding, so obviously, over time if not at maturity, we will retire those in due course. And otherwise, with respect to capital structure, our big driver is to keep driving on",70,"No, I think there's some small amounts of the '11 and '12 maturities still outstanding, so obviously, over time if not at maturity, we will retire those in due course. And otherwise, with respect to capital structure, our big driver is to keep driving on improving free cash flow, drive up earnings and drive free cash flow along with it. And further improve all of the statistics and the ratios."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Darren Lehrich with Deutsche Bank.",13,"Our next question comes from the line of Darren Lehrich with Deutsche Bank."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Just around capital and deployment of capital, if you include some value of your NOL, you're probably trading just a little under 5x your guidance for 2010 on an EBITDA basis. So I guess, I'd be curious to hear your thoughts what kind of assets you can bu",93,"Just around capital and deployment of capital, if you include some value of your NOL, you're probably trading just a little under 5x your guidance for 2010 on an EBITDA basis. So I guess, I'd be curious to hear your thoughts what kind of assets you can buy that are out there that are more favorable than that type of valuation. So are you seeing any acute-care assets? You've commented a little bit more about your interest in getting aggressive on the outpatient side. Maybe just update us generally on capital deployment priorities."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Obviously, if you employ a rule of thumb that says you should only acquire things that trade at a lower multiple than your own multiple, it's very limiting. Based on my comments about outpatient, it appears that we are doing that, and we're very pleased w",321,"Obviously, if you employ a rule of thumb that says you should only acquire things that trade at a lower multiple than your own multiple, it's very limiting. Based on my comments about outpatient, it appears that we are doing that, and we're very pleased with the outpatient acquisitions that we're making. I would say that the potential acquisitions of acute care hospitals that would be of interest to us or of the greatest interest to us, there are certainly more hospitals considering selling themselves or seeking partnerships of some kind. And we're spending more time than we ever have exploring those types of things. I think it's premature to talk about value and whether we would actually proceed and devote our capital in that way. What we haven't been doing, you obviously noticed, is we have not been competing in the auctions that have been out there for standalone hospitals or hospitals that are distressed or whatever other acute-care transactions are out there. I don't think we are necessarily the best potential acquirers for those kinds of things. Where we have been focused is more in our markets of things that have some degree of synergy, where we understand the market, we understand the dynamics and the future trends. And obviously, given the uncertainties around healthcare reform, is something you have to take into consideration when you evaluate the hospitals. So for that reason, we've been most focused on the outpatient side. I think that you'll agree, since we gave some disclosure on those numbers, that those are incrementally very helpful acquisitions for us. We like that business and will continue to do that as much as possible. And then, with -- there may be opportunities in the future within our Services business, which we're also very excited about. The multiple issue tends to present a barrier there, but we have to keep our eyes open on that as well."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And if I could just follow-up maybe clarify a point you made earlier about the cost savings actions in Q3. I guess just putting some rough numbers on the FTE figures you provided us, Biggs, it would seem like that's about maybe a $20 million to $30 millio",70,"And if I could just follow-up maybe clarify a point you made earlier about the cost savings actions in Q3. I guess just putting some rough numbers on the FTE figures you provided us, Biggs, it would seem like that's about maybe a $20 million to $30 million type of annualized savings run rate. Is that a good range to work off of for what we'll see in Q4?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","As I said, it's 1.2% improvement in productivity. So it's probably a little north of that, approaching $40 million on an annual basis. Real near term, comparing third quarter to the fourth quarter, other improvements we expect are on the malpractice and w",197,"As I said, it's 1.2% improvement in productivity. So it's probably a little north of that, approaching $40 million on an annual basis. Real near term, comparing third quarter to the fourth quarter, other improvements we expect are on the malpractice and workers comp side where we took the hits in the third quarter for the discount rate. We expect those to not occur in the fourth quarter and possibly will have improvement again in the fourth quarter as a result of what continues to be good claims experience. Another thing looking at the third quarter, as I said, there was a couple million dollars of severance costs in there, so that was the cost of achieving the reductions and we don't expect that to occur in the fourth quarter in the future. So there's a number of things going on in addition to just the pure FTE reductions to be considered looking at or later [ph] (1:05:48) this year and on to the future. And of course, we're still driving on the Medicare Performance Initiative, which was worth $30 million this year and expect to do a similar amount next year in terms of incremental savings."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Gary Lieberman with Wells Fargo.",13,"Our next question comes from the line of Gary Lieberman with Wells Fargo."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I was wondering if youd just maybe elaborate a little bit more on the line in the slide about the Managed Care portion of the provider taxes still awaiting approval from CMS and what that involves.",37,"I was wondering if youd just maybe elaborate a little bit more on the line in the slide about the Managed Care portion of the provider taxes still awaiting approval from CMS and what that involves."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Sure. The way this has been approved is in pieces. The fee for service portion of it was a little simpler in that it only involves the hospitals, the state and CMS. And so, that approval came first. The Managed Care portion of this has to flow through the",136,"Sure. The way this has been approved is in pieces. The fee for service portion of it was a little simpler in that it only involves the hospitals, the state and CMS. And so, that approval came first. The Managed Care portion of this has to flow through the Managed Care payers. And so contracts and structures have to be adjusted in order to allow for that money to flow through the Managed Care payers. And until that is totally defined, CMS basically withholds their approval on that portion of it. And so it should be seen as largely administrative in our mind, and that's why we're counting on the entire $64 million in our outlook. But it is a step that has yet to be completed between the states, the Managed Care payers and CMS."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And I guess just does the Managed Care portion have to be put to bed before the entire plan can take place? Or should we view it kind of as separate, so if by some chance the Managed Care portion didnt get approved",43,"And I guess just does the Managed Care portion have to be put to bed before the entire plan can take place? Or should we view it kind of as separate, so if by some chance the Managed Care portion didnt get approved"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","It's happening in pieces. And in fact, the direct payment portion of it, the fee-for-service portion, has already been implemented. And we've been invoiced and also are receiving funds on that portion of it, which is about half of the total. The other hal",61,"It's happening in pieces. And in fact, the direct payment portion of it, the fee-for-service portion, has already been implemented. And we've been invoiced and also are receiving funds on that portion of it, which is about half of the total. The other half the Managed Care piece will happen separately. But as I said, we expect it to happen."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Trevor, I know you mentioned that there wasn't any data on volumes for October. Any initial thoughts just in terms of anything that might stand out?",26,"Trevor, I know you mentioned that there wasn't any data on volumes for October. Any initial thoughts just in terms of anything that might stand out?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I actually commented on the volumes on October. I'm not sure what you mean by your question.",17,"I actually commented on the volumes on October. I'm not sure what you mean by your question."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Just in terms of any picture of service lines that look like they've been reversing trend or sort of continuation in trend.",23,"Just in terms of any picture of service lines that look like they've been reversing trend or sort of continuation in trend."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, it's too early for that. Usually, we have the volume data daily and then at the close of the month, but then to get clean service line and payer data takes a little longer.",35,"Well, it's too early for that. Usually, we have the volume data daily and then at the close of the month, but then to get clean service line and payer data takes a little longer."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Whit Mayo with Robert W. Baird.",14,"Our next question comes from the line of Whit Mayo with Robert W. Baird."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Trevor, can you go back and talk about the delay in merit paid? Did you say that, that was going to be pushed to January? I guess I didn't follow you.",31,"Trevor, can you go back and talk about the delay in merit paid? Did you say that, that was going to be pushed to January? I guess I didn't follow you."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Let me just tell you conceptually what we decided to do. We had multiple employee populations with an expectation of annual inflation/merit-oriented salary increases at different times in the year. So we've had for a long time a desire to standardize that",159,"Let me just tell you conceptually what we decided to do. We had multiple employee populations with an expectation of annual inflation/merit-oriented salary increases at different times in the year. So we've had for a long time a desire to standardize that all at the same time of the year, which is really the spring being the best time. And so, given the sort of rapidly decreasing expectations of inflation and also the observations we made of competitive practice declining in terms of the increases that competitors appear to be giving to people, what we've decided to do was to implement the program effective January 1, but to tell people in advance what they would get. So I think it's a very good solution from a cost management perspective. It also administratively will simplify our administration of these programs in the future. And it obviously was a prudent move to save costs in the second half of this year."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Is there any chance that, that may be delayed further into 2011? I guess I'm just wondering if that's a concrete start in January or whether or not",28,"Is there any chance that, that may be delayed further into 2011? I guess I'm just wondering if that's a concrete start in January or whether or not"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","No, that's concrete for January.",5,"No, that's concrete for January."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And any other benefit design changes, anything that's meaningful as we look out to 2011?",15,"And any other benefit design changes, anything that's meaningful as we look out to 2011?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Not that we're contemplating at this moment.",8,"Not that we're contemplating at this moment."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Biggs, I was just curious if we could get the P&L expense and the cash CapEx numbers for your electronic health records spend this year, at least year-to-date, and maybe a peek into what those two numbers may look like in 2011.",42,"Biggs, I was just curious if we could get the P&L expense and the cash CapEx numbers for your electronic health records spend this year, at least year-to-date, and maybe a peek into what those two numbers may look like in 2011."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'll do the second part first. On 2011, we're still in the planning process. We've completed, as I said, four implementations here in the last couple weeks. We have three more that are going live shortly among other things. We have to look at that experie",196,"I'll do the second part first. On 2011, we're still in the planning process. We've completed, as I said, four implementations here in the last couple weeks. We have three more that are going live shortly among other things. We have to look at that experience, what it's cost us, what lessons learned are as a part of fully defining next year's budget and expectations that we would communicate as a part of our outlook. But in any event -- but we do expect it to go up, as I said earlier. And maybe that's not so much an increase off of what we originally expected for this year as it is just an increase on where we actually landed for this year. So the comparative number for this year has come down as opposed to saying next year is increased off of what we might have expected before. This year, we're spending around $90 million in incremental spend. Actually, thats total spend. It's about $66 million of that is CapEx and about $23 million is expense. And like I said, the expense of $23 million represents an $11 million increase over the prior year."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","On the P&L.",4,"On the P&L."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","We do expect that number in total both on CapEx and expense to go up next year. But as I said, it's a little early to give a hard number.",30,"We do expect that number in total both on CapEx and expense to go up next year. But as I said, it's a little early to give a hard number."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Justin Lake with UBS.",12,"Our next question comes from the line of Justin Lake with UBS."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","First question just on the outpatient side, specifically, you looked at that as being opportunity. Talked about outpatient margin being significantly greater than inpatient. I'm just wondering if you can give us some color there in terms of a magnitude of",46,"First question just on the outpatient side, specifically, you looked at that as being opportunity. Talked about outpatient margin being significantly greater than inpatient. I'm just wondering if you can give us some color there in terms of a magnitude of the differential between those margins."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, I think they tend to be more than double. And the comments that I made in the opening suggest that we're buying these at very attractive multiples and that they have very high margins relative to the overall business. And so it's a very attractive f",49,"Well, I think they tend to be more than double. And the comments that I made in the opening suggest that we're buying these at very attractive multiples and that they have very high margins relative to the overall business. And so it's a very attractive form of acquisition."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Are you just talking about surgical centers at this point on the margin side because I think we all -- I think it's pretty clear those have margins that are much better than an in-patient hospital or acute care hospital.",40,"Are you just talking about surgical centers at this point on the margin side because I think we all -- I think it's pretty clear those have margins that are much better than an in-patient hospital or acute care hospital."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Most of what we've been doing is imaging centers. We have bought some surgery centers. But this year, not exactly clear how many will be able to close, but it'll be in the magnitude of 22-plus-ish imaging centers and three to four surgery centers. So far",52,"Most of what we've been doing is imaging centers. We have bought some surgery centers. But this year, not exactly clear how many will be able to close, but it'll be in the magnitude of 22-plus-ish imaging centers and three to four surgery centers. So far more on the imaging side."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then just a little bit of a cleanup on some of the 2011 moving parts. Can you give us any specifics on how much of a headwind healthcare IT is going to be next year? And then just to confirm, I think I heard you say that the provider taxes would be a",58,"And then just a little bit of a cleanup on some of the 2011 moving parts. Can you give us any specifics on how much of a headwind healthcare IT is going to be next year? And then just to confirm, I think I heard you say that the provider taxes would be a $36 million headwind year-over-year."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I think, actually, the latter one on the provider fee, the amount of the provider fee attributable to 2009 is what I said was the most challenging of the California provider fee and that's actually about $27 million of the $64 million. The amount, which i",59,"I think, actually, the latter one on the provider fee, the amount of the provider fee attributable to 2009 is what I said was the most challenging of the California provider fee and that's actually about $27 million of the $64 million. The amount, which is carrying over to next year from a cash standpoint is about $36 million."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","Is there other kind of provider fees or provider tax benefit you're getting this year that you don't expect? So you expect the other $37 million of the $64 million to reoccur again in 2011. Or is that something you would expect to guide to?",46,"Is there other kind of provider fees or provider tax benefit you're getting this year that you don't expect? So you expect the other $37 million of the $64 million to reoccur again in 2011. Or is that something you would expect to guide to?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Yes, well, what I've said was if you take the California fee, the current year portion of it will be replaced by in part a half year extension on California, we would expect, not yet done, but we would expect that plus $25 million from Pennsylvania and al",72,"Yes, well, what I've said was if you take the California fee, the current year portion of it will be replaced by in part a half year extension on California, we would expect, not yet done, but we would expect that plus $25 million from Pennsylvania and also not yet done but in works, and the sum of those two, yes, would offset the $37 million of current year California provider fee."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then just the healthcare IT increase year-over-year.",9,"And then just the healthcare IT increase year-over-year."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","As I just said, it's a little early to say. I think that this year, we've under-run significantly based upon incurring as much in the way of start-up costs and also being very efficient in the implementations that we have successfully completed here in th",122,"As I just said, it's a little early to say. I think that this year, we've under-run significantly based upon incurring as much in the way of start-up costs and also being very efficient in the implementations that we have successfully completed here in the last few weeks. So we've got to assess, if you will, what that means with respect to the implementation for next year. However, we do have more implementations next year than this year. More hospitals will be in process, so we do expect the number to go up. It's probably in the say low tens of millions kind of number, not a radical change in overall profitability associated with it, but we just have to finalize that."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So is that like $10 million to $30 million or is that $10 million to $15 million?",17,"So is that like $10 million to $30 million or is that $10 million to $15 million?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","$10 million to $30 million would be in the low tens territory I referred to. But as I said, it's early yet to put a hard number out there.",29,"$10 million to $30 million would be in the low tens territory I referred to. But as I said, it's early yet to put a hard number out there."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our next question comes from the line of Sheryl Skolnick with CRT Capital Group.",14,"Our next question comes from the line of Sheryl Skolnick with CRT Capital Group."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","If I take out the provider fee anticipated impact in fourth quarter, which I believe you said was $64 million, and I look at that, first of all, would it be correct to assume that, that would drop 100% to the EBITDA line?",43,"If I take out the provider fee anticipated impact in fourth quarter, which I believe you said was $64 million, and I look at that, first of all, would it be correct to assume that, that would drop 100% to the EBITDA line?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Yes.",1,"Yes."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","The answer to that I think is yes. And then second, if that's the case, then your guidance sort of implies something on the order of a quarter thats flat on the EBITDA line with third quarter to something that is would be up around the sort of $270 mil",130,"The answer to that I think is yes. And then second, if that's the case, then your guidance sort of implies something on the order of a quarter thats flat on the EBITDA line with third quarter to something that is would be up around the sort of $270 million to $280 million in order to achieve the $1.050 billion to $1.1 billion if my math is correct. So if I look at those numbers, I'm still not sure how you get to the upper end of the range. So my question then becomes, what really has to go right for us to be optimistic that you can get back on the path of exceeding not only consensus but achieving the high end of your guidance or even exceeding it?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I'll try to answer the first batch. Obviously, we've taken cost out. We've talked about that. And if you look at this from a per-adjusted patient-day basis in Q3, our experience was around $2,050. Q3 year-to-date was $1,995. So clearly, Q3 jumped up. Q4,",312,"I'll try to answer the first batch. Obviously, we've taken cost out. We've talked about that. And if you look at this from a per-adjusted patient-day basis in Q3, our experience was around $2,050. Q3 year-to-date was $1,995. So clearly, Q3 jumped up. Q4, we look at being back around that $1,995 kind of level. So based upon the reductions in staff, the improvements forecast on med mal, severance not recurring as I already talked about, some other initiatives to drive down costs, we think we get back down to that $1,995 kind of level. So that's at the middle of the range. And of course, there's opportunity to go beyond that to help drive towards the other end of the range as well. From a revenue standpoint, we've just looked at what's real recent experience on volumes. And as I said, we didn't presume any kind of a hockey stick in the last two months of the year. But from an overall admit standpoint, at the middle of the range, we could be at a negative 4% to 5% and still hit the middle of the range and commercial still be in that 6% to 7% kind of range that we were at in the first half. Once again, it would be at the middle of the range. So those seem like, based on everything we know, still some reasonably conservative positions to be taking as we look at the underlying trends. So there's opportunity in my mind for us to do better than those, both on the cost side and on the volume side, but as you know, we didn't take up the upper end of the range because we wanted to stay conservative and not presume that we were going to do better than those and lift ourselves, I'd say, to build a range based on those stats."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And then with, because all of these questions, I think, are getting around the point of just for how long is the pattern we've been seeing in your earnings as well as others, for how long will the cost savings continue to save the day as it were as volume",115,"And then with, because all of these questions, I think, are getting around the point of just for how long is the pattern we've been seeing in your earnings as well as others, for how long will the cost savings continue to save the day as it were as volume continues to deteriorate? I mean that's not an issue unique to Tenet. And I guess the answer to that is nobody really knows, but how much more do you have left on the cost? And it seems like you've been doing just about everything you can on that score. You found another 800 FTEs. But at what point do you have to stop doing that?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well staff reductions arent the only place where were reducing cost. The Medicare Performance Initiative is driving cost out and supply costs were basically flat and had a very low inflationary rate, even with higher acuity. So there is success in o",129,"Well staff reductions arent the only place where were reducing cost. The Medicare Performance Initiative is driving cost out and supply costs were basically flat and had a very low inflationary rate, even with higher acuity. So there is success in our efforts there, and there'll be continuing success. But cost also isnt the only way we're going to drive value, even if we don't have increasing inpatient volumes over the near future, because we have the outpatient acquisition is driving value. We have our investments in Conifer yield increasing value. The price negotiations on commercial are still favorable; the price on government, pretty much flat. So there's plenty of things we're operating on to create value besides just driving out cost, but there's more cost opportunity too."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I would just add to what Biggs said, Sheryl; opportunity longer term is the clinical standardization, where we really get in on more and more of the DRGs, both inpatient as well as our outpatient care, standardize that, eliminate some redundancy, drive do",102,"I would just add to what Biggs said, Sheryl; opportunity longer term is the clinical standardization, where we really get in on more and more of the DRGs, both inpatient as well as our outpatient care, standardize that, eliminate some redundancy, drive down that variable cost, and really affect the cost metrics in something outside necessarily of the salary wages and benefits or direct supply cost. We're also working on length of stay. We're working on readmission rates as we look at more prospective payments. So there are lots of opportunities to drive on the cost side of the equation going forward."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","And just finally, on your commercial Managed Care negotiations, we've begun to see some more, shall we say, innovative almost back to the future kinds of tactics at the Main Street level on the part of some of the Managed Care companies with their relatio",178,"And just finally, on your commercial Managed Care negotiations, we've begun to see some more, shall we say, innovative almost back to the future kinds of tactics at the Main Street level on the part of some of the Managed Care companies with their relationship with physicians, with restructuring their contract for payment, for example, United with oncology [ph] (1:24:19), we've heard about the potential for some of the companies to have more direct even ownership relationships with providers, physicians, hospitals, outpatients, et cetera, to have them do the rationing rather than the health plan, but the health plan gets the benefits thereof. But is there anything that you can see in your negotiations with the commercial Managed Care plans that might get more creative i.e., contracting for guaranteed volume within a disease or within a procedure or service line where you might be the dominant or best quality provider in the market that could assure you some commercial Managed Care share in those markets and help you even to take share rather than just to maintain share?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","So the short answer is, every creative structure that you can imagine and probably more are under discussion. But still, it is today an environment that's all about cost and access and companies obtaining benefits with the sort of least amount of friction",137,"So the short answer is, every creative structure that you can imagine and probably more are under discussion. But still, it is today an environment that's all about cost and access and companies obtaining benefits with the sort of least amount of friction for their employees and all that. But I think we're well positioned on those creative types of structures because of quality, because of our visibility and ability to understand what it is that we're actually doing in terms of the provision of the service. And then we have this little secret weapon that we've used for decades in California that is a unit that assesses risk and helps us on capitated types of arrangement and serves clients beyond Tenet. And so I think we're very well positioned when risk-taking enters the question as well."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Our final question comes from the line of A.J. Rice with Susquehanna.",13,"Our final question comes from the line of A.J. Rice with Susquehanna."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","First of all, Ill ask one that's sort of a long shot, but I think, Biggs, you alluded to the idea that people may have been managing their deductibles this year with a weak economy more aggressively, and therefore speculation get into Q4, you might see",93,"First of all, Ill ask one that's sort of a long shot, but I think, Biggs, you alluded to the idea that people may have been managing their deductibles this year with a weak economy more aggressively, and therefore speculation get into Q4, you might see some pent-up demand as those deductibles hit. I guess my question first off would be, you guys have any way to measure that? Can you see whether people are taking longer to hit their deductibles this year than they did last year or anything along those lines?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","There really isn't any clear way for us to see that. We don't have that kind of visibility as the patient comes in or as we send the bill to the payers, so not great insight.",37,"There really isn't any clear way for us to see that. We don't have that kind of visibility as the patient comes in or as we send the bill to the payers, so not great insight."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","I have heard the theory espoused by payers, they have obviously much more insight, but I don't think theres evidence, at least as I mentioned earlier, through the first 28 days of October that, that demand wave was ready to hit the beach.",43,"I have heard the theory espoused by payers, they have obviously much more insight, but I don't think theres evidence, at least as I mentioned earlier, through the first 28 days of October that, that demand wave was ready to hit the beach."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","The $100 million to $150 million of acquired outpatient revenues that you're looking for this year, is this year in your mind unusual with the focus on acquiring things like outpatient imaging? Do you think you can run at that rate of acquisitions for a c",47,"The $100 million to $150 million of acquired outpatient revenues that you're looking for this year, is this year in your mind unusual with the focus on acquiring things like outpatient imaging? Do you think you can run at that rate of acquisitions for a couple years?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Well, we said we think we can do it for next year. I mean, obviously, we've been very sensitive about doing this, where we have the ability to put these centers within the hospital structure. So you run out of opportunities just geographically over time.",98,"Well, we said we think we can do it for next year. I mean, obviously, we've been very sensitive about doing this, where we have the ability to put these centers within the hospital structure. So you run out of opportunities just geographically over time. But there are other ones where the sellers -- we've seen somewhere the sellers initially said they didn't want to sell or their price expectations were unrealistic and they're coming back to us now. So that's way we made the comment with respect to 2011. I wouldn't speculate on 2012 at this point."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","I don't think you quantified how much benefit you get from delaying the merit increase, maybe I missed it if you did, for the extra quarter. How much will that benefit you in the fourth quarter? And then if you could just, maybe I made you curious, when d",82,"I don't think you quantified how much benefit you get from delaying the merit increase, maybe I missed it if you did, for the extra quarter. How much will that benefit you in the fourth quarter? And then if you could just, maybe I made you curious, when do you guys think you would offer -- we're talking around the 2011 outlook a lot; have you given some thoughts exactly when you're likely to actually give a formal outlook for 2011?"
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","On the benefit of deferral of the merit increases, it's in the neighborhood of $15 million for the quarter. And that would be similar to numbers we've given in the past. And we've talked about what the effect of merit increases were on the fourth quarter",110,"On the benefit of deferral of the merit increases, it's in the neighborhood of $15 million for the quarter. And that would be similar to numbers we've given in the past. And we've talked about what the effect of merit increases were on the fourth quarter when we gave them by example last year. In terms of when we would give an outlook, I mean, our baseline is we will look at results, we complete our planning process otherwise in December, we look at results through December ultimately and sort of re-evaluate and validate our expectation based upon that and then give the outlook when we release fourth quarter earnings."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts","So in February, at some point.",6,"So in February, at some point."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Yes.",1,"Yes."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives","Thanks, everybody, for joining the call. And see you on the next one.",13,"Thanks, everybody, for joining the call. And see you on the next one."
107911,114307236,84546,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator","Ladies and gentlemen, that concludes today's conference. Thank you for your participation. You may now disconnect. Have a wonderful day.",20,"Ladies and gentlemen, that concludes today's conference. Thank you for your participation. You may now disconnect. Have a wonderful day."
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator"," Good day, ladies and gentlemen, and welcome to the Third Quarter 2010 Tenet Healthcare Earnings Conference Call. My name is Jeff, and I'll be your operator for today. [Operator Instructions] I would now like to turn the conference over to your host for t",57," Good day, ladies and gentlemen, and welcome to the Third Quarter 2010 Tenet Healthcare Earnings Conference Call. My name is Jeff, and I'll be your operator for today. [Operator Instructions] I would now like to turn the conference over to your host for today, Mr. Thomas Rice, Senior Vice President of Investor Relations. Please proceed, Mr. Rice.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," Thank you, operator, and good morning, everyone. Tenet's management will be making forward-looking statements on this call. These statements are based on management's current expectations and are subject to risk and uncertainties that may cause those for",97," Thank you, operator, and good morning, everyone. Tenet's management will be making forward-looking statements on this call. These statements are based on management's current expectations and are subject to risk and uncertainties that may cause those forward-looking statements to be materially incorrect. Management cautions you not to rely on and makes no promises to update any of the forward-looking statements. During the question-and-answer portion of the call, callers are requested to limit themselves to one question and one follow-up question.
 At this time, I will turn the call over to Trevor Fetter, Tenet's President and CEO. Trevor?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," Thank you, Tom, and good morning, everyone. Well, I will blame you if you write report saying that this is a noisy quarter. In summary, our earnings number was huge and we're raising the bottom end of our 2010 outlook. The volumes were soft, and the EBIT",1672," Thank you, Tom, and good morning, everyone. Well, I will blame you if you write report saying that this is a noisy quarter. In summary, our earnings number was huge and we're raising the bottom end of our 2010 outlook. The volumes were soft, and the EBITDA is flat to 2009, if you make appropriate adjustments.
 We generated over $900 million in net income due to the accounting recognition of the value of our tax loss carryforward. Biggs will explain this further, but the key point is that while existence of the NOL has been well known it should be more tangible to investors now that it's on the books.
 Looking beyond net income, we were challenged by soft volumes in the quarter. We reacted to a particularly weak July by implementing a reduction in force in August. The impact of these actions to reduce costs along with improved volume trends after July led to a positive earnings trend in the quarter, in which EBITDA grew steadily from July to August to September.
 It's worth noting that we face the very tough comparison this year as adjusted EBITDA was up 50% in the third quarter last year. Once you allow for year-over-year variability, our longer-term EBITDA trend remains strong. You can see the variability and the clear long-term trend demonstrated on Slide 4.
 Clearly, our growth has been very strong but not a steady as I'd like. When you make your assessment of our growth in EBITDA in the quarter, please consider the items on Slide 5. The third quarter of 2009 included three favorable items contributing a total of $20 million. We called out these items in last year's third quarter call, and nearly all of you noted them when assessing our performance.
 In contrast, this year's third quarter includes items with a net unfavorable impact of $16 million. In total, these items created a $36 million unfavorable swing from the third quarter of 2009 to this year's quarter. Net of these items, this quarter was essentially unchanged.
 As I mentioned earlier, we're raising the bottom end of our outlook for 2010 EBITDA to a new range of $1,050,000,000 to $1.1 billion. This is the second time this year we've increased one or both ends of the range. Volumes were certainly weaker than we originally anticipated, but this has been offset by stronger pricing, enhanced acuity and excellent cost control. We're also benefiting from the California provider fee being larger than we forecast and health IT spending being less than we anticipated.
 Soft volumes were a dominant theme across the industry last quarter, so I'd like to give you some color on our experience. The overall takeaways that the volume declines were contained to a small number of hospitals, and once again a single service line. OB accounted for a full third of our volume loss.
 Total admissions declined 3.5%, and commercial admissions declined 8.6% in the quarter. July was by far our weakest month for patient volumes. The trend was more encouraging in August and through mid-September. Through the first 28 days of October, commercial admissions trended slightly better than in Q3 but total admissions were slightly weaker.
 As you can see on Slide 7, outpatient visits were down 2% in the third quarter. Emergency department outpatient visits were down 1.7% in the quarter, but just over 70% of that decline is due to a reduction in flu, so non-flu ED visits are basically flat year-over-year. Outpatient surgeries were up modestly, increasing by 0.1% and adjusted admissions were down only 1.8%.
 The volume losses this quarter and this year have been confined to a small number of hospitals. In fact, just seven hospitals comprise more than 70% of our total admissions declines in the third quarter. But while these seven hospitals cost the majority of our volume losses, the other 42 hospitals in the aggregate are performing better than the industry average.
 The seven hospitals are widely dispersed. There are two in Texas, but they're not in the same market. The other five are each in different states. Interestingly, although California is challenged by extremely high unemployment in some of our markets, none of our California hospitals are among the seven.
 There is no single theme for the volume losses at these seven hospitals. One of the hospitals are having a solid and growing year but facing extremely tough comparison on volumes in Q3. Another one lost the unprofitable volume. Those two, plus three others, grew EBITDA significantly despite their volume losses.
 The two others saw challenges with their physician channels. These are instances where physicians have gone into direct competition with the hospitals, where we're competing hospitals have engaged in very aggressive and sudden physician employment strategies. No matter the reason for the volume declines, we're responding appropriately, and we believe that we're already turning the losses around. In October, in these seven hospitals, while still down, the volumes were down by a lower percentage than in the third quarter.
 Turning to service lines. I already mentioned that the third of the total volume decline was in OB. Looking beyond OB, there's some elective service lines, I'd like to share some interesting insights with you. As we're deep into the recession, it's very clear that patients who have a significant personal financial responsibility are behaving very differently than patients who don't. We've known all along that this was driving reductions in our commercial elective surgical volumes. But let me give you some facts that our other orthopedic surgery as an example.
 If you look at Slide 10, you'll see that total admissions for orthopedic surgeries declined by 2.5%. Commercially insured orthopedic surgeries declined by 9%. Orthopedic surgeries for all other patients, most of whom are covered by Medicare and Medicaid, actually increased 0.2%.
 The same pattern is true with spinal fusions. Commercially insured spinal fusions declined by 160 admissions or 15% in the third quarter, but noncommercial spinal fusions increased by 17% or over 150 admissions in the quarter. Since the same physicians are doing these surgeries for both payer classes, the loss of commercial volumes and the growth of noncommercial volumes to just this behavior is being driven by the patient not the physicians. We believe this patient behavior is largely related to economic uncertainty on the part of the patients, commercial enrollment losses and rising co-pays and deductibles for those who remain insured.
 Again, on Slide 10, you can see this pattern holds through across several service lines that we would consider as elective and easy to defer. Slide 11 illustrates that when the procedure is harder to defer, like in the case of OB, the changes in volumes in other commercial and noncommercial populations are very similar.
 Despite the challenges to volume growth, favorable pricing and acuity continue to drive a stable picture for revenues. Commercial pricing remains particularly strong. We also had a 2.4% increase in commercial acuity. The result was positive commercial revenue growth of nearly 1% for the quarter. Collectively, this helped us generate adjusted free cash flow of $53 million in Q3, bringing year-to-date free cash flow deposit of $74 million.
 We've made a lot of progress on other front in the quarter. We continue to improve and de-risk our capital structure, pushing out the majority of our 2013 maturities to 2020, while retiring $229 million face value of debt. This brings our total debt slightly more than $4 billion with no meaningful maturities for five years. We also entered into a new $800 million credit line with new flexibility with regard to our capital allocation options, including lifting an existing limitation on stock repurchases.
 Earlier this year, we drew your attention to the seven items on Slide 14, which we believe can drive significant margin expansion and earnings growth over the next few years. While some of these items depends on a recovering economy, three of these initiatives, Outpatient, Medicare Performance Initiative and Conifer, were more directly under our control and less dependent on an economic recovery.
 Just walking down the list for a minute, our newly acquired outpatient centers are already coming online. We expect to have invested about $70 million in outpatient acquisitions by the end of 2010 and believe there are enough great opportunities that we could do that again in 2011. We anticipate these acquisitions will add $100 million to $150 million to revenues in 2011, and given the much higher margins in this business, contribute as much as $30 million to $40 million in 2011 EBITDA.
 Turning to MPI, we are very much on track with our 2010 objective of a $30 million incremental EBITDA contribution. While we have not yet completed our MPI plan for 2011, our preliminary view is for another $30 million. Conifer will take longer to gain visibility, but we remain very excited about its prospects. Conifer's contributions from outside clients to 2011's EBITDA growth will exceed $10 million.
 Our healthcare information technology initiative will again create incremental expenses in 2011. And as previously disclosed, we're not planning on a net positive net financial contribution from the initiative prior to 2012. Earlier last month, we went live at four hospitals, and the rollout went smoothly. We're going live in an additional three hospitals this month.
 In addition, we continue to achieve solid commercial pricing that's consistent with the trends of recent years. To make major progress on margin expansion and EBITDA growth, we need volume growth and to go back towards prerecession bad debt expense levels. But it's still clear there's much we can achieve even in the absence of recovery.
 So to wrap-up, I believe we demonstrated once again that we have the appropriate and effective leverage to pull in the short term to keep us on track relative to our longer-term performance milestone. I also believe our long-term growth strategy have us well positioned to face the myriad challenges that 2011 will bring.
 And with that, let me turn the floor over to Biggs Porter, our Chief Financial Officer. Biggs?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," Thank you, Trevor, and good morning, everyone. The biggest item impacting our net income for the quarter is a recognition of the tax benefit or our net operating loss carry forward. This recognition resulted from our reversal of the previously-establishe",2154," Thank you, Trevor, and good morning, everyone. The biggest item impacting our net income for the quarter is a recognition of the tax benefit or our net operating loss carry forward. This recognition resulted from our reversal of the previously-established valuation allowance and added $981 million to our net income or $1.75 per diluted share.
 Under generally accepted accounting principles, which arguably are conservative on this point and in recognition of our sustained and sustainable return to profitability, the realization of this tax benefits has become sufficiently likely as to require its recognition in our financial statements. Given the conservative criteria applied in our GAAP, this makes a strong statement about the expectations of our future profitability and the value of the NOL.
 As a result of this recognition, our income statement tax rate in future quarters will approximate a normalized tax rate of approximately 40%. From a cash perspective, however, we will continue to benefit from the tax shield, and our tax payments on future income will be primarily limited to state taxes, and will continue at the low level of recent years. It will remain low until our loss carry forward is fully utilized, which is still a number of years out.
 The biggest item not impacting either net income or adjusted EBITDA in the third quarter was the $64 million net receipt of revenues related to the California provider fee. Due to delays in a very complex approval process, this materially favorable event was not recognized in the third quarter. The portion of the plan related to direct medical payments was approved after the end of the quarter, with the Managed Care portion still pending. We had expected that up to $55 million would be recognized in the third quarter. This delay has no affect on full year income but will cost some of the cash receipts to slip out of this year into next, which we estimate at a net $36 million.
 Looking forward to next year, the California provider fee may be renewed for a half year, and a new fee in Pennsylvania worth approximately $25 million is in the process of development. Other states are also working on these types of arrangements. Just as food for thought, if you put the normalized 2010 value of the California provider fee at $37 million, but Pennsylvania fee and a partial extension of the California fee could more than replace that. So you should not think of the revenue from the California provider fee as being entirely non-recurring and looking at next year. For a cash basis, the cash received from provider fees could actually go up next year.
 Adjusting both quarters for prior cost quarter adjustments, revenues grew slightly in the third quarter as a result of strong commercial pricing and case mix, offset by adverse payer mix in aggregate declines in paying volumes. As in the prior quarters of this year, case mix on commercial Managed Care was strong relative to last year reflecting about a 3% increase. As I said in last quarter's comments, this increase in acuity has to be considered in understanding the economic effect of lower volume.
 Our overall pricing picture remains positive. Even with the commercial volume declines we experienced in the quarter, commercial pricing gains were sufficient to drive growth of 0.9% in commercial revenues in the quarter. Because of the payer mix shift, however, net inpatient revenue per admission increased by only 1.1%, and net outpatient revenue per visit increased by 5.6%.
 The strong increase in outpatient pricing reflects the loss of H1N1 volumes from last year, which had generated lower revenues per outpatient visit. The absence of flu volumes in this year's third quarter drove average pricing higher. Once again, this demonstrates the necessity of understanding acuity and patient mix when assessing the economic effects of volume fluctuations.
 While among the topic of pricing, I will comment that we continue to have very good visibility with regard to our forward pricing. At this point, approximately 80% of our commercial contracting is complete for 2011 and 40% for 2012.
 Turning to cost. Although the benefits weren't fully visible in the third quarter, we successfully took action to flex our cost structure. As Trevor mentioned, July's volumes were particularly weak. We responded very quickly to reduce our staffing and implemented the significant reduction for us in August. We incurred a couple of million in severance costs as part of this, but this August, the action left us well positioned for the balance of the quarter.  Those cut should also have full visibility in our fourth quarter.
 In addition, we have delayed our annual merit increases for the general population from October 1 to January 1. This takes us a step closer to timing our merit increases for all employees in the April time period where they used to be.
 The result of these actions are merely evident in our internal measures of productivity, which looks at FTEs per adjusted average daily census. Despite the soft volumes in the quarter, this productivity measure actually improved in the third quarter as FTEs per adjusted average daily census declined in September by 1.2%.
 Supplies cost were essentially flat in the quarter. On a per-adjusted patient-day basis, the increase in supplies cost was 2.6% as adverse operating leverage and the increase in acuity offset the effects of our supply cost initiatives. Because we recorded within other controllable cost line were more of a challenge. Many of the costs recorded in this heading are more heavily fixed or semi-variable in nature and as a result are more difficult to flex in response to soft volumes.
 We also recorded some incremental expense from items whose actual early determine impact is adversely influenced by declining interest rates. While now practice expenses increased by only $1 million relative to last year's third quarter, the decline in interest and therefore discount rates at $11 million to malpractice expense in the current quarter. Combined with an increase of $3 million in workers comp expense, lower discount rates added $14 million to operating expense in the quarter. This discount rate adjustment should be considered unusual at this point given low rates we were already seeing on U.S. Treasuries and can be expected to more than reversed itself in the future when interest rates rise to normal levels, thereby creating earnings upside of up to $40 million at some point in the future.
 In addition, we recorded an incremental $4 million of HIT expense. As Trevor mentioned, we successfully went live on the first phase of the system of four of our hospitals in the month of October, and we now expect the internal effects of these expenses to be down to $11 million in 2010. We expect this incremental expense to increase in 2011 prior to being offset in 2012 by the recognition of federal incentive payments. This increase is now a deferral of 2010 expenses, but is reflective of the increase and number of implementations in 2011.
 Our bad debt ratio declined to 8.3% in the quarter, a 20 basis point decline relative to 8.5% a year ago. This decline includes the recurring benefits of federal Medicare bad debt recoveries, as well as declines in uninsured volumes. We view the size of this quarter's Medicare bad debt recovery as representative of ongoing sustainable impacts that can be expected in future quarters.
 We had $398 million in cash and cash equivalents at quarter end, a decrease of $313 million from June 30. The largest driver of the cash decline was the use of $274 million to reduce debt. Cash provided from continuing operations was $160 million, and adjusted free cash flow was $53 million after capital expenditures of $107 million in the quarter.
 In the third quarter year-to-date, our cash from operations has been held back by lower levels of accounts payable and in the prior year. Some of this is due to the timing of expenditures or aggressive disbursements. We've not changed policy or contractual arrangements however, and we expect payables to expand again by year end.
 Subsequent to the end of the quarter, we completed the sale of a number of our Florida medical office buildings, generating cash of $46 million. As a part of the sale, the buyers committed to certain capital improvements to facilities, which will benefit our position Tenet's. These MOBs had immaterial annual ends and EBITDA.
 We continue to actually market additional MOBs, and we believe a number of these transactions could be completed in the next few quarters. At this point, we have other MOB sales contracts pending worth approximately $50 million, but in real estate, nothing is done until it closes so there's not reflected in our outlook.
 Turning to our outlook. We have raised the lower end of our outlook to a new range of $1.05 billion to $1.1 billion. We raised both ends of the range of pretax income, reflecting lower depreciation and interest expense. Our revised assumptions are detailed on Slide 24. This revision includes the lowering of our volume and revenue estimates, which are tied to a later reductions in our cost estimates for the balance of the year.
 There's been speculation that volumes will grow in the fourth quarter of more than a seasonal basis due to the effects of co-pays and deductibles. At this point, we're going to be conservative and not count on that in our outlook. The walk forward of cash from September 30 to December 31 is provided on Slide 25 breaks down fourth quarter cash flow into its major components.
 It's too early to give an outlook for 2011, but I do think it's appropriate to give a little balance to what the headwinds and opportunities are going into next year. First, the biggest challenge remains on the volume side, but some of the effects of the economy and flu should have average rate by the end of this year. Economic stability followed by recovery would presumably create upside. Second, we expect the full year benefit on the outpatient acquisition we're completing on the second half of this year and a partial benefit of those we're targeting for next year.
 Third, we're already seeing improvement in the yield on our physician additions the last couple of years, and we expect expansion of that benefit in 2011 and beyond. Fourth, commercial pricing is almost completely negotiated with reasonable existent price increases expected next year. Medicare, all in, is basically flat as outpatient increases offset inpatient decreases. I've already talked about state signing and potentially new provider fees with the 2009 retroactive portion of the California provider fee being the one element most challenging to replace.
 Finally on the cost side, we will increase our investment in our physician base and HIT both of which will yield improvements for the future. And we will continue to drive on our Medicare performance and related initiatives to reduce link to stay in supply costs.
 In the aggregate, we will continue to drive toward industry margins. We have confidence in the path we have laid out. The only gating consideration in what the near-term timing and slow for progress is going to be is the degree of economic headwinds we must offset. On the positive side for 2011, we expect to drive value in the outpatient investments, position base initiatives, commercial pricing and the Medicare performance initiative. The big potential near-term negative, longer-term appositive is, as I just said, the effect of economic conditions. It is not clear and therefore remains subject to continuing evaluation by us as to what extent economic conditions will offset the net positive drivers of growth in 2011.
 So to summarize. The value of our NOL carryforwards has been confirmed from accounting standpoint. We have raised our outlook for EBITDA and pretax and net income for the year. We approved cost efficiencies in the quarter, as we were able to react quickly to significant volume declines in the first month of the quarter. This will be fully visible in the fourth quarter.
 Free cash flow came under pressure due to the timing of disbursements in rising CapEx. But because of the timing effects on accounts payable will reverse themselves, we have retained our free cash flow outlook for the year. Pricing continued as the source of strength. Commercial case mix remained favorable compared to the prior year. California provider fee, has been partially approved while full approval expected this quarter.
 And one last point. From a volume and payer mix standpoint, this was the weakest quarter we've experienced, clearly reflective of the economic headwinds. However, the fact that we held earnings flat on a normalized basis and even in this harsh environment demonstrates that we are well positioned to grow earnings as the economy moderates and/or as our volume initiatives yield increasing results.
 Let me now ask the operator to assemble the queue for Q&A. Operator?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator"," [Operator Instructions] Our first question comes from the line of John Rex with JPMorgan.",14," [Operator Instructions] Our first question comes from the line of John Rex with JPMorgan.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," And the issue here for me is when we look at the share, the erosion in commercial, and it's just been persistent now as many quarters in terms of actually kind of seeing accelerating losses. So my question is, it looks like you're losing share when that",98," And the issue here for me is when we look at the share, the erosion in commercial, and it's just been persistent now as many quarters in terms of actually kind of seeing accelerating losses. So my question is, it looks like you're losing share when that compared to what I'm seeing from others and when I even think about what I'm seeing is kind of more stabilizing trends in just commercial coverage broadly. So can you tell us how you look at that in terms of the potential share losses you might be seeing in the markets?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," Yes, John. This is Trevor. That's a good question. I have to comment first and I'm going to turn it over to Steve Newman, because we've done extensive analysis of this share question. But first, we'd have to make the comment that it is very difficult to",135," Yes, John. This is Trevor. That's a good question. I have to comment first and I'm going to turn it over to Steve Newman, because we've done extensive analysis of this share question. But first, we'd have to make the comment that it is very difficult to compare the commercial statistics that we've been disclosing in any kind of context to the industry at large or even the peer companies, because you're not getting that same type of disclosure. So not that everybody should do it and not to say that we don't regret starting with disclosure. But you really can't look at these commercial numbers and draw any conclusion about share from them. Now having said that, we've done a lot of work on shares so I'll ask Steve to comment on that. Steve?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," John, I think it's an excellent point, and we've got a great deal of evidence that we're not losing commercial managed care or market share except in the markets of the hospitals that Trevor mentioned in his comments. Our evidence comes from three separa",100," John, I think it's an excellent point, and we've got a great deal of evidence that we're not losing commercial managed care or market share except in the markets of the hospitals that Trevor mentioned in his comments. Our evidence comes from three separate sources: First, our statewide all-payer database; second, our large statewide Blue Cross plants, where we have significant penetration in those markets; the third is a review of our market share with three of the largest national commercial payers. In summary, these studies also guess, except in a few isolated instances, our commercial market share is stable.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," And I think, John, we triangulated on that question. As Steve said, there's several different approaches to it. But very hard to do with precision. So this quarter, we did something we haven't done before, which was essentially go to the payers who would",107," And I think, John, we triangulated on that question. As Steve said, there's several different approaches to it. But very hard to do with precision. So this quarter, we did something we haven't done before, which was essentially go to the payers who would give us this information to say, ""Look, this is our change in volume with you in this particular market. Tell us, because you have access to it, what is the share change and was very reassuring in all cases with the exception of a few, where it's clear that we're losing share because there's, some new competitors some different dynamic in the market.""
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," And my follow-up, if you look at the seven hospitals that you spiked out, what percent of company revenues were they representing? I'm trying to compare, I think about your top seven hospitals and percentage revenue there. Group this seven, where would t",45," And my follow-up, if you look at the seven hospitals that you spiked out, what percent of company revenues were they representing? I'm trying to compare, I think about your top seven hospitals and percentage revenue there. Group this seven, where would they fall?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," They do tend to be some of our larger hospitals. So we have a portfolio that ranges in size, but does have some large ones. And I think, when you have a quarter where the large hospitals are underperforming at any given statistics, it tends to drive the",88," They do tend to be some of our larger hospitals. So we have a portfolio that ranges in size, but does have some large ones. And I think, when you have a quarter where the large hospitals are underperforming at any given statistics, it tends to drive the company in that direction and vice versa. And unfortunately, this is one of those quarters and I've seen other ones over the time that I've been with Tenet, where the largest hospitals with exceptions were moving in the wrong direction.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," So these are not our seven largest hospitals but amongst them are [indiscernible] hospitals.",14," So these are not our seven largest hospitals but amongst them are [indiscernible] hospitals.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," So I'd find some of that in that category then. And does stabilizing coverage levels, do you think there's going to have impact or what you're seeing at this point, is it less about erosion and just commercial coverage and more just about avoidance of th",52," So I'd find some of that in that category then. And does stabilizing coverage levels, do you think there's going to have impact or what you're seeing at this point, is it less about erosion and just commercial coverage and more just about avoidance of the carenstein [ph] at all ?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," Well, you've got the baseline high-shrinking issue of the commercial enrollment losses that's been running around 4% among the big payers. You start with that. And then you add to it some utilization issue that potentially is driven by the economic incen",166," Well, you've got the baseline high-shrinking issue of the commercial enrollment losses that's been running around 4% among the big payers. You start with that. And then you add to it some utilization issue that potentially is driven by the economic incentive that are inherent in higher deductible health plans. And now the enrollment losses you could see turnaround in a stronger economy, the shift towards a higher deductible plans and whatever's depression of consumption exist that could be a longer-term trend. But like just this morning, I'm encouraged to see in the newspaper the results of the Kaiser survey that among very small employers, coverage is going way up to these tax incentives that they've been provided with. So among firms with something like nine to 13 employees or five to 13 employees. But the average percentage is up like nine points. I may have sound of that a little bit wrong but it's an encouraging trend among the smallest segment of the employer population.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator"," Our next question comes from the line of Shelley Gnall with Goldman Sachs.",13," Our next question comes from the line of Shelley Gnall with Goldman Sachs.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," I'm wondering, is it possible to generalize across your markets those that are hardest hit? So for example, in California, you've got a number of markets where you got unemployment north of 15% and 16%. And then, you've got healthier markets, like those",79," I'm wondering, is it possible to generalize across your markets those that are hardest hit? So for example, in California, you've got a number of markets where you got unemployment north of 15% and 16%. And then, you've got healthier markets, like those in Texas that are 8% to 10% unemployment. Is it possible to generalize where you are able to take share and where you just don't see a market share opportunity across all of payer classes?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," So hard to generalize and one of the reasons I mentioned that among the seven hospitals generating 70% of the admissions decline is none in our California, because we did not see in terms of the volume performance of our hospitals, a correlation with une",217," So hard to generalize and one of the reasons I mentioned that among the seven hospitals generating 70% of the admissions decline is none in our California, because we did not see in terms of the volume performance of our hospitals, a correlation with unemployment. And our highest unemployment market were really not having a volume problem. And conversely, where we've seen these physician competition phenomenon that has really created new capacity and a new entrant into a market that's very aggressive owned by physicians were they have the ability to direct patients, that in some of our markets with the lowest unemployment are the best trends in unemployment. So I would set aside the unemployment correlation. We've also seen some very strong volume performance in Florida, which is a market that's struggled for a long time. And that I think can be attributed to strong management actions and market working to see sizeably on business development activity. So you really -- at the risk of having added two paragraphs to my script on this volume side, I'm trying to convey an impression that there is not an overall trend, one way or another that you can point to or some correlation that it's really more one-off issues. And that's the way we've had to manage them.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," Other than the cost shifting that you're seeing from the commercial payers, are there any other specific actions that they're taking to limit utilization specifically on the inpatient side?",30," Other than the cost shifting that you're seeing from the commercial payers, are there any other specific actions that they're taking to limit utilization specifically on the inpatient side?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," Well, one thing that's causing a lot of noise in the statistics is this trend towards observation status, which originally was contemplated to something only to be used in Medicare and now it's widely used in the payers. And I think other companies have",63," Well, one thing that's causing a lot of noise in the statistics is this trend towards observation status, which originally was contemplated to something only to be used in Medicare and now it's widely used in the payers. And I think other companies have talked about that. We didn't break it out specifically but it's of course the contributor to weak inpatient admissions.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator"," Our next question comes from the line of Tom Gallucci with Lazard Capital.",13," Our next question comes from the line of Tom Gallucci with Lazard Capital.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," First, the Slides 10 and 11 that you offered the commercial versus noncommercial admission trends, very interesting data. Curious if you look back is the discrepancy between those two payer classes growing or moderating? Or how would you consider that tr",41," First, the Slides 10 and 11 that you offered the commercial versus noncommercial admission trends, very interesting data. Curious if you look back is the discrepancy between those two payer classes growing or moderating? Or how would you consider that trend?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," For the time being, that it's a new slide. We didn't really look back on it. We don't have a trend for you on that. We've looked for quite a long time at what we would consider discretionary versus last discretionary service lines. And have had more pres",106," For the time being, that it's a new slide. We didn't really look back on it. We don't have a trend for you on that. We've looked for quite a long time at what we would consider discretionary versus last discretionary service lines. And have had more pressure in the discretionary. And obviously, when you're in a quarter that's as tough as the one that we just emerged from, you dig a lot harder for explanations and this was a very interesting one that came through, but we didn't go back up and run at historically, it's actually not that difficult to do so we could.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," And then you mentioned Managed Care 80% of your contracting, I guess you're done for next year, 40% the following year. Could you just remind us of sort of the average rates that you're expecting and also maybe more importantly, comment sort of on the to",85," And then you mentioned Managed Care 80% of your contracting, I guess you're done for next year, 40% the following year. Could you just remind us of sort of the average rates that you're expecting and also maybe more importantly, comment sort of on the tone of discussion I guess there have been some suggestions out there that obviously the Managed Care environment is getting a little more difficult for the payers. I'm wondering if that's leaking into the tone of conversation with you all?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," This is Biggs. First of all, to address the rate question, the rates that we've negotiated for next year are pretty much in-line with what we've budgeted as negotiated rates for 2010. It ultimately, the yield, we get on those will determined by patient m",74," This is Biggs. First of all, to address the rate question, the rates that we've negotiated for next year are pretty much in-line with what we've budgeted as negotiated rates for 2010. It ultimately, the yield, we get on those will determined by patient mix index and any payer shifts between the plants, but the negotiation are very much in line with what we've budgeted and achieved this year from a peer-rate negotiation standpoint.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," And the tone of discussions, as you're looking further out, maybe one or two years out?",16," And the tone of discussions, as you're looking further out, maybe one or two years out?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," As for tone, Steve, you want to add anything to that?",11," As for tone, Steve, you want to add anything to that?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," I'd just say that negotiations are taking a little bit longer than they have in the past, and we're pushing for more pay for performance to be added to those contracts as we move toward a valued base purchasing environment.",41," I'd just say that negotiations are taking a little bit longer than they have in the past, and we're pushing for more pay for performance to be added to those contracts as we move toward a valued base purchasing environment.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," I guess the only thing I would add is, I've made an effort to stay close to the senior executives, some of our largest customers and to remind them that we provide a very good value solution for them. We have demonstrated high quality. They assess that t",192," I guess the only thing I would add is, I've made an effort to stay close to the senior executives, some of our largest customers and to remind them that we provide a very good value solution for them. We have demonstrated high quality. They assess that themselves. I don't need to convince them of that. And our price point relative to our competitors in virtually all of our markets is certainly not the highest, and sometimes it's on the low end of the market pricing. And typically with a large prominent successful not-for-profit system leading the way on pricing. So I feel that we are well positioned with the national payers from a value point of view. We're also exceedingly well positioned when they look at the total cost to doing business with us because we have streamlined and automated the revenue cycle process with them. So we have lowered -- they tell us, we have lowered lower-than-average denials. We have better-than-average electronic connectivity and we offer a total solution that I think is very effective as they start to look harder at price sensitivity and narrow networks in their markets.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator"," Our next question comes from the line of Adam Feinstein with Barclays Capital.",13," Our next question comes from the line of Adam Feinstein with Barclays Capital.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," I guess to follow-up a few thoughts here. I guess the volume weakness is something that everyone was talking about throughout the quarter. So I do think that really caught people that of off-guard. I guess it was just throughout the year with the volume",173," I guess to follow-up a few thoughts here. I guess the volume weakness is something that everyone was talking about throughout the quarter. So I do think that really caught people that of off-guard. I guess it was just throughout the year with the volume weakness you guys have able to offset it through better unit pricing growth, as well as just cost cutting. So I guess the question is, as you look back on the quarter, Trevor, just maybe talk about -- and you guys called out a few things like the discount rate and some of the issues around cost there, but I guess just in terms of the ability to offset the volume weakness and not even the most recent quarter but going forward as well maybe just to go back through and talk about some of the initiatives there and certainly, you have the great slide deck here with that, but to just get some more clarity in terms of just visibility around the ability to offset volumes.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," I think, Adam, in the beginning of your question, you touched on a topic that I think is important just to be very clear about in case it wasn't clear enough in the scripts. But we were trying to make the point that although I think the industry-wide vol",357," I think, Adam, in the beginning of your question, you touched on a topic that I think is important just to be very clear about in case it wasn't clear enough in the scripts. But we were trying to make the point that although I think the industry-wide volume weakness was well known throughout the quarter. There were plenty of surveys and other indicators that, that was taking place. What was surprisingly negative was July. And so, I mentioned that July was particularly weak and then we took actions to reduce cost. Of course, these actions couldn't be taken in July, they were taken in August and have that effect of creating a positive trajectory in EBITDA from July to August to September. And as volume losses moderated from July through August through mid-September, then they did turn down in late September, that's the implication of saying that they were strong through mid-September. So I think one way -- the thing I would characterize as being unusual in the third quarter at least for us was how negative the first month was and then the fact that although many in the industry anticipated some snap back in August was encouraging, that, that encouraging trend at least in terms of volume did not persist through the entire quarter. And then based on our comments about October, it didn't persist into October. but I think to answer your question about what we can do and how we've been able to offset weak volumes, obviously, it's very hard on a month-to-month basis, because it's easier on a quarterly basis and it gets easier to accomplish. I shouldn't use the word easy. That's not easy but it's less difficult to accomplish on a yearly basis. And so, if you look at the quarter as a whole, we really overcame a lot of challenge that we had right out of the box in July. But it's difficult to do more in a short period of time. I think we have positioned ourselves well going into the fourth quarter. But again, we don't even have the first month of results on that yet.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," Just on the unit pricing, the 1.1% you talked about mix having some impact there, maybe just go back some of that. I guess, the commercial piece you talked about but just within the other categories just maybe a quick update there in terms of -- and I gu",75," Just on the unit pricing, the 1.1% you talked about mix having some impact there, maybe just go back some of that. I guess, the commercial piece you talked about but just within the other categories just maybe a quick update there in terms of -- and I guess, what are you guys thinking about in terms of being normalized revenue per admin number if you try to clean up some of the noise there?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," Well, what's normal at this point will depend largely upon whether the OB admissions stayed down or not for an extended period because one of the reasons why case mix is up is because obstetrics are down. Obstetrics supply stayed down for quite a while.",143," Well, what's normal at this point will depend largely upon whether the OB admissions stayed down or not for an extended period because one of the reasons why case mix is up is because obstetrics are down. Obstetrics supply stayed down for quite a while. So I would expect on that basis case mix do not changed radically over the near term. As I said, case mix on commercial Managed Care was up about 3%. It was up about 1% on a Medicare Managed Care and up almost 5% on Medicaid Managed Care. So in most of the categories, it was up in the quarter. We'll see, of course, with that was a longer term but there's nothing right now that indicates that, that would change. So we'll just have to watch it but I think is reflective of the economics of today.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," I just point, Adam, that we had a 5.6% increase in revenue per outpatient visit. That's largely driven by increases relatively speaking about patient surgery and high-end imaging like CT and MRI.",32," I just point, Adam, that we had a 5.6% increase in revenue per outpatient visit. That's largely driven by increases relatively speaking about patient surgery and high-end imaging like CT and MRI.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," I'm going to add a response to, I think it was John's question earlier on the revenue from the seven hospitals. We want to pull the statistic and from the period of merit standpoint is the seven hospitals are 14% of our hospital count from a revenue stan",94," I'm going to add a response to, I think it was John's question earlier on the revenue from the seven hospitals. We want to pull the statistic and from the period of merit standpoint is the seven hospitals are 14% of our hospital count from a revenue standpoint, they comprise 18% of the revenues in the quarter. So a little more heavily weighted than the peer hospital account but not, as I said, because there's not all the largest hospitals that are in there. It's not a real disproportionate share of the revenue.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator"," Our next question comes from the line of Ralph Giacobbe with Credit Suisse.",13," Our next question comes from the line of Ralph Giacobbe with Credit Suisse.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," In the release, you mentioned increased physician employment. And I think in the past, you've talked about not necessarily wanting to employ. Can you maybe talk about what's changed to your strategy there and maybe just give us a sense of the base that's",50," In the release, you mentioned increased physician employment. And I think in the past, you've talked about not necessarily wanting to employ. Can you maybe talk about what's changed to your strategy there and maybe just give us a sense of the base that's employed currently where that can go?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," Biggs, you want to take that?",6," Biggs, you want to take that?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," Sure. Ralph, we've got a number of things to affect physician recruitment. First thing we've done is expanded the number of staff focused at the hospital level, as well as at the regional corporate level on physician recruiting. Another thing we've done",120," Sure. Ralph, we've got a number of things to affect physician recruitment. First thing we've done is expanded the number of staff focused at the hospital level, as well as at the regional corporate level on physician recruiting. Another thing we've done is we've reassessed our community need and revised the medical staff development plan for each of our hospitals. The third thing, and I think we've done at significant is we revised the process for targeting redirection of our local physicians, and we've improved that on-boarding process, as well as orientation for these successfully recruited or redirected physicians. Finally, we believe that this will improve the productivity and retention rate of the physicians that we've been able to recruit.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," And I guess I'm just trying to get a sense of, is this sort of in reaction to what's going on in your markets, where there perhaps was a reluctance to employ in the past, but now you need to because others are doing it and perhaps that can explain some o",60," And I guess I'm just trying to get a sense of, is this sort of in reaction to what's going on in your markets, where there perhaps was a reluctance to employ in the past, but now you need to because others are doing it and perhaps that can explain some of the weaker volume trends that you see?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," Well, look, I will be the first to say that I had a particularly bad attitude about jumping into the employment trend having experienced first hand the disasters of the late 90s when hospitals rapidly purchased practices and employed physicians and lost",435," Well, look, I will be the first to say that I had a particularly bad attitude about jumping into the employment trend having experienced first hand the disasters of the late 90s when hospitals rapidly purchased practices and employed physicians and lost on a tremendous amount of money. But this is a trend that is inexorable. It started with the large most prosperous, not for profits. We compete against a lot of this in our markets and we have completely adopted, I think new and improved way to do this. So just to go in order of sort of the promise that we're doing about it. Purchasing practices is really not market practice anymore. It's employing physicians. So you don't have the problem from the 90s of spending a lot of capital on purchasing something that turns out to not be worth of what you paid for. So it's really hiring talent. And then in terms of hiring talent, we've become very sophisticated about how to do it in terms of providing incentives for productivity so we don't experience the next problem that was characteristic for the 90s, which is hiring physicians, which essentially was enabling them to retire at the expense of the hospital. So we're incentivizing productivity. And we've also experienced some churn of the employed physicians based on those who failed to meet the productivity target leaving and those who are succeeding in the productivity target staying and enjoying the benefits of that. We've also been very selective in terms of the credentials of the physicians that we've been hiring. So just as if you undertook to hire a cadre of 200 MBA students you want to go to the top schools and hire the best students, we're doing the same thing when it comes to physicians. We're also being very selective about filling certain holes and specialties or building primary-care networks, where that strategy is right. And then finally, rather than attempting to manage all these practices ourselves, we've employed in a joint venture format a practice management company that's an expert in doing this and running them at economic results that are superior to what hospitals generally experience. So I think, all of these things together and I didn't mention the EMR solution that we're offering for physicians, I think it's a better solution, and we probably got started later than we should have. And perhaps it's because of historic bias, at least on my part, against that as a strategy. But we are well into it now and have a very strong pipeline of physicians that we are employing.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," And just my follow-up, I'm wondering sort of revisit capital structure. You talked about sort of refinancing, pushing out debt maturities. Are you kind of happy with where the company sits from that perspective? Is there anything else you would contempla",63," And just my follow-up, I'm wondering sort of revisit capital structure. You talked about sort of refinancing, pushing out debt maturities. Are you kind of happy with where the company sits from that perspective? Is there anything else you would contemplate? Obviously, you mentioned share repo in your commentary, just given where the credit markets are in just the overall rate environment?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," Well, I think, I'll answer and if there's anything left, Biggs, you can chime in. But as I mentioned, there are no significant maturities for five years. That's a long time. I don't think it would make any sense to push it up farther. That's actually qui",139," Well, I think, I'll answer and if there's anything left, Biggs, you can chime in. But as I mentioned, there are no significant maturities for five years. That's a long time. I don't think it would make any sense to push it up farther. That's actually quite a conservative approach to a capital structure, which I think is appropriate given the risk in the business and the historic leverage that we've had. We've also obviously brought down the leverage ratios substantially, this new credit line offers us a lot of flexibility. We obviously not commenting today on the potential for share buybacks, but it's obviously something we couldn't even consider prior to this new credit line. So we'll just have to see depending on circumstances what we decide to do there. Biggs, is there anything you want to add?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," No, I think there's some small amounts of the '11 and '12 maturities still outstanding, so obviously, over time if not at maturity, we will retire those in due course. And otherwise, if the capital structure are big drivers to keep driving on improving f",68," No, I think there's some small amounts of the '11 and '12 maturities still outstanding, so obviously, over time if not at maturity, we will retire those in due course. And otherwise, if the capital structure are big drivers to keep driving on improving free cash flow, drive up earnings and drive free cash flow along with it. And further improve all of the statistics and the ratios.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator"," Our next question comes from the line of Darren Lehrich with Deutsche Bank.",13," Our next question comes from the line of Darren Lehrich with Deutsche Bank.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," So maybe I'll just follow-on to that point a little bit more just to round capital and deployment of capital. If you include some value of your NOL, you're probably trading just a little under 5x your guidance for 2010 on an EBITDA basis. So I guess, I'd",107," So maybe I'll just follow-on to that point a little bit more just to round capital and deployment of capital. If you include some value of your NOL, you're probably trading just a little under 5x your guidance for 2010 on an EBITDA basis. So I guess, I'd be curious to hear your thoughts what kind of assets you can buy that are out there that are more favorable than that type of valuation. So are you seeing any acute-care assets? You've commented a little bit more about your interest in getting aggressive on the outpatient side? Maybe just update us generally on capital deployment priorities.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," Obviously, if you employ a rule of thumb that says you should only acquire things to trade a lower multiple than your own multiple. It's very limiting. Based on my comments about outpatient, it appears that we are doing that, and we're very pleased to ou",317," Obviously, if you employ a rule of thumb that says you should only acquire things to trade a lower multiple than your own multiple. It's very limiting. Based on my comments about outpatient, it appears that we are doing that, and we're very pleased to outpatient acquisitions that we're making. I would say that the potential acquisitions of the acute care hospitals that would be of interest to us or of the greatest interest to us, there are certainly more hospitals considering selling themselves or seeking partnerships of some kind. And we're spending more time than we ever have exploring those types of things. I think it's premature to talk about value and whether we would actually proceed and devote our capital in that way. What we haven't been doing, you obviously noticed is we have not been competing in the auctions that has been out there for standalone hospitals or possibles that or -- whatever other acute-care transactions are out there. I don't think we are necessarily the best potential acquirers for those kinds of things. Where we have been focused is more in our markets and things that have some degree of synergy, where we understand the market, we understand the dynamics and the future trends. And obviously, given the uncertainties around healthcare reforms something you have to take into consideration when you evaluate the hospitals. So for that reason, we've been most focused on the outpatient side. I think that you'll agree since we gave some disclosure on those numbers that those are incrementally very helpful acquisitions for us. We like that business and will continue to do that as much as possible. And then, with -- there maybe opportunities in the future within our Services business, which we're also very excited about, the multiple issue tends to present a barrier there, but we have to keep our eyes open on that as well.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," And if I could just follow-up maybe clarify a point you made earlier about the cost savings actions in Q3. I guess just putting some rough numbers on the FTE figures you provided, Biggs, it would seem like that's about maybe a $20 million, $30 million ty",67," And if I could just follow-up maybe clarify a point you made earlier about the cost savings actions in Q3. I guess just putting some rough numbers on the FTE figures you provided, Biggs, it would seem like that's about maybe a $20 million, $30 million type of annualized savings run rate. Is that a good range to work off of what we'll see in Q4?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," Like I said it's 1.2% improvement in productivity. So it's quite a little north of that approaching $40 million on an annual basis. Real near term depending on third quarter, the fourth quarter other improvements we expect on the malpractice and workers",193," Like I said it's 1.2% improvement in productivity. So it's quite a little north of that approaching $40 million on an annual basis. Real near term depending on third quarter, the fourth quarter other improvements we expect on the malpractice and workers comp side really took the hits in the third quarter for the discount rate. We expect those to not occur in the fourth quarter and possibly will have improvement again in the first quarter as a result of what continues to be good claims experience. Another thing looking at the third quarter was it was a couple of million dollars of severance costs in there, so that was that was the cost of achieving the reductions and we don't expect that to occur in the fourth quarter of the future. So there's a number of things going on in addition to just appear FTE reductions to be considered looking at or maybe this year and on to the future. And of course, we're still driving on the MediCare performance initiatives, which is worth $30 million this year and expect to do similar amount next year in terms of incremental savings.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator"," Our next question comes from the line of Gary Lieberman with Wells Fargo.",13," Our next question comes from the line of Gary Lieberman with Wells Fargo.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," I was wondering if you just maybe elaborate a little bit more on the line in the slide about the Managed Care portion of the provider taxes still awaiting approval from CMS and what that involves?",36," I was wondering if you just maybe elaborate a little bit more on the line in the slide about the Managed Care portion of the provider taxes still awaiting approval from CMS and what that involves?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," Sure. The way it has been approved is in pieces. The fee for service portion of it was a little simpler, and it only involves the hospitals, the state and the CMS. And so, that approval came first. The Managed Care portion of this has to flow through the",137," Sure. The way it has been approved is in pieces. The fee for service portion of it was a little simpler, and it only involves the hospitals, the state and the CMS. And so, that approval came first. The Managed Care portion of this has to flow through the Managed Care payers. And so, contracts and structures have to be adjusted in order to allow for that money to flow through the Managed Care payers. And until that it's totally defined, CMS basically that holds our approval on that portion of it. And so it should be seen as largely administrative in our mind, and that's why we're counting on the entire $64 million in our outlook. But it is a step that has yet to be completed between the states, the Managed Care payers and CMS.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," And I guess just the Managed Care portion have to be put to bed before the  entire plan can take place? Or is it should we view it kind of separate by some chance the Managed Care portion gets approved?",40," And I guess just the Managed Care portion have to be put to bed before the  entire plan can take place? Or is it should we view it kind of separate by some chance the Managed Care portion gets approved?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," It's happening in pieces. And In fact, the direct payment portion of it, the fee-for-service portion, has already been implemented. And we've been invoiced and also receiving funds on that portion of it, which is about half of the total, near half the Ma",59," It's happening in pieces. And In fact, the direct payment portion of it, the fee-for-service portion, has already been implemented. And we've been invoiced and also receiving funds on that portion of it, which is about half of the total, near half the Managed Care piece will happen separately. But as I said, we expect it to happen.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," And then one quick follow-up, Trevor, I know you mentioned that there wasn't any data on volumes for October. Any initial thoughts just in terms of where it might going to stand up?",34," And then one quick follow-up, Trevor, I know you mentioned that there wasn't any data on volumes for October. Any initial thoughts just in terms of where it might going to stand up?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," I actually commented on the volumes on October. I'm not sure what you mean by your question.",17," I actually commented on the volumes on October. I'm not sure what you mean by your question.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," Just in terms of any picture or service lines that look like they've been reversing trend or so continuation in trend.",22," Just in terms of any picture or service lines that look like they've been reversing trend or so continuation in trend.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," No, it's too early for that. Usually, we have the volume data daily. And then at the close of the month but then to get clean service line and payer data takes a little longer.",35," No, it's too early for that. Usually, we have the volume data daily. And then at the close of the month but then to get clean service line and payer data takes a little longer.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator"," Our next question comes from the line of Whit Mayo with Robert W. Baird.",14," Our next question comes from the line of Whit Mayo with Robert W. Baird.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," Trevor, can you go back and talk about the delay in merit paid? Did you say that, that was going to be pushed to January? I guess, I didn't follow you.",31," Trevor, can you go back and talk about the delay in merit paid? Did you say that, that was going to be pushed to January? I guess, I didn't follow you.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," Let me just tell you conceptually what we decided to do. We had multiple employee populations with an expectation of annual inflation/merit-oriented salary increases at different times in the year. So we've had for a long time a desire to standardize tha",159," Let me just tell you conceptually what we decided to do. We had multiple employee populations with an expectation of annual inflation/merit-oriented salary increases at different times in the year. So we've had for a long time a desire to standardize that all at the same time of the year, which is really the spring being the best time. And so, given the sort of rapidly decreasing expectations of inflation and also the observations we made of competitive practice declining in terms of the increases that competitors appear to be giving to people, what we've decided to do was to implement the program effective January 1, but to tell people in advance what they would get. So I think it's a very good solution from a cost management perspective. It also administratively will simplify our administration of these programs in the future. And it obviously, was a prudent move to save costs in the second half of this year.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," Is there any chance that, that may be delayed further in between '11? I guess I'm just wondering if that's a concrete start in January or whether or not?",29," Is there any chance that, that may be delayed further in between '11? I guess I'm just wondering if that's a concrete start in January or whether or not?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," No, that's concrete for January.",5," No, that's concrete for January.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," And any other benefit design changes, anything that's meaningful as we look out to 2011?",15," And any other benefit design changes, anything that's meaningful as we look out to 2011?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," Not that we're contemplating at this moment.",8," Not that we're contemplating at this moment.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," My last question, Biggs, I was just curious if we could get the P&L expense and the cash CapEx numbers for your electronic health records been this year at least year-to-date and maybe a peek into what those two numbers may look like in 2011?",45," My last question, Biggs, I was just curious if we could get the P&L expense and the cash CapEx numbers for your electronic health records been this year at least year-to-date and maybe a peek into what those two numbers may look like in 2011?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," I'll do the second part first. On 2011, we're still in the planning process. We've completed, as we said four implementations here in the last couple of weeks. We have three more that are going live shortly among other things. We have to look at that exp",199," I'll do the second part first. On 2011, we're still in the planning process. We've completed, as we said four implementations here in the last couple of weeks. We have three more that are going live shortly among other things. We have to look at that experience what it's cost us what lessons learned are as a part of fully defining next year's budget and expectations that we would communicate as a part of our outlook. But in any event -- but we do expect it to go up as I said earlier. And maybe that's not so much, an increase off of what we originally expected for this year as it is just an increase in where we actually landed for this year. So the comparative number for this year has come down as opposed to saying next year is increased off of what might we have expected before. This year, we're spending around $90 million in incremental spend. It's actually that total spend -- it's about $66 million of that is CapEx and about $23 million is expense. And like I said, the expense of $23 million represents an $11 million increase over the prior year.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," On the P&L?",4," On the P&L?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," We do expect that number in total both on CapEx and expense to go up next year. But as I said, it's still early to give a hard number.",29," We do expect that number in total both on CapEx and expense to go up next year. But as I said, it's still early to give a hard number.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator"," Our next question comes from the line of Justin Lake with UBS.",12," Our next question comes from the line of Justin Lake with UBS.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," First question just on the outpatient side, specifically, you look at that as being opportunity. Talk about outpatient margin being significantly greater than inpatient. I'm just wondering if you can give us some color there in terms of a magnitude of di",45," First question just on the outpatient side, specifically, you look at that as being opportunity. Talk about outpatient margin being significantly greater than inpatient. I'm just wondering if you can give us some color there in terms of a magnitude of differential between those margins?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," Well, I think it tend to be more than double. And the comments that I made in the opening suggest that we're buying this at very attractive multiples and that they have very high margins relative to the overall business. And so, it's a very attractive fo",49," Well, I think it tend to be more than double. And the comments that I made in the opening suggest that we're buying this at very attractive multiples and that they have very high margins relative to the overall business. And so, it's a very attractive form of acquisition.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," Are you just talking about surgical centers at this point on the margin side because if that will all -- I think it's pretty clear those out margins that are much better than in in-patient hospital or acute care hospital.",40," Are you just talking about surgical centers at this point on the margin side because if that will all -- I think it's pretty clear those out margins that are much better than in in-patient hospital or acute care hospital.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," Most of what we've been doing is imaging centers we have bought some surgery centers. But this year, not exactly clear how many will be able to close, but it'll be on the magnitude of 22-plus-ish imaging centers and three to four surgery centers. So far",52," Most of what we've been doing is imaging centers we have bought some surgery centers. But this year, not exactly clear how many will be able to close, but it'll be on the magnitude of 22-plus-ish imaging centers and three to four surgery centers. So far more on the imaging side.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," And then just a little bit of the cleanup on some of the 2011 moving parts. Can you give us any specifics on how much of the headwind healthcare IT is going to be next year? And then just to confirm, I think, I heard you say that the provider taxes would",58," And then just a little bit of the cleanup on some of the 2011 moving parts. Can you give us any specifics on how much of the headwind healthcare IT is going to be next year? And then just to confirm, I think, I heard you say that the provider taxes would be a $36 million headwind year-over-year?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," I think, actually, the latter one on the provider fee, the amount of the provider fee attributable to 2009 is what I said the most challenging of the care provider fee and that's actually about $27 million of the $64 million. The amount, which is carryin",58," I think, actually, the latter one on the provider fee, the amount of the provider fee attributable to 2009 is what I said the most challenging of the care provider fee and that's actually about $27 million of the $64 million. The amount, which is carrying over to next year from a cash standpoint is about $36 million.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," Any other kind of provider fees or provider tax benefit you're getting this year that you don't expect? So you expect the other $37 million of the $64 million to reoccur again in 2011? Or that you would expect to guide to?",43," Any other kind of provider fees or provider tax benefit you're getting this year that you don't expect? So you expect the other $37 million of the $64 million to reoccur again in 2011? Or that you would expect to guide to?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," Yes, well, what I've said was if you take the California fee, the current year portion of it, will be replaced by in part a half year extension on California, we would expect not yet done, but we would expect that plus $25 million from Pennsylvania and a",72," Yes, well, what I've said was if you take the California fee, the current year portion of it, will be replaced by in part a half year extension on California, we would expect not yet done, but we would expect that plus $25 million from Pennsylvania and also not yet done but in works and the sum of those two, yes, would offset the $37 million of current year California provider fee.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," And then just healthcare IT increase year-over-year?",8," And then just healthcare IT increase year-over-year?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," As I said, it's a little early to say. I think that this year, we've underrun significantly based upon not as occurring as much in a way of start-up costs and also being very efficient in the implementations that we have successfully completed here in th",124," As I said, it's a little early to say. I think that this year, we've underrun significantly based upon not as occurring as much in a way of start-up costs and also being very efficient in the implementations that we have successfully completed here in the last few weeks. So we've got to assess, if you will, what that means with respect to the implementation for next year have or we do have more implementations next year than this year. More hospitals will be in process, so we do expect the number to go up. It's probably in the say low tens of millions kind of number not a radical change in overall profitability associated with it, but we just have to finalize that.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," So is that like $10 million to $30 million or is that $10 million to $15 million?",17," So is that like $10 million to $30 million or is that $10 million to $15 million?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," $10 million to $30 million would be in the low. Low tens is very [indiscernible]. But as I said, it's early yet to put a hard number out there.",29," $10 million to $30 million would be in the low. Low tens is very [indiscernible]. But as I said, it's early yet to put a hard number out there.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator"," Our next question comes from the line of Sheryl Skolnick with CRT Capital Group.",14," Our next question comes from the line of Sheryl Skolnick with CRT Capital Group.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," First, I want to complement you on the extensive diligence you've done on all the key questions that I would have had about the composition of the volume shortfall in trying to get comforted guidance in bridging, where we are from third quarter and the d",131," First, I want to complement you on the extensive diligence you've done on all the key questions that I would have had about the composition of the volume shortfall in trying to get comforted guidance in bridging, where we are from third quarter and the difficulties here versus the fourth quarter and then to 2011. So it's extremely helpful, and I think it was fair to do. But I'm going to turn to sort of a more conceptual question about the fourth quarter guidance if I could. If I take out the provider fee, anticipated impact in fourth quarter, which I believe you said was $64 million, and I look at that -- first of all, would it be correct to assume that, that would drop 100% to the EBITDA line?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," Yes.",1," Yes.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," The answer to that I think is yes. And then second, if that's the case, then your guidance sort of implies something on the order of a quarter to flat on the EBITDA line with third quarter to something that is would be up around the sort of $270 million",130," The answer to that I think is yes. And then second, if that's the case, then your guidance sort of implies something on the order of a quarter to flat on the EBITDA line with third quarter to something that is would be up around the sort of $270 million to $280 million in order to achieve the $10.50 million to $1.1 billion if my math is correct. So if I look at those numbers, I'm still not sure how you get to the upper end of the range. So my question then becomes, what really has to go right for us to be optimistic that you can get back on the path of exceeding not only consensus but achieving the high end of your guidance or even exceeding it?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," I'll try to answer the first batch. Obviously, we've taken cost out. We've talked about that. And if you look at this from adjusted patient-day basis in Q3, our experience was around $2,050. Q3 year-to-date was $1,995. So clearly, Q3 jumped up. Q4, we lo",311," I'll try to answer the first batch. Obviously, we've taken cost out. We've talked about that. And if you look at this from adjusted patient-day basis in Q3, our experience was around $2,050. Q3 year-to-date was $1,995. So clearly, Q3 jumped up. Q4, we look at being back around that $1,995 kind of levels. So based upon the reductions in staff, the improvements we forecast on mid now, severance is not recurring as I talked about some of other initiatives to drive down costs. We think we get back down to that $1,995 kind of level. So it's at the middle of the range. And of course, there's opportunity, they'll beyond with that to help drive towards the end of the range as well. From a revenue standpoint, we've just looked at what's real recent experience on volumes. And as I said, we didn't presume many kind of a hockey stick in the last two months of the year. But from an overall admit standpoint, at the middle of the range, we could be at a negative 4% to 5% and still hit the middle of the range and commercial still be in that 6% to 7% kind of range where we were at for the first half. Once again, be in the middle of the race. So those seem like based on everything we know, still some recent very conservative positions to be taken as we look at the underlying trends. So there's opportunity in my mind for us to do better than those of both on the cost side and on the volume side but as you know, we didn't take up the upper end of the range because we wanted to stay conservative and not presume that we're going to do better than those and left ourselves, I'd say to build a range based on those stats.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," And then with, I think with all of these questions, I think you're getting around the point of just for how long is the pattern we've been seeing in your earnings as well as others, for how long will the cost savings continue to save the day as it were a",117," And then with, I think with all of these questions, I think you're getting around the point of just for how long is the pattern we've been seeing in your earnings as well as others, for how long will the cost savings continue to save the day as it were as volume continues to deteriorate? I mean that's not an issue unique to Tenet. And I guess the answer to that is nobody really knows, but how much more do you have left on the cost? And it seems like you've been doing just about everything you can on that score. You found another 800 FTEs. But at what point do you have to stop doing that?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," Well staff reductions, it's the only place for reducing cost to make our performance initiatives driving cost out and supply cost were basically flat and have very low inflationary rate even with higher acuity. So there is success in our efforts there, a",127," Well staff reductions, it's the only place for reducing cost to make our performance initiatives driving cost out and supply cost were basically flat and have very low inflationary rate even with higher acuity. So there is success in our efforts there, and they'll be continuing in success. But cost is also not the only way we're going to drive value. Even if we don't have increasing inpatient volumes over the near future because we have the outpatient acquisition is driving value. We have our investments in Conifer yield increasing value. The price negotiation, the commercially still favorable, the price on government, pretty much flat. So there's plenty of things we're operating on to create value besides just driving our cost but there's more cost opportunity too.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," I would just add to what Biggs said, Sheryl, opportunity on longer term is the clinical standardization, where we really get in on more and more of the BRGs both inpatient, as well as our outpatient care standardized that, eliminate some redundancy, driv",104," I would just add to what Biggs said, Sheryl, opportunity on longer term is the clinical standardization, where we really get in on more and more of the BRGs both inpatient, as well as our outpatient care standardized that, eliminate some redundancy, drive down that variable costs, and really affect the cost metrics and something outside necessarily of the salary wages and benefits or direct supply cost. We're also working on length of stay. We're working on readmission rates as we look at more was prospective payments. So there are lots of opportunities to drive on the cost side of the equation going forward.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," And just finally, on your commercial Managed Care negotiations, we've begun to see some more, shall we say, innovative almost back to the future kinds of tactics at the Main Street level on the part of some of the Managed Care companies with their relati",177," And just finally, on your commercial Managed Care negotiations, we've begun to see some more, shall we say, innovative almost back to the future kinds of tactics at the Main Street level on the part of some of the Managed Care companies with their relationship with physicians, with restructuring their contract for payment, for example, United with an oncology we've heard about the potential force some of the company's to have more direct even ownership relationship with providers, physicians, hospitals, outpatient, et cetera to have them do the rationing rather than the health plan, but the health plan gets the benefits thereof. But is there anything that you can see in your negotiations with the commercial Managed Care plans that might get more creative i.e., contracting for guaranteed volume within a disease or within a procedure or service lines where you might give a dominant or best quality provider in the market that could assure you some commercial Managed Care share in those markets and help you even to take share rather than just to maintain share?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," So the short answer is, every creative structure that you can imagine and probably more are under discussion. But still, it is today an environment that's all about costs and access and companies obtaining benefits with the sort of least amount of fricti",137," So the short answer is, every creative structure that you can imagine and probably more are under discussion. But still, it is today an environment that's all about costs and access and companies obtaining benefits with the sort of least amount of friction for their employees and all that. But I think, we're well positioned on those creative types of structures because of quality, because of our visibility and ability to understand what it is that we're actually doing in terms of the provision of the service. And then we have this little secret weapon that we've used for decades in California that as of unit that assesses risk and helps us on capitated types of arrangement and serves clients beyond Tenet. And so, I think we're very well positioned when risk-taking enters the question as well.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator"," Our final question comes from the line of A.J. Rice with Susquehanna.",13," Our final question comes from the line of A.J. Rice with Susquehanna.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," First of all, I ask one that's sort of a long shot, but I think, Biggs, you alluded to the idea that people may have been managing their deductibles this year [indiscernible] more aggressively and therefore speculation get into Q4, you might see some pen",89," First of all, I ask one that's sort of a long shot, but I think, Biggs, you alluded to the idea that people may have been managing their deductibles this year [indiscernible] more aggressively and therefore speculation get into Q4, you might see some pent-up demands so as deductibles hit. I guess my question first off would be, you guys have anyway to measure that? Can you see whether people are taking longer to hit their deductibles this year than they did last there or anything along those lines?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," There really isn't any clear way for us to see that. We don't have that kind of visibility as to patient comes in or as we send the bill to the payers, so not great insight.",37," There really isn't any clear way for us to see that. We don't have that kind of visibility as to patient comes in or as we send the bill to the payers, so not great insight.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," I have heard the theories as spouse payers, they have obviously much more insight, but I don't think that evidence at least as I mentioned earlier through the first 28 days of October that, that demand wave was ready to hit the beach.",43," I have heard the theories as spouse payers, they have obviously much more insight, but I don't think that evidence at least as I mentioned earlier through the first 28 days of October that, that demand wave was ready to hit the beach.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," The $100 million to $150 million that acquired outpatient revenues that you're looking for this year, is this year in your mind unusual with the focus on acquiring things like outpatient imaging? Do you think you can run at that rate of acquisitions for",48," The $100 million to $150 million that acquired outpatient revenues that you're looking for this year, is this year in your mind unusual with the focus on acquiring things like outpatient imaging? Do you think you can run at that rate of acquisitions for a couple of years?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," Well, we said we think we can do it for next year. I mean, obviously, we've been very sensitive about doing this, where we have the ability to put the centers within a hospital structure. So you run out of opportunities just geographically over time. But",97," Well, we said we think we can do it for next year. I mean, obviously, we've been very sensitive about doing this, where we have the ability to put the centers within a hospital structure. So you run out of opportunities just geographically over time. But there are other ones where the sellers -- we've seen somewhere the sellers initially said they don't want to sell their price expectation or unrealistic and they're coming back to us now. So that's way we made the comment with respect to 2011. I wouldn't speculate on 2012 at this point.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," I don't think you quantify to how much benefit you get from delaying the merit increase, maybe I missed it if you did for the extra quarters. How much would that benefit you in the fourth quarter? And then if you could just maybe I'm curious, when do you",81," I don't think you quantify to how much benefit you get from delaying the merit increase, maybe I missed it if you did for the extra quarters. How much would that benefit you in the fourth quarter? And then if you could just maybe I'm curious, when do you guys think you would offer -- we're talking around the 2011 outlook a lot, have you given some thoughts exactly when you're likely to actually give a formal outlook for 2011?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," On the benefit of deferral of the merit increases, it's in the neighborhood of $15 million for the quarter. And that would be similar to numbers we've given in the past. And we've talked about what the effect of the merit increases were in the fourth qua",110," On the benefit of deferral of the merit increases, it's in the neighborhood of $15 million for the quarter. And that would be similar to numbers we've given in the past. And we've talked about what the effect of the merit increases were in the fourth quarter when we gave them by example last year? In terms of when we were given outlook, I mean, our baseline is we will look at results, we complete our planning process otherwise in December, we look at results through December ultimately and sort of re-evaluate and validate our expectations based upon that and then give you outlook when we released fourth quarter earnings.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Analysts"," So in February, at some point?",6," So in February, at some point?
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," Yes.",1," Yes.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Executives"," Thanks AJ and thanks, everybody, for joining the call. And see you on the next one.",16," Thanks AJ and thanks, everybody, for joining the call. And see you on the next one.
"
107911,114307236,86586,"Tenet Healthcare Corp., Q3 2010 Earnings Call, Nov 02, 2010",2010-11-02,"Earnings Calls","Tenet Healthcare Corporation","Operator"," Ladies and gentlemen, that concludes today's conference. Thank you for your participation. You may now disconnect. Have a wonderful day.",20," Ladies and gentlemen, that concludes today's conference. Thank you for your participation. You may now disconnect. Have a wonderful day.
 
"
